FUNGICIDAL MIXTURES

Abstract
The present invention relates to fungicidal mixtures comprising, as active components, 1) azolylmethyloxiranes of the general formula I
Description

The present invention relates to pesticidal, in particular fungicidal compositions comprising, as active components,


1) azolylmethyloxiranes of the general formula I




embedded image


in which the variables have the following meanings:

  • A phenyl which is substituted by one F and contains a further substituent L different from Br, where the phenyl may additionally contain one or two substituents L;
  • B phenyl which is unsubstituted or substituted by one, two, three or four identical or different substituents L, where L is as defined below:
    • L is halogen, cyano, nitro, cyanato (OCN), C1-C8-alkyl, C1-C8-haloalkyl, phenyl-C1-C6-alkyloxy, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C4-C10-alkadienyl, C4-C10-haloalkadienyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkylcarbonyloxy, C1-C8-alkylsulfonyloxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocyclo-alkenyl, C3-C8-cycloalkoxy, C3-C6-cycloalkenyloxy, hydroxyimino-C1-C8-alkyl, C1-C6-alkylene, oxy-C2-C4-alkylene, oxy-C1-C3-alkyleneoxy, C1-C8-alkoximino-C1-C8-alkyl, C2-C8-alkenyloximino-C1-C8-alkyl, C2-C8-alkynyl-oximino-C1-C8-alkyl, S(═O)nA1, C(═O)A2, C(═S)A2, NA3A4, phenyl, phenyloxy or a five- or six-membered saturated, partially unsaturated or aromatic heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S; where n, A1, A2, A3, A4 are as defined below:
      • n is 0, 1 or 2;
      • A1 is hydrogen, hydroxyl, C1-C8-alkyl, C1-C8-haloalkyl, amino, C1-C8-alkylamino or di-C1-C8-alkylamino,
      • A2 is one of the groups mentioned for A1 or C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkoxy or C3-C8-halocycloalkoxy;
      • A3,A4 independently of one another are hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl or C3-C8-halocycloalkenyl;
      • where the aliphatic and/or alicyclic and/or aromatic groups of the radical definitions of L for their part may carry one, two, three or four identical or different groups RL:
      • RL is halogen, cyano, nitro, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C1-C8-alkylcarbonyl, C1-C8-alkylcarbonyloxy, C1-C8-alkoxycarbonyl, amino, C1-C8-alkylamino, di-C1-C8-alkylamino;


        D is —S—R, where
    • R is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C(═O)R3, C(═S)R3, SO2R4 or CN; where
    • R3 is C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy or NA3A4; and
    • R4 is C1-C8-alkyl, phenyl-C1-C8-alkyl or phenyl, where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently of one another selected from the group consisting of halogen and C1-C4-alkyl;
    • a group DI




embedded image




    • where A and B are as defined above;

    • a group DII







embedded image




    • where # denotes the point of attachment to the triazolyl ring and Q, R1 and R2 are as defined below:

    • Q is O or S;

    • R1,R2 independently of one another are C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-alkoxy-C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio, C2-C8-alkenylthio, C2-C8-alkynylthio, C3-C8-cycloalkyl, C3-C8-cycloalkylthio, phenyl, phenyl-C1-C4-alkyl, phenoxy, phenylthio, phenyl-C1-C4-alkoxy or NR5R6, where R5 is H or C1-C8-alkyl and R6 is C1-C8-alkyl, phenyl-C1-C4-alkyl or phenyl or R5 and R6 together are an alkylene chain having four or five carbon atoms or form a radical of the formula —CH2—CH2—O—CH2—CH2— or —CH2—CH2—NR7—CH2—CH2— in which R7 is hydrogen or C1-C4-alkyl; where the aromatic groups in the radicals mentioned above are in each case independently of one another unsubstituted or substituted by one, two or three groups selected from the group consisting of halogen and C1-C4-alkyl;

    • or

    • a group SM, where M is as defined below:

    • M is an alkali metal cation, an equivalent of an alkaline earth metal cation, an equivalent of a copper, zinc, iron or nickel cation or an ammonium cation of the formula (E)







embedded image


in which

    • Z1 and Z2 independently are hydrogen or C1-C8-alkyl;
    • Z3 and Z4 independently are hydrogen, C1-C8-alkyl, benzyl or phenyl; where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently selected from the group consisting of halogen and C1-C4-alkyl;


      and agriculturally acceptable salts thereof, and


      2) a compound II, and


      3) optionally a further compound II,


      where the compounds II of components 2 and 3 independently of one another are selected from the group consisting of the compounds below, with the proviso that components 2 and 3 are not identical:


      A) strobilurins:
    • azoxystrobin, dimoxystrobin, coumoxystrobin, coumethoxystrobin, enestroburin, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin, pyraclostrobin, pyrametostrobin, pyraoxystrobin, pyribencarb, trifloxystrobin, 2-(2-(6-(3-chloro-2-methylphenoxy)-5-fluoropyrimidin-4-yloxy)phenyl)-2-methoxyimino-N-methylacetamide, methyl 2-(ortho-((2,5-dimethylphenyloxymethylene)phenyl)-3-methoxyacrylate, methyl 3-methoxy-2-(2-(N-(4-methoxyphenyl)-cyclopropanecarboximidoylsulfanylmethyl)phenyl)acrylate, 2-(2-(3-(2,6-dichloro-phenyl)-1-methylallylideneaminooxymethyl)phenyl)-2-methoxyimino-N-methyl-acetamide;


      B) carboxamides:
    • carboxanilides: benalaxyl, benalaxyl-M, benodanil, bixafen, boscalid, carboxin, fen-furam, fenhexamid, flutolanil, furametpyr, isopyrazam, isotianil, kiralaxyl, mepronil, metalaxyl, metalaxyl-M (mefenoxam), ofurace, oxadixyl, oxycarboxin, penthiopyrad, sedaxane, tecloftalam, thifluzamide, tiadinil, 2-amino-4-methylthiazole-5-carboxanilide, 2-chloro-N-(1,1,3-trimethylindan-4-yl)nicotinamide, N-(3′,4′,5′-tri-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide, N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carbox-amide, N-(2-(1,3-dimethylbutyl)phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carbox-amide (penflufen), N-(2-(1,3,3-trimethylbutyl)phenyl)-1,3-dimethyl-5-fluoro-1H-pyrazole-4-carboxamide;
    • carboxylic acid morpholides: dimethomorph, flumorph, pyrimorph;
    • benzamides: flumetover, fluopicolide, fluopyram, zoxamide, N-(3-ethyl-3,5,5-tri-methylcyclohexyl)-3-formylamino-2-hydroxybenzamide;
    • other carboxamides: carpropamid, diclocymet, mandipropamid, oxytetracyclin, silthiofam, N-(6-methoxypyridin-3-yl)cyclopropanecarboxamide;


      C) azoles:
    • triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, difenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenconazole, ipconazole, metconazole, myclobutanil, oxpoconazole, paclobutrazole, penconazole, propiconazole, prothioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1-(4-chlorophenyl)-2-([1,2,4]triazol-1-yl)cycloheptanol;
    • imidazoles: cyazofamid, imazalil, imazalil sulfate, pefurazoate, prochloraz, triflumizole;
    • benzimidazoles: benomyl, carbendazim, fuberidazole, thiabendazole;
    • others: ethaboxam, etridiazole, hymexazole, 2-(4-chlorophenyl)-N-[4-(3,4-dimethoxyphenyl)isoxazol-5-yl]-2-prop-2-ynyloxyacetamide;


      D) nitrogenous heterocyclyl compounds
    • pyridines: fluazinam, pyrifenox, 3-[5-(4-chlorophenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine, 3-[5-(4-methylphenyl)-2,3-dimethylisoxazolidin-3-yl]pyridine, 2,3,5,6-tetra-chloro-4-methanesulfonylpyridine, 3,4,5-trichloropyridine-2,6-dicarbonitrile, N-(1-(5-bromo-3-chloropyridin-2-yl)ethyl)-2,4-dichloronicotinamide, N-((5-bromo-3-chloro-pyridin-2-yl)methyl)-2,4-dichloronicotinamide;
    • pyrimidines: bupirimate, cyprodinil, diflumetorim, fenarimol, ferimzone, mepanipyrim, nitrapyrin, nuarimol, pyrimethanil;
    • piperazines: triforine;
    • pyrroles: fludioxonil, fenpiclonil;
    • morpholines: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph;
    • piperidines: fenpropidin;
    • dicarboximides: fluoroimide, iprodione, procymidone, vinclozolin;
    • nonaromatic 5-membered heterocycles: famoxadone, fenamidone, flutianil, octhilinone, probenazole, S-allyl 5-amino-2-isopropyl-3-oxo-4-ortho-tolyl-2,3-dihydropyrazole-1-thiocarboxylate;
    • others: acibenzolar-S-methyl, amisulbrom, anilazine, blasticidin-S, captafol, captan, chinomethionat, dazomet, debacarb, diclomezine, difenzoquat, difenzoquat-methylsulfate, fenoxanil, folpet, oxolinic acid, piperalin, proquinazid, pyroquilon, quin-oxyfen, triazoxide, tricyclazole, 2-butoxy-6-iodo-3-propylchromen-4-one, 5-chloro-1-(4,6-dimethoxypyrimidin-2-yl)-2-methyl-1H-benzoimidazole, 5-chloro-7-(4-methyl-piperidin-1-yl)-6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo[1,5-a]pyrimidine, 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine;


      E) carbamates and dithiocarbamates
    • thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, methasulfocarb, metiram, propineb, thiram, zineb, ziram;
    • carbamates: diethofencarb, benthiavalicarb, iprovalicarb, propamocarb, propamocarb hydrochloride, valiphenal, 4-fluorophenyl N-(1-(1-(4-cyanophenyl)ethanesulfonyl)but-2-yl)carbamate;


      F) other fungicides
    • guanidines: dodine, dodine free base, guazatine, guazatine acetate, iminoctadine, iminoctadine triacetate, iminoctadine tris(albesilate);
    • antibiotics: kasugamycin, kasugamycin hydrochloride hydrate, polyoxins, streptomycin, validamycin A;
    • nitrophenyl derivatives: binapacryl, dicloran, dinobuton, dinocap, nitrothal isopropyl, tecnazene;
    • organometallic compounds: fentin salts, such as, for example, fentin acetate, fentin chloride, fentin hydroxide;
    • sulfur-containing heterocyclyl compounds: dithianon, isoprothiolane;
    • organophosphorus compounds: edifenphos, fosetyl, fosetyl aluminum, iprobenfos, phosphorous acid and its salts, pyrazophos, tolclofos-methyl;
    • organochlorine compounds: chlorothalonil, dichlofluanid, dichlorophen, flusulfamide, hexachlorobenzene, pencycuron, pentachlorophenol and its salts, phthalide, quintozene, thiophanate methyl, tolylfluanid, N-(4-chloro-2-nitrophenyl)-N-ethyl-4-methylbenzenesulfonamide;
    • inorganic active compounds: phosphorous acid and its salts, Bordeaux mixture, copper salts, such as, for example, copper acetate, copper hydroxide, copper oxy-chloride, basic copper sulfate, sulfur;
    • others: biphenyl, bronopol, cyflufenamid, cymoxanil, diphenylamine, metrafenone, pyriofenone, mildiomycin, oxine-copper, prohexadione-calcium, spiroxamine, tolylfluanid, N-(cyclopropylmethoxyimino-(6-difluoromethoxy-2,3-difluorophenyl)methyl)-2-phenylacetamide, N′-(4-(4-chloro-3-trifluoromethylphenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methylformamidine, N′-(4-(4-fluoro-3-trifluoromethylphenoxy)-2,5-dimethylphenyl)-N-ethyl-N-methylformamidine, N′-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanylpropoxy)phenyl)-N-ethyl-N-methylformamidine, N′-(5-difluoromethyl-2-methyl-4-(3-trimethyl-silanylpropoxy)phenyl)-N-ethyl-N-methylformamidine, methyl N-(1,2,3,4-tetra-hydronaphthalen-1-yl)-2-{1-[2-(5-methyl-3-trifluoromethylpyrazol-1-yl)acetyl]piperidin-4-yl}thiazole-4-carboxamide, methyl (R)—N-(1,2,3,4-tetrahydronaphthalen-1-yl)-2-{1-[2-(5-methyl-3-trifluoromethylpyrazol-1-yl)acetyl]piperidin-4-yl}thiazole-4-carboxamide, 6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl acetate, 6-tert-butyl-8-fluoro-2,3-dimethylquinolin-4-yl methoxyacetate, N-methyl-2-{1-[2-(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)acetyl]piperidin-4-yl}-N-[(1R)-1,2,3,4-tetrahydro-naphthalen-1-yl]-4-thiazolecarboxamide;


      G) growth regulators


      abscisic acid, amidochlor, ancymidol, 6-benzylaminopurine, brassinolide, butralin, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipin, 2,6-dimethylpuridine, ethephon, flumetralin, flurprimidol, fluthiacet, forchlorfenuron, gibberellic acid, inabenfid, indole-3-acetic acid, maleic hydrazide, mefluidide, mepiquat (mepiquat chloride), metconazole, naphthalene acetic acid, N-6-benzyladenine, paclobutrazole, prohexadione (prohexadione-calcium), prohydrojasmon, thidiazuron, triapenthenol, tributyl phosphorotrithioate, 2,3,5-triiodobenzoic acid, trinexapac-ethyl and uniconazole;


      H) herbicides
    • acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamid, flufenacet, mefenacet, metolachlor, metazachlor, napropamide, naproanilide, pethoxamid, pretilachlor, propachlor, thenylchlor;
    • amino acid analogs: bilanafos, glyphosate, glufosinate, sulfosate;
    • aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxyfop, metamifop, propaquizafop, quizalofop, quizalofop-p-tefuryl;
    • bipyridyls: diquat, paraquat;
    • carbamates and thiocarbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPIC), esprocarb, molinate, orbencarb, phenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;
    • cyclohexanediones: butroxydim, clethodim, cycloxydim, profoxydim, sethoxydim, tepraloxydim, tralkoxydim;
    • dinitroanilines: benfluralin, ethalfluralin, oryzalin, pendimethalin, prodiamine, trifluralin;


diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyfen, fomesafen, lactofen, oxyfluorfen;

    • hydroxybenzonitriles: bromoxynil, dichlobenil, ioxynil;
    • imidazolinones: imazamethabenz, imazamox, imazapic, imazapyr, imazaquin, imazethapyr;
    • phenoxyacetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, mecoprop;
    • pyrazines: chloridazon, flufenpyr-ethyl, fluthiacet, norflurazone, pyridate;
    • pyridines: aminopyralid, clopyralid, diflufenican, dithiopyr, fluridone, fluoroxypyr, picloram, picolinafen, thiazopyr;
    • sulfonylureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethoxysulfuron, flazasulfuron, fluce-tosulfuron, flupyrsulfuron, foramsulfuron, halosulfuron, imazosulfuron, iodosulfuron, mesosulfuron, metsulfuron-methyl, nicosulfuron, oxasulfuron, primisulfuron, prosul-furon, pyrazosulfuron, rimsulfuron, sulfometuron, sulfosulfuron, thifensulfuron, tria-sulfuron, tribenuron, trifloxysulfuron, triflusulfuron, tritosulfuron, 1-((2-chloro-6-propyl-imidazo[1,2-b]pyridazin-3-yl)sulfonyl)-3-(4,6-dimethoxypyrimidin-2-yl)urea;
    • triazines: ametryn, atrazine, cyanazine, dimethametryn, ethiozine, hexazinone, meta-mitron, metribuzin, prometryn, simazine, terbuthylazine, terbutryn, triaziflam;
    • ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, methabenzthiazuron, tebuthiuron;
    • other inhibitors of acetolactate synthase: bispyribac-sodium, cloransulam-methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortho-sulfamuron, penoxsulam, propoxycarbazone, pyribambenz-propyl, pyribenzoxim, pyriftalid, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyroxasulfone, pyroxsulam;
    • others: amicarbazone, aminotriazole, anilofos, beflubutamid, benazolin, bencarbazone, benfluresate, benzofenap, bentazone, benzobicyclon, bromacil, bromobutide, butafenacil, butamifos, cafenstrole, carfentrazone, cinidon-ethlyl, chlorthal, cinmethylin, clomazone, cumyluron, cyprosulfamide, dicamba, difenzoquat, diflufenzopyr, Drechslera monoceras, endothal, ethofumesate, etobenzanid, fentrazamide, flumiclorac-pentyl, flumioxazin, flupoxam, fluorochloridone, flurtamone, indanofan, isoxaben, isoxaflutole, lenacil, propanil, propyzamide, quinclorac, quinmerac, mesotrione, methylarsenic acid, naptalam, oxadiargyl, oxadiazon, oxaziclomefone, pentoxazone, pinoxaden, pyraclonil, pyraflufen-ethyl, pyrasulfotol, pyrazoxyfen, pyrazolynate, quinoclamine, saflufenacil, sulcotrione, sulfentrazone, terbacil, tefuryltrione, tembotrione, thiencarbazone, topramezone, 4-hydroxy-3-[2-(2-methoxyethoxymethyl)-6-trifluoromethylpyridine-3-carbonyl]bicyclo[3.2.1]oct-3-en-2-one, ethyl (3-[2-chloro-4-fluoro-5-(3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl)phenoxy]pyridin-2-yloxy)acetate, methyl 6-amino-5-chloro-2-cyclopropylpyrimidine-4-carboxylate, 6-chloro-3-(2-cyclopropyl-6-methylphenoxy)-pyridazin-4-ol, 4-amino-3-chloro-6-(4-chlorophenyl)-5-fluoropyridine-2-carboxylic acid, methyl 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylate and methyl 4-amino-3-chloro-6-(4-chloro-3-dimethylamino-2-fluorophenyl)pyridine-2-carboxylate;


      I) insecticides
    • organo(thio)phosphates: acephate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyrifos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophos, methidathion, methyl-parathion, mevinphos, monocrotophos, oxydemeton-methyl, paraoxon, parathion, phenthoate, phosalone, phosmet, phosphamidon, phorate, phoxim, pirimiphos-methyl, profenofos, prothiofos, sulprophos, tetrachlorvinphos, terbufos, triazophos, trichlorfon;
    • carbamates: alanycarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, fenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pirimicarb, propoxur, thiodicarb, triazamate;
    • pyrethroids: allethrin, betacyfluthrin, bifenthrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, imiprothrin, lambda-cyhalothrin, permethrin, prallethrin, pyrethrin I and II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralomethrin, transfluthrin, profluthrin, dimefluthrin,
    • inhibitors of insect growth: a) chitin synthesis inhibitors: benzoylureas: chlorfluazuron, cyromazine, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexythiazox, etoxazole, clofentazin; b) ecdysone antagonists: halofenozide, methoxyfenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, fenoxycarb; d) lipid biosynthesis inhibitors: spirodiclofen, spiromesifen, spirotetramate;
    • nicotine receptor agonists/antagonists: clothianidin, dinotefuran, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1-(2-chlorothiazol-5-ylmethyl)-2-nitrimino-3,5-dimethyl-[1,3,5]triazinane;
    • GABA antagonists: endosulfan, ethiprol, fipronil, vaniliprol, pyrafluprol, pyriprol, 5-amino-1-(2,6-dichloro-4-methylphenyl)-4-sulfinamoyl-1H-pyrazole-3-thiocarboxamide;
    • macrocyclic lactones: abamectin, emamectin, milbemectin, lepimectin, spinosad, spinetoram;
    • mitochondrial electron transport chain inhibitor (METI) I acaricides: fenazaquin, pyridaben, tebufenpyrad, tolfenpyrad, flufenerim;
    • METI Hand III substances: acequinocyl, fluacyprim, hydramethylnon;
    • decouplers: chlorfenapyr;
    • inhibitors of oxidative phosphorylation: cyhexatin, diafenthiuron, fenbutatin oxide, propargite;
    • insect molting inhibitors: cryomazine;
    • mixed function oxidase inhibitors: piperonyl butoxide;
    • sodium channel blockers: indoxacarb, metaflumizone;
    • others: benclothiaz, bifenazate, cartap, flonicamid, pyridalyl, pymetrozine, sulfur, thiocyclam, flubendiamid, chlorantraniliprol, cyazypyr (HGW86); cyenopyrafen, flupyrazofos, cyflumetofen, amidoflumet, imicyafos, bistrifluoron, and pyrifluquinazon, [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-(cyclopropanecarbonyloxy)-6,12-dihydroxy-4,6a,12b-trimethyl-II-oxo-9-(pyridin-3-yl)-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-11H,12H-benzo[f]pyrano[4,3-b]chromen-4-yl]methyl cyclopropanecarboxylate,


      in a synergistically effective amount.


The invention furthermore relates to compositions in which component 2) is defined as follows:

    • biological products for controlling fungi, plant strengthening products: Ampelomyces quisqualis (for example the product AQ 10® from Intrachem Bio GmbH & Co. KG, Germany), Aspergillus flavus (for example the product AFLAGUARD® from Syngenta, Switzerland), Aureobasidium pullulans (for example the product BOTECTOR® from bio-ferm GmbH, Germany), Bacillus pumilus (for example strain NRRL No. B-30087 in SONATA® and BALLAD® Plus from AgraQuest Inc., USA), Bacillus subtilis (for example strain NRRL No. B-21661 in RHAPSODY®, SERENADE® MAX and SERENADE® ASO from AgraQuest Inc., USA), Bacillus subtilis var. amyloliquefaciens FZB24 (for example the product TAEGRO® from Novozyme Biologicals, Inc., USA), Candida oleophila 1-82 (for example the product ASPIRE® from Ecogen Inc., USA), Candida saitoana (for example the products BIOCURE® (as a mixture with Lysozym) and BIOCOAT® from Micro Flo Company, USA (BASF SE) and Arysta), Chitosan (for example ARMOUR-ZEN from BotriZen Ltd., New Zealand), Clonostachys rosea f. catenulata, also referred to as Gliocladium catenulatum (for example strain J1446: PRESTOP® from Verdera, Finland), Coniothyrium minitans (for example the product CONTANS® from Prophyta, Germany), Cryphonectria parasitica (for example the product Endothia parasitica from CNICM, France), Cryptococcus albidus (for example the product YIELD PLUS® from Anchor Bio-Technologies, South Africa), Fusarium oxysporum (for example the products BIOFOX® from S.I.A.P.A., Italy, and FUSACLEAN® from Natural Plant Protection, France), Metschnikowia fructicola (for example the product SHEMER® from Agrogreen, Israel), Microdochium dimerum (for example the product ANTIBOT® from Agrauxine, France), Phlebiopsis gigantea (for example the product ROTSOP® from Verdera, Finland), Pseudozyma flocculosa (for example the product SPORODEX® from Plant Products Co. Ltd., Canada), Pythium oligandrum DV74 (for example the product POLYVERSUM® from Remeslo SSRO, Biopreparaty, Czech Republic), Reynoutria sachlinensis (for example the product REGALIA® from Marrone Biolnnovations, USA), Talaromyces flavus V117b (for example the product PROTUS® from Prophyta, Germany), Trichoderma asperellum SKT-1 (for example the product ECO-HOPE® from Kumiai Chemical Industry Co., Ltd., Japan), T. atroviride LC52 (for example the product SENTINEL® from Agrimm Technologies Ltd, New Zealand), T. harzianum T-22 (for example the product PLANTSHIELD® from BioWorks Inc., USA), T. harzianum TH 35 (for example the product ROOT PRO® from Mycontrol Ltd., Israel), T. harzianum T-39 (for example the products TRICHODEX® and TRICHODERMA 2000® from Mycontrol Ltd., Israel, and Makhteshim Ltd., Israel), T. harzianum and T. viride (for example the product TRICHOPEL from Agrimm Technologies Ltd, New Zealand), T. harzianum ICC012 and T. viride ICC080 (for example the product REMEDIER® WP from Isagro Ricerca, Italy), T. polysporum and T. harzianum (for example the product BINAB® from BINAB Bio-Innovation AB, Sweden), T. stromaticum (for example the product TRICOVAB® from C.E.P.L.A.C., Brazil), T. virens GL-21 (for example the product SOILGARD® from Certis LLC, USA), T. viride (for example the products TRIECO® from Ecosense Labs. (India) Pvt. Ltd., India, and BIO-CURE® F from T. Stanes & Co. Ltd., India), T. viride TV1 (for example the prdouct T. viride TV1 from Agribiotec srl, Italy), Ulocladium oudemansii HRU3 (for example the product BOTRY-ZEN® from Botry-Zen Ltd, New Zealand); where components 1) and 2) are present in a synergistically effective amount.


In addition to the three components mentioned above, the mixtures according to the invention may also comprise at least one further compound II as additional components (for example component 4 or components 4 and 5), where the compound II of the additional components (for example component 4 or components 4 and 5) is selected from the compounds of groups A) to I) mentioned above, with the proviso that all components are different from one another.


The present invention relates in particular to synergistic mixtures which, in addition to the 3 components defined above, comprise a further compound II as 4th component, where this component 4 is selected from the compounds of groups A) to I) defined above, with the proviso that components 2, 3 and 4 are different from one another. The invention furthermore relates to the use of the fungicidal mixtures for controlling phytopathogenic fungi and preparations or compositions comprising them. The invention furthermore also relates to seed comprising the fungicidal mixtures. The invention furthermore also relates to methods for controlling phytopathogenic fungi wherein the fungi or the materials, plants, the soil or seed to be protected from fungal attack are treated with an effective amount of a fungicidal mixture according to the invention. The invention furthermore also relates to processes for preparing the mixtures according to the invention.


The invention relates in particular to fungicidal mixtures comprising


1) azolylmethyloxiranes of the general formula I as described above


and


2) a compound II,


where the compound II of component 2 is selected from the compounds of groups A to I as described above,


in a synergistically effective amount.


The invention relates in particular to fungicidal mixtures comprising


1) azolylmethyloxiranes of the general formula I as described above


and


2) a compound II, and


3) a further compound II,


where the compounds II of components 2 and 3 independently of one another are selected from the compounds of groups A to I as described above, with the proviso that component 2 and component 3 are not identical,


in a synergistically effective amount.


The invention relates in particular also to fungicidal mixtures comprising


1) azolylmethyloxiranes of the general formula I as described above


and


2) a compound II, and


3) a further compound II, and


4) a further compound II,


where the compounds II of components 2, 3 and 4 independently of one another are selected from the compounds of groups A to I as described above, with the proviso that components 2, 3 and 4 are not identical,


in a synergistically effective amount.


The mixtures comprising at least one compound of the formula I (component 1) and at least one further active compound II (component 2 and optional component 3) are the mixtures according to the invention. The mixtures according to the invention are preferably binary mixtures, particularly preferably ternary mixtures.


Mixtures according to the invention are furthermore mixtures comprising at least one compound of the formula I (component 1) and three further independently selected, different active compounds II (components 2, 3 and 4).


Azolylmethyloxiranes of component 1, their preparation and their use in crop protection are known from WO 2009/077443 (PCT/EP2008/067394), which also mentions certain mixtures of the azolylmethyloxiranes of component 1 with other active compounds. Azolylmethyloxiranes of the general formula I are the compounds I according to the invention.


The active compounds mentioned as component 2 and 3 and 4 or as “further active compound” above (compounds II), their preparation and their action against harmful fungi are known (cf.: http://www.alanwood.net/pesticides/); they are available commercially. The compounds with IUPAC nomenclature, their preparation, and their fungicidal activity are likewise known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; U.S. Pat. No. 3,296,272; U.S. Pat. No. 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624).


With a view to reducing the application rates and broadening the activity spectrum of the known compounds, it was an object of the present invention to provide mixtures which, at a reduced total amount of active compounds applied, show improved activity against harmful fungi, in particular for certain indications.


Accordingly we have found the mixtures defined at the outset. The present invention relates in particular also to fungicidal compositions which comprise at least one compound of the general formula I and at least one further fungicidally active compound (component 2 and optional component 3), for example one or more, for example 1 or 2, active compounds of groups A to I mentioned above and, if appropriate, one or more agriculturally suitable carriers. The present invention furthermore also relates to fungicidal compositions which comprise at least one compound of the general formula I and at least three further fungicidally active compounds (components 2, 3 and 4) of groups A to I mentioned above and, if appropriate, one or more agriculturally suitable carriers. Moreover, it has been found that simultaneous, that is joint or separate, application of compound I and one or more compounds II, or compound I and compound(s) II applied in succession, allows better control of harmful fungi than with the individual compounds (synergistic mixtures). As mentioned above, these mixtures are of interest with a view to reducing the application rates, since many show, at a reduced total amount of active compounds applied, an improved activity against harmful fungi, in particular for certain indications. Simultaneous, that is joint or separate, application of compound I and one or more compounds II can increase the fungicidal activity in a superadditive manner.


In the sense of the present application, joint application means that at least one compound I and the at least one further active compound II are present simultaneously at the site of action (i.e. the plant-damaging fungi to be controlled and their habitat, such as infected plants, plant propagation materials, in particular seed, soils, materials or spaces and also the plants, plant propagation materials, in particular seed, soils, materials or spaces to be protected against fungal attack) in an amount sufficient for an effective control of fungal growth. This can be achieved by applying the compounds I and at least one further active compound II jointly in a joint active compound preparation or in at least two separate active compound preparations simultaneously, or by applying the active compounds successively to the site of action, the time interval between the individual active compound applications being chosen such that the active compound applied first is, at the time of application of the further active compound(s), present at the site of action in a sufficient amount. The order in which the active compounds are applied is of minor importance.


In a preferred embodiment, the mixtures are binary mixtures, i.e. compositions according to the invention comprising one compound I and one further active compound II (component 2), for example one active compound from groups A) to I). Here, the weight ratio of compound I to further active compound II depends on the properties of the active compounds in question; usually, it is in the range of from 1:100 to 100:1, frequently in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, particularly preferably in the range of from 1:10 to 10:1, in particular in the range of from 1:3 to 3:1. It may also be preferable for the weight ratio to be in the range of from 1:2 to 2:1.


In a further preferred embodiment, the mixtures are ternary mixtures, i.e. compositions according to the invention comprising one compound I and one 1st further active compound (component 2) and one 2nd further active compound (component 3), for example two different active compounds from groups A) to I). Here, the weight ratio of compound I to the 1st further active compound (component 2) depends on the properties of the active compounds in question; preferably, it is in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of compound I to the 2nd further active compound (component 3) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of 1st further active compound (component 2) to 2nd further active compound (component 3) is preferably in the range of from 1:100 to 100:1, frequently in the range of from 1:50 to 50:1, preferably in the range of from 1:20 to 20:1, and in particular in the range of from 1:10 to 10:1. It may be preferable for the weight to be in the range of from 1:3 to 3:1, in particular from 1:2 to 2:1.


In a further preferred embodiment, the mixtures are quarternary mixtures, i.e. compositions according to the invention comprising one compound I and one 1st further active compound II (component 2), one 2nd further active compound II (component 3) and one 3rd further active compounds (component 4), where these three active compounds II are different active compounds independently selected from groups A) to I). Here, the weight ratio of compound I to the 1st further active compound (component 2) depends on the properties of the active compounds in question; preferably, it is in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of compound I to the 2nd further active compound (component 3) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of compound I to the 3rd further active compound (component 4) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of 1st further active compound (component 2) to 2nd further active compound (component 3) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 2:10 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of 1st further active compound (component 2) to 3rd further active compound (component 4) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1 and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1. The weight ratio of 2nd further active compound (component 3) to 3rd further active compound (component 4) is preferably in the range of from 1:100 to 100:1, preferably in the range of from 1:50 to 50:1, and in particular in the range of from 1:20 to 20:1. It may be preferable for the weight ratio to be in the region of from 1:10 to 10:1, preferably from 1:3 to 3:1, in particular from 1:2 to 2:1.


The components of the composition according to the invention can be packaged and used individually or as a ready-mix or as a kit of parts.


In one embodiment of the invention, the kits may comprise one or more, and even all, components which may be used for preparing an agrochemical composition according to the invention. For example, these kits may comprise one or more fungicide components and/or an adjuvant component and/or an insecticide component and/or a growth regulator component and/or a herbicide. One or more components may be present combined or preformulated with one another. In the embodiments where more than two components are provided in a kit, the components can be present combined with one another and packaged in a single container, such as a vessel, a bottle, a tin, a bag, a sack or a canister. In other embodiments, two or more components of a kit may be packaged separately, i.e. not preformulated or mixed. Kits may comprise one or more separate containers, such as vessels, bottles, tins, bags, sacks or canisters, each container comprising a separate component of the agrochemical composition. The components of the composition according to the invention can be packaged and used individually or as a ready-mix or as a kit of parts. In both forms, a component may be used separately or together with the other components or as a part of a kit of parts according to the invention for preparing the mixture according to the invention.


The user uses the composition according to the invention usually for use in a predosage device, a knapsack sprayer, a spray tank or a spray plane. Here, the agrochemical composition is diluted with water and/or buffer to the desired application concentration, with further auxiliaries being added, if appropriate, thus giving the ready-to-use spray liquor or the agrochemical composition according to the invention. Usually, from 50 to 500 liters of the ready-to-use spray liquor are applied per hectare of agricultural utilized area, preferably from 100 to 400 liters.


According to one embodiment, the user may himself mix individual components, such as, for example, parts of a kit or a two- or three-component mixture of the composition according to the invention in a spray tank and, if appropriate, add further auxiliaries (tank mix).


In a further embodiment, the user may mix both individual components of the composition according to the invention and partially pre-mixed components, for example components comprising compounds I and/or active compounds from groups A) to I), in a spray tank and, if appropriate, add further auxiliaries (tank mix).


In a further embodiment, the user may use both individual components of the composition according to the invention and partially pre-mixed components, for example components comprising compounds I and/or active compounds from groups A) to I), jointly (for example as a tank mix) or in succession.


The compounds of the formula I can be present in the “thiol” form of the formula Ia or in the “thiono” form of the formula Ib:




embedded image


in which D* is:

    • R, where R has the meaning defined above;
    • a group DII*




embedded image




    • where # is the point of attachment to the sulfur atom in formula Ia or the azolyl ring in formula Ib and Q, R1 and R2 have the meaning defined above; or

    • a group M, where M has the meaning defined above, and in which the remaining substituents have the meaning defined above.





In particular, the tautomeric forms Ia and Ib are present when D* represents hydrogen. Here, for the sake of simplicity, in each case only one of the two forms, in general the “thiol” form is shown.


Owing to the basic character of their nitrogen atoms, the compounds I are capable of forming salts or adducts with inorganic or organic acids or with metal ions. This also applies to most of the precursors described herein of compounds I, the salts and adducts of which are also provided by the present invention.


Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, carbonic acid, sulfuric acid, phosphoric acid and nitric acid.


Suitable organic acids are, for example, formic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid and other arylcarboxylic acids, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight-chain or branched alkyl radicals of 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl, which carry one or two sulfonic acid groups), alkylphosphonic acids (phosphonic acids having straight-chain or branched alkyl radicals with 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids (aromatic radicals, such as phenyl and naphthyl, which carry one or two phosphoric acid radicals), where the alkyl or aryl radicals may carry further substituents, for example p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid etc.


Suitable metal ions are in particular the ions of the elements of the second main group, in particular calcium and magnesium, of the third and fourth main group, in particular aluminum, tin and lead, and also of the elements of transition groups one to eight, in particular chromium, manganese, iron, cobalt, nickel, copper, zinc, and others. Particular preference is given to the metal ions of the elements of transition groups of the fourth period. The metals can be present in the various valencies that they can assume.


The compounds I comprise chiral centers and are generally obtained in the form of racemates or as diastereomer mixtures of erythro and threo forms. The erythro and threo diastereomers of the compounds according to the invention can be separated and isolated in pure form, for example, on the basis of their different solubilities or by column chromatography. Using known methods, such uniform pairs of diastereomers can be used to obtain uniform enantiomers. Suitable for use as antimicrobial agents are both the uniform diastereomers or enantiomers and mixtures thereof obtained in the synthesis. This applies correspondingly to the fungicidal compositions.


Accordingly, the invention provides both mixtures in which compound I is the pure enantiomers or diastereomers and mixtures thereof. This applies to the mixtures according to the invention of the compounds of the formula I. The scope of the present invention includes in particular the (R) and (S) isomer mixtures and the racemates of the compounds I which have centers of chirality. Suitable compounds I also comprise all possible stereoisomers (cis/trans isomers) and mixtures thereof.


The compounds of the formula I according to the invention can be prepared by various routes analogously to prior art processes known per se (see, for example, the prior art cited at the outset and Pflanzenschutz-Nachrichten Bayer 57/2004, 2, pages 145-162), or as described in WO 2009/077443 (PCT/EP2008/067394).


In some of the definitions of the symbols in the formulae given herein, collective terms are used which are generally representative of the following substituents:


halogen: fluorine, chlorine, bromine and iodine;


alkyl and the alkyl moieties of composite groups such as, for example, alkylamino: saturated straight-chain or branched hydrocarbon radicals having 1 to 4, 6, 8 or 12 carbon atoms, for example C1-C6-alkyl, such as methyl, ethyl, propyl, 1-methylethyl, butyl, 1-methylpropyl, 2-methylpropyl, 1,1-dimethylethyl, pentyl, 1-methylbutyl, 2-me-thylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methyl pentyl, 2-methylpentyl, 3-methyl pentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dime-thylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethyl butyl, 1,1,2-trimethylpropyl, 1,2,2-tri-methylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl;


haloalkyl: alkyl as mentioned above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above; in particular C1-C2-haloalkyl, such as chloromethyl, bromomethyl, dichloromethyl, trichloromethyl, fluoromethyl, difluoromethyl, trifluoromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, 1-chloroethyl, 1-bromoethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 2,2,2-trichloroethyl, pentafluoroethyl or 1,1,1-trifluoroprop-2-yl;


alkenyl and also the alkenyl moieties in composite groups, such as alkenyloxy: unsaturated straight-chain or branched hydrocarbon radicals having 2 to 4, 2 to 6 or 2 to 8 carbon atoms and one double bond in any position. According to the invention, it may be preferred to use small alkenyl groups, such as (C2-C4)-alkenyl; on the other hand, it may also be preferred to employ larger alkenyl groups, such as (C5-C8)-alkenyl. Examples of alkenyl groups are, for example, C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl and 1-ethyl-2-methyl-2-propenyl;


haloalkenyl: alkenyl as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine;


alkadienyl: unsaturated straight-chain or branched hydrocarbon radicals having 4 to 6 or 4 to 8 carbon atoms and two double bonds in any position;


alkynyl and the alkynyl moieties in composite groups: straight-chain or branched hydrocarbon groups having 2 to 4, 2 to 6 or 2 to 8 carbon atoms and one or two triple bonds in any position, for example C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl and 1-ethyl-1-methyl-2-propynyl;


haloalkynyl: alkoxy as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine;


cycloalkyl and also the cycloalkyl moieties in composite groups: mono- or bicyclic saturated hydrocarbon groups having 3 to 8, in particular 3 to 6, carbon ring members, for example C3-C6-cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl;


halocycloalkyl: cycloalkyl as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine;


cycloalkenyl: monocyclic monounsaturated hydrocarbon groups having preferably 3 to 8 or 4 to 6, in particular 5 to 6, carbon ring members, such as cyclopenten-1-yl, cyclopenten-3-yl, cyclohexen-1-yl, cyclohexen-3-yl, cyclohexen-4-yl and the like;


halocycloalkenyl: cycloalkenyl as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine;


alkoxy: an alkyl group as defined above which is attached via an oxygen, preferably having 1 to 8, more preferably 2 to 6, carbon atoms. Examples are: methoxy, ethoxy, n-propoxy, 1-methylethoxy, butoxy, 1-methylpropoxy, 2-methylpropoxy or 1,1-dimethylethoxy, and also, for example, pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy;


haloalkoxy: alkoxy as defined above, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as described above under haloalkyl, in particular by fluorine, chlorine or bromine. Examples are OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoro-methoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, OC2F5, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2—C2F5, OCF2—C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy, 1-(CH2Br)-2-bromoethoxy, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy; and also 5-fluoropentoxy, 5-chloropentoxy, 5-bromopentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy;


alkylene: divalent unbranched chains of CH2 groups. Preference is given to (C1-C6)-alkylene, more preference to (C2-C4)-alkylene; furthermore, it may be preferred to use (C1-C3)-alkylene groups. Examples of preferred alkylene radicals are CH2, CH2CH2, CH2CH2CH2, CH2(CH2)2CH2, CH2(CH2)3CH2 and CH2(CH2)4CH2;


a 3-, 4-, 5-, 6-, 7-, 8-, 9- or 10-membered saturated or partially unsaturated heterocycle which contains 1, 2, 3 or 4 heteroatoms from the group consisting of O, N and S, where the heterocycle in question may be attached via a carbon atom or, if present, via a nitrogen atom. According to the invention, it may be preferred for the heterocycle in question to be attached via carbon; on the other hand, it may also be preferred for the heterocycle to be attached via nitrogen. In particular:

    • a three- or four-membered saturated heterocycle (hereinbelow also referred to as heterocyclyl) which contains one or two heteroatoms from the group consisting of O, N and S as ring members;
    • a five- or six-membered saturated or partially unsaturated heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S as ring members: for example monocyclic saturated or partially unsaturated heterocycles which, in addition to carbon ring members, contain one, two or three nitrogen atoms and/or one oxygen or sulfur atom or one or two oxygen and/or sulfur atoms, for example 2-tetrahydrofuranyl, 3-tetrahydrofuranyl, 2-tetrahydrothienyl, 3-tetrahydrothienyl, 2-pyrrolidinyl, 3-pyrrolidinyl, 3-isoxazolidinyl, 4-isoxazolidinyl, 5-isoxazolidinyl, 3-isothiazolidinyl, 4-isothiazolidinyl, 5-isothiazolidinyl, 3-pyrazolidinyl, 4-pyrazolidinyl, 5-pyrazolidinyl, 2-oxazolidinyl, 4-oxazolidinyl, 5-oxazolidinyl, 2-thiazolidinyl, 4-thiazolidinyl, 5-thiazolidinyl, 2-imidazolidinyl, 4-imidazolidinyl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,2,4-triazolidin-3-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 1,3,4-triazolidin-2-yl, 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,4-dihydrofur-2-yl, 2,4-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,4-dihydrothien-2-yl, 2,4-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydro-oxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 2-piperidinyl, 3-piperidinyl, 4-piperidinyl, 1,3-dioxan-5-yl, 2-tetrahydropyranyl, 4-tetrahydropyranyl, 2-tetrahydrothienyl, 3-hexahydropyridazinyl, 4-hexa-hydropyridazinyl, 2-hexahydropyrimidinyl, 4-hexahydropyrimidinyl, 5-hexahydro-pyrimidinyl, 2-piperazinyl, 1,3,5-hexahydrotriazin-2-yl and 1,2,4-hexahydrotriazin-3-yl and also the corresponding-ylidene radicals;
    • a seven-membered saturated or partially unsaturated heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S as ring members: for example mono- and bicyclic heterocycles having 7 ring members which, in addition to carbon ring members, contain one, two or three nitrogen atoms and/or one oxygen or sulfur atom or one or two oxygen and/or sulfur atoms, for example tetra- and hexahydroazepinyl, such as 2,3,4,5-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 3,4,5,6-tetra-hydro[2H]azepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]azepin-1-, -2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepin-1-, -2-, -3- or -4-yl, tetra- and hexahydrooxepinyl such as 2,3,4,5-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,4,7-te-trahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, 2,3,6,7-tetrahydro[1H]oxepin-2-, -3-, -4-, -5-, -6- or -7-yl, hexahydroazepin-1-, -2-, -3- or -4-yl, tetra- and hexahydro-1,3-diazepinyl, tetra- and hexahydro-1,4-diazepinyl, tetra- and hexahydro-1,3-oxazepinyl, tetra- and hexahydro-1,4-oxazepinyl, tetra- and hexahydro-1,3-dioxepinyl, tetra- and hexahydro-1,4-dioxepinyl and the corresponding-ylidene radicals;


      a 5-, 6-, 7-, 8-, 9- or 10-membered aromatic heterocycle which contains 1, 2, 3 or 4 heteroatoms from the group consisting of O, N and S: in particular a five- or six-membered aromatic mono- or bicyclic heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S: the heterocycle in question may be attached via a carbon atom or, if present, via a nitrogen atom. According to the invention, it may be preferred for the heterocycle in question to be attached via carbon; on the other hand, it may also be preferred for the heterocycle to be attached via nitrogen. The heterocycle is in particular:
    • 5-membered heteroaryl which contains one, two, three or four nitrogen atoms or one, two or three nitrogen atoms and/or one sulfur or oxygen atom, where the heteroaryl may be attached via carbon or nitrogen, if present: 5-membered heteroaryl groups which, in addition to carbon atoms, may contain one to four nitrogen atoms or one, two or three nitrogen atoms and/or one sulfur or oxygen atom as ring members, for example furyl, thienyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl (1,2,3-; 1,2,4-triazolyl), tetrazolyl, oxazolyl, isoxazolyl, 1,3,4-oxadiazolyl, thiazolyl, isothiazolyl and thiadiazolyl, in particular 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 2-pyrrolyl, 3-pyrrolyl, 3-isoxazolyl, 4-isoxazolyl, 5-isoxazolyl, 3-isothiazolyl, 4-isothiazolyl, 5-isothiazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 2-imidazolyl, 4-imidazolyl, 1,2,4-oxadiazol-3-yl, 1,2,4-oxadiazol-5-yl, 1,2,4-thiadiazol-3-yl, 1,2,4-thiadiazol-5-yl, 1,2,4-triazol-3-yl, 1,3,4-oxadiazol-2-yl, 1,3,4-thiadiazol-2-yl and 1,3,4-triazol-2-yl;
    • 6-membered heteroaryl which contains one, two, three or four, preferably one, two or three, nitrogen atoms, where the heteroaryl may be attached via carbon or nitrogen, if present: 6-membered heteroaryl groups which, in addition to carbon atoms, may contain one to four or one, two or three nitrogen atoms as ring members, for example pyridinyl, pyrimidinyl, pyrazinyl, pyridazinyl, 1,2,3-triazinyl, 1,2,4-triazinyl, 1,3,5-triazinyl, in particular 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl, 2-pyrazinyl, 1,3,5-triazin-2-yl and 1,2,4-triazin-3-yl.


In the compounds I (component 1 of the mixtures according to the invention), particular preference is given to the following meanings of the substituents, in each case on their own or in combination.


According to the invention, A is phenyl which is substituted by one F and contains a further substituent L different from Br, where the phenyl may additionally contain one or two independently selected substituents L. According to a preferred embodiment, A is a group A-1




embedded image


in which # denotes the point of attachment of the phenyl ring to the oxirane ring; and

  • L2 is selected from the group consisting of F, Cl, NO2, phenyl, halophenyl, phenoxy, halophenoxy, C1-C4-alkoxy, C1-C4-haloalkoxy and C1-C4-haloalkylthio;
  • L3 is independently selected from the group consisting of F, Cl, Br, NO2, phenyl, halophenyl, phenoxy, halophenoxy, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy and C1-C4-haloalkylthio; and
  • m is 0, 1 or 2.


In one embodiment, L2 is selected from the group consisting of F, Cl, methyl, methoxy, CF3, CHF2, OCF3, OCF3 and OCHF2. According to a more specific embodiment, L2 is F or Cl.


In one embodiment, L3 is independently selected from the group consisting of F, Cl, methyl, methoxy, CF3, CHF2, OCF3, OCF3 and OCHF2. According to a more specific embodiment, L3 is independently F or Cl.


According to a preferred embodiment, m=0. According to a further preferred embodiment, m=1.


In formula A-1, according to a preferred aspect, the fluorine substituent is in the 4-position.


According to yet a further preferred embodiment, A is disubstituted phenyl which contains one F and one further substituent L selected from the group consisting of Cl, C1-C4-haloalkyl and C1-C4-alkoxy, in particular selected from the group consisting of Cl, methyl, trifluoromethyl and methoxy. Specifically, the second substituent L is selected from the group consisting of methyl, methoxy and chlorine. According to one aspect thereof, one of the substituents is located in the 4-position of the phenyl ring.


According to a further preferred embodiment, A is phenyl which is substituted by F and one substituent L selected from the group consisting of F, Cl, CH3, OCH3, CF3, CHF2, OCF3 and OCHF2 and does not contain any further substituents.


According to a further embodiment, the phenyl ring A is substituted in the 2,4-position.


According to a further preferred embodiment of the invention, A is phenyl which is substituted by exactly two F. According to one aspect, A is 2,3-difluoro-substituted. According to a further aspect, A is 2,4-difluoro-substituted. According to yet a further aspect, A is 2,5-difluoro-substituted. According to yet a further aspect, A is 2,6-difluoro-substituted. According to yet a further aspect, A is 3,4-difluoro-substituted. According to yet a further aspect, A is 3,5-difluoro-substituted.


According to a further preferred embodiment, A is 2,4-difluorophenyl or 3,4-difluorophenyl.


According to yet a further preferred embodiment, A is phenyl which is substituted by exactly three F. According to one aspect, A is 2,3,4-trifluoro-substituted. According to a further aspect, A is 2,3,5-trifluoro-substituted. According to yet a further aspect, A is 2,3,6-trifluoro-substituted. According to yet a further aspect, A is 2,4,6-trifluoro-substituted. According to yet a further aspect, A is 3,4,5-trifluoro-substituted. According to yet a further aspect, A is 2,4,5-trifluoro-substituted.


According to one embodiment of the invention, B is unsubstituted phenyl.


According to a further embodiment, B is phenyl which contains one, two, three or four independently selected substituents L.


According to a further embodiment, the phenyl ring is monosubstituted by a substituent L, where L, according to a specific aspect of this embodiment, is located in the ortho position to the point of attachment of the phenyl ring to the oxirane ring.


According to a further embodiment, B is phenyl which contains one, two or three independently selected substituents L, as defined below. In a preferred embodiment, B is phenyl which is substituted by one, two or three halogen atoms.


According to a further embodiment of the invention, B is a phenyl ring which contains one substituent L in the ortho position and furthermore has a further independently selected substituent L. According to one aspect, the phenyl ring is 2,3-disubstituted. According to a further aspect, the phenyl ring is 2,4-disubstituted. According to a yet further aspect, the phenyl ring is 2,5-disubstituted. According to a yet further aspect, the phenyl ring is 2,6-disubstituted.


According to a further embodiment of the invention, B is a phenyl ring which contains one substituent L in the ortho position and furthermore has two further independently selected substituents L. According to one aspect, the phenyl ring is 2,3,5-trisubstituted. According to a further aspect, the phenyl ring is 2,3,4-trisubstituted. According to yet a further aspect, the phenyl ring is 2,4,5-trisubstituted.


In a further embodiment of the invention, B is not ortho-methylphenyl.


In a further embodiment of the invention, B is not ortho- or para-trifluoromethylphenyl.


Unless indicated otherwise, L has independently the following preferred meanings:


According to one embodiment, L is independently selected from the group consisting of halogen, cyano, nitro, cyanato (OCN), C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, S-A1, C(═O)A2, C(═S)A2, NA3A4; where A1, A2, A3, A4 are as defined below:

    • A1 is hydrogen, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl;
    • A2 is one of the groups mentioned for A1 or C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkoxy or C3-C6-halocycloalkoxy;
    • A3,A4 independently of one another are hydrogen, C1-C4-alkyl, C1-C4-haloalkyl;
    • where the aliphatic and/or alicyclic groups of the radical definitions of L for their part may carry one, two, three or four identical or different groups RL:
    • RL is halogen, cyano, nitro, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, amino, C1-C8-alkylamino.


Furthermore preferably, L is independently selected from the group consisting of halogen, NO2, amino, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, C1-C4-alkylamino, C1-C4-dialkylamino, thio and C1-C4-alkylthio.


Furthermore preferably, L is independently selected from the group consisting of halogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy and C1-C4-haloalkylthio.


According to a further preferred embodiment, L is independently selected from the group consisting of F, Cl, Br, CH3, C2H5, i-C3H7, t-C4H9, OCH3, OC2H5, CF3, CCl3, CHF2, CClF2, OCF3, OCHF2 and SCF3, in particular selected from the group consisting of F, Cl, CH3, C2H5, OCH3, OC2H5, CF3, CHF2, OCF3, OCHF2 and SCF3. According to one aspect, L is independently selected from the group consisting of F, Cl, CH3, OCH3, CF3, OCF3 and OCHF2. It may be preferred for L to be independently F or Cl.


In a preferred embodiment, the present invention relates to mixtures of the compounds of the formula I in which the variables have the following meanings:

  • A is phenyl which is substituted by one F and one further substituent L*, where the phenyl may additionally contain one or two substituents L, where L* is as defined below:
    • L* is fluorine, chlorine, iodine, cyano, nitro, cyanato (OCN), C1-C8-alkyl, phenyl-C1-C6-alkyloxy, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C4-C10-alkadienyl, C4-C10-haloalkadienyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkylcarbonyloxy, C1-C8-alkylsulfonyloxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocycloalkenyl, C3-C8-cycloalkoxy, C3-C6-cyclo-alkenyloxy, hydroxyimino-C1-C8-alkyl, C1-C6-alkylene, oxy-C2-C4-alkylene, oxy-C1-C3-alkyleneoxy, C1-C8-alkoximino-C1-C8-alkyl, C2-C8-alkenyloximino-C1-C8-alkyl, C2-C8-alkynyloximino-C1-C8-alkyl, S(═O)nA1, C(═O)A2, C(═S)A2, NA3A4, phenyl, phenyloxy or a five- or six-membered saturated, partially unsaturated or aromatic heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S; where n, A1, A2, A3, A4 are as defined below:
      • n is 0, 1 or 2;
      • A1 is hydrogen, hydroxyl, C1-C8-alkyl, C1-C8-haloalkyl, amino, C1-C8-alkylamino or di-C1-C8-alkylamino,
      • A2 is one of the groups mentioned for A1 or C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkoxy or C3-C8-halocycloalkoxy;
      • A3,A4 independently of one another are hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl or C3-C8-halocycloalkenyl;
    • where the aliphatic and/or alicyclic and/or aromatic groups of the radical definitions of L for their part may carry one, two, three or four identical or different groups RL:
      • RL is halogen, cyano, nitro, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C1-C8-alkylcarbonyl, C1-C8-alkylcarbonyloxy, C1-C8-alkoxycarbonyl, amino, C1-C8-alkylamino, di-C1-C8-alkylamino;
  • B phenyl which is unsubstituted or substituted by one, two, three or four identical or different substituents L, where L is as defined below:
    • L is halogen, cyano, nitro, cyanato (OCN), C1-C8-alkyl, C1-C8-haloalkyl, phenyl-C1-C6-alkyloxy, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C4-C10-alkadienyl, C4-C10-halo-alkadienyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkylcarbonyloxy, C1-C8-alkylsulfonyloxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocycloalkenyl, C3-C8-cycloalkoxy, C3-C6-cycloalkenyloxy, hydroxyimino-C1-C8-alkyl, C1-C6-alkylene, oxy-C2-C4-alkylene, oxy-C1-C3-alkyleneoxy, C2-C8-alkenyloximino-C1-C8-alkyl, C2-C8-alkynyloximino-C1-C8-alkyl, S(═O)nA1, C(═O)A2, C(═S)A2, NA3A4, phenyl, phenyloxy or a five- or six-membered saturated, partially unsaturated or aromatic heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S; where n, A1, A2, A3, A4 are as defined below:
    • n is 0, 1 or 2;
    • A1 is hydrogen, hydroxyl, C1-C8-alkyl, C1-C8-haloalkyl, amino, C1-C8-alkylamino or di-C1-C8-alkylamino,
    • A2 is one of the groups mentioned for A1 or C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkoxy or C3-C8-halocycloalkoxy;
    • A3,A4 independently of one another are hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl or C3-C8-halocycloalkenyl;
    • where the aliphatic and/or alicyclic and/or aromatic groups of the radical definitions of L for their part may carry one, two, three or four identical or different groups RL:
    • RL is halogen, cyano, nitro, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C1-C8-alkylcarbonyl, C1-C8-alkylcarbonyloxy, C1-C8-alkoxycarbonyl, amino, C1-C8-alkylamino, di-C1-C8-alkylamino;


      D is —S—R, where
    • R is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C(═O)R3, C(═S)R3, SO2R4 or CN; where
    • R3 is C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy or NA3A4; and
    • R4 is C1-C8-alkyl, phenyl-C1-C8-alkyl or phenyl, where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently of one another selected from the group consisting of halogen and C1-C4-alkyl;
    • a group DI




embedded image




    • where A and B are as defined above;

    • a group DII







embedded image




    • where # denotes the point of attachment to the triazolyl ring and Q, R1 and R2 are as defined below:

    • Q is O or S;

    • R1,R2 independently of one another are C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-alkoxy-C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio, C2-C8-alkenylthio, C2-C8-alkynylthio, C3-C8-cycloalkyl, C3-C8-cycloalkylthio, phenyl, phenyl-C1-C4-alkyl, phenoxy, phenylthio, phenyl-C1-C4-alkoxy or NR5R6, where R5 is H or C1-C8-alkyl and R6 is C1-C8-alkyl, phenyl-C1-C4-alkyl or phenyl or R5 and R6 together are an alkylene chain having four or five carbon atoms or form a radical of the formula —CH2—CH2—O—CH2—CH2— or —CH2—CH2—NR7—CH2—CH2— in which R7 is hydrogen or C1-C4-alkyl; where the aromatic groups in the radicals mentioned above are in each case independently of one another unsubstituted or substituted by one, two or three groups selected from the group consisting of halogen and C1-C4-alkyl;

    • or

    • a group SM, where M is as defined below:

    • M is an alkali metal cation, an equivalent of an alkaline earth metal cation, an equivalent of a copper, zinc, iron or nickel cation or an ammonium cation of the formula (E)







embedded image


in which

    • Z1 and Z2 independently are hydrogen or C1-C8-alkyl;
    • Z3 and Z4 independently are hydrogen, C1-C8-alkyl, benzyl or phenyl; where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently selected from the group consisting of halogen and C1-C4-alkyl;


      and agriculturally acceptable salts thereof.


In a preferred embodiment, the present invention relates to mixtures of the compounds of the formula I in which the variables have the following meanings:

  • A is phenyl which is substituted by one F and one further substituent L*, where the phenyl may additionally contain one or two substituents L, where L* is as defined below:
    • L* is fluorine, chlorine, C1-C8-alkyl, C1-C8-alkylcarbonyloxy, C3-C8-cycloalkyl, C3-C8-cycloalkoxy,
  • B phenyl which is unsubstituted or substituted by one, two, three or four identical or different substituents L, where L is as defined below:
    • L is halogen, cyano, nitro, cyanato (OCN), C1-C8-alkyl, C1-C8-haloalkyl, phenyl-C1-C6-alkyloxy, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C4-C10-alkadienyl, C4-C10-haloalkadienyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkylcarbonyloxy, C1-C8-alkylsulfonyloxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-halocyclo-alkenyl, C3-C8-cycloalkoxy, C3-C6-cycloalkenyloxy, hydroxyimino-C1-C8-alkyl, C1-C6-alkylene, oxy-C2-C4-alkylene, oxy-C1-C3-alkyleneoxy, C1-C8-alkoximino-C1-C8-alkyl, C2-C8-alkenyloximino-C1-C8-alkyl, C2-C8-alkynyl-oximino-C1-C8-alkyl, S(═O)nA1, C(═O)A2, C(═S)A2, NA3A4, phenyl, phenyloxy or a five- or six-membered saturated, partially unsaturated or aromatic heterocycle which contains one, two, three or four heteroatoms from the group consisting of O, N and S; where n, A1, A2, A3, A4 are as defined below:
      • n is 0, 1 or 2;
      • A1 is hydrogen, hydroxyl, C1-C8-alkyl, C1-C8-haloalkyl, amino, C1-C8-alkylamino or di-C1-C8-alkylamino,
      • A2 is one of the groups mentioned for A1 or C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C2-C8-alkenyloxy, C2-C8-haloalkenyloxy, C2-C8-alkynyloxy, C2-C8-haloalkynyloxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkoxy or C3-C8-halocycloalkoxy;
      • A3,A4 independently of one another are hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl or C3-C8-halocycloalkenyl;
      • where the aliphatic and/or alicyclic and/or aromatic groups of the radical definitions of L for their part may carry one, two, three or four identical or different groups RL:
      • RL is halogen, cyano, nitro, C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy, C3-C8-cycloalkyl, C3-C8-halocycloalkyl, C3-C8-cycloalkenyl, C3-C8-cycloalkoxy, C3-C8-halocycloalkoxy, C1-C8-alkylcarbonyl, C1-C8-alkylcarbonyloxy, C1-C8-alkoxycarbonyl, amino, C1-C8-alkylamino, di-C1-C8-alkylamino;


        D is —S—R, where
    • R is hydrogen, C1-C8-alkyl, C1-C8-haloalkyl, C2-C8-alkenyl, C2-C8-haloalkenyl, C2-C8-alkynyl, C2-C8-haloalkynyl, C(═O)R3, C(═S)R3, SO2R4 or CN; where
    • R3 is C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-haloalkoxy or NA3A4; and
    • R4 is C1-C8-alkyl, phenyl-C1-C8-alkyl or phenyl, where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently of one another selected from the group consisting of halogen and C1-C4-alkyl;
    • a group DI




embedded image




    • where A and B are as defined above;

    • a group DII







embedded image




    • where # denotes the point of attachment to the triazolyl ring and Q, R1 and R2 are as defined below:

    • Q is O or S;

    • R1,R2 independently of one another are C1-C8-alkyl, C1-C8-haloalkyl, C1-C8-alkoxy, C1-C8-alkoxy-C1-C8-alkoxy, C1-C8-haloalkoxy, C1-C8-alkoxy-C1-C8-alkyl, C1-C8-alkylthio, C2-C8-alkenylthio, C2-C8-alkynylthio, C3-C8-cycloalkyl, C3-C8-cycloalkylthio, phenyl, phenyl-C1-C4-alkyl, phenoxy, phenylthio, phenyl-C1-C4-alkoxy or NR5R6, where R5 is H or C1-C8-alkyl and R6 is C1-C8-alkyl, phenyl-C1-C4-alkyl or phenyl or R5 and R6 together are an alkylene chain having four or five carbon atoms or form a radical of the formula —CH2—CH2—O—CH2—CH2— or —CH2—CH2—NR7—CH2—CH2— in which R7 is hydrogen or C1-C4-alkyl; where the aromatic groups in the radicals mentioned above are in each case independently of one another unsubstituted or substituted by one, two or three groups selected from the group consisting of halogen and C1-C4-alkyl;

    • or

    • a group SM, where M is as defined below:

    • M is an alkali metal cation, an equivalent of an alkaline earth metal cation, an equivalent of a copper, zinc, iron or nickel cation or an ammonium cation of the formula (E)







embedded image


in which

    • Z1 and Z2 independently are hydrogen or C1-C8-alkyl;
    • Z3 and Z4 independently are hydrogen, C1-C8-alkyl, benzyl or phenyl; where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently selected from the group consisting of halogen and C1-C4-alkyl;


      and agriculturally acceptable salts thereof.


In a further embodiment, B is phenyl which is unsubstituted or substituted by one, two or three substituents independently selected from the group consisting of halogen, NO2, amino, C1-C4-alkyl, C1-C4-alkoxy, C1-C4-haloalkyl, C1-C4-haloalkoxy, C1-C4-alkylamino, C1-C4-dialkylamino, thio and C1-C4-alkylthio.


According to one embodiment of the invention, D is a group SR where R is hydrogen (compounds I-SH). According to a further embodiment, D is a group SR where R is C1-C4-alkyl, in particular methyl or ethyl, preferably methyl.


According to a further embodiment of the invention, D is a group SR where R is C(═O)R3 and R3 is NA3A4, where A3 and A4 independently of one another are hydrogen or C1-C8-alkyl.


According to a further embodiment of the invention, D is a group SR where R is C(═O)R3 and R3 is hydrogen, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, phenyl or benzyl. According to a specific aspect thereof, R3 is here hydrogen. According to a further aspect thereof, R3 is C1-C4-alkyl, in particular methyl or ethyl, preferably methyl. According to yet a further aspect, R3 is C1-C4-haloalkyl, in particular trifluoromethyl. According to yet a further aspect, R3 is C1-C4-alkoxy, in particular methoxy or ethoxy.


According to a further embodiment of the invention, D is a group SR where R is C(═O)R3 and R3 is (C1-C4)alkylamino, di(C1-C4)alkylamino or phenylamino. According to one aspect thereof, R3 is methylamino, dimethylamino, ethylamino, diethylamino or phenylamino.


According to a further embodiment of the invention, D is a group SR where R is CN.


According to a further embodiment of the invention, D is a group SR where R is SO2R4 and R4 is C1-C4-alkyl, phenyl-C1-C4-alkyl or phenyl, where the phenyl groups are in each case unsubstituted or substituted by one, two or three groups independently of one another selected from the group consisting of halogen and C1-C4-alkyl.


According to a further embodiment of the invention, D is a group SM, where M is an alkali metal cation, an equivalent of an alkaline earth metal cation, an equivalent of a copper, zinc, iron or nickel cation or an ammonium cation of the formula (E)




embedded image


in which


Z1 and Z2 independently are hydrogen or C1-C4-alkyl; and


Z3 and Z4 independently are hydrogen, C1-C4-alkyl, benzyl or phenyl.


According to one embodiment, M is Na, ½ Cu, ⅓ Fe, HN(CH3)3, HN(C2H5)3, N(CH3)4 or H2N(C3H7)2, in particular Na, ½ Cu, HN(CH3)3 or HN(C2H5)3, especially Na, ½ Cu, HN(CH3)3 or HN(C2H5)3.


According to a further embodiment of the invention, D is a group DI (compounds I-dimer) where A and B independently are as defined herein or as defined herein as preferred:




embedded image


Preferably, both A and both B in the compounds I-dimer have the same meaning.


According to a further embodiment of the invention, D is a group DII, where # denotes the point of attachment to the triazolyl ring and Q, R1 and R2 are as defined herein or as defined as being preferred:




embedded image


Particular preference is given to mixtures of the compounds of the formula I (component 1) in which the variables have the following meanings:

  • A is phenyl which is substituted by one F and contains one further substituent F or Cl.


Particular preference is given to mixtures of the compounds of the formula I (component 1) in which the variables have the following meanings:

  • A is phenyl which is substituted by one F and contains one further substituent F or Cl;
  • B is phenyl which is substituted by one substituent L, where L is as defined below:
    • L is halogen, C1-C8-alkyl, C1-C8-haloalkyl.


Particular preference is given to mixtures of the compounds of the formula I (component 1) in which the variables have the following meanings:


A is 2,4-difluorophenyl, 3,4-difluorophenyl;


B is 2-chlorophenyl, 2-fluorophenyl, 2-trifluoromethylphenyl.


Particular preference is given to mixtures of the compounds of the formula I (component 1) in which the variables have the following meanings:


D is —S—R, where


R is hydrogen, C1-C8-alkyl, C(═O)R3, SO2R4 or CN; where

    • R3 is C1-C8-alkyl or C1-C8-alkoxy;
    • R4 is C1-C8-alkyl.


Particular preference is given to mixtures of the compounds of the formula I (component 1) in which the variables have the following meanings:

  • A is phenyl which is substituted by one F and contains one further substituent F or Cl;
  • B is phenyl which is substituted by one substituent L, where L is as defined below:
    • L is halogen, C1-C8-alkyl, C1-C8-haloalkyl.
  • D is —S—R, where
  • R is hydrogen, C1-C8-alkyl, C(═O)R3, SO2R4 or CN; where
    • R3 is C1-C8-alkyl or C1-C8-alkoxy;
    • R4 is C1-C8-alkyl.


The most preferred compounds of the formula I are the compounds I-1 to I-9 below, with, in each case, preference being given, in particular, to pairs of enantiomers or enantiomers with the trans-configuration of ring A and ring B:

  • I-1 2-[trans-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-2 2-[trans-2-(3,4-difluorophenyl)-3-o-tolyloxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-3 2-[trans-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol
  • I-4 2-[trans-2-(3,4-difluorophenyl)-3-(2-trifluoromethylphenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-5 1-[trans-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-6 1-[trans-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-7 1-[trans-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-8 1-[trans-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole
  • I-9 S-{2-[trans-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazol-3-yl}methyl thiocarbonate


Alternative notation of the trans-enantiomeric pairs:

  • I-1 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranyl methyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-2 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-o-tolyloxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranyl methyl]-2H-[1,2,4]triazole-3-thiol
  • I-4 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-(2-trifluoromethylphenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione
  • I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranyl methyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)-oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranyl methyl]-5-methylsulfanyl-1H-[1,2,4]triazole
  • I-8 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranyl methyl]-5-thiocyanato-1H-[1,2,4]triazole
  • I-9 rel S-{2-[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazol-3-yl}methyl rel (2R,3S)-thiocarbonate









TABLE 1







Specific examples of compounds of the formula I:










Exam-





ple


No.
A
B
D





I-1
2,4-difluorophenyl
2-chlorophenyl
SH


I-2
3,4-difluorophenyl
2-methylphenyl
SH


I-3
3,4-difluorophenyl
2-chlorophenyl
SH


I-4
3,4-difluorophenyl
2-
SH




trifluoromethylphenyl


I-5
3,4-difluorophenyl
2-chlorophenyl
SMe


I-6
2,4-difluorophenyl
2-fluorophenyl
SMe


I-7
2,4-difluorophenyl
2-chlorophenyl
SMe


I-8
2,4-difluorophenyl
2-chlorophenyl
S—CN


I-9
2,4-difluorophenyl
2-chlorophenyl
S—CO—OCH3









Independently of one another, components 2 and 3 are preferably selected as illustrated in the compositions below:


Preference is given to compositions of a compound I (component 1) with at least one active compound from group A) (component 2 and/or 3) of the strobilurins and in particular selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group A) (component 2 and/or 3 and/or 4) of the strobilurins, which are preferably selected from those just mentioned. According to one specific embodiment of the invention, preference is given to compositions comprising a compound I (component 1), in particular a compound selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9, and, as component 2, an active compound from group A) of the strobilurins, where component 2 is selected in particular from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orysastrobin, picoxystrobin, pyraclostrobin and trifloxystrobin. According to a specific aspect, these are binary mixtures which, as active compounds, comprise in each case only the two components. According to a further aspect, these mixtures comprise a further component (component 3) selected from the group B) of the carboxamides, in particular selected from the group consisting of bixafen, boscalid, fluopyram, isopyrazam, penthiopyrad, sedaxane, N-(3′,4′,5′-tri-fluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide and penflufen.


Preference is also given to compositions of a compound I (component 1) with at least one active compound selected from group B) (component 2 and/or 3) of the carboxamides and particularly preferably selected from the group consisting of bixafen, boscalid, isopyrazam, fluopyram, penflufen, penthiopyrad, sedaxane, fenhexamid, metalaxyl, mefenoxam, ofurace, dimethomorph, flumorph, fluopicolide (picobenzamid), zoxamide, carpropamid, mandipropamid and N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group B) (component 2 and/or 3 and/or 4) of the carboxamides, which are preferably selected from those just mentioned. According to a specific embodiment of the invention, the compound I (component I) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


Preference is also given to compositions of a compound I (component I) with at least one active compound selected from group C) (component 2 and/or 3) of the azoles and in particular selected from the group consisting of cyproconazole, difenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, myclobutanil, penconazole, propiconazole, prothioconazole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, cyazofamid, benomyl, carbendazim and ethaboxam. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group C) (component 2 and/or 3 and/or 4) of the azoles, which are preferably selected from those just mentioned. According to a specific embodiment of the invention, the compound I (component I) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


Preference is also given to compositions of a compound I (component I) with at least one active compound selected from group D) (component 2 and/or 3) of the nitrogenous heterocyclyl compounds and in particular selected from the group consisting of fluazinam, cyprodinil, fenarimol, mepanipyrim, pyrimethanil, triforin, fludioxonil, fodemorph, fenpropimorph, tridemorph, fenpropidin, iprodione, vinclozolin, famoxadone, fenamidone, probenazole, proquinazid, acibenzolar-S-methyl, captafol, folpet, fenoxanil, quinoxyfen and 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group D) (component 2 and/or 3 and/or 4) of the nitrogenous heterocyclyl compounds, which are preferably selected from those just mentioned. According to a specific embodiment of the invention, the compound I (component I) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


Preference is also given to compositions of a compound I (component I) with at least one active compound selected from group E) (component 2 and/or 3) of the carbamates and in particular selected from the group consisting of mancozeb, metiram, propineb, thiram, iprovalicarb, benthiavalicarb and propamocarb. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group E) (component 2 and/or 3 and/or 4) of the carbamates, which are preferably selected from those just mentioned. According to a specific embodiment of the invention, the compound I (component I) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


Preference is also given to compositions of a compound I (component I) with at least one active compound selected from the fungicides of group F) (component 2 and/or 3) and in particular selected from the group consisting of dithianon, fentin salts, such as fentin acetate, fosetyl, fosetyl-aluminum, H3PO3 and salts thereof, chlorothalonil, dichlofluanid, thiophanate-methyl, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, cymoxanil, metrafenone, spiroxamine and N-methyl-2-{1-[(5-methyl-3-trifluoromethyl-1H-pyrazol-1-yl)acetyl]piperidin-4-yl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-1-yl]-4-thiazolecarboxamide. Specific quarternary compositions of the invention comprise a compound I (component 1) and at least one active compound from group F) (component 2 and/or 3 and/or 4), which are preferably selected from those just mentioned. According to a specific embodiment of the invention, the compound I (component I) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to one embodiment, the compositions according to the invention comprise a compound I (component 1), and a component 2, component 2 being a G) growth regulator. Component 2 is selected in particular from the group consisting of chlormequat (chlormequat chloride), mepiquat (mepiquat chloride), metconazole, paclobutrazole, prohexadione (prohexadione-calcium), trinexapac-ethyl and uniconazole. According to one specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to a further embodiment, the compositions according to the invention comprise a compound I (component 1), and a component 2, component 2 being an insecticide selected from group I). According to a preferred embodiment, these are binary mixtures comprising, as active compounds, a component 1) and a component 2) selected from group I). According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to one aspect, the insecticide of component 2) is selected from the group of the organo(thio)phosphates, in particular selected from the group consisting of acephate, chlorpyrifos, diazinon, dichlorvos, dimethoate, fenitrothion, methamidophos, methidathion, methyl-parathion, monocrotophos, phorate, profenofos and terbufos. According to a specific embodiment of the invention, compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to a further aspect, the insecticide of component 2) is selected from the group of the carbamates, in particular selected from the group consisting of aldicarb, carbaryl, carbofuran, carbosulfan, methomyl and thiodicarb. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group of the pyrethroids, in particular selected from the group consisting of: bifenthrin, cyfluthrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, deltamethrin, esfenvalerate, lambda-cyhalothrin and tefluthrin. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group of inhibitors of insect growth, in particular selected from the group consisting of lufenuron and spirotetramat. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group of the nicotine receptor agonists/antagonists, in particular selected from the group consisting of: clothianidin, imidacloprid, thiamethoxam and thiacloprid. According to a specific embodiment of the invention, compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group of the GABA antagonists, in particular selected from the group consisting of: endosulfan and fipronil. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group of the macrocyclic lactones, in particular selected from the group consisting of: abamectin, emamectin, spinosad and spinetoram. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is hydramethylnon. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is fenbutatin oxide. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to yet a further aspect, the insecticide of component 2) is selected from the group consisting of chlorfenapyr, cyazypyr (HGW86), cyflumetofen, flonicamid, flubendiamide, indoxacarb and metaflumizone. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to a further embodiment, the mixtures are ternary mixtures comprising, in addition to the components mentioned, a component 3) selected from the active compounds II of group I) mentioned above. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


According to a further embodiment, the mixtures are ternary mixtures comprising, in addition to the two components mentioned, a component 3) selected from the active compounds II of groups A) to G). According to one specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and I-9.


The active compounds II of group I) and their pesticidal action and processes for their preparation are known (see also http://www.hclrss.demon.co.uk/index.html). Commercially available active compounds can be found, for example, in The Pesticide Manual, 14th Edition, British Crop Protection Council (2006) and other publications. The compound BB) of group I)




embedded image


having the IUPAC name [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-(cyclopropanecarbonyloxy)-6,12-dihydroxy-4,6a,12b-trimethyl-II-oxo-9-(pyridin-3-yl)-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-11H,12H-benzo[f]pyrano[4,3-b]chromen-4-yl]methyl cyclopropanecarboxylate and its pesticidal action are disclosed in WO2006/129714 and WO2009/081851.


In compositions according to the invention comprising, in addition to a compound I (component 1), the components 2, 3 and 4, the components 2 and 3 are independently preferably selected as described above as preferred for the components 2 and 3, and component 4 is likewise preferably selected as described for components 2 and 3. Altogether, the components present in the compositions according to the invention are different from one another.


In a preferred embodiment, component 2 is a fungicide selected from groups A to F. If a component 3 is present, this is, in another preferred embodiment, an independently selected fungicide selected from groups A to F. In a further preferred embodiment, components 2 and 3 are two fungicides selected from groups A to F. According to a specific embodiment of the invention, the compound I (component 1) is in each case selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and 1-9.


If a component 4 is present, this is, in another preferred embodiment, an independently selected fungicide selected from groups A to F. In a further preferred embodiment, components 2, 3 and 4 are three fungicides independently selected from groups A to F.


Accordingly, the present invention furthermore relates to compositions of a compound I (component 1) with a further active compound (component 2), the latter being selected from rows A-1 to A-366 in the column “component 2” of Table A.


A further embodiment of the invention relates to the compositions A-1 to A-366 listed in Table A, where a row of Table A corresponds in each case to an agrochemical composition comprising one of the compounds of the formula I individualized in the present description (component 1) and the respective further active compound from the groups A) to 1) (component 2) stated in the row in question. In the compositions described, the active compounds are in each case preferably present in synergistically effective amounts. In each case, component 1 is preferably selected from the compounds I-1, I-2, I-3, I-4, I-5, I-6, I-7, I-8 and 1-9. According to a specific aspect, these are in each case binary mixtures comprising, as active compounds, in each case only these two components.









TABLE A







Active compound composition, comprising an individualized compound I and a


further active compound from the groups A) to I)









Row
Component 1
Component 2





A-1
an individualized compound I
azoxystrobin


A-2
an individualized compound I
dimoxystrobin


A-3
an individualized compound I
enestroburin


A-4
an individualized compound I
fluoxastrobin


A-5
an individualized compound I
kresoxim-methyl


A-6
an individualized compound I
metominostrobin


A-7
an individualized compound I
orysastrobin


A-8
an individualized compound I
picoxystrobin


A-9
an individualized compound I
pyraclostrobin


A-10
an individualized compound I
pyribencarb


A-11
an individualized compound I
trifloxystrobin


A-12
an individualized compound I
2-(2-(6-(3-chloro-2-methylphenoxy)-




5-fluoropyrimidin-4-yloxy)phenyl)-




2-methoxyimino-N-methylacetamide


A-13
an individualized compound I
methyl 2-(o-((2,5-dimethylphenyloxy-




methylene)phenyl)-3-methoxyacrylate


A-14
an individualized compound I
methyl 3-methoxy-2-(2-(N-(4-methoxy-




phenyl)cyclopropanecarboximidoylsulfanylmethyl)phenyl)acrylate


A-15
an individualized compound I
2-(2-(3-(2,6-dichlorophenyl)-1-




methylallylideneaminooxymethyl)phenyl)-




2-methoxyimino-N-methylacetamide


A-16
an individualized compound I
benalaxyl


A-17
an individualized compound I
benalaxyl-M


A-18
an individualized compound I
benodanil


A-19
an individualized compound I
bixafen


A-20
an individualized compound I
boscalid


A-21
an individualized compound I
carboxin


A-22
an individualized compound I
fenfuram


A-23
an individualized compound I
fenhexamid


A-24
an individualized compound I
flutolanil


A-25
an individualized compound I
furametpyr


A-26
an individualized compound I
isopyrazam


A-27
an individualized compound I
isotianil


A-28
an individualized compound I
kiralaxyl


A-29
an individualized compound I
mepronil


A-30
an individualized compound I
metalaxyl


A-31
an individualized compound I
metalaxyl-M


A-32
an individualized compound I
ofurace


A-33
an individualized compound I
oxadixyl


A-34
an individualized compound I
oxycarboxin


A-35
an individualized compound I
penflufen


A-36
an individualized compound I
penthiopyrad


A-37
an individualized compound I
sedaxane


A-38
an individualized compound I
tecloftalam


A-39
an individualized compound I
thifluzamide


A-40
an individualized compound I
tiadinil


A-41
an individualized compound I
2-amino-4-methylthiazole-5-carboxanilide


A-42
an individualized compound I
2-chloro-N-(1,1,3-trimethylindan-4-yl)-




nicotinamide


A-43
an individualized compound I
N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-




difluoromethyl-1-methyl-1H-pyrazole-4-




carboxamide


A-44
an individualized compound I
N-(4′-trifluoromethylthiobiphenyl-2-yl)-3-




difluoromethyl-1-methyl-1H-pyrazole-4-




carboxamide


A-45
an individualized compound I
N-(2-(1,3-dimethylbutyl)phenyl)-1,3-




dimethyl-5-fluoro-1H-pyrazole-4-




carboxamide


A-46
an individualized compound I
N-(2-(1,3,3-trimethylbutyl)phenyl)-1,3-




dimethyl-5-fluoro-1H-pyrazole-4-




carboxamide


A-47
an individualized compound I
dimethomorph


A-48
an individualized compound I
flumorph


A-49
an individualized compound I
pyrimorph


A-50
an individualized compound I
flumetover


A-51
an individualized compound I
fluopicolide


A-52
an individualized compound I
fluopyram


A-53
an individualized compound I
zoxamide


A-54
an individualized compound I
N-(3-ethyl-3,5,5-trimethylcyclohexyl)-




3-formylamino-2-hydroxybenzamide


A-55
an individualized compound I
carpropamid


A-56
an individualized compound I
diclocymet


A-57
an individualized compound I
mandipropamid


A-58
an individualized compound I
oxytetracyclin


A-59
an individualized compound I
silthiofam


A-60
an individualized compound I
N-(6-methoxypyridin-3-yl)cyclopropane-




carboxamide


A-61
an individualized compound I
azaconazole


A-62
an individualized compound I
bitertanol


A-63
an individualized compound I
bromuconazole


A-64
an individualized compound I
cyproconazole


A-65
an individualized compound I
difenoconazole


A-66
an individualized compound I
diniconazole


A-67
an individualized compound I
diniconazole-M


A-68
an individualized compound I
epoxiconazole


A-69
an individualized compound I
fenbuconazole


A-70
an individualized compound I
fluquinconazole


A-71
an individualized compound I
flusilazole


A-72
an individualized compound I
flutriafol


A-73
an individualized compound I
hexaconazole


A-74
an individualized compound I
imibenconazole


A-75
an individualized compound I
ipconazole


A-76
an individualized compound I
metconazole


A-77
an individualized compound I
myclobutanil


A-78
an individualized compound I
oxpoconazole


A-79
an individualized compound I
paclobutrazole


A-80
an individualized compound I
penconazole


A-81
an individualized compound I
propiconazole


A-82
an individualized compound I
prothioconazole


A-83
an individualized compound I
simeconazole


A-84
an individualized compound I
tebuconazole


A-85
an individualized compound I
tetraconazole


A-86
an individualized compound I
triadimefon


A-87
an individualized compound I
triadimenol


A-88
an individualized compound I
triticonazole


A-89
an individualized compound I
uniconazole


A-90
an individualized compound I
1-(4-chlorophenyl)-2-([1,2,4]triazol-1-yl)-




cycloheptanol


A-91
an individualized compound I
cyazofamid


A-92
an individualized compound I
imazalil


A-93
an individualized compound I
imazalil-sulfate


A-94
an individualized compound I
pefurazoate


A-95
an individualized compound I
prochloraz


A-96
an individualized compound I
triflumizole


A-97
an individualized compound I
benomyl


A-98
an individualized compound I
carbendazim


A-99
an individualized compound I
fuberidazole


A-100
an individualized compound I
thiabendazole


A-101
an individualized compound I
ethaboxam


A-102
an individualized compound I
etridiazole


A-103
an individualized compound I
hymexazole


A-104
an individualized compound I
2-(4-chlorophenyl)-N-[4-(3,4-




dimethoxyphenyl)isoxazol-5-yl]-2-prop-2-




ynyloxyacetamide


A-105
an individualized compound I
fluazinam


A-106
an individualized compound I
pyrifenox


A-107
an individualized compound I
3-[5-(4-chlorophenyl)-2,3-dimethyl-




isoxazolidin-3-yl]pyridine


A-108
an individualized compound I
3-[5-(4-methylphenyl)-2,3-




dimethylisoxazolidin-3-yl]pyridine


A-109
an individualized compound I
2,3,5,6-tetrachloro-4-methanesulfonyl-




pyridine


A-110
an individualized compound I
3,4,5-trichloropyridine-2,6-dicarbonitrile


A-111
an individualized compound I
N-(1-(5-bromo-3-chloropyridin-2-yl)ethyl)-




2,4-dichloronicotinamide


A-112
an individualized compound I
N-((5-bromo-3-chloropyridin-2-yl)methyl)-




2,4-dichloronicotinamide


A-113
an individualized compound I
bupirimate


A-114
an individualized compound I
cyprodinil


A-115
an individualized compound I
diflumetorim


A-116
an individualized compound I
fenarimol


A-117
an individualized compound I
ferimzone


A-118
an individualized compound I
mepanipyrim


A-119
an individualized compound I
nitrapyrin


A-120
an individualized compound I
nuarimol


A-121
an individualized compound I
pyrimethanil


A-122
an individualized compound I
triforine


A-123
an individualized compound I
fenpiclonil


A-124
an individualized compound I
fludioxonil


A-125
an individualized compound I
aldimorph


A-126
an individualized compound I
dodemorph


A-127
an individualized compound I
dodemorph acetate


A-128
an individualized compound I
fenpropimorph


A-129
an individualized compound I
tridemorph


A-130
an individualized compound I
fenpropidin


A-131
an individualized compound I
fluoroimide


A-132
an individualized compound I
iprodione


A-133
an individualized compound I
procymidone


A-134
an individualized compound I
vinclozolin


A-135
an individualized compound I
famoxadone


A-136
an individualized compound I
fenamidone


A-137
an individualized compound I
flutianil


A-138
an individualized compound I
octhilinone


A-139
an individualized compound I
probenazole


A-140
an individualized compound I
S-allyl 5-amino-2-isopropyl-4-




orthotolylpyrazol-3-one-1-thiocarboxylate


A-141
an individualized compound I
acibenzolar-S-methyl


A-142
an individualized compound I
amisulbrom


A-143
an individualized compound I
anilazine


A-144
an individualized compound I
blasticidin-S


A-145
an individualized compound I
captafol


A-146
an individualized compound I
captan


A-147
an individualized compound I
chinomethionat


A-148
an individualized compound I
dazomet


A-149
an individualized compound I
debacarb


A-150
an individualized compound I
diclomezine


A-151
an individualized compound I
difenzoquat


A-152
an individualized compound I
difenzoquat methylsulfate


A-153
an individualized compound I
fenoxanil


A-154
an individualized compound I
folpet


A-155
an individualized compound I
oxolinic acid


A-156
an individualized compound I
piperalin


A-157
an individualized compound I
proquinazid


A-158
an individualized compound I
pyroquilon


A-159
an individualized compound I
quinoxyfen


A-160
an individualized compound I
triazoxide


A-161
an individualized compound I
tricyclazole


A-162
an individualized compound I
2-butoxy-6-iodo-3-propylchromen-4-one


A-163
an individualized compound I
5-chloro-1-(4,6-dimethoxypyrimidin-2-yl)-




2-methyl-1H-benzimidazole


A-164
an individualized compound I
5-chloro-7-(4-methylpiperidin-1-yl)-




6-(2,4,6-trifluorophenyl)-[1,2,4]triazolo-




[1,5-a]pyrimidine


A-165
an individualized compound I
5-ethyl-6-octyl-[1,2,4]triazolo[1,5-




a]pyrimidin-7-ylamine


A-166
an individualized compound I
ferbam


A-167
an individualized compound I
mancozeb


A-168
an individualized compound I
maneb


A-169
an individualized compound I
metam


A-170
an individualized compound I
methasulfocarb


A-171
an individualized compound I
metiram


A-172
an individualized compound I
propineb


A-173
an individualized compound I
thiram


A-174
an individualized compound I
zineb


A-175
an individualized compound I
ziram


A-176
an individualized compound I
diethofencarb


A-177
an individualized compound I
benthiavalicarb


A-178
an individualized compound I
iprovalicarb


A-179
an individualized compound I
propamocarb


A-180
an individualized compound I
propamocarb hydrochloride


A-181
an individualized compound I
valiphenal


A-182
an individualized compound I
4-fluorophenyl N-(1-(1-(4-cyanophenyl)-




ethanesulfonyl)but-2-yl)carbamate


A-183
an individualized compound I
dodine


A-184
an individualized compound I
dodine free base


A-185
an individualized compound I
guazatine


A-186
an individualized compound I
guazatine acetate


A-187
an individualized compound I
iminoctadine


A-188
an individualized compound I
iminoctadine triacetate


A-189
an individualized compound I
iminoctadine tris(albesilate)


A-190
an individualized compound I
kasugamycin


A-191
an individualized compound I
kasugamycin hydrochloride hydrate


A-192
an individualized compound I
polyoxin


A-193
an individualized compound I
streptomycin


A-194
an individualized compound I
validamycin A


A-195
an individualized compound I
binapacryl


A-196
an individualized compound I
dicloran


A-197
an individualized compound I
dinobuton


A-198
an individualized compound I
dinocap


A-199
an individualized compound I
nitrothal-isopropyl


A-200
an individualized compound I
tecnazene


A-201
an individualized compound I
fentin salts


A-202
an individualized compound I
dithianon


A-203
an individualized compound I
isoprothiolane


A-204
an individualized compound I
edifenphos


A-205
an individualized compound I
fosetyl, fosetyl aluminum


A-206
an individualized compound I
iprobenfos


A-207
an individualized compound I
phosphorous acid and derivatives


A-208
an individualized compound I
pyrazophos


A-209
an individualized compound I
tolclofos-methyl


A-210
an individualized compound I
chlorothalonil


A-211
an individualized compound I
dichlofluanid


A-212
an individualized compound I
dichlorophene


A-213
an individualized compound I
flusulfamide


A-214
an individualized compound I
hexachlorobenzene


A-215
an individualized compound I
pencycuron


A-216
an individualized compound I
pentachlorophenol and salts


A-217
an individualized compound I
phthalide


A-218
an individualized compound I
quintozene


A-219
an individualized compound I
thiophanate methyl


A-220
an individualized compound I
tolylfluanid


A-221
an individualized compound I
N-(4-chloro-2-nitrophenyl)-N-ethyl-




4-methylbenzenesulfonamide


A-222
an individualized compound I
Bordeaux mixture


A-223
an individualized compound I
copper acetate


A-224
an individualized compound I
copper hydroxide


A-225
an individualized compound I
copper oxychloride


A-226
an individualized compound I
basic copper sulfate


A-227
an individualized compound I
sulfur


A-228
an individualized compound I
biphenyl


A-229
an individualized compound I
bronopol


A-230
an individualized compound I
cyflufenamid


A-231
an individualized compound I
cymoxanil


A-232
an individualized compound I
diphenylamine


A-233
an individualized compound I
metrafenone


A-234
an individualized compound I
mildiomycin


A-235
an individualized compound I
oxine-copper


A-236
an individualized compound I
prohexadione-calcium


A-237
an individualized compound I
spiroxamine


A-238
an individualized compound I
tolylfluanid


A-239
an individualized compound I
N-(cyclopropylmethoxyimino-(6-difluoro-




methoxy-2,3-difluorophenyl)methyl)-




2-phenylacetamide


A-240
an individualized compound I
N′-(4-(4-chloro-3-trifluoromethylphenoxy)-




2,5-dimethylphenyl)-N-ethyl-N-methyl-




formamidine


A-241
an individualized compound I
N′-(4-(4-fluoro-3-trifluoromethylphenoxy)-




2,5-dimethylphenyl)-N-ethyl-N-methyl-




formamidine


A-242
an individualized compound I
N′-(2-methyl-5-trifluoromethyl-4-(3-tri-




methylsilanylpropoxy)phenyl)-N-ethyl-




N-methylformamidine


A-243
an individualized compound I
N′-(5-difluoromethyl-2-methyl-4-(3-tri-




methylsilanylpropoxy)phenyl)-N-ethyl-




N-methylformamidine


A-244
an individualized compound I
methyl N-(1,2,3,4-tetrahydronaphthalen-




1-yl)-2-{1-[2-(5-methyl-3-trifluoromethyl-




pyrazol-1-yl)acetyl]piperidin-4-yl}thiazole-




4-carboxamide


A-245
an individualized compound I
methyl (R)—N-(1,2,3,4-




tetrahydronaphthalen-1-yl)-2-{1-[2-(5-




methyl-3-trifluoromethyl-pyrazol-1-




yl)acetyl]piperidin-4-yl}thiazole-4-




carboxamide


A-246
an individualized compound I
6-tert-butyl-8-fluoro-2,3-dimethylquinolin-




4-yl acetate


A-247
an individualized compound I
6-tert-butyl-8-fluoro-2,3-dimethylquinolin-




4-yl methoxyacetate


A-248
an individualized compound I
N-methyl-2-{1-[(5-methyl-3-trifluoro-




methyl-1H-pyrazol-1-yl)acetyl]piperidin-4-




yl}-N-[(1R)-1,2,3,4-tetrahydronaphthalen-




1-yl]-4-thiazolecarboxamide


A-249
an individualized compound I
carbaryl


A-250
an individualized compound I
carbofuran


A-251
an individualized compound I
carbosulfan


A-252
an individualized compound I
methomylthiodicarb


A-253
an individualized compound I
bifenthrin


A-254
an individualized compound I
cyfluthrin


A-255
an individualized compound I
cypermethrin


A-256
an individualized compound I
alpha-cypermethrin


A-257
an individualized compound I
zeta-cypermethrin


A-258
an individualized compound I
deltamethrin


A-259
an individualized compound I
esfenvalerate


A-260
an individualized compound I
lambda-cyhalothrin


A-261
an individualized compound I
permethrin


A-262
an individualized compound I
tefluthrin


A-263
an individualized compound I
diflubenzuron


A-264
an individualized compound I
flufenoxuron


A-265
an individualized compound I
lufenuron


A-266
an individualized compound I
teflubenzuron


A-267
an individualized compound I
spirotetramate


A-268
an individualized compound I
clothianidin


A-269
an individualized compound I
dinotefuran


A-270
an individualized compound I
imidacloprid


A-271
an individualized compound I
thiamethoxam


A-272
an individualized compound I
acetamiprid


A-273
an individualized compound I
thiacloprid


A-274
an individualized compound I
endosulfan


A-275
an individualized compound I
fipronil


A-276
an individualized compound I
abamectin


A-277
an individualized compound I
emamectin


A-278
an individualized compound I
spinosad


A-279
an individualized compound I
spinetoram


A-280
an individualized compound I
hydramethylnon


A-281
an individualized compound I
chlorfenapyr


A-282
an individualized compound I
fenbutatin oxide


A-283
an individualized compound I
indoxacarb


A-284
an individualized compound I
metaflumizone


A-285
an individualized compound I
flonicamid


A-286
an individualized compound I
lubendiamid


A-287
an individualized compound I
chlorantraniliprole


A-288
an individualized compound I
cyazypyr (HGW86)


A-289
an individualized compound I
cyflumetofen


A-290
an individualized compound I
acetochlor


A-291
an individualized compound I
dimethenamid


A-292
an individualized compound I
metolachlor


A-293
an individualized compound I
metazachlor


A-294
an individualized compound I
glyphosate


A-295
an individualized compound I
glufosinate


A-296
an individualized compound I
sulfosate


A-297
an individualized compound I
clodinafop


A-298
an individualized compound I
fenoxaprop


A-299
an individualized compound I
fluazifop


A-300
an individualized compound I
haloxyfop


A-301
an individualized compound I
paraquat


A-302
an individualized compound I
phenmedipham


A-303
an individualized compound I
clethodim


A-304
an individualized compound I
cycloxydim


A-305
an individualized compound I
profoxydim


A-306
an individualized compound I
sethoxydim


A-307
an individualized compound I
tepraloxydim


A-308
an individualized compound I
pendimethalin


A-309
an individualized compound I
prodiamine


A-310
an individualized compound I
trifluralin


A-311
an individualized compound I
acifluorfen


A-312
an individualized compound I
bromoxynil


A-313
an individualized compound I
imazamethabenz


A-314
an individualized compound I
imazamox


A-315
an individualized compound I
imazapic


A-316
an individualized compound I
imazapyr


A-317
an individualized compound I
imazaquin


A-318
an individualized compound I
imazethapyr


A-319
an individualized compound I
2,4-dichlorophenoxyacetic acid (2,4-D)


A-320
an individualized compound I
chloridazon


A-321
an individualized compound I
clopyralid


A-322
an individualized compound I
fluroxypyr


A-323
an individualized compound I
picloram


A-324
an individualized compound I
picolinafen


A-325
an individualized compound I
bensulfuron


A-326
an individualized compound I
chlorimuron-ethyl


A-327
an individualized compound I
cyclosulfamuron


A-328
an individualized compound I
iodosulfuron


A-329
an individualized compound I
mesosulfuron


A-330
an individualized compound I
metsulfuron-methyl


A-331
an individualized compound I
nicosulfuron


A-332
an individualized compound I
rimsulfuron


A-333
an individualized compound I
triflusulfuron


A-334
an individualized compound I
atrazine


A-335
an individualized compound I
hexazinone


A-336
an individualized compound I
diuron


A-337
an individualized compound I
florasulam


A-338
an individualized compound I
pyroxasulfon


A-339
an individualized compound I
bentazone


A-340
an individualized compound I
cinidon-ethyl


A-341
an individualized compound I
cinmethylin


A-342
an individualized compound I
dicamba


A-343
an individualized compound I
diflufenzopyr


A-344
an individualized compound I
quinclorac


A-345
an individualized compound I
quinmerac


A-346
an individualized compound I
mesotrione


A-347
an individualized compound I
saflufenacil


A-348
an individualized compound I
topramezone


A-349
an individualized compound I
betacyfluthrin


A-350
an individualized compound I
pirimicarb


A-351
an individualized compound I
acephate


A-352
an individualized compound I
chlorpyrifos


A-353
an individualized compound I
dimethoate


A-354
an individualized compound I
methamidophos


A-355
an individualized compound I
terbufos


A-356
an individualized compound I
aldicarb


A-357
an individualized compound I
flubendiamide


A-358
an individualized compound I
nitenpyram


A-359
an individualized compound I
[(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-




(cyclopropanecarbonyloxy)-6,12-




dihydroxy-4,6a,12b-trimethyl-11-oxo-9-




(pyridin-3-yl)-1,2,3,4,4a,5,6,6a,12a,12b-




decahydro-11H,12H-benzo[f]pyrano[4,3-




b]chromen-4-yl]methyl cyclopropane-




carboxylate


A-360
an individualized compound I
mepiquat


A-361
an individualized compound I
mepiquat chloride


A-362
an individualized compound I
chlormequat


A-363
an individualized compound I
chlormequat chloride


A-364
an individualized compound I
trinexapac


A-365
an individualized compound I
trinexapac ethyl


A-366
an individualized compound I
prohexadione









Particularly preferred components 2 are compounds II selected from the group of the following compounds:

    • II-1 epoxiconazole
    • II-2 metconazole
    • II-3 tebuconazole
    • II-4 fluquinconazole
    • II-5 flutriafol
    • II-6 triticonazole
    • II-7 prothioconazole
    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-10 orysastrobin
    • II-11 dimethomorph
    • II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine
    • II-13 pyrimethanil
    • II-14 metalaxyl
    • II-15 fenpropimorph
    • II-16 dodemorph
    • II-17 iprodione
    • II-18 mancozeb
    • II-19 metiram
    • II-20 thiophanate-methyl
    • II-21 chlorothalonil
    • II-22 metrafenone
    • II-23 bixafen
    • II-24 boscalid
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-27 isopyrazam
    • II-28 fluopyram
    • II-29 penflufen


Particularly preferred mixtures are the binary mixtures of Table B, where each row corresponds to one aspect of the mixtures according to the invention. According to one specific aspect, these are binary mixtures which each only contain these two components as the active compound.









TABLE B







Binary mixtures comprising one component 1 selected from compounds


of the formula I and one component 2 selected from groups A to I











Mixture
1
2







B-1
I-1
II-1



B-2
I-1
II-2



B-3
I-1
II-3



B-4
I-1
II-4



B-5
I-1
II-5



B-6
I-1
II-6



B-7
I-1
II-7



B-8
I-1
II-8



B-9
I-1
II-9



B-10
I-1
II-10



B-11
I-1
II-11



B-12
I-1
II-12



B-13
I-1
II-13



B-14
I-1
II-14



B-15
I-1
II-15



B-16
I-1
II-16



B-17
I-1
II-17



B-18
I-1
II-18



B-19
I-1
II-19



B-20
I-1
II-20



B-21
I-1
II-21



B-22
I-1
II-22



B-23
I-1
II-23



B-24
I-1
II-24



B-25
I-1
II-25



B-26
I-1
II-26



B-27
I-1
II-27



B-28
I-1
II-28



B-29
I-1
II-29



B-30
I-2
II-1



B-31
I-2
II-2



B-32
I-2
II-3



B-33
I-2
II-4



B-34
I-2
II-5



B-35
I-2
II-6



B-36
I-2
II-7



B-37
I-2
II-8



B-38
I-2
II-9



B-39
I-2
II-10



B-40
I-2
II-11



B-41
I-2
II-12



B-42
I-2
II-13



B-43
I-2
II-14



B-44
I-2
II-15



B-45
I-2
II-16



B-46
I-2
II-17



B-47
I-2
II-18



B-48
I-2
II-19



B-49
I-2
II-20



B-50
I-2
II-21



B-51
I-2
II-22



B-52
I-2
II-23



B-53
I-2
II-24



B-54
I-2
II-25



B-55
I-2
II-26



B-56
I-2
II-27



B-57
I-2
II-28



B-58
I-2
II-29



B-59
I-3
II-1



B-60
I-3
II-2



B-61
I-3
II-3



B-62
I-3
II-4



B-63
I-3
II-5



B-64
I-3
II-6



B-65
I-3
II-7



B-66
I-3
II-8



B-67
I-3
II-9



B-68
I-3
II-10



B-69
I-3
II-11



B-70
I-3
II-12



B-71
I-3
II-13



B-72
I-3
II-14



B-73
I-3
II-15



B-74
I-3
II-16



B-75
I-3
II-17



B-76
I-3
II-18



B-77
I-3
II-19



B-78
I-3
II-20



B-79
I-3
II-21



B-80
I-3
II-22



B-81
I-3
II-23



B-82
I-3
II-24



B-83
I-3
II-25



B-84
I-3
II-26



B-85
I-3
II-27



B-86
I-3
II-28



B-87
I-3
II-29



B-88
I-4
II-1



B-89
I-4
II-2



B-90
I-4
II-3



B-91
I-4
II-4



B-92
I-4
II-5



B-93
I-4
II-6



B-94
I-4
II-7



B-95
I-4
II-8



B-96
I-4
II-9



B-97
I-4
II-10



B-98
I-4
II-11



B-99
I-4
II-12



B-100
I-4
II-13



B-101
I-4
II-14



B-102
I-4
II-15



B-103
I-4
II-16



B-104
I-4
II-17



B-105
I-4
II-18



B-106
I-4
II-19



B-107
I-4
II-20



B-108
I-4
II-21



B-109
I-4
II-22



B-110
I-4
II-23



B-111
I-4
II-24



B-112
I-4
II-25



B-113
I-4
II-26



B-114
I-4
II-27



B-115
I-4
II-28



B-116
I-4
II-29



B-117
I-5
II-1



B-118
I-5
II-2



B-119
I-5
II-3



B-120
I-5
II-4



B-121
I-5
II-5



B-122
I-5
II-6



B-123
I-5
II-7



B-124
I-5
II-8



B-125
I-5
II-9



B-126
I-5
II-10



B-127
I-5
II-11



B-128
I-5
II-12



B-129
I-5
II-13



B-130
I-5
II-14



B-131
I-5
II-15



B-132
I-5
II-16



B-133
I-5
II-17



B-134
I-5
II-18



B-135
I-5
II-19



B-136
I-5
II-20



B-137
I-5
II-21



B-138
I-5
II-22



B-139
I-5
II-23



B-140
I-5
II-24



B-141
I-5
II-25



B-142
I-5
II-26



B-143
I-5
II-27



B-144
I-5
II-28



B-145
I-5
II-29



B-146
I-6
II-1



B-147
I-6
II-2



B-148
I-6
II-3



B-149
I-6
II-4



B-150
I-6
II-5



B-151
I-6
II-6



B-152
I-6
II-7



B-153
I-6
II-8



B-154
I-6
II-9



B-155
I-6
II-10



B-156
I-6
II-11



B-157
I-6
II-12



B-158
I-6
II-13



B-159
I-6
II-14



B-160
I-6
II-15



B-161
I-6
II-16



B-162
I-6
II-17



B-163
I-6
II-18



B-164
I-6
II-19



B-165
I-6
II-20



B-166
I-6
II-21



B-167
I-6
II-22



B-168
I-6
II-23



B-169
I-6
II-24



B-170
I-6
II-25



B-171
I-6
II-26



B-172
I-6
II-27



B-173
I-6
II-28



B-174
I-6
II-29



B-175
I-7
II-1



B-176
I-7
II-2



B-177
I-7
II-3



B-178
I-7
II-4



B-179
I-7
II-5



B-180
I-7
II-6



B-181
I-7
II-7



B-182
I-7
II-8



B-183
I-7
II-9



B-184
I-7
II-10



B-185
I-7
II-11



B-186
I-7
II-12



B-187
I-7
II-13



B-188
I-7
II-14



B-189
I-7
II-15



B-190
I-7
II-16



B-191
I-7
II-17



B-192
I-7
II-18



B-193
I-7
II-19



B-194
I-7
II-20



B-195
I-7
II-21



B-196
I-7
II-22



B-197
I-7
II-23



B-198
I-7
II-24



B-199
I-7
II-25



B-200
I-7
II-26



B-201
I-7
II-27



B-202
I-7
II-28



B-203
I-7
II-29



B-204
I-8
II-1



B-205
I-8
II-2



B-206
I-8
II-3



B-207
I-8
II-4



B-208
I-8
II-5



B-209
I-8
II-6



B-210
I-8
II-7



B-211
I-8
II-8



B-212
I-8
II-9



B-213
I-8
II-10



B-214
I-8
II-11



B-215
I-8
II-12



B-216
I-8
II-13



B-217
I-8
II-14



B-218
I-8
II-15



B-219
I-8
II-16



B-220
I-8
II-17



B-221
I-8
II-18



B-222
I-8
II-19



B-223
I-8
II-20



B-224
I-8
II-21



B-225
I-8
II-22



B-226
I-8
II-23



B-227
I-8
II-24



B-228
I-8
II-25



B-229
I-8
II-26



B-230
I-8
II-27



B-231
I-8
II-28



B-232
I-8
II-29



B-233
I-9
II-1



B-234
I-9
II-2



B-235
I-9
II-3



B-236
I-9
II-4



B-237
I-9
II-5



B-238
I-9
II-6



B-239
I-9
II-7



B-240
I-9
II-8



B-241
I-9
II-9



B-242
I-9
II-10



B-243
I-9
II-11



B-244
I-9
II-12



B-245
I-9
II-13



B-246
I-9
II-14



B-247
I-9
II-15



B-248
I-9
II-16



B-249
I-9
II-17



B-250
I-9
II-18



B-251
I-9
II-19



B-252
I-9
II-20



B-253
I-9
II-21



B-254
I-9
II-22



B-255
I-9
II-23



B-256
I-9
II-24



B-257
I-9
II-25



B-258
I-9
II-26



B-259
I-9
II-27



B-260
I-9
II-28



B-261
I-9
II-29










According to one embodiment of the invention, preference is given to the following mixtures:


I-3 and boscalid II-24


I-8 and chlorothalonil II-21


I-6 and orysastrobin II-10


I-3 and pyraclostrobin II-9


I-3 and orysastrobin II-10


I-5 and chlorothalonil II-21


I-7 and chlorothalonil II-21


I-6 and boscalid II-24


I-5 and boscalid II-24


I-7 and boscalid II-24


I-7 and epoxiconazole II-1.


Further preferred components 2 are compounds II selected from the group of the following compounds:

    • II-30 cyflufenamid
    • II-31 spiroxamine
    • II-32 fenpropidin
    • II-33 proquinazid
    • II-34 dimoxystrobin
    • II-35 iprovalicarb
    • II-36 cyprodinil
    • II-37 folpet
    • II-38 fludioxonil
    • II-39 zoxamide
    • II-40 fluazinam
    • II-41 cyazofamid
    • II-42 benthiavalicarb
    • II-43 fluopicolide
    • II-44 ethaboxam
    • II-45 amisulbrom


Further preferred mixtures are the mixtures of Table B1, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.









TABLE B1







Mixtures comprising a component 1 selected from compounds


of the formula I and a component 2 selected from groups A to F










Component












Mixture
1
2







B1-1
I-1
II-30



B1-2
I-1
II-31



B1-3
I-1
II-32



B1-4
I-1
II-33



B1-5
I-1
II-34



B1-6
I-1
II-35



B1-7
I-1
II-36



B1-8
I-1
II-37



B1-9
I-1
II-38



B1-10
I-1
II-39



B1-11
I-1
II-40



B1-12
I-1
II-41



B1-13
I-1
II-42



B1-14
I-1
II-43



B1-15
I-1
II-44



B1-16
I-1
II-45



B1-17
I-2
II-30



B1-18
I-2
II-31



B1-19
I-2
II-32



B1-20
I-2
II-33



B1-21
I-2
II-34



B1-22
I-2
II-35



B1-23
I-2
II-36



B1-24
I-2
II-37



B1-25
I-2
II-38



B1-26
I-2
II-39



B1-27
I-2
II-40



B1-28
I-2
II-41



B1-29
I-2
II-42



B1-30
I-2
II-43



B1-31
I-2
II-44



B1-32
I-2
II-45



B1-33
I-3
II-30



B1-34
I-3
II-31



B1-35
I-3
II-32



B1-36
I-3
II-33



B1-37
I-3
II-34



B1-38
I-3
II-35



B1-39
I-3
II-36



B1-40
I-3
II-37



B1-41
I-3
II-38



B1-42
I-3
II-39



B1-43
I-3
II-40



B1-44
I-3
II-41



B1-45
I-3
II-42



B1-46
I-3
II-43



B1-47
I-3
II-44



B1-48
I-3
II-45



B1-49
I-4
II-30



B1-50
I-4
II-31



B1-51
I-4
II-32



B1-52
I-4
II-33



B1-53
I-4
II-34



B1-54
I-4
II-35



B1-55
I-4
II-36



B1-56
I-4
II-37



B1-57
I-4
II-38



B1-58
I-4
II-39



B1-59
I-4
II-40



B1-60
I-4
II-41



B1-61
I-4
II-42



B1-62
I-4
II-43



B1-63
I-4
II-44



B1-64
I-4
II-45



B1-65
I-5
II-30



B1-66
I-5
II-31



B1-67
I-5
II-32



B1-68
I-5
II-33



B1-69
I-5
II-34



B1-70
I-5
II-35



B1-71
I-5
II-36



B1-72
I-5
II-37



B1-73
I-5
II-38



B1-74
I-5
II-39



B1-75
I-5
II-40



B1-76
I-5
II-41



B1-77
I-5
II-42



B1-78
I-5
II-43



B1-79
I-5
II-44



B1-80
I-5
II-45



B1-81
I-6
II-30



B1-82
I-6
II-31



B1-83
I-6
II-32



B1-84
I-6
II-33



B1-85
I-6
II-34



B1-86
I-6
II-35



B1-87
I-6
II-36



B1-88
I-6
II-37



B1-89
I-6
II-38



B1-90
I-6
II-39



B1-91
I-6
II-40



B1-92
I-6
II-41



B1-93
I-6
II-42



B1-94
I-6
II-43



B1-95
I-6
II-44



B1-96
I-6
II-45



B1-97
I-7
II-30



B1-98
I-7
II-31



B1-99
I-7
II-32



B1-100
I-7
II-33



B1-101
I-7
II-34



B1-102
I-7
II-35



B1-103
I-7
II-36



B1-104
I-7
II-37



B1-105
I-7
II-38



B1-106
I-7
II-39



B1-107
I-7
II-40



B1-108
I-7
II-41



B1-109
I-7
II-42



B1-110
I-7
II-43



B1-111
I-7
II-44



B1-112
I-7
II-45



B1-113
I-8
II-30



B1-114
I-8
II-31



B1-115
I-8
II-32



B1-116
I-8
II-33



B1-117
I-8
II-34



B1-118
I-8
II-35



B1-119
I-8
II-36



B1-120
I-8
II-37



B1-121
I-8
II-38



B1-122
I-8
II-39



B1-123
I-8
II-40



B1-124
I-8
II-41



B1-125
I-8
II-42



B1-126
I-8
II-43



B1-127
I-8
II-44



B1-128
I-8
II-45



B1-129
I-9
II-30



B1-130
I-9
II-31



B1-131
I-9
II-32



B1-132
I-9
II-33



B1-133
I-9
II-34



B1-134
I-9
II-35



B1-135
I-9
II-36



B1-136
I-9
II-37



B1-137
I-9
II-38



B1-138
I-9
II-39



B1-139
I-9
II-40



B1-140
I-9
II-41



B1-141
I-9
II-42



B1-142
I-9
II-43



B1-143
I-9
II-44



B1-144
I-9
II-45










Further preferred components 2 are compounds II selected from the group of the following compounds:

    • II-46 prochloraz
    • II-47 dithianon
    • II-48 difenoconazole


Further preferred mixtures are the mixtures of Table B2, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.









TABLE B2







Mixtures comprising a component 1 selected from compounds


of the formula I and a component 2 selected from groups A to F










Component












Mixture
1
2







B2-1
I-1
II-46



B2-2
I-1
II-47



B2-3
I-1
II-48



B2-4
I-2
II-46



B2-5
I-2
II-47



B2-6
I-2
II-48



B2-7
I-3
II-46



B2-8
I-3
II-47



B2-9
I-3
II-48



B2-10
I-4
II-46



B2-11
I-4
II-47



B2-12
I-4
II-48



B2-13
I-5
II-46



B2-14
I-5
II-47



B2-15
I-5
II-48



B2-16
I-6
II-46



B2-17
I-6
II-47



B2-18
I-6
II-48



B2-19
I-7
II-46



B2-20
I-7
II-47



B2-21
I-7
II-48



B2-22
I-8
II-46



B2-23
I-8
II-47



B2-24
I-8
II-48



B2-25
I-9
II-46



B2-26
I-9
II-47



B2-27
I-9
II-48










Further preferred components 2 are compounds II selected from the group of the following compounds:

    • II-49 azoxystrobin
    • II-50 trifloxystrobin
    • II-51 penthiopyrad
    • II-56 picoxystrobin
    • II-57 fluoxastrobin


Further preferred mixtures are the mixtures of continuation of Table B2, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.












Continuation of Table B2: Mixtures comprising a component 1


selected from compounds of the formula I and a component 2


selected from groups A to F










Component












Mixture
1
2







B2-28
I-1
II-49



B2-29
I-1
II-50



B2-30
I-1
II-51



B2-31
I-1
II-56



B2-32
I-1
II-57



B2-33
I-2
II-49



B2-34
I-2
II-50



B2-35
I-2
II-51



B2-36
I-2
II-56



B2-37
I-2
II-57



B2-38
I-3
II-49



B2-39
I-3
II-50



B2-40
I-3
II-51



B2-41
I-3
II-56



B2-42
I-3
II-57



B2-43
I-4
II-49



B2-44
I-4
II-50



B2-45
I-4
II-51



B2-46
I-4
II-56



B2-47
I-4
II-57



B2-48
I-5
II-49



B2-49
I-5
II-50



B2-50
I-5
II-51



B2-51
I-5
II-56



B2-52
I-5
II-57



B2-53
I-6
II-49



B2-54
I-6
II-50



B2-55
I-6
II-51



B2-56
I-6
II-56



B2-57
I-6
II-57



B2-58
I-7
II-49



B2-59
I-7
II-50



B2-60
I-7
II-51



B2-61
I-7
II-56



B2-62
I-7
II-57



B2-63
I-8
II-49



B2-64
I-8
II-50



B2-65
I-8
II-51



B2-66
I-8
II-56



B2-67
I-8
II-57



B2-68
I-9
II-49



B2-69
I-9
II-50



B2-70
I-9
II-51



B2-71
I-9
II-56



B2-72
I-9
II-57










Further preferred components 2 are compounds II selected from the group of the growth regulators G), in particular selected from the following compounds:

    • II-52 mepiquat chloride
    • II-53 chlormequat chloride
    • II-54 trinexapac-ethyl
    • II-55 prohexadione-calcium


Further preferred mixtures are the mixtures of 2. Continuation of Table B2, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.












2. Continuation of Table B2: Mixtures comprising a component 1


selected from compounds of the formula I and a component 2


selected from group G)










Component












Mixture
1
2







B2-73
I-1
II-52



B2-74
I-1
II-53



B2-75
I-1
II-54



B2-76
I-1
II-55



B2-77
I-2
II-52



B2-78
I-2
II-53



B2-79
I-2
II-54



B2-80
I-2
II-55



B2-81
I-3
II-52



B2-82
I-3
II-53



B2-83
I-3
II-54



B2-84
I-3
II-55



B2-85
I-4
II-52



B2-86
I-4
II-53



B2-87
I-4
II-54



B2-88
I-4
II-55



B2-89
I-5
II-52



B2-90
I-5
II-53



B2-91
I-5
II-54



B2-92
I-5
II-55



B2-93
I-6
II-52



B2-94
I-6
II-53



B2-95
I-6
II-54



B2-96
I-6
II-55



B2-97
I-7
II-52



B2-98
I-7
II-53



B2-99
I-7
II-54



B2-100
I-7
II-55



B2-101
I-8
II-52



B2-102
I-8
II-53



B2-103
I-8
II-54



B2-104
I-8
II-55



B2-105
I-9
II-52



B2-106
I-9
II-53



B2-107
I-9
II-54



B2-108
I-9
II-55










According to a further embodiment, particularly preferred components 2 are compounds II selected from the group I), in particular selected from the following compounds:

    • II-1a acephate
    • II-2a chlorpyrifos
    • II-3a dimethoate
    • II-4a methamidophos
    • II-5a terbufos
    • II-6a aldicarb
    • II-7a carbofuran
    • II-8a bifenthrin
    • II-9a alpha-cypermethrin
    • II-10a deltamethrin
    • II-11a lambda-cyhalothrin
    • II-12a betacyfluthrin
    • II-13a zetacypermethrin
    • II-14a esfenvalerate
    • II-15a pirimicarb
    • II-16a tefluthrin
    • II-17a spirotetramat
    • II-18a endosulfan
    • II-19a abamectin
    • II-20a spinosad
    • II-21a spinetoram
    • II-22a hydramethylnon
    • II-23a fenbutatin oxide
    • II-24a chlorfenapyr
    • II-25a cyazypyr
    • II-26a cyflumetofen
    • II-27a flubendiamide
    • II-28a indoxacarb
    • II-29a metaflumizon
    • II-30a fipronil
    • II-31a [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-(cyclopropanecarbonyloxy)-6,12-dihydroxy-4,6a,12b-trimethyl-11-oxo-9-(pyridin-3-yl)-1,2,3,4,4a,5,6,6a,12a,12b-decahydro-11H,12H-benzo[f]pyrano[4,3-b]chromen-4-yl]methyl cyclopropanecarboxylate.


Particularly preferred mixtures are the mixtures of Table B3, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.









TABLE B3







Mixtures comprising a component 1 selected from preferred


compounds of the formula I and a component 2 selected from


group I)










Component












Mixture
1
2







B3-1
I-1
II-1a



B3-2
I-1
II-2a



B3-3
I-1
II-3a



B3-4
I-1
II-4a



B3-5
I-1
II-5a



B3-6
I-1
II-6a



B3-7
I-1
II-7a



B3-8
I-1
II-8a



B3-9
I-1
II-9a



B3-10
I-1
II-10a



B3-11
I-1
II-11a



B3-12
I-1
II-12a



B3-13
I-1
II-13a



B3-14
I-1
II-14a



B3-15
I-1
II-15a



B3-16
I-1
II-16a



B3-17
I-1
II-17a



B3-18
I-1
II-18a



B3-19
I-1
II-19a



B3-20
I-1
II-20a



B3-21
I-1
II-21a



B3-22
I-1
II-22a



B3-23
I-1
II-23a



B3-24
I-1
II-24a



B3-25
I-1
II-25a



B3-26
I-1
II-26a



B3-27
I-1
II-27a



B3-28
I-1
II-28a



B3-29
I-1
II-29a



B3-30
I-1
II-30a



B3-31
I-1
II-31a



B3-32
I-2
II-1a



B3-33
I-2
II-2a



B3-34
I-2
II-3a



B3-35
I-2
II-4a



B3-36
I-2
II-5a



B3-37
I-2
II-6a



B3-38
I-2
II-7a



B3-39
I-2
II-8a



B3-40
I-2
II-9a



B3-41
I-2
II-10a



B3-42
I-2
II-11a



B3-43
I-2
II-12a



B3-44
I-2
II-13a



B3-45
I-2
II-14a



B3-46
I-2
II-15a



B3-47
I-2
II-16a



B3-48
I-2
II-17a



B3-49
I-2
II-18a



B3-50
I-2
II-19a



B3-51
I-2
II-20a



B3-52
I-2
II-21a



B3-53
I-2
II-22a



B3-54
I-2
II-23a



B3-55
I-2
II-24a



B3-56
I-2
II-25a



B3-57
I-2
II-26a



B3-58
I-2
II-27a



B3-59
I-2
II-28a



B3-60
I-2
II-29a



B3-61
I-2
II-30a



B3-62
I-2
II-31a



B3-63
I-3
II-1a



B3-64
I-3
II-2a



B3-65
I-3
II-3a



B3-66
I-3
II-4a



B3-67
I-3
II-5a



B3-68
I-3
II-6a



B3-69
I-3
II-7a



B3-70
I-3
II-8a



B3-71
I-3
II-9a



B3-72
I-3
II-10a



B3-73
I-3
II-11a



B3-74
I-3
II-12a



B3-75
I-3
II-13a



B3-76
I-3
II-14a



B3-77
I-3
II-15a



B3-78
I-3
II-16a



B3-79
I-3
II-17a



B3-80
I-3
II-18a



B3-81
I-3
II-19a



B3-82
I-3
II-20a



B3-83
I-3
II-21a



B3-84
I-3
II-22a



B3-85
I-3
II-23a



B3-86
I-3
II-24a



B3-87
I-3
II-25a



B3-88
I-3
II-26a



B3-89
I-3
II-27a



B3-90
I-3
II-28a



B3-91
I-3
II-29a



B3-92
I-3
II-30a



B3-93
I-3
II-31a



B3-94
I-4
II-1a



B3-95
I-4
II-2a



B3-96
I-4
II-3a



B3-97
I-4
II-4a



B3-98
I-4
II-5a



B3-99
I-4
II-6a



B3-100
I-4
II-7a



B3-101
I-4
II-8a



B3-102
I-4
II-9a



B3-103
I-4
II-10a



B3-104
I-4
II-11a



B3-105
I-4
II-12a



B3-106
I-4
II-13a



B3-107
I-4
II-14a



B3-108
I-4
II-15a



B3-109
I-4
II-16a



B3-110
I-4
II-17a



B3-111
I-4
II-18a



B3-112
I-4
II-19a



B3-113
I-4
II-20a



B3-114
I-4
II-21a



B3-115
I-4
II-22a



B3-116
I-4
II-23a



B3-117
I-4
II-24a



B3-118
I-4
II-25a



B3-119
I-4
II-26a



B3-120
I-4
II-27a



B3-121
I-4
II-28a



B3-122
I-4
II-29a



B3-123
I-4
II-30a



B3-124
I-4
II-31a



B3-125
I-5
II-1a



B3-126
I-5
II-2a



B3-127
I-5
II-3a



B3-128
I-5
II-4a



B3-129
I-5
II-5a



B3-130
I-5
II-6a



B3-131
I-5
II-7a



B3-132
I-5
II-8a



B3-133
I-5
II-9a



B3-134
I-5
II-10a



B3-135
I-5
II-11a



B3-136
I-5
II-12a



B3-137
I-5
II-13a



B3-138
I-5
II-14a



B3-139
I-5
II-15a



B3-140
I-5
II-16a



B3-141
I-5
II-17a



B3-142
I-5
II-18a



B3-143
I-5
II-19a



B3-144
I-5
II-20a



B3-145
I-5
II-21a



B3-146
I-5
II-22a



B3-147
I-5
II-23a



B3-148
I-5
II-24a



B3-149
I-5
II-25a



B3-150
I-5
II-26a



B3-151
I-5
II-27a



B3-152
I-5
II-28a



B3-153
I-5
II-29a



B3-154
I-5
II-30a



B3-155
I-5
II-31a



B3-156
I-6
II-1a



B3-157
I-6
II-2a



B3-158
I-6
II-3a



B3-159
I-6
II-4a



B3-160
I-6
II-5a



B3-161
I-6
II-6a



B3-162
I-6
II-7a



B3-163
I-6
II-8a



B3-164
I-6
II-9a



B3-165
I-6
II-10a



B3-166
I-6
II-11a



B3-167
I-6
II-12a



B3-168
I-6
II-13a



B3-169
I-6
II-14a



B3-170
I-6
II-15a



B3-171
I-6
II-16a



B3-172
I-6
II-17a



B3-173
I-6
II-18a



B3-174
I-6
II-19a



B3-175
I-6
II-20a



B3-176
I-6
II-21a



B3-177
I-6
II-22a



B3-178
I-6
II-23a



B3-179
I-6
II-24a



B3-180
I-6
II-25a



B3-181
I-6
II-26a



B3-182
I-6
II-27a



B3-183
I-6
II-28a



B3-184
I-6
II-29a



B3-185
I-6
II-30a



B3-186
I-6
II-31a



B3-187
I-7
II-1a



B3-188
I-7
II-2a



B3-189
I-7
II-3a



B3-190
I-7
II-4a



B3-191
I-7
II-5a



B3-192
I-7
II-6a



B3-193
I-7
II-7a



B3-194
I-7
II-8a



B3-195
I-7
II-9a



B3-196
I-7
II-10a



B3-197
I-7
II-11a



B3-198
I-7
II-12a



B3-199
I-7
II-13a



B3-200
I-7
II-14a



B3-201
I-7
II-15a



B3-202
I-7
II-16a



B3-203
I-7
II-17a



B3-204
I-7
II-18a



B3-205
I-7
II-19a



B3-206
I-7
II-20a



B3-207
I-7
II-21a



B3-208
I-7
II-22a



B3-209
I-7
II-23a



B3-210
I-7
II-24a



B3-211
I-7
II-25a



B3-212
I-7
II-26a



B3-213
I-7
II-27a



B3-214
I-7
II-28a



B3-215
I-7
II-29a



B3-216
I-7
II-30a



B3-217
I-7
II-31a



B3-218
I-8
II-1a



B3-219
I-8
II-2a



B3-220
I-8
II-3a



B3-221
I-8
II-4a



B3-222
I-8
II-5a



B3-223
I-8
II-6a



B3-224
I-8
II-7a



B3-225
I-8
II-8a



B3-226
I-8
II-9a



B3-227
I-8
II-10a



B3-228
I-8
II-11a



B3-229
I-8
II-12a



B3-230
I-8
II-13a



B3-231
I-8
II-14a



B3-232
I-8
II-15a



B3-233
I-8
II-16a



B3-234
I-8
II-17a



B3-235
I-8
II-18a



B3-236
I-8
II-19a



B3-237
I-8
II-20a



B3-238
I-8
II-21a



B3-239
I-8
II-22a



B3-240
I-8
II-23a



B3-241
I-8
II-24a



B3-242
I-8
II-25a



B3-243
I-8
II-26a



B3-244
I-8
II-27a



B3-245
I-8
II-28a



B3-246
I-8
II-29a



B3-247
I-8
II-30a



B3-248
I-8
II-31a



B3-249
I-9
II-1a



B3-250
I-9
II-2a



B3-251
I-9
II-3a



B3-252
I-9
II-4a



B3-253
I-9
II-5a



B3-254
I-9
II-6a



B3-255
I-9
II-7a



B3-256
I-9
II-8a



B3-257
I-9
II-9a



B3-258
I-9
II-10a



B3-259
I-9
II-11a



B3-260
I-9
II-12a



B3-261
I-9
II-13a



B3-262
I-9
II-14a



B3-263
I-9
II-15a



B3-264
I-9
II-16a



B3-265
I-9
II-17a



B3-266
I-9
II-18a



B3-267
I-9
II-19a



B3-268
I-9
II-20a



B3-269
I-9
II-21a



B3-270
I-9
II-22a



B3-271
I-9
II-23a



B3-272
I-9
II-24a



B3-273
I-9
II-25a



B3-274
I-9
II-26a



B3-275
I-9
II-27a



B3-276
I-9
II-28a



B3-277
I-9
II-29a



B3-278
I-9
II-30a



B3-279
I-9
II-31a










According to a further embodiment, particularly preferred components 2 are compounds II selected from the group of the following compounds:

    • II-32a clothianidin
    • II-33a dinotefuran
    • II-34a imidacloprid
    • II-35a thiamethoxam
    • II-36a nitenpyram
    • II-37a acetamiprid
    • II-38a thiacloprid


Particularly preferred mixtures are the mixtures of Table B4, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.









TABLE B4







Mixtures comprising a component 1 selected from preferred


compounds of the formula I and a component 2 selected from


group I)










Component












Mixture
1
2







B4-1
I-1
II-32a



B4-2
I-1
II-33a



B4-3
I-1
II-34a



B4-4
I-1
II-35a



B4-5
I-1
II-36a



B4-6
I-1
II-37a



B4-7
I-1
II-38a



B4-8
I-2
II-32a



B4-9
I-2
II-33a



B4-10
I-2
II-34a



B4-11
I-2
II-35a



B4-12
I-2
II-36a



B4-13
I-2
II-37a



B4-14
I-2
II-38a



B4-15
I-3
II-32a



B4-16
I-3
II-33a



B4-17
I-3
II-34a



B4-18
I-3
II-35a



B4-19
I-3
II-36a



B4-20
I-3
II-37a



B4-21
I-3
II-38a



B4-22
I-4
II-32a



B4-23
I-4
II-33a



B4-24
I-4
II-34a



B4-25
I-4
II-35a



B4-26
I-4
II-36a



B4-27
I-4
II-37a



B4-28
I-4
II-38a



B4-29
I-5
II-32a



B4-30
I-5
II-33a



B4-31
I-5
II-34a



B4-32
I-5
II-35a



B4-33
I-5
II-36a



B4-34
I-5
II-37a



B4-35
I-5
II-38a



B4-36
I-6
II-32a



B4-37
I-6
II-33a



B4-38
I-6
II-34a



B4-39
I-6
II-35a



B4-40
I-6
II-36a



B4-41
I-6
II-37a



B4-42
I-6
II-38a



B4-43
I-7
II-32a



B4-44
I-7
II-33a



B4-45
I-7
II-34a



B4-46
I-7
II-35a



B4-47
I-7
II-36a



B4-48
I-7
II-37a



B4-49
I-7
II-38a



B4-50
I-8
II-32a



B4-51
I-8
II-33a



B4-52
I-8
II-34a



B4-53
I-8
II-35a



B4-54
I-8
II-36a



B4-55
I-8
II-37a



B4-56
I-8
II-38a



B4-57
I-9
II-32a



B4-58
I-9
II-33a



B4-59
I-9
II-34a



B4-60
I-9
II-35a



B4-61
I-9
II-36a



B4-62
I-9
II-37a



B4-63
I-9
II-38a










According to a further embodiment, particularly preferred components 2 are compounds II selected from the active compounds of group H). With special preference, the active compounds according to this embodiment are selected from the group of the following compounds of group H):

    • II-1b glyphosate
    • II-2b imazamox


Particularly preferred mixtures are the mixtures of Table B5, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are binary mixtures comprising, as active compounds, in each case only these two components.









TABLE B5







Mixtures comprising a component 1 selected from preferred


compounds of the formula I and a component 2 selected from


group H)










Component












Mixture
1
2







B5-1
I-1
II-1b



B5-2
I-1
II-2b



B5-3
I-2
II-1b



B5-4
I-2
II-2b



B5-5
I-3
II-1b



B5-6
I-3
II-2b



B5-7
I-4
II-1b



B5-8
I-4
II-2b



B5-9
I-5
II-1b



B5-10
I-5
II-2b



B5-11
I-6
II-1b



B5-12
I-6
II-2b



B5-13
I-7
II-1b



B5-14
I-7
II-2b



B5-15
I-8
II-1b



B5-16
I-8
II-2b



B5-17
I-9
II-1b



B5-18
I-9
II-2b










In a preferred embodiment, the invention relates to fungicidal mixtures, comprising a component 1 and a component 2 (compound II) and a further component 3 (further compound II), with the proviso that component 2 and component 3 are not identical. According to a specific aspect, these are ternary mixtures comprising, as active compounds, in each case only these three components.


More preferred mixtures are the mixtures of Table B, where each row corresponds to one aspect of the mixtures according to the invention. According to a specific aspect, these are ternary mixtures comprising, as active compounds, in each case only these three components.


Furthermore, the present invention relates to compositions of a compound I (component 1) with two further active compounds selected from the compounds II (component 2 and component 3). In particular, the present invention relates to compositions of the mixtures, described as preferred, of the compounds I and II with a further active compound II. Here, particular preference is given to ternary mixtures comprising, as active compounds, in each case only these three components.


A further aspect of the invention relates to the compositions T-1 to T-348 listed in Table B, where in each case one row of Table B corresponds to an agrochemical composition comprising one of the mixtures individualized in the present description (referred to as “Mixture B”) of the compounds of the formula I and the compounds II (component 1 and 2) and the respective further active compound from groups A) to I) (component 3) stated in the row in question. In the compositions described, the active compounds are in each case preferably present in synergistically effective amounts.


The invention relates in particular to the compositions of the mixtures A-1 to A-366 with a further compound II selected from rows B-1 to B-348 in the column “Component 3” of Table B, in particular selected from the compounds II-1 to II-29. In each case, components 2 and 3 must not be identical. According to a specific aspect, these are ternary mixtures comprising, as active compounds, in each case only the three components.









TABLE B







Mixtures comprising an Individualized mixture of component 1


and component 2 (referred as to Mixture B) and also a component 3


selected from groups A to I:









Row
Components 1 and 2
Component 3





B-1
an individualized mixture B
azoxystrobin


B-2
an individualized mixture B
dimoxystrobin


B-3
an individualized mixture B
enestroburin


B-4
an individualized mixture B
fluoxastrobin


B-5
an individualized mixture B
kresoxim-methyl


B-6
an individualized mixture B
metominostrobin


B-7
an individualized mixture B
orysastrobin


B-8
an individualized mixture B
picoxystrobin


B-9
an individualized mixture B
pyraclostrobin


B-10
an individualized mixture B
pyribencarb


B-11
an individualized mixture B
trifloxystrobin


B-12
an individualized mixture B
2-(2-(6-(3-chloro-2-methylphenoxy)-




5-fluoropyrimidin-4-yloxy)phenyl)-




2-methoxyimino-N-methylacetamide


B-13
an individualized mixture B
methyl 2-(o-((2,5-dimethylphenyloxy-




methylene)phenyl)-3-methoxyacrylate


B-14
an individualized mixture B
methyl 3-methoxy-2-(2-(N-(4-




methoxy-




phenyl)cyclopropanecarboximidoylsulfanylmethyl)phenyl)acrylate


B-15
an individualized mixture B
2-(2-(3-(2,6-dichlorophenyl)-1-




methylallylideneaminooxymethyl)phenyl)-




2-methoxyimino-N-




methylacetamide


B-16
an individualized mixture B
benalaxyl


B-17
an individualized mixture B
benalaxyl-M


B-18
an individualized mixture B
benodanil


B-19
an individualized mixture B
bixafen


B-20
an individualized mixture B
boscalid


B-21
an individualized mixture B
carboxin


B-22
an individualized mixture B
fenfuram


B-23
an individualized mixture B
fenhexamid


B-24
an individualized mixture B
flutolanil


B-25
an individualized mixture B
furametpyr


B-26
an individualized mixture B
isopyrazam


B-27
an individualized mixture B
isotianil


B-28
an individualized mixture B
kiralaxyl


B-29
an individualized mixture B
mepronil


B-30
an individualized mixture B
metalaxyl


B-31
an individualized mixture B
metalaxyl-M


B-32
an individualized mixture B
ofurace


B-33
an individualized mixture B
oxadixyl


B-34
an individualized mixture B
oxycarboxin


B-35
an individualized mixture B
penflufen


B-36
an individualized mixture B
penthiopyrad


B-37
an individualized mixture B
sedaxane


B-38
an individualized mixture B
tecloftalam


B-39
an individualized mixture B
thifluzamide


B-40
an individualized mixture B
tiadinil


B-41
an individualized mixture B
2-amino-4-methylthiazole-5-




carboxanilide


B-42
an individualized mixture B
2-chloro-N-(1,1,3-trimethylindan-4-yl)-




nicotinamide


B-43
an individualized mixture B
N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-




difluoromethyl-1-methyl-1H-pyrazole-




4-carboxamide


B-44
an individualized mixture B
N-(4′-trifluoromethylthiobiphenyl-2-yl)-




3-difluoromethyl-1-methyl-1H-




pyrazole-4-carboxamide


B-45
an individualized mixture B
N-(2-(1,3-dimethylbutyl)phenyl)-1,3-




dimethyl-5-fluoro-1H-pyrazole-4-




carboxamide


B-46
an individualized mixture B
N-(2-(1,3,3-trimethylbutyl)phenyl)-1,3-




dimethyl-5-fluoro-1H-pyrazole-4-




carboxamide


B-47
an individualized mixture B
dimethomorph


B-48
an individualized mixture B
flumorph


B-49
an individualized mixture B
pyrimorph


B-50
an individualized mixture B
flumetover


B-51
an individualized mixture B
fluopicolide


B-52
an individualized mixture B
fluopyram


B-53
an individualized mixture B
zoxamide


B-54
an individualized mixture B
N-(3-ethyl-3,5,5-trimethylcyclohexyl)-




3-formylamino-2-hydroxybenzamide


B-55
an individualized mixture B
carpropamid


B-56
an individualized mixture B
diclocymet


B-57
an individualized mixture B
mandipropamid


B-58
an individualized mixture B
oxytetracyclin


B-59
an individualized mixture B
silthiofam


B-60
an individualized mixture B
N-(6-methoxypyridin-3-




yl)cyclopropanecarboxamide


B-61
an individualized mixture B
azaconazole


B-62
an individualized mixture B
bitertanol


B-63
an individualized mixture B
bromuconazole


B-64
an individualized mixture B
cyproconazole


B-65
an individualized mixture B
difenoconazole


B-66
an individualized mixture B
diniconazole


B-67
an individualized mixture B
diniconazole-M


B-68
an individualized mixture B
epoxiconazole


B-69
an individualized mixture B
fenbuconazole


B-70
an individualized mixture B
fluquinconazole


B-71
an individualized mixture B
flusilazole


B-72
an individualized mixture B
flutriafol


B-73
an individualized mixture B
hexaconazole


B-74
an individualized mixture B
imibenconazole


B-75
an individualized mixture B
ipconazole


B-76
an individualized mixture B
metconazole


B-77
an individualized mixture B
myclobutanil


B-78
an individualized mixture B
oxpoconazole


B-79
an individualized mixture B
paclobutrazole


B-80
an individualized mixture B
penconazole


B-81
an individualized mixture B
propiconazole


B-82
an individualized mixture B
prothioconazole


B-83
an individualized mixture B
simeconazole


B-84
an individualized mixture B
tebuconazole


B-85
an individualized mixture B
tetraconazole


B-86
an individualized mixture B
triadimefon


B-87
an individualized mixture B
triadimenol


B-88
an individualized mixture B
triticonazole


B-89
an individualized mixture B
uniconazole


B-90
an individualized mixture B
1-(4-chlorophenyl)-2-([1,2,4]triazol-1-




yl)cycloheptanol


B-91
an individualized mixture B
cyazofamid


B-92
an individualized mixture B
imazalil


B-93
an individualized mixture B
imazalil-sulfate


B-94
an individualized mixture B
pefurazoate


B-95
an individualized mixture B
prochloraz


B-96
an individualized mixture B
triflumizole


B-97
an individualized mixture B
benomyl


B-98
an individualized mixture B
carbendazim


B-99
an individualized mixture B
fuberidazole


B-100
an individualized mixture B
thiabendazole


B-101
an individualized mixture B
ethaboxam


B-102
an individualized mixture B
etridiazole


B-103
an individualized mixture B
hymexazole


B-104
an individualized mixture B
2-(4-chlorophenyl)-N-[4-(3,4-




dimethoxyphenyl)isoxazol-5-yl]-2-




prop-2-ynyloxyacetamide


B-105
an individualized mixture B
fluazinam


B-106
an individualized mixture B
pyrifenox


B-107
an individualized mixture B
3-[5-(4-chlorophenyl)-2,3-dimethyl-




isoxazolidin-3-yl]pyridine


B-108
an individualized mixture B
3-[5-(4-methylphenyl)-2,3-




dimethylisoxazolidin-3-yl]pyridine


B-109
an individualized mixture B
2,3,5,6-tetrachloro-4-methanesulfonyl-




pyridine


B-110
an individualized mixture B
3,4,5-trichloropyridine-2,6-




dicarbonitrile


B-111
an individualized mixture B
N-(1-(5-bromo-3-chloropyridin-2-




yl)ethyl)-2,4-dichloronicotinamide


B-112
an individualized mixture B
N-((5-bromo-3-chloropyridin-2-




yl)methyl)-2,4-dichloronicotinamide


B-113
an individualized mixture B
bupirimate


B-114
an individualized mixture B
cyprodinil


B-115
an individualized mixture B
diflumetorim


B-116
an individualized mixture B
fenarimol


B-117
an individualized mixture B
ferimzone


B-118
an individualized mixture B
mepanipyrim


B-119
an individualized mixture B
nitrapyrin


B-120
an individualized mixture B
nuarimol


B-121
an individualized mixture B
pyrimethanil


B-122
an individualized mixture B
triforine


B-123
an individualized mixture B
fenpiclonil


B-124
an individualized mixture B
fludioxonil


B-125
an individualized mixture B
aldimorph


B-126
an individualized mixture B
dodemorph


B-127
an individualized mixture B
dodemorph acetate


B-128
an individualized mixture B
fenpropimorph


B-129
an individualized mixture B
tridemorph


B-130
an individualized mixture B
fenpropidin


B-131
an individualized mixture B
fluoroimide


B-132
an individualized mixture B
iprodione


B-133
an individualized mixture B
procymidone


B-134
an individualized mixture B
vinclozolin


B-135
an individualized mixture B
famoxadone


B-136
an individualized mixture B
fenamidone


B-137
an individualized mixture B
flutianil


B-138
an individualized mixture B
octhilinone


B-139
an individualized mixture B
probenazole


B-140
an individualized mixture B
S-allyl 5-amino-2-isopropyl-4-




orthotolylpyrazol-3-one-1-




thiocarboxylate


B-141
an individualized mixture B
acibenzolar-S-methyl


B-142
an individualized mixture B
amisulbrom


B-143
an individualized mixture B
anilazine


B-144
an individualized mixture B
blasticidin-S


B-145
an individualized mixture B
captafol


B-146
an individualized mixture B
captan


B-147
an individualized mixture B
chinomethionat


B-148
an individualized mixture B
dazomet


B-149
an individualized mixture B
debacarb


B-150
an individualized mixture B
diclomezine


B-151
an individualized mixture B
difenzoquat


B-152
an individualized mixture B
difenzoquat methylsulfate


B-153
an individualized mixture B
fenoxanil


B-154
an individualized mixture B
folpet


B-155
an individualized mixture B
oxolinic acid


B-156
an individualized mixture B
piperalin


B-157
an individualized mixture B
proquinazid


B-158
an individualized mixture B
pyroquilon


B-159
an individualized mixture B
quinoxyfen


B-160
an individualized mixture B
triazoxide


B-161
an individualized mixture B
tricyclazole


B-162
an individualized mixture B
2-butoxy-6-iodo-3-propylchromen-4-




one


B-163
an individualized mixture B
5-chloro-1-(4,6-dimethoxypyrimidin-2-




yl)-2-methyl-1H-benzimidazole


B-164
an individualized mixture B
5-chloro-7-(4-methylpiperidin-1-yl)-




6-(2,4,6-trifluorophenyl)-




[1,2,4]triazolo[1,5-a]pyrimidine


B-165
an individualized mixture B
5-ethyl-6-octyl-[1,2,4]triazolo[1,5-




a]pyrimidin-7-ylamine


B-166
an individualized mixture B
ferbam


B-167
an individualized mixture B
mancozeb


B-168
an individualized mixture B
maneb


B-169
an individualized mixture B
metam


B-170
an individualized mixture B
methasulfocarb


B-171
an individualized mixture B
metiram


B-172
an individualized mixture B
propineb


B-173
an individualized mixture B
thiram


B-174
an individualized mixture B
zineb


B-175
an individualized mixture B
ziram


B-176
an individualized mixture B
diethofencarb


B-177
an individualized mixture B
benthiavalicarb


B-178
an individualized mixture B
iprovalicarb


B-179
an individualized mixture B
propamocarb


B-180
an individualized mixture B
propamocarb hydrochloride


B-181
an individualized mixture B
valiphenal


B-182
an individualized mixture B
4-fluorophenyl N-(1-(1-(4-




cyanophenyl)ethanesulfonyl)but-2-




yl)carbamate


B-183
an individualized mixture B
dodine


B-184
an individualized mixture B
dodine free base


B-185
an individualized mixture B
guazatine


B-186
an individualized mixture B
guazatine acetate


B-187
an individualized mixture B
iminoctadine


B-188
an individualized mixture B
iminoctadine triacetate


B-189
an individualized mixture B
iminoctadine tris(albesilate)


B-190
an individualized mixture B
kasugamycin


B-191
an individualized mixture B
kasugamycin hydrochloride hydrate


B-192
an individualized mixture B
polyoxin


B-193
an individualized mixture B
streptomycin


B-194
an individualized mixture B
validamycin A


B-195
an individualized mixture B
binapacryl


B-196
an individualized mixture B
dicloran


B-197
an individualized mixture B
dinobuton


B-198
an individualized mixture B
dinocap


B-199
an individualized mixture B
nitrothal-isopropyl


B-200
an individualized mixture B
tecnazen


B-201
an individualized mixture B
fentin salts


B-202
an individualized mixture B
dithianon


B-203
an individualized mixture B
isoprothiolane


B-204
an individualized mixture B
edifenphos


B-205
an individualized mixture B
fosetyl, fosetyl aluminum


B-206
an individualized mixture B
iprobenfos


B-207
an individualized mixture B
phosphorous acid and derivatives


B-208
an individualized mixture B
pyrazophos


B-209
an individualized mixture B
tolclofos-methyl


B-210
an individualized mixture B
chlorthalonil


B-211
an individualized mixture B
dichlofluanid


B-212
an individualized mixture B
dichlorophene


B-213
an individualized mixture B
flusulfamide


B-214
an individualized mixture B
hexachlorobenzene


B-215
an individualized mixture B
pencycuron


B-216
an individualized mixture B
pentachlorophenol and salts


B-217
an individualized mixture B
phthalide


B-218
an individualized mixture B
quintozene


B-219
an individualized mixture B
thiophanate methyl


B-220
an individualized mixture B
tolylfluanid


B-221
an individualized mixture B
N-(4-chloro-2-nitrophenyl)-N-ethyl-




4-methylbenzenesulfonamide


B-222
an individualized mixture B
Bordeaux mixture


B-223
an individualized mixture B
copper acetate


B-224
an individualized mixture B
copper hydroxide


B-225
an individualized mixture B
copper oxychloride


B-226
an individualized mixture B
basic copper sulfate


B-227
an individualized mixture B
sulfur


B-228
an individualized mixture B
biphenyl


B-229
an individualized mixture B
bronopol


B-230
an individualized mixture B
cyflufenamid


B-231
an individualized mixture B
cymoxanil


B-232
an individualized mixture B
diphenylamine


B-233
an individualized mixture B
metrafenone


B-234
an individualized mixture B
mildiomycin


B-235
an individualized mixture B
oxine-copper


B-236
an individualized mixture B
prohexadione-calcium


B-237
an individualized mixture B
spiroxamine


B-238
an individualized mixture B
tolylfluanid


B-239
an individualized mixture B
N-(cyclopropylmethoxyimino-(6-




difluoromethoxy-2,3-




difluorophenyl)methyl)-




2-phenylacetamide


B-240
an individualized mixture B
N′-(4-(4-chloro-3-




trifluoromethylphenoxy)-




2,5-dimethylphenyl)-N-ethyl-N-methyl-




formamidine


B-241
an individualized mixture B
N′-(4-(4-fluoro-3-




trifluoromethylphenoxy)-




2,5-dimethylphenyl)-N-ethyl-N-methyl-




formamidine


B-242
an individualized mixture B
N′-(2-methyl-5-trifluoromethyl-4-(3-tri-




methylsilanylpropoxy)phenyl)-N-ethyl-




N-methylformamidine


B-243
an individualized mixture B
N′-(5-difluoromethyl-2-methyl-4-(3-tri-




methylsilanylpropoxy)phenyl)-N-ethyl-




N-methylformamidine


B-244
an individualized mixture B
methyl N-(1,2,3,4-




tetrahydronaphthalen-1-yl)-2-{1-[2-(5-




methyl-3-trifluoromethyl-pyrazol-1-




yl)acetyl]piperidin-4-yl}thiazole-4-




carboxamide


B-245
an individualized mixture B
methyl (R)-N-(1,2,3,4-




tetrahydronaphthalen-1-yl)-2-{1-[2-(5-




methyl-3-trifluoromethyl-pyrazol-1-




yl)acetyl]piperidin-4-yl}thiazole-4-




carboxamide


B-246
an individualized mixture B
6-tert-butyl-8-fluoro-2,3-




dimethylquinolin-4-yl acetate


B-247
an individualized mixture B
6-tert-butyl-8-fluoro-2,3-




dimethylquinolin-4-yl methoxyacetate


B-248
an individualized mixture B
N-methyl-2-{1-[(5-methyl-3-trifluoro-




methyl-1H-pyrazol-1-




yl)acetyl]piperidin-4-yl}-N-[(1R)-




1,2,3,4-tetrahydronaphthalen-1-yl]-4-




thiazolecarboxamide


B-249
an individualized mixture B
carbaryl


B-250
an individualized mixture B
carbofuran


B-251
an individualized mixture B
carbosulfan


B-252
an individualized mixture B
methomylthiodicarb


B-253
an individualized mixture B
bifenthrin


B-254
an individualized mixture B
cyfluthrin


B-255
an individualized mixture B
cypermethrin


B-256
an individualized mixture B
alpha-cypermethrin


B-257
an individualized mixture B
zeta-cypermethrin


B-258
an individualized mixture B
deltamethrin


B-259
an individualized mixture B
esfenvalerate


B-260
an individualized mixture B
lambda-cyhalothrin


B-261
an individualized mixture B
permethrin


B-262
an individualized mixture B
tefluthrin


B-263
an individualized mixture B
diflubenzuron


B-264
an individualized mixture B
flufenoxuron


B-265
an individualized mixture B
lufenuron


B-266
an individualized mixture B
teflubenzuron


B-267
an individualized mixture B
spirotetramate


B-268
an individualized mixture B
clothianidin


B-269
an individualized mixture B
dinotefuran


B-270
an individualized mixture B
imidacloprid


B-271
an individualized mixture B
thiamethoxam


B-272
an individualized mixture B
acetamiprid


B-273
an individualized mixture B
thiacloprid


B-274
an individualized mixture B
endosulfan


B-275
an individualized mixture B
fipronil


B-276
an individualized mixture B
abamectin


B-277
an individualized mixture B
emamectin


B-278
an individualized mixture B
spinosad


B-279
an individualized mixture B
spinetoram


B-280
an individualized mixture B
hydramethylnon


B-281
an individualized mixture B
chlorfenapyr


B-282
an individualized mixture B
fenbutatin oxide


B-283
an individualized mixture B
indoxacarb


B-284
an individualized mixture B
metaflumizone


B-285
an individualized mixture B
flonicamid


B-286
an individualized mixture B
lubendiamid


B-287
an individualized mixture B
chlorantraniliprol


B-288
an individualized mixture B
cyazypyr (HGW86)


B-289
an individualized mixture B
cyflumetofen


B-290
an individualized mixture B
acetochlor


B-291
an individualized mixture B
dimethenamid


B-292
an individualized mixture B
metolachlor


B-293
an individualized mixture B
metazachlor


B-294
an individualized mixture B
glyphosate


B-295
an individualized mixture B
glufosinate


B-296
an individualized mixture B
sulfosate


B-297
an individualized mixture B
clodinafop


B-298
an individualized mixture B
fenoxaprop


B-299
an individualized mixture B
fluazifop


B-300
an individualized mixture B
haloxyfop


B-301
an individualized mixture B
paraquat


B-302
an individualized mixture B
phenmedipham


B-303
an individualized mixture B
clethodim


B-304
an individualized mixture B
cycloxydim


B-305
an individualized mixture B
profoxydim


B-306
an individualized mixture B
sethoxydim


B-307
an individualized mixture B
tepraloxydim


B-308
an individualized mixture B
pendimethalin


B-309
an individualized mixture B
prodiamine


B-310
an individualized mixture B
trifluralin


B-311
an individualized mixture B
acifluorfen


B-312
an individualized mixture B
bromoxynil


B-313
an individualized mixture B
imazamethabenz


B-314
an individualized mixture B
imazamox


B-315
an individualized mixture B
imazapic


B-316
an individualized mixture B
imazapyr


B-317
an individualized mixture B
imazaquin


B-318
an individualized mixture B
imazethapyr


B-319
an individualized mixture B
2,4-dichlorophenoxyacetic acid (2,4-




D)


B-320
an individualized mixture B
chloridazon


B-321
an individualized mixture B
clopyralid


B-322
an individualized mixture B
fluroxypyr


B-323
an individualized mixture B
picloram


B-324
an individualized mixture B
picolinafen


B-325
an individualized mixture B
bensulfuron


B-326
an individualized mixture B
chlorimuron-ethyl


B-327
an individualized mixture B
cyclosulfamuron


B-328
an individualized mixture B
iodosulfuron


B-329
an individualized mixture B
mesosulfuron


B-330
an individualized mixture B
metsulfuron-methyl


B-331
an individualized mixture B
nicosulfuron


B-332
an individualized mixture B
rimsulfuron


B-333
an individualized mixture B
triflusulfuron


B-334
an individualized mixture B
atrazine


B-335
an individualized mixture B
hexazinone


B-336
an individualized mixture B
diuron


B-337
an individualized mixture B
florasulam


B-338
an individualized mixture B
pyroxasulfon


B-339
an individualized mixture B
bentazone


B-340
an individualized mixture B
cinidon-ethyl


B-341
an individualized mixture B
cinmethylin


B-342
an individualized mixture B
dicamba


B-343
an individualized mixture B
diflufenzopyr


B-344
an individualized mixture B
quinclorac


B-345
an individualized mixture B
quinmerac


B-346
an individualized mixture B
mesotrione


B-347
an individualized mixture B
saflufenacil


B-348
an individualized mixture B
topramezone









Particularly preferred components 3 are compounds II selected from the group of the following compounds:

    • II-1 epoxiconazole
    • II-2 metconazole
    • II-3 tebuconazole
    • II-6 triticonazole
    • II-7 prothioconazole
    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-11 dimethomorph
    • II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine
    • II-13 pyrimethanil
    • II-14 metalaxyl
    • II-15 fenpropimorph
    • II-18 mancozeb
    • II-19 metiram
    • II-20 thiophanate methyl
    • II-21 chlorothalonil
    • II-22 metrafenone
    • II-23 bixafen
    • II-24 boscalid
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-27 isopyrazam
    • II-28 fluopyram
    • I-29 penflufen


      with the proviso that component 2 and component 3 are not identical.


Particularly preferred mixtures are the ternary mixtures of Table T, where each row corresponds to one aspect of the mixtures according to the invention. According to one specific aspect, these are ternary mixtures which each only contain these three components as the active compound.









TABLE T







Ternary mixtures T-1 to T-3564 comprising one component 1 selected


from the compounds of the formula I, one component 2 selected from


groups A to I and one component 3 selected from groups A to I. In the


table below, each row of a mixture according to the invention


corresponds to each mixture component 1 to 3 given in the


corresponding row.










Components













Mixture
C1
C2
C3







T-1
I-1
II-1
II-2



T-2
I-1
II-1
II-3



T-3
I-1
II-1
II-6



T-4
I-1
II-1
II-7



T-5
I-1
II-1
II-8



T-6
I-1
II-1
II-9



T-7
I-1
II-1
II-11



T-8
I-1
II-1
II-12



T-9
I-1
II-1
II-13



T-10
I-1
II-1
II-14



T-11
I-1
II-1
II-15



T-12
I-1
II-1
II-18



T-13
I-1
II-1
II-19



T-14
I-1
II-1
II-20



T-15
I-1
II-1
II-21



T-16
I-1
II-1
II-22



T-17
I-1
II-1
II-23



T-18
I-1
II-1
II-24



T-19
I-1
II-1
II-25



T-20
I-1
II-1
II-26



T-21
I-1
II-1
II-27



T-22
I-1
II-1
II-28



T-23
I-1
II-1
II-29



T-24
I-1
II-2
II-3



T-25
I-1
II-2
II-6



T-26
I-1
II-2
II-7



T-27
I-1
II-2
II-8



T-28
I-1
II-2
II-9



T-29
I-1
II-2
II-11



T-30
I-1
II-2
II-12



T-31
I-1
II-2
II-13



T-32
I-1
II-2
II-14



T-33
I-1
II-2
II-15



T-34
I-1
II-2
II-18



T-35
I-1
II-2
II-19



T-36
I-1
II-2
II-20



T-37
I-1
II-2
II-21



T-38
I-1
II-2
II-22



T-39
I-1
II-2
II-23



T-40
I-1
II-2
II-24



T-41
I-1
II-2
II-25



T-42
I-1
II-2
II-26



T-43
I-1
II-2
II-27



T-44
I-1
II-2
II-28



T-45
I-1
II-2
II-29



T-46
I-1
II-3
II-6



T-47
I-1
II-3
II-7



T-48
I-1
II-3
II-8



T-49
I-1
II-3
II-9



T-50
I-1
II-3
II-11



T-51
I-1
II-3
II-12



T-52
I-1
II-3
II-13



T-53
I-1
II-3
II-14



T-54
I-1
II-3
II-15



T-55
I-1
II-3
II-18



T-56
I-1
II-3
II-19



T-57
I-1
II-3
II-20



T-58
I-1
II-3
II-21



T-59
I-1
II-3
II-22



T-60
I-1
II-3
II-23



T-61
I-1
II-3
II-24



T-62
I-1
II-3
II-25



T-63
I-1
II-3
II-26



T-64
I-1
II-3
II-27



T-65
I-1
II-3
II-28



T-66
I-1
II-3
II-29



T-67
I-1
II-4
II-1



T-68
I-1
II-4
II-2



T-69
I-1
II-4
II-3



T-70
I-1
II-4
II-6



T-71
I-1
II-4
II-7



T-72
I-1
II-4
II-8



T-73
I-1
II-4
II-9



T-74
I-1
II-4
II-11



T-75
I-1
II-4
II-12



T-76
I-1
II-4
II-13



T-77
I-1
II-4
II-14



T-78
I-1
II-4
II-15



T-79
I-1
II-4
II-18



T-80
I-1
II-4
II-19



T-81
I-1
II-4
II-20



T-82
I-1
II-4
II-21



T-83
I-1
II-4
II-22



T-84
I-1
II-4
II-23



T-85
I-1
II-4
II-24



T-86
I-1
II-4
II-25



T-87
I-1
II-4
II-26



T-88
I-1
II-4
II-27



T-89
I-1
II-4
II-28



T-90
I-1
II-4
II-29



T-91
I-1
II-5
II-1



T-92
I-1
II-5
II-2



T-93
I-1
II-5
II-3



T-94
I-1
II-5
II-6



T-95
I-1
II-5
II-7



T-96
I-1
II-5
II-8



T-97
I-1
II-5
II-9



T-98
I-1
II-5
II-11



T-99
I-1
II-5
II-12



T-100
I-1
II-5
II-13



T-101
I-1
II-5
II-14



T-102
I-1
II-5
II-15



T-103
I-1
II-5
II-18



T-104
I-1
II-5
II-19



T-105
I-1
II-5
II-20



T-106
I-1
II-5
II-21



T-107
I-1
II-5
II-22



T-108
I-1
II-5
II-23



T-109
I-1
II-5
II-24



T-110
I-1
II-5
II-25



T-111
I-1
II-5
II-26



T-112
I-1
II-5
II-27



T-113
I-1
II-5
II-28



T-114
I-1
II-5
II-29



T-115
I-1
II-6
II-7



T-116
I-1
II-6
II-8



T-117
I-1
II-6
II-9



T-118
I-1
II-6
II-11



T-119
I-1
II-6
II-12



T-120
I-1
II-6
II-13



T-121
I-1
II-6
II-14



T-122
I-1
II-6
II-15



T-123
I-1
II-6
II-18



T-124
I-1
II-6
II-19



T-125
I-1
II-6
II-20



T-126
I-1
II-6
II-21



T-127
I-1
II-6
II-22



T-128
I-1
II-6
II-23



T-129
I-1
II-6
II-24



T-130
I-1
II-6
II-25



T-131
I-1
II-6
II-26



T-132
I-1
II-6
II-27



T-133
I-1
II-6
II-28



T-134
I-1
II-6
II-29



T-135
I-1
II-7
II-8



T-136
I-1
II-7
II-9



T-137
I-1
II-7
II-11



T-138
I-1
II-7
II-12



T-139
I-1
II-7
II-13



T-140
I-1
II-7
II-14



T-141
I-1
II-7
II-15



T-142
I-1
II-7
II-18



T-143
I-1
II-7
II-19



T-144
I-1
II-7
II-20



T-145
I-1
II-7
II-21



T-146
I-1
II-7
II-22



T-147
I-1
II-7
II-23



T-148
I-1
II-7
II-24



T-149
I-1
II-7
II-25



T-150
I-1
II-7
II-26



T-151
I-1
II-7
II-27



T-152
I-1
II-7
II-28



T-153
I-1
II-7
II-29



T-154
I-1
II-8
II-9



T-155
I-1
II-8
II-11



T-156
I-1
II-8
II-12



T-157
I-1
II-8
II-13



T-158
I-1
II-8
II-14



T-159
I-1
II-8
II-15



T-160
I-1
II-8
II-18



T-161
I-1
II-8
II-19



T-162
I-1
II-8
II-20



T-163
I-1
II-8
II-21



T-164
I-1
II-8
II-22



T-165
I-1
II-8
II-23



T-166
I-1
II-8
II-24



T-167
I-1
II-8
II-25



T-168
I-1
II-8
II-26



T-169
I-1
II-8
II-27



T-170
I-1
II-8
II-28



T-171
I-1
II-8
II-29



T-172
I-1
II-9
II-11



T-173
I-1
II-9
II-12



T-174
I-1
II-9
II-13



T-175
I-1
II-9
II-14



T-176
I-1
II-9
II-15



T-177
I-1
II-9
II-18



T-178
I-1
II-9
II-19



T-179
I-1
II-9
II-20



T-180
I-1
II-9
II-21



T-181
I-1
II-9
II-22



T-182
I-1
II-9
II-23



T-183
I-1
II-9
II-24



T-184
I-1
II-9
II-25



T-185
I-1
II-9
II-26



T-186
I-1
II-9
II-27



T-187
I-1
II-9
II-28



T-188
I-1
II-9
II-29



T-189
I-1
II-10
II-1



T-190
I-1
II-10
II-2



T-191
I-1
II-10
II-3



T-192
I-1
II-10
II-6



T-193
I-1
II-10
II-7



T-194
I-1
II-10
II-8



T-195
I-1
II-10
II-9



T-196
I-1
II-10
II-11



T-197
I-1
II-10
II-12



T-198
I-1
II-10
II-13



T-199
I-1
II-10
II-14



T-200
I-1
II-10
II-15



T-201
I-1
II-10
II-18



T-202
I-1
II-10
II-19



T-203
I-1
II-10
II-20



T-204
I-1
II-10
II-21



T-205
I-1
II-10
II-22



T-206
I-1
II-10
II-23



T-207
I-1
II-10
II-24



T-208
I-1
II-10
II-25



T-209
I-1
II-10
II-26



T-210
I-1
II-10
II-27



T-211
I-1
II-10
II-28



T-212
I-1
II-10
II-29



T-213
I-1
II-11
II-12



T-214
I-1
II-11
II-13



T-215
I-1
II-11
II-14



T-216
I-1
II-11
II-15



T-217
I-1
II-11
II-18



T-218
I-1
II-11
II-19



T-219
I-1
II-11
II-20



T-220
I-1
II-11
II-21



T-221
I-1
II-11
II-22



T-222
I-1
II-11
II-23



T-223
I-1
II-11
II-24



T-224
I-1
II-11
II-25



T-225
I-1
II-11
II-26



T-226
I-1
II-11
II-27



T-227
I-1
II-11
II-28



T-228
I-1
II-11
II-29



T-229
I-1
II-12
II-13



T-230
I-1
II-12
II-14



T-231
I-1
II-12
II-15



T-232
I-1
II-12
II-18



T-233
I-1
II-12
II-19



T-234
I-1
II-12
II-20



T-235
I-1
II-12
II-21



T-236
I-1
II-12
II-22



T-237
I-1
II-12
II-23



T-238
I-1
II-12
II-24



T-239
I-1
II-12
II-25



T-240
I-1
II-12
II-26



T-241
I-1
II-12
II-27



T-242
I-1
II-12
II-28



T-243
I-1
II-12
II-29



T-244
I-1
II-13
II-14



T-245
I-1
II-13
II-15



T-246
I-1
II-13
II-18



T-247
I-1
II-13
II-19



T-248
I-1
II-13
II-20



T-249
I-1
II-13
II-21



T-250
I-1
II-13
II-22



T-251
I-1
II-13
II-23



T-252
I-1
II-13
II-24



T-253
I-1
II-13
II-25



T-254
I-1
II-13
II-26



T-255
I-1
II-13
II-27



T-256
I-1
II-13
II-28



T-257
I-1
II-13
II-29



T-258
I-1
II-14
II-15



T-259
I-1
II-14
II-18



T-260
I-1
II-14
II-19



T-261
I-1
II-14
II-20



T-262
I-1
II-14
II-21



T-263
I-1
II-14
II-22



T-264
I-1
II-14
II-23



T-265
I-1
II-14
II-24



T-266
I-1
II-14
II-25



T-267
I-1
II-14
II-26



T-268
I-1
II-14
II-27



T-269
I-1
II-14
II-28



T-270
I-1
II-14
II-29



T-271
I-1
II-15
II-18



T-272
I-1
II-15
II-19



T-273
I-1
II-15
II-20



T-274
I-1
II-15
II-21



T-275
I-1
II-15
II-22



T-276
I-1
II-15
II-23



T-277
I-1
II-15
II-24



T-278
I-1
II-15
II-25



T-279
I-1
II-15
II-26



T-280
I-1
II-15
II-27



T-281
I-1
II-15
II-28



T-282
I-1
II-15
II-29



T-283
I-1
II-16
II-1



T-284
I-1
II-16
II-2



T-285
I-1
II-16
II-3



T-286
I-1
II-16
II-6



T-287
I-1
II-16
II-7



T-288
I-1
II-16
II-8



T-289
I-1
II-16
II-9



T-290
I-1
II-16
II-11



T-291
I-1
II-16
II-12



T-292
I-1
II-16
II-13



T-293
I-1
II-16
II-14



T-294
I-1
II-16
II-15



T-295
I-1
II-16
II-18



T-296
I-1
II-16
II-19



T-297
I-1
II-16
II-20



T-298
I-1
II-16
II-21



T-299
I-1
II-16
II-22



T-300
I-1
II-16
II-23



T-301
I-1
II-16
II-24



T-302
I-1
II-16
II-25



T-303
I-1
II-16
II-26



T-304
I-1
II-16
II-27



T-305
I-1
II-16
II-28



T-306
I-1
II-16
II-29



T-307
I-1
II-17
II-1



T-308
I-1
II-17
II-2



T-309
I-1
II-17
II-3



T-310
I-1
II-17
II-6



T-311
I-1
II-17
II-7



T-312
I-1
II-17
II-8



T-313
I-1
II-17
II-9



T-314
I-1
II-17
II-11



T-315
I-1
II-17
II-12



T-316
I-1
II-17
II-13



T-317
I-1
II-17
II-14



T-318
I-1
II-17
II-15



T-319
I-1
II-17
II-18



T-320
I-1
II-17
II-19



T-321
I-1
II-17
II-20



T-322
I-1
II-17
II-21



T-323
I-1
II-17
II-22



T-324
I-1
II-17
II-23



T-325
I-1
II-17
II-24



T-326
I-1
II-17
II-25



T-327
I-1
II-17
II-26



T-328
I-1
II-17
II-27



T-329
I-1
II-17
II-28



T-330
I-1
II-17
II-29



T-331
I-1
II-18
II-19



T-332
I-1
II-18
II-20



T-333
I-1
II-18
II-21



T-334
I-1
II-18
II-22



T-335
I-1
II-18
II-23



T-336
I-1
II-18
II-24



T-337
I-1
II-18
II-25



T-338
I-1
II-18
II-26



T-339
I-1
II-18
II-27



T-340
I-1
II-18
II-28



T-341
I-1
II-18
II-29



T-342
I-1
II-19
II-20



T-343
I-1
II-19
II-21



T-344
I-1
II-19
II-22



T-345
I-1
II-19
II-23



T-346
I-1
II-19
II-24



T-347
I-1
II-19
II-25



T-348
I-1
II-19
II-26



T-349
I-1
II-19
II-27



T-350
I-1
II-19
II-28



T-351
I-1
II-19
II-29



T-352
I-1
II-20
II-21



T-353
I-1
II-20
II-22



T-354
I-1
II-20
II-23



T-355
I-1
II-20
II-24



T-356
I-1
II-20
II-25



T-357
I-1
II-20
II-26



T-358
I-1
II-20
II-27



T-359
I-1
II-20
II-28



T-360
I-1
II-20
II-29



T-361
I-1
II-21
II-22



T-362
I-1
II-21
II-23



T-363
I-1
II-21
II-24



T-364
I-1
II-21
II-25



T-365
I-1
II-21
II-26



T-366
I-1
II-21
II-27



T-367
I-1
II-21
II-28



T-368
I-1
II-21
II-29



T-369
I-1
II-22
II-23



T-370
I-1
II-22
II-24



T-371
I-1
II-22
II-25



T-372
I-1
II-22
II-26



T-373
I-1
II-22
II-27



T-374
I-1
II-22
II-28



T-375
I-1
II-22
II-29



T-376
I-1
II-23
II-24



T-377
I-1
II-23
II-25



T-378
I-1
II-23
II-26



T-379
I-1
II-23
II-27



T-380
I-1
II-23
II-28



T-381
I-1
II-23
II-29



T-382
I-1
II-24
II-25



T-383
I-1
II-24
II-26



T-384
I-1
II-24
II-27



T-385
I-1
II-24
II-28



T-386
I-1
II-24
II-29



T-387
I-1
II-25
II-26



T-388
I-1
II-25
II-27



T-389
I-1
II-25
II-28



T-390
I-1
II-25
II-29



T-391
I-1
II-26
II-27



T-392
I-1
II-26
II-28



T-393
I-1
II-26
II-29



T-394
I-1
II-27
II-28



T-395
I-1
II-27
II-29



T-396
I-1
II-28
II-29



T-397
I-2
II-1
II-2



T-398
I-2
II-1
II-3



T-399
I-2
II-1
II-6



T-400
I-2
II-1
II-7



T-401
I-2
II-1
II-8



T-402
I-2
II-1
II-9



T-403
I-2
II-1
II-11



T-404
I-2
II-1
II-12



T-405
I-2
II-1
II-13



T-406
I-2
II-1
II-14



T-407
I-2
II-1
II-15



T-408
I-2
II-1
II-18



T-409
I-2
II-1
II-19



T-410
I-2
II-1
II-20



T-411
I-2
II-1
II-21



T-412
I-2
II-1
II-22



T-413
I-2
II-1
II-23



T-414
I-2
II-1
II-24



T-415
I-2
II-1
II-25



T-416
I-2
II-1
II-26



T-417
I-2
II-1
II-27



T-418
I-2
II-1
II-28



T-419
I-2
II-1
II-29



T-420
I-2
II-2
II-3



T-421
I-2
II-2
II-6



T-422
I-2
II-2
II-7



T-423
I-2
II-2
II-8



T-424
I-2
II-2
II-9



T-425
I-2
II-2
II-11



T-426
I-2
II-2
II-12



T-427
I-2
II-2
II-13



T-428
I-2
II-2
II-14



T-429
I-2
II-2
II-15



T-430
I-2
II-2
II-18



T-431
I-2
II-2
II-19



T-432
I-2
II-2
II-20



T-433
I-2
II-2
II-21



T-434
I-2
II-2
II-22



T-435
I-2
II-2
II-23



T-436
I-2
II-2
II-24



T-437
I-2
II-2
II-25



T-438
I-2
II-2
II-26



T-439
I-2
II-2
II-27



T-440
I-2
II-2
II-28



T-441
I-2
II-2
II-29



T-442
I-2
II-3
II-6



T-443
I-2
II-3
II-7



T-444
I-2
II-3
II-8



T-445
I-2
II-3
II-9



T-446
I-2
II-3
II-11



T-447
I-2
II-3
II-12



T-448
I-2
II-3
II-13



T-449
I-2
II-3
II-14



T-450
I-2
II-3
II-15



T-451
I-2
II-3
II-18



T-452
I-2
II-3
II-19



T-453
I-2
II-3
II-20



T-454
I-2
II-3
II-21



T-455
I-2
II-3
II-22



T-456
I-2
II-3
II-23



T-457
I-2
II-3
II-24



T-458
I-2
II-3
II-25



T-459
I-2
II-3
II-26



T-460
I-2
II-3
II-27



T-461
I-2
II-3
II-28



T-462
I-2
II-3
II-29



T-463
I-2
II-4
II-1



T-464
I-2
II-4
II-2



T-465
I-2
II-4
II-3



T-466
I-2
II-4
II-6



T-467
I-2
II-4
II-7



T-468
I-2
II-4
II-8



T-469
I-2
II-4
II-9



T-470
I-2
II-4
II-11



T-471
I-2
II-4
II-12



T-472
I-2
II-4
II-13



T-473
I-2
II-4
II-14



T-474
I-2
II-4
II-15



T-475
I-2
II-4
II-18



T-476
I-2
II-4
II-19



T-477
I-2
II-4
II-20



T-478
I-2
II-4
II-21



T-479
I-2
II-4
II-22



T-480
I-2
II-4
II-23



T-481
I-2
II-4
II-24



T-482
I-2
II-4
II-25



T-483
I-2
II-4
II-26



T-484
I-2
II-4
II-27



T-485
I-2
II-4
II-28



T-486
I-2
II-4
II-29



T-487
I-2
II-5
II-1



T-488
I-2
II-5
II-2



T-489
I-2
II-5
II-3



T-490
I-2
II-5
II-6



T-491
I-2
II-5
II-7



T-492
I-2
II-5
II-8



T-493
I-2
II-5
II-9



T-494
I-2
II-5
II-11



T-495
I-2
II-5
II-12



T-496
I-2
II-5
II-13



T-497
I-2
II-5
II-14



T-498
I-2
II-5
II-15



T-499
I-2
II-5
II-18



T-500
I-2
II-5
II-19



T-501
I-2
II-5
II-20



T-502
I-2
II-5
II-21



T-503
I-2
II-5
II-22



T-504
I-2
II-5
II-23



T-505
I-2
II-5
II-24



T-506
I-2
II-5
II-25



T-507
I-2
II-5
II-26



T-508
I-2
II-5
II-27



T-509
I-2
II-5
II-28



T-510
I-2
II-5
II-29



T-511
I-2
II-6
II-7



T-512
I-2
II-6
II-8



T-513
I-2
II-6
II-9



T-514
I-2
II-6
II-11



T-515
I-2
II-6
II-12



T-516
I-2
II-6
II-13



T-517
I-2
II-6
II-14



T-518
I-2
II-6
II-15



T-519
I-2
II-6
II-18



T-520
I-2
II-6
II-19



T-521
I-2
II-6
II-20



T-522
I-2
II-6
II-21



T-523
I-2
II-6
II-22



T-524
I-2
II-6
II-23



T-525
I-2
II-6
II-24



T-526
I-2
II-6
II-25



T-527
I-2
II-6
II-26



T-528
I-2
II-6
II-27



T-529
I-2
II-6
II-28



T-530
I-2
II-6
II-29



T-531
I-2
II-7
II-8



T-532
I-2
II-7
II-9



T-533
I-2
II-7
II-11



T-534
I-2
II-7
II-12



T-535
I-2
II-7
II-13



T-536
I-2
II-7
II-14



T-537
I-2
II-7
II-15



T-538
I-2
II-7
II-18



T-539
I-2
II-7
II-19



T-540
I-2
II-7
II-20



T-541
I-2
II-7
II-21



T-542
I-2
II-7
II-22



T-543
I-2
II-7
II-23



T-544
I-2
II-7
II-24



T-545
I-2
II-7
II-25



T-546
I-2
II-7
II-26



T-547
I-2
II-7
II-27



T-548
I-2
II-7
II-28



T-549
I-2
II-7
II-29



T-550
I-2
II-8
II-9



T-551
I-2
II-8
II-11



T-552
I-2
II-8
II-12



T-553
I-2
II-8
II-13



T-554
I-2
II-8
II-14



T-555
I-2
II-8
II-15



T-556
I-2
II-8
II-18



T-557
I-2
II-8
II-19



T-558
I-2
II-8
II-20



T-559
I-2
II-8
II-21



T-560
I-2
II-8
II-22



T-561
I-2
II-8
II-23



T-562
I-2
II-8
II-24



T-563
I-2
II-8
II-25



T-564
I-2
II-8
II-26



T-565
I-2
II-8
II-27



T-566
I-2
II-8
II-28



T-567
I-2
II-8
II-29



T-568
I-2
II-9
II-11



T-569
I-2
II-9
II-12



T-570
I-2
II-9
II-13



T-571
I-2
II-9
II-14



T-572
I-2
II-9
II-15



T-573
I-2
II-9
II-18



T-574
I-2
II-9
II-19



T-575
I-2
II-9
II-20



T-576
I-2
II-9
II-21



T-577
I-2
II-9
II-22



T-578
I-2
II-9
II-23



T-579
I-2
II-9
II-24



T-580
I-2
II-9
II-25



T-581
I-2
II-9
II-26



T-582
I-2
II-9
II-27



T-583
I-2
II-9
II-28



T-584
I-2
II-9
II-29



T-585
I-2
II-10
II-1



T-586
I-2
II-10
II-2



T-587
I-2
II-10
II-3



T-588
I-2
II-10
II-6



T-589
I-2
II-10
II-7



T-590
I-2
II-10
II-8



T-591
I-2
II-10
II-9



T-592
I-2
II-10
II-11



T-593
I-2
II-10
II-12



T-594
I-2
II-10
II-13



T-595
I-2
II-10
II-14



T-596
I-2
II-10
II-15



T-597
I-2
II-10
II-18



T-598
I-2
II-10
II-19



T-599
I-2
II-10
II-20



T-600
I-2
II-10
II-21



T-601
I-2
II-10
II-22



T-602
I-2
II-10
II-23



T-603
I-2
II-10
II-24



T-604
I-2
II-10
II-25



T-605
I-2
II-10
II-26



T-606
I-2
II-10
II-27



T-607
I-2
II-10
II-28



T-608
I-2
II-10
II-29



T-609
I-2
II-11
II-12



T-610
I-2
II-11
II-13



T-611
I-2
II-11
II-14



T-612
I-2
II-11
II-15



T-613
I-2
II-11
II-18



T-614
I-2
II-11
II-19



T-615
I-2
II-11
II-20



T-616
I-2
II-11
II-21



T-617
I-2
II-11
II-22



T-618
I-2
II-11
II-23



T-619
I-2
II-11
II-24



T-620
I-2
II-11
II-25



T-621
I-2
II-11
II-26



T-622
I-2
II-11
II-27



T-623
I-2
II-11
II-28



T-624
I-2
II-11
II-29



T-625
I-2
II-12
II-13



T-626
I-2
II-12
II-14



T-627
I-2
II-12
II-15



T-628
I-2
II-12
II-18



T-629
I-2
II-12
II-19



T-630
I-2
II-12
II-20



T-631
I-2
II-12
II-21



T-632
I-2
II-12
II-22



T-633
I-2
II-12
II-23



T-634
I-2
II-12
II-24



T-635
I-2
II-12
II-25



T-636
I-2
II-12
II-26



T-637
I-2
II-12
II-27



T-638
I-2
II-12
II-28



T-639
I-2
II-12
II-29



T-640
I-2
II-13
II-14



T-641
I-2
II-13
II-15



T-642
I-2
II-13
II-18



T-643
I-2
II-13
II-19



T-644
I-2
II-13
II-20



T-645
I-2
II-13
II-21



T-646
I-2
II-13
II-22



T-647
I-2
II-13
II-23



T-648
I-2
II-13
II-24



T-649
I-2
II-13
II-25



T-650
I-2
II-13
II-26



T-651
I-2
II-13
II-27



T-652
I-2
II-13
II-28



T-653
I-2
II-13
II-29



T-654
I-2
II-14
II-15



T-655
I-2
II-14
II-18



T-656
I-2
II-14
II-19



T-657
I-2
II-14
II-20



T-658
I-2
II-14
II-21



T-659
I-2
II-14
II-22



T-660
I-2
II-14
II-23



T-661
I-2
II-14
II-24



T-662
I-2
II-14
II-25



T-663
I-2
II-14
II-26



T-664
I-2
II-14
II-27



T-665
I-2
II-14
II-28



T-666
I-2
II-14
II-29



T-667
I-2
II-15
II-18



T-668
I-2
II-15
II-19



T-669
I-2
II-15
II-20



T-670
I-2
II-15
II-21



T-671
I-2
II-15
II-22



T-672
I-2
II-15
II-23



T-673
I-2
II-15
II-24



T-674
I-2
II-15
II-25



T-675
I-2
II-15
II-26



T-676
I-2
II-15
II-27



T-677
I-2
II-15
II-28



T-678
I-2
II-15
II-29



T-679
I-2
II-16
II-1



T-680
I-2
II-16
II-2



T-681
I-2
II-16
II-3



T-682
I-2
II-16
II-6



T-683
I-2
II-16
II-7



T-684
I-2
II-16
II-8



T-685
I-2
II-16
II-9



T-686
I-2
II-16
II-11



T-687
I-2
II-16
II-12



T-688
I-2
II-16
II-13



T-689
I-2
II-16
II-14



T-690
I-2
II-16
II-15



T-691
I-2
II-16
II-18



T-692
I-2
II-16
II-19



T-693
I-2
II-16
II-20



T-694
I-2
II-16
II-21



T-695
I-2
II-16
II-22



T-696
I-2
II-16
II-23



T-697
I-2
II-16
II-24



T-698
I-2
II-16
II-25



T-699
I-2
II-16
II-26



T-700
I-2
II-16
II-27



T-701
I-2
II-16
II-28



T-702
I-2
II-16
II-29



T-703
I-2
II-17
II-1



T-704
I-2
II-17
II-2



T-705
I-2
II-17
II-3



T-706
I-2
II-17
II-6



T-707
I-2
II-17
II-7



T-708
I-2
II-17
II-8



T-709
I-2
II-17
II-9



T-710
I-2
II-17
II-11



T-711
I-2
II-17
II-12



T-712
I-2
II-17
II-13



T-713
I-2
II-17
II-14



T-714
I-2
II-17
II-15



T-715
I-2
II-17
II-18



T-716
I-2
II-17
II-19



T-717
I-2
II-17
II-20



T-718
I-2
II-17
II-21



T-719
I-2
II-17
II-22



T-720
I-2
II-17
II-23



T-721
I-2
II-17
II-24



T-722
I-2
II-17
II-25



T-723
I-2
II-17
II-26



T-724
I-2
II-17
II-27



T-725
I-2
II-17
II-28



T-726
I-2
II-17
II-29



T-727
I-2
II-18
II-19



T-728
I-2
II-18
II-20



T-729
I-2
II-18
II-21



T-730
I-2
II-18
II-22



T-731
I-2
II-18
II-23



T-732
I-2
II-18
II-24



T-733
I-2
II-18
II-25



T-734
I-2
II-18
II-26



T-735
I-2
II-18
II-27



T-736
I-2
II-18
II-28



T-737
I-2
II-18
II-29



T-738
I-2
II-19
II-20



T-739
I-2
II-19
II-21



T-740
I-2
II-19
II-22



T-741
I-2
II-19
II-23



T-742
I-2
II-19
II-24



T-743
I-2
II-19
II-25



T-744
I-2
II-19
II-26



T-745
I-2
II-19
II-27



T-746
I-2
II-19
II-28



T-747
I-2
II-19
II-29



T-748
I-2
II-20
II-21



T-749
I-2
II-20
II-22



T-750
I-2
II-20
II-23



T-751
I-2
II-20
II-24



T-752
I-2
II-20
II-25



T-753
I-2
II-20
II-26



T-754
I-2
II-20
II-27



T-755
I-2
II-20
II-28



T-756
I-2
II-20
II-29



T-757
I-2
II-21
II-22



T-758
I-2
II-21
II-23



T-759
I-2
II-21
II-24



T-760
I-2
II-21
II-25



T-761
I-2
II-21
II-26



T-762
I-2
II-21
II-27



T-763
I-2
II-21
II-28



T-764
I-2
II-21
II-29



T-765
I-2
II-22
II-23



T-766
I-2
II-22
II-24



T-767
I-2
II-22
II-25



T-768
I-2
II-22
II-26



T-769
I-2
II-22
II-27



T-770
I-2
II-22
II-28



T-771
I-2
II-22
II-29



T-772
I-2
II-23
II-24



T-773
I-2
II-23
II-25



T-774
I-2
II-23
II-26



T-775
I-2
II-23
II-27



T-776
I-2
II-23
II-28



T-777
I-2
II-23
II-29



T-778
I-2
II-24
II-25



T-779
I-2
II-24
II-26



T-780
I-2
II-24
II-27



T-781
I-2
II-24
II-28



T-782
I-2
II-24
II-29



T-783
I-2
II-25
II-26



T-784
I-2
II-25
II-27



T-785
I-2
II-25
II-28



T-786
I-2
II-25
II-29



T-787
I-2
II-26
II-27



T-788
I-2
II-26
II-28



T-789
I-2
II-26
II-29



T-790
I-2
II-27
II-28



T-791
I-2
II-27
II-29



T-792
I-2
II-28
II-29



T-793
I-3
II-1
II-2



T-794
I-3
II-1
II-3



T-795
I-3
II-1
II-6



T-796
I-3
II-1
II-7



T-797
I-3
II-1
II-8



T-798
I-3
II-1
II-9



T-799
I-3
II-1
II-11



T-800
I-3
II-1
II-12



T-801
I-3
II-1
II-13



T-802
I-3
II-1
II-14



T-803
I-3
II-1
II-15



T-804
I-3
II-1
II-18



T-805
I-3
II-1
II-19



T-806
I-3
II-1
II-20



T-807
I-3
II-1
II-21



T-808
I-3
II-1
II-22



T-809
I-3
II-1
II-23



T-810
I-3
II-1
II-24



T-811
I-3
II-1
II-25



T-812
I-3
II-1
II-26



T-813
I-3
II-1
II-27



T-814
I-3
II-1
II-28



T-815
I-3
II-1
II-29



T-816
I-3
II-2
II-3



T-817
I-3
II-2
II-6



T-818
I-3
II-2
II-7



T-819
I-3
II-2
II-8



T-820
I-3
II-2
II-9



T-821
I-3
II-2
II-11



T-822
I-3
II-2
II-12



T-823
I-3
II-2
II-13



T-824
I-3
II-2
II-14



T-825
I-3
II-2
II-15



T-826
I-3
II-2
II-18



T-827
I-3
II-2
II-19



T-828
I-3
II-2
II-20



T-829
I-3
II-2
II-21



T-830
I-3
II-2
II-22



T-831
I-3
II-2
II-23



T-832
I-3
II-2
II-24



T-833
I-3
II-2
II-25



T-834
I-3
II-2
II-26



T-835
I-3
II-2
II-27



T-836
I-3
II-2
II-28



T-837
I-3
II-2
II-29



T-838
I-3
II-3
II-6



T-839
I-3
II-3
II-7



T-840
I-3
II-3
II-8



T-841
I-3
II-3
II-9



T-842
I-3
II-3
II-11



T-843
I-3
II-3
II-12



T-844
I-3
II-3
II-13



T-845
I-3
II-3
II-14



T-846
I-3
II-3
II-15



T-847
I-3
II-3
II-18



T-848
I-3
II-3
II-19



T-849
I-3
II-3
II-20



T-850
I-3
II-3
II-21



T-851
I-3
II-3
II-22



T-852
I-3
II-3
II-23



T-853
I-3
II-3
II-24



T-854
I-3
II-3
II-25



T-855
I-3
II-3
II-26



T-856
I-3
II-3
II-27



T-857
I-3
II-3
II-28



T-858
I-3
II-3
II-29



T-859
I-3
II-4
II-1



T-860
I-3
II-4
II-2



T-861
I-3
II-4
II-3



T-862
I-3
II-4
II-6



T-863
I-3
II-4
II-7



T-864
I-3
II-4
II-8



T-865
I-3
II-4
II-9



T-866
I-3
II-4
II-11



T-867
I-3
II-4
II-12



T-868
I-3
II-4
II-13



T-869
I-3
II-4
II-14



T-870
I-3
II-4
II-15



T-871
I-3
II-4
II-18



T-872
I-3
II-4
II-19



T-873
I-3
II-4
II-20



T-874
I-3
II-4
II-21



T-875
I-3
II-4
II-22



T-876
I-3
II-4
II-23



T-877
I-3
II-4
II-24



T-878
I-3
II-4
II-25



T-879
I-3
II-4
II-26



T-880
I-3
II-4
II-27



T-881
I-3
II-4
II-28



T-882
I-3
II-4
II-29



T-883
I-3
II-5
II-1



T-884
I-3
II-5
II-2



T-885
I-3
II-5
II-3



T-886
I-3
II-5
II-6



T-887
I-3
II-5
II-7



T-888
I-3
II-5
II-8



T-889
I-3
II-5
II-9



T-890
I-3
II-5
II-11



T-891
I-3
II-5
II-12



T-892
I-3
II-5
II-13



T-893
I-3
II-5
II-14



T-894
I-3
II-5
II-15



T-895
I-3
II-5
II-18



T-896
I-3
II-5
II-19



T-897
I-3
II-5
II-20



T-898
I-3
II-5
II-21



T-899
I-3
II-5
II-22



T-900
I-3
II-5
II-23



T-901
I-3
II-5
II-24



T-902
I-3
II-5
II-25



T-903
I-3
II-5
II-26



T-904
I-3
II-5
II-27



T-905
I-3
II-5
II-28



T-906
I-3
II-5
II-29



T-907
I-3
II-6
II-7



T-908
I-3
II-6
II-8



T-909
I-3
II-6
II-9



T-910
I-3
II-6
II-11



T-911
I-3
II-6
II-12



T-912
I-3
II-6
II-13



T-913
I-3
II-6
II-14



T-914
I-3
II-6
II-15



T-915
I-3
II-6
II-18



T-916
I-3
II-6
II-19



T-917
I-3
II-6
II-20



T-918
I-3
II-6
II-21



T-919
I-3
II-6
II-22



T-920
I-3
II-6
II-23



T-921
I-3
II-6
II-24



T-922
I-3
II-6
II-25



T-923
I-3
II-6
II-26



T-924
I-3
II-6
II-27



T-925
I-3
II-6
II-28



T-926
I-3
II-6
II-29



T-927
I-3
II-7
II-8



T-928
I-3
II-7
II-9



T-929
I-3
II-7
II-11



T-930
I-3
II-7
II-12



T-931
I-3
II-7
II-13



T-932
I-3
II-7
II-14



T-933
I-3
II-7
II-15



T-934
I-3
II-7
II-18



T-935
I-3
II-7
II-19



T-936
I-3
II-7
II-20



T-937
I-3
II-7
II-21



T-938
I-3
II-7
II-22



T-939
I-3
II-7
II-23



T-940
I-3
II-7
II-24



T-941
I-3
II-7
II-25



T-942
I-3
II-7
II-26



T-943
I-3
II-7
II-27



T-944
I-3
II-7
II-28



T-945
I-3
II-7
II-29



T-946
I-3
II-8
II-9



T-947
I-3
II-8
II-11



T-948
I-3
II-8
II-12



T-949
I-3
II-8
II-13



T-950
I-3
II-8
II-14



T-951
I-3
II-8
II-15



T-952
I-3
II-8
II-18



T-953
I-3
II-8
II-19



T-954
I-3
II-8
II-20



T-955
I-3
II-8
II-21



T-956
I-3
II-8
II-22



T-957
I-3
II-8
II-23



T-958
I-3
II-8
II-24



T-959
I-3
II-8
II-25



T-960
I-3
II-8
II-26



T-961
I-3
II-8
II-27



T-962
I-3
II-8
II-28



T-963
I-3
II-8
II-29



T-964
I-3
II-9
II-11



T-965
I-3
II-9
II-12



T-966
I-3
II-9
II-13



T-967
I-3
II-9
II-14



T-968
I-3
II-9
II-15



T-969
I-3
II-9
II-18



T-970
I-3
II-9
II-19



T-971
I-3
II-9
II-20



T-972
I-3
II-9
II-21



T-973
I-3
II-9
II-22



T-974
I-3
II-9
II-23



T-975
I-3
II-9
II-24



T-976
I-3
II-9
II-25



T-977
I-3
II-9
II-26



T-978
I-3
II-9
II-27



T-979
I-3
II-9
II-28



T-980
I-3
II-9
II-29



T-981
I-3
II-10
II-1



T-982
I-3
II-10
II-2



T-983
I-3
II-10
II-3



T-984
I-3
II-10
II-6



T-985
I-3
II-10
II-7



T-986
I-3
II-10
II-8



T-987
I-3
II-10
II-9



T-988
I-3
II-10
II-11



T-989
I-3
II-10
II-12



T-990
I-3
II-10
II-13



T-991
I-3
II-10
II-14



T-992
I-3
II-10
II-15



T-993
I-3
II-10
II-18



T-994
I-3
II-10
II-19



T-995
I-3
II-10
II-20



T-996
I-3
II-10
II-21



T-997
I-3
II-10
II-22



T-998
I-3
II-10
II-23



T-999
I-3
II-10
II-24



T-1000
I-3
II-10
II-25



T-1001
I-3
II-10
II-26



T-1002
I-3
II-10
II-27



T-1003
I-3
II-10
II-28



T-1004
I-3
II-10
II-29



T-1005
I-3
II-11
II-12



T-1006
I-3
II-11
II-13



T-1007
I-3
II-11
II-14



T-1008
I-3
II-11
II-15



T-1009
I-3
II-11
II-18



T-1010
I-3
II-11
II-19



T-1011
I-3
II-11
II-20



T-1012
I-3
II-11
II-21



T-1013
I-3
II-11
II-22



T-1014
I-3
II-11
II-23



T-1015
I-3
II-11
II-24



T-1016
I-3
II-11
II-25



T-1017
I-3
II-11
II-26



T-1018
I-3
II-11
II-27



T-1019
I-3
II-11
II-28



T-1020
I-3
II-11
II-29



T-1021
I-3
II-12
II-13



T-1022
I-3
II-12
II-14



T-1023
I-3
II-12
II-15



T-1024
I-3
II-12
II-18



T-1025
I-3
II-12
II-19



T-1026
I-3
II-12
II-20



T-1027
I-3
II-12
II-21



T-1028
I-3
II-12
II-22



T-1029
I-3
II-12
II-23



T-1030
I-3
II-12
II-24



T-1031
I-3
II-12
II-25



T-1032
I-3
II-12
II-26



T-1033
I-3
II-12
II-27



T-1034
I-3
II-12
II-28



T-1035
I-3
II-12
II-29



T-1036
I-3
II-13
II-14



T-1037
I-3
II-13
II-15



T-1038
I-3
II-13
II-18



T-1039
I-3
II-13
II-19



T-1040
I-3
II-13
II-20



T-1041
I-3
II-13
II-21



T-1042
I-3
II-13
II-22



T-1043
I-3
II-13
II-23



T-1044
I-3
II-13
II-24



T-1045
I-3
II-13
II-25



T-1046
I-3
II-13
II-26



T-1047
I-3
II-13
II-27



T-1048
I-3
II-13
II-28



T-1049
I-3
II-13
II-29



T-1050
I-3
II-14
II-15



T-1051
I-3
II-14
II-18



T-1052
I-3
II-14
II-19



T-1053
I-3
II-14
II-20



T-1054
I-3
II-14
II-21



T-1055
I-3
II-14
II-22



T-1056
I-3
II-14
II-23



T-1057
I-3
II-14
II-24



T-1058
I-3
II-14
II-25



T-1059
I-3
II-14
II-26



T-1060
I-3
II-14
II-27



T-1061
I-3
II-14
II-28



T-1062
I-3
II-14
II-29



T-1063
I-3
II-15
II-18



T-1064
I-3
II-15
II-19



T-1065
I-3
II-15
II-20



T-1066
I-3
II-15
II-21



T-1067
I-3
II-15
II-22



T-1068
I-3
II-15
II-23



T-1069
I-3
II-15
II-24



T-1070
I-3
II-15
II-25



T-1071
I-3
II-15
II-26



T-1072
I-3
II-15
II-27



T-1073
I-3
II-15
II-28



T-1074
I-3
II-15
II-29



T-1075
I-3
II-16
II-1



T-1076
I-3
II-16
II-2



T-1077
I-3
II-16
II-3



T-1078
I-3
II-16
II-6



T-1079
I-3
II-16
II-7



T-1080
I-3
II-16
II-8



T-1081
I-3
II-16
II-9



T-1082
I-3
II-16
II-11



T-1083
I-3
II-16
II-12



T-1084
I-3
II-16
II-13



T-1085
I-3
II-16
II-14



T-1086
I-3
II-16
II-15



T-1087
I-3
II-16
II-18



T-1088
I-3
II-16
II-19



T-1089
I-3
II-16
II-20



T-1090
I-3
II-16
II-21



T-1091
I-3
II-16
II-22



T-1092
I-3
II-16
II-23



T-1093
I-3
II-16
II-24



T-1094
I-3
II-16
II-25



T-1095
I-3
II-16
II-26



T-1096
I-3
II-16
II-27



T-1097
I-3
II-16
II-28



T-1098
I-3
II-16
II-29



T-1099
I-3
II-17
II-1



T-1100
I-3
II-17
II-2



T-1101
I-3
II-17
II-3



T-1102
I-3
II-17
II-6



T-1103
I-3
II-17
II-7



T-1104
I-3
II-17
II-8



T-1105
I-3
II-17
II-9



T-1106
I-3
II-17
II-11



T-1107
I-3
II-17
II-12



T-1108
I-3
II-17
II-13



T-1109
I-3
II-17
II-14



T-1110
I-3
II-17
II-15



T-1111
I-3
II-17
II-18



T-1112
I-3
II-17
II-19



T-1113
I-3
II-17
II-20



T-1114
I-3
II-17
II-21



T-1115
I-3
II-17
II-22



T-1116
I-3
II-17
II-23



T-1117
I-3
II-17
II-24



T-1118
I-3
II-17
II-25



T-1119
I-3
II-17
II-26



T-1120
I-3
II-17
II-27



T-1121
I-3
II-17
II-28



T-1122
I-3
II-17
II-29



T-1123
I-3
II-18
II-19



T-1124
I-3
II-18
II-20



T-1125
I-3
II-18
II-21



T-1126
I-3
II-18
II-22



T-1127
I-3
II-18
II-23



T-1128
I-3
II-18
II-24



T-1129
I-3
II-18
II-25



T-1130
I-3
II-18
II-26



T-1131
I-3
II-18
II-27



T-1132
I-3
II-18
II-28



T-1133
I-3
II-18
II-29



T-1134
I-3
II-19
II-20



T-1135
I-3
II-19
II-21



T-1136
I-3
II-19
II-22



T-1137
I-3
II-19
II-23



T-1138
I-3
II-19
II-24



T-1139
I-3
II-19
II-25



T-1140
I-3
II-19
II-26



T-1141
I-3
II-19
II-27



T-1142
I-3
II-19
II-28



T-1143
I-3
II-19
II-29



T-1144
I-3
II-20
II-21



T-1145
I-3
II-20
II-22



T-1146
I-3
II-20
II-23



T-1147
I-3
II-20
II-24



T-1148
I-3
II-20
II-25



T-1149
I-3
II-20
II-26



T-1150
I-3
II-20
II-27



T-1151
I-3
II-20
II-28



T-1152
I-3
II-20
II-29



T-1153
I-3
II-21
II-22



T-1154
I-3
II-21
II-23



T-1155
I-3
II-21
II-24



T-1156
I-3
II-21
II-25



T-1157
I-3
II-21
II-26



T-1158
I-3
II-21
II-27



T-1159
I-3
II-21
II-28



T-1160
I-3
II-21
II-29



T-1161
I-3
II-22
II-23



T-1162
I-3
II-22
II-24



T-1163
I-3
II-22
II-25



T-1164
I-3
II-22
II-26



T-1165
I-3
II-22
II-27



T-1166
I-3
II-22
II-28



T-1167
I-3
II-22
II-29



T-1168
I-3
II-23
II-24



T-1169
I-3
II-23
II-25



T-1170
I-3
II-23
II-26



T-1171
I-3
II-23
II-27



T-1172
I-3
II-23
II-28



T-1173
I-3
II-23
II-29



T-1174
I-3
II-24
II-25



T-1175
I-3
II-24
II-26



T-1176
I-3
II-24
II-27



T-1177
I-3
II-24
II-28



T-1178
I-3
II-24
II-29



T-1179
I-3
II-25
II-26



T-1180
I-3
II-25
II-27



T-1181
I-3
II-25
II-28



T-1182
I-3
II-25
II-29



T-1183
I-3
II-26
II-27



T-1184
I-3
II-26
II-28



T-1185
I-3
II-26
II-29



T-1186
I-3
II-27
II-28



T-1187
I-3
II-27
II-29



T-1188
I-3
II-28
II-29



T-1189
I-4
II-1
II-2



T-1190
I-4
II-1
II-3



T-1191
I-4
II-1
II-6



T-1192
I-4
II-1
II-7



T-1193
I-4
II-1
II-8



T-1194
I-4
II-1
II-9



T-1195
I-4
II-1
II-11



T-1196
I-4
II-1
II-12



T-1197
I-4
II-1
II-13



T-1198
I-4
II-1
II-14



T-1199
I-4
II-1
II-15



T-1200
I-4
II-1
II-18



T-1201
I-4
II-1
II-19



T-1202
I-4
II-1
II-20



T-1203
I-4
II-1
II-21



T-1204
I-4
II-1
II-22



T-1205
I-4
II-1
II-23



T-1206
I-4
II-1
II-24



T-1207
I-4
II-1
II-25



T-1208
I-4
II-1
II-26



T-1209
I-4
II-1
II-27



T-1210
I-4
II-1
II-28



T-1211
I-4
II-1
II-29



T-1212
I-4
II-2
II-3



T-1213
I-4
II-2
II-6



T-1214
I-4
II-2
II-7



T-1215
I-4
II-2
II-8



T-1216
I-4
II-2
II-9



T-1217
I-4
II-2
II-11



T-1218
I-4
II-2
II-12



T-1219
I-4
II-2
II-13



T-1220
I-4
II-2
II-14



T-1221
I-4
II-2
II-15



T-1222
I-4
II-2
II-18



T-1223
I-4
II-2
II-19



T-1224
I-4
II-2
II-20



T-1225
I-4
II-2
II-21



T-1226
I-4
II-2
II-22



T-1227
I-4
II-2
II-23



T-1228
I-4
II-2
II-24



T-1229
I-4
II-2
II-25



T-1230
I-4
II-2
II-26



T-1231
I-4
II-2
II-27



T-1232
I-4
II-2
II-28



T-1233
I-4
II-2
II-29



T-1234
I-4
II-3
II-6



T-1235
I-4
II-3
II-7



T-1236
I-4
II-3
II-8



T-1237
I-4
II-3
II-9



T-1238
I-4
II-3
II-11



T-1239
I-4
II-3
II-12



T-1240
I-4
II-3
II-13



T-1241
I-4
II-3
II-14



T-1242
I-4
II-3
II-15



T-1243
I-4
II-3
II-18



T-1244
I-4
II-3
II-19



T-1245
I-4
II-3
II-20



T-1246
I-4
II-3
II-21



T-1247
I-4
II-3
II-22



T-1248
I-4
II-3
II-23



T-1249
I-4
II-3
II-24



T-1250
I-4
II-3
II-25



T-1251
I-4
II-3
II-26



T-1252
I-4
II-3
II-27



T-1253
I-4
II-3
II-28



T-1254
I-4
II-3
II-29



T-1255
I-4
II-4
II-1



T-1256
I-4
II-4
II-2



T-1257
I-4
II-4
II-3



T-1258
I-4
II-4
II-6



T-1259
I-4
II-4
II-7



T-1260
I-4
II-4
II-8



T-1261
I-4
II-4
II-9



T-1262
I-4
II-4
II-11



T-1263
I-4
II-4
II-12



T-1264
I-4
II-4
II-13



T-1265
I-4
II-4
II-14



T-1266
I-4
II-4
II-15



T-1267
I-4
II-4
II-18



T-1268
I-4
II-4
II-19



T-1269
I-4
II-4
II-20



T-1270
I-4
II-4
II-21



T-1271
I-4
II-4
II-22



T-1272
I-4
II-4
II-23



T-1273
I-4
II-4
II-24



T-1274
I-4
II-4
II-25



T-1275
I-4
II-4
II-26



T-1276
I-4
II-4
II-27



T-1277
I-4
II-4
II-28



T-1278
I-4
II-4
II-29



T-1279
I-4
II-5
II-1



T-1280
I-4
II-5
II-2



T-1281
I-4
II-5
II-3



T-1282
I-4
II-5
II-6



T-1283
I-4
II-5
II-7



T-1284
I-4
II-5
II-8



T-1285
I-4
II-5
II-9



T-1286
I-4
II-5
II-11



T-1287
I-4
II-5
II-12



T-1288
I-4
II-5
II-13



T-1289
I-4
II-5
II-14



T-1290
I-4
II-5
II-15



T-1291
I-4
II-5
II-18



T-1292
I-4
II-5
II-19



T-1293
I-4
II-5
II-20



T-1294
I-4
II-5
II-21



T-1295
I-4
II-5
II-22



T-1296
I-4
II-5
II-23



T-1297
I-4
II-5
II-24



T-1298
I-4
II-5
II-25



T-1299
I-4
II-5
II-26



T-1300
I-4
II-5
II-27



T-1301
I-4
II-5
II-28



T-1302
I-4
II-5
II-29



T-1303
I-4
II-6
II-7



T-1304
I-4
II-6
II-8



T-1305
I-4
II-6
II-9



T-1306
I-4
II-6
II-11



T-1307
I-4
II-6
II-12



T-1308
I-4
II-6
II-13



T-1309
I-4
II-6
II-14



T-1310
I-4
II-6
II-15



T-1311
I-4
II-6
II-18



T-1312
I-4
II-6
II-19



T-1313
I-4
II-6
II-20



T-1314
I-4
II-6
II-21



T-1315
I-4
II-6
II-22



T-1316
I-4
II-6
II-23



T-1317
I-4
II-6
II-24



T-1318
I-4
II-6
II-25



T-1319
I-4
II-6
II-26



T-1320
I-4
II-6
II-27



T-1321
I-4
II-6
II-28



T-1322
I-4
II-6
II-29



T-1323
I-4
II-7
II-8



T-1324
I-4
II-7
II-9



T-1325
I-4
II-7
II-11



T-1326
I-4
II-7
II-12



T-1327
I-4
II-7
II-13



T-1328
I-4
II-7
II-14



T-1329
I-4
II-7
II-15



T-1330
I-4
II-7
II-18



T-1331
I-4
II-7
II-19



T-1332
I-4
II-7
II-20



T-1333
I-4
II-7
II-21



T-1334
I-4
II-7
II-22



T-1335
I-4
II-7
II-23



T-1336
I-4
II-7
II-24



T-1337
I-4
II-7
II-25



T-1338
I-4
II-7
II-26



T-1339
I-4
II-7
II-27



T-1340
I-4
II-7
II-28



T-1341
I-4
II-7
II-29



T-1342
I-4
II-8
II-9



T-1343
I-4
II-8
II-11



T-1344
I-4
II-8
II-12



T-1345
I-4
II-8
II-13



T-1346
I-4
II-8
II-14



T-1347
I-4
II-8
II-15



T-1348
I-4
II-8
II-18



T-1349
I-4
II-8
II-19



T-1350
I-4
II-8
II-20



T-1351
I-4
II-8
II-21



T-1352
I-4
II-8
II-22



T-1353
I-4
II-8
II-23



T-1354
I-4
II-8
II-24



T-1355
I-4
II-8
II-25



T-1356
I-4
II-8
II-26



T-1357
I-4
II-8
II-27



T-1358
I-4
II-8
II-28



T-1359
I-4
II-8
II-29



T-1360
I-4
II-9
II-11



T-1361
I-4
II-9
II-12



T-1362
I-4
II-9
II-13



T-1363
I-4
II-9
II-14



T-1364
I-4
II-9
II-15



T-1365
I-4
II-9
II-18



T-1366
I-4
II-9
II-19



T-1367
I-4
II-9
II-20



T-1368
I-4
II-9
II-21



T-1369
I-4
II-9
II-22



T-1370
I-4
II-9
II-23



T-1371
I-4
II-9
II-24



T-1372
I-4
II-9
II-25



T-1373
I-4
II-9
II-26



T-1374
I-4
II-9
II-27



T-1375
I-4
II-9
II-28



T-1376
I-4
II-9
II-29



T-1377
I-4
II-10
II-1



T-1378
I-4
II-10
II-2



T-1379
I-4
II-10
II-3



T-1380
I-4
II-10
II-6



T-1381
I-4
II-10
II-7



T-1382
I-4
II-10
II-8



T-1383
I-4
II-10
II-9



T-1384
I-4
II-10
II-11



T-1385
I-4
II-10
II-12



T-1386
I-4
II-10
II-13



T-1387
I-4
II-10
II-14



T-1388
I-4
II-10
II-15



T-1389
I-4
II-10
II-18



T-1390
I-4
II-10
II-19



T-1391
I-4
II-10
II-20



T-1392
I-4
II-10
II-21



T-1393
I-4
II-10
II-22



T-1394
I-4
II-10
II-23



T-1395
I-4
II-10
II-24



T-1396
I-4
II-10
II-25



T-1397
I-4
II-10
II-26



T-1398
I-4
II-10
II-27



T-1399
I-4
II-10
II-28



T-1400
I-4
II-10
II-29



T-1401
I-4
II-11
II-12



T-1402
I-4
II-11
II-13



T-1403
I-4
II-11
II-14



T-1404
I-4
II-11
II-15



T-1405
I-4
II-11
II-18



T-1406
I-4
II-11
II-19



T-1407
I-4
II-11
II-20



T-1408
I-4
II-11
II-21



T-1409
I-4
II-11
II-22



T-1410
I-4
II-11
II-23



T-1411
I-4
II-11
II-24



T-1412
I-4
II-11
II-25



T-1413
I-4
II-11
II-26



T-1414
I-4
II-11
II-27



T-1415
I-4
II-11
II-28



T-1416
I-4
II-11
II-29



T-1417
I-4
II-12
II-13



T-1418
I-4
II-12
II-14



T-1419
I-4
II-12
II-15



T-1420
I-4
II-12
II-18



T-1421
I-4
II-12
II-19



T-1422
I-4
II-12
II-20



T-1423
I-4
II-12
II-21



T-1424
I-4
II-12
II-22



T-1425
I-4
II-12
II-23



T-1426
I-4
II-12
II-24



T-1427
I-4
II-12
II-25



T-1428
I-4
II-12
II-26



T-1429
I-4
II-12
II-27



T-1430
I-4
II-12
II-28



T-1431
I-4
II-12
II-29



T-1432
I-4
II-13
II-14



T-1433
I-4
II-13
II-15



T-1434
I-4
II-13
II-18



T-1435
I-4
II-13
II-19



T-1436
I-4
II-13
II-20



T-1437
I-4
II-13
II-21



T-1438
I-4
II-13
II-22



T-1439
I-4
II-13
II-23



T-1440
I-4
II-13
II-24



T-1441
I-4
II-13
II-25



T-1442
I-4
II-13
II-26



T-1443
I-4
II-13
II-27



T-1444
I-4
II-13
II-28



T-1445
I-4
II-13
II-29



T-1446
I-4
II-14
II-15



T-1447
I-4
II-14
II-18



T-1448
I-4
II-14
II-19



T-1449
I-4
II-14
II-20



T-1450
I-4
II-14
II-21



T-1451
I-4
II-14
II-22



T-1452
I-4
II-14
II-23



T-1453
I-4
II-14
II-24



T-1454
I-4
II-14
II-25



T-1455
I-4
II-14
II-26



T-1456
I-4
II-14
II-27



T-1457
I-4
II-14
II-28



T-1458
I-4
II-14
II-29



T-1459
I-4
II-15
II-18



T-1460
I-4
II-15
II-19



T-1461
I-4
II-15
II-20



T-1462
I-4
II-15
II-21



T-1463
I-4
II-15
II-22



T-1464
I-4
II-15
II-23



T-1465
I-4
II-15
II-24



T-1466
I-4
II-15
II-25



T-1467
I-4
II-15
II-26



T-1468
I-4
II-15
II-27



T-1469
I-4
II-15
II-28



T-1470
I-4
II-15
II-29



T-1471
I-4
II-16
II-1



T-1472
I-4
II-16
II-2



T-1473
I-4
II-16
II-3



T-1474
I-4
II-16
II-6



T-1475
I-4
II-16
II-7



T-1476
I-4
II-16
II-8



T-1477
I-4
II-16
II-9



T-1478
I-4
II-16
II-11



T-1479
I-4
II-16
II-12



T-1480
I-4
II-16
II-13



T-1481
I-4
II-16
II-14



T-1482
I-4
II-16
II-15



T-1483
I-4
II-16
II-18



T-1484
I-4
II-16
II-19



T-1485
I-4
II-16
II-20



T-1486
I-4
II-16
II-21



T-1487
I-4
II-16
II-22



T-1488
I-4
II-16
II-23



T-1489
I-4
II-16
II-24



T-1490
I-4
II-16
II-25



T-1491
I-4
II-16
II-26



T-1492
I-4
II-16
II-27



T-1493
I-4
II-16
II-28



T-1494
I-4
II-16
II-29



T-1495
I-4
II-17
II-1



T-1496
I-4
II-17
II-2



T-1497
I-4
II-17
II-3



T-1498
I-4
II-17
II-6



T-1499
I-4
II-17
II-7



T-1500
I-4
II-17
II-8



T-1501
I-4
II-17
II-9



T-1502
I-4
II-17
II-11



T-1503
I-4
II-17
II-12



T-1504
I-4
II-17
II-13



T-1505
I-4
II-17
II-14



T-1506
I-4
II-17
II-15



T-1507
I-4
II-17
II-18



T-1508
I-4
II-17
II-19



T-1509
I-4
II-17
II-20



T-1510
I-4
II-17
II-21



T-1511
I-4
II-17
II-22



T-1512
I-4
II-17
II-23



T-1513
I-4
II-17
II-24



T-1514
I-4
II-17
II-25



T-1515
I-4
II-17
II-26



T-1516
I-4
II-17
II-27



T-1517
I-4
II-17
II-28



T-1518
I-4
II-17
II-29



T-1519
I-4
II-18
II-19



T-1520
I-4
II-18
II-20



T-1521
I-4
II-18
II-21



T-1522
I-4
II-18
II-22



T-1523
I-4
II-18
II-23



T-1524
I-4
II-18
II-24



T-1525
I-4
II-18
II-25



T-1526
I-4
II-18
II-26



T-1527
I-4
II-18
II-27



T-1528
I-4
II-18
II-28



T-1529
I-4
II-18
II-29



T-1530
I-4
II-19
II-20



T-1531
I-4
II-19
II-21



T-1532
I-4
II-19
II-22



T-1533
I-4
II-19
II-23



T-1534
I-4
II-19
II-24



T-1535
I-4
II-19
II-25



T-1536
I-4
II-19
II-26



T-1537
I-4
II-19
II-27



T-1538
I-4
II-19
II-28



T-1539
I-4
II-19
II-29



T-1540
I-4
II-20
II-21



T-1541
I-4
II-20
II-22



T-1542
I-4
II-20
II-23



T-1543
I-4
II-20
II-24



T-1544
I-4
II-20
II-25



T-1545
I-4
II-20
II-26



T-1546
I-4
II-20
II-27



T-1547
I-4
II-20
II-28



T-1548
I-4
II-20
II-29



T-1549
I-4
II-21
II-22



T-1550
I-4
II-21
II-23



T-1551
I-4
II-21
II-24



T-1552
I-4
II-21
II-25



T-1553
I-4
II-21
II-26



T-1554
I-4
II-21
II-27



T-1555
I-4
II-21
II-28



T-1556
I-4
II-21
II-29



T-1557
I-4
II-22
II-23



T-1558
I-4
II-22
II-24



T-1559
I-4
II-22
II-25



T-1560
I-4
II-22
II-26



T-1561
I-4
II-22
II-27



T-1562
I-4
II-22
II-28



T-1563
I-4
II-22
II-29



T-1564
I-4
II-23
II-24



T-1565
I-4
II-23
II-25



T-1566
I-4
II-23
II-26



T-1567
I-4
II-23
II-27



T-1568
I-4
II-23
II-28



T-1569
I-4
II-23
II-29



T-1570
I-4
II-24
II-25



T-1571
I-4
II-24
II-26



T-1572
I-4
II-24
II-27



T-1573
I-4
II-24
II-28



T-1574
I-4
II-24
II-29



T-1575
I-4
II-25
II-26



T-1576
I-4
II-25
II-27



T-1577
I-4
II-25
II-28



T-1578
I-4
II-25
II-29



T-1579
I-4
II-26
II-27



T-1580
I-4
II-26
II-28



T-1581
I-4
II-26
II-29



T-1582
I-4
II-27
II-28



T-1583
I-4
II-27
II-29



T-1584
I-4
II-28
II-29



T-1585
I-5
II-1
II-2



T-1586
I-5
II-1
II-3



T-1587
I-5
II-1
II-6



T-1588
I-5
II-1
II-7



T-1589
I-5
II-1
II-8



T-1590
I-5
II-1
II-9



T-1591
I-5
II-1
II-11



T-1592
I-5
II-1
II-12



T-1593
I-5
II-1
II-13



T-1594
I-5
II-1
II-14



T-1595
I-5
II-1
II-15



T-1596
I-5
II-1
II-18



T-1597
I-5
II-1
II-19



T-1598
I-5
II-1
II-20



T-1599
I-5
II-1
II-21



T-1600
I-5
II-1
II-22



T-1601
I-5
II-1
II-23



T-1602
I-5
II-1
II-24



T-1603
I-5
II-1
II-25



T-1604
I-5
II-1
II-26



T-1605
I-5
II-1
II-27



T-1606
I-5
II-1
II-28



T-1607
I-5
II-1
II-29



T-1608
I-5
II-2
II-3



T-1609
I-5
II-2
II-6



T-1610
I-5
II-2
II-7



T-1611
I-5
II-2
II-8



T-1612
I-5
II-2
II-9



T-1613
I-5
II-2
II-11



T-1614
I-5
II-2
II-12



T-1615
I-5
II-2
II-13



T-1616
I-5
II-2
II-14



T-1617
I-5
II-2
II-15



T-1618
I-5
II-2
II-18



T-1619
I-5
II-2
II-19



T-1620
I-5
II-2
II-20



T-1621
I-5
II-2
II-21



T-1622
I-5
II-2
II-22



T-1623
I-5
II-2
II-23



T-1624
I-5
II-2
II-24



T-1625
I-5
II-2
II-25



T-1626
I-5
II-2
II-26



T-1627
I-5
II-2
II-27



T-1628
I-5
II-2
II-28



T-1629
I-5
II-2
II-29



T-1630
I-5
II-3
II-6



T-1631
I-5
II-3
II-7



T-1632
I-5
II-3
II-8



T-1633
I-5
II-3
II-9



T-1634
I-5
II-3
II-11



T-1635
I-5
II-3
II-12



T-1636
I-5
II-3
II-13



T-1637
I-5
II-3
II-14



T-1638
I-5
II-3
II-15



T-1639
I-5
II-3
II-18



T-1640
I-5
II-3
II-19



T-1641
I-5
II-3
II-20



T-1642
I-5
II-3
II-21



T-1643
I-5
II-3
II-22



T-1644
I-5
II-3
II-23



T-1645
I-5
II-3
II-24



T-1646
I-5
II-3
II-25



T-1647
I-5
II-3
II-26



T-1648
I-5
II-3
II-27



T-1649
I-5
II-3
II-28



T-1650
I-5
II-3
II-29



T-1651
I-5
II-4
II-1



T-1652
I-5
II-4
II-2



T-1653
I-5
II-4
II-3



T-1654
I-5
II-4
II-6



T-1655
I-5
II-4
II-7



T-1656
I-5
II-4
II-8



T-1657
I-5
II-4
II-9



T-1658
I-5
II-4
II-11



T-1659
I-5
II-4
II-12



T-1660
I-5
II-4
II-13



T-1661
I-5
II-4
II-14



T-1662
I-5
II-4
II-15



T-1663
I-5
II-4
II-18



T-1664
I-5
II-4
II-19



T-1665
I-5
II-4
II-20



T-1666
I-5
II-4
II-21



T-1667
I-5
II-4
II-22



T-1668
I-5
II-4
II-23



T-1669
I-5
II-4
II-24



T-1670
I-5
II-4
II-25



T-1671
I-5
II-4
II-26



T-1672
I-5
II-4
II-27



T-1673
I-5
II-4
II-28



T-1674
I-5
II-4
II-29



T-1675
I-5
II-5
II-1



T-1676
I-5
II-5
II-2



T-1677
I-5
II-5
II-3



T-1678
I-5
II-5
II-6



T-1679
I-5
II-5
II-7



T-1680
I-5
II-5
II-8



T-1681
I-5
II-5
II-9



T-1682
I-5
II-5
II-11



T-1683
I-5
II-5
II-12



T-1684
I-5
II-5
II-13



T-1685
I-5
II-5
II-14



T-1686
I-5
II-5
II-15



T-1687
I-5
II-5
II-18



T-1688
I-5
II-5
II-19



T-1689
I-5
II-5
II-20



T-1690
I-5
II-5
II-21



T-1691
I-5
II-5
II-22



T-1692
I-5
II-5
II-23



T-1693
I-5
II-5
II-24



T-1694
I-5
II-5
II-25



T-1695
I-5
II-5
II-26



T-1696
I-5
II-5
II-27



T-1697
I-5
II-5
II-28



T-1698
I-5
II-5
II-29



T-1699
I-5
II-6
II-7



T-1700
I-5
II-6
II-8



T-1701
I-5
II-6
II-9



T-1702
I-5
II-6
II-11



T-1703
I-5
II-6
II-12



T-1704
I-5
II-6
II-13



T-1705
I-5
II-6
II-14



T-1706
I-5
II-6
II-15



T-1707
I-5
II-6
II-18



T-1708
I-5
II-6
II-19



T-1709
I-5
II-6
II-20



T-1710
I-5
II-6
II-21



T-1711
I-5
II-6
II-22



T-1712
I-5
II-6
II-23



T-1713
I-5
II-6
II-24



T-1714
I-5
II-6
II-25



T-1715
I-5
II-6
II-26



T-1716
I-5
II-6
II-27



T-1717
I-5
II-6
II-28



T-1718
I-5
II-6
II-29



T-1719
I-5
II-7
II-8



T-1720
I-5
II-7
II-9



T-1721
I-5
II-7
II-11



T-1722
I-5
II-7
II-12



T-1723
I-5
II-7
II-13



T-1724
I-5
II-7
II-14



T-1725
I-5
II-7
II-15



T-1726
I-5
II-7
II-18



T-1727
I-5
II-7
II-19



T-1728
I-5
II-7
II-20



T-1729
I-5
II-7
II-21



T-1730
I-5
II-7
II-22



T-1731
I-5
II-7
II-23



T-1732
I-5
II-7
II-24



T-1733
I-5
II-7
II-25



T-1734
I-5
II-7
II-26



T-1735
I-5
II-7
II-27



T-1736
I-5
II-7
II-28



T-1737
I-5
II-7
II-29



T-1738
I-5
II-8
II-9



T-1739
I-5
II-8
II-11



T-1740
I-5
II-8
II-12



T-1741
I-5
II-8
II-13



T-1742
I-5
II-8
II-14



T-1743
I-5
II-8
II-15



T-1744
I-5
II-8
II-18



T-1745
I-5
II-8
II-19



T-1746
I-5
II-8
II-20



T-1747
I-5
II-8
II-21



T-1748
I-5
II-8
II-22



T-1749
I-5
II-8
II-23



T-1750
I-5
II-8
II-24



T-1751
I-5
II-8
II-25



T-1752
I-5
II-8
II-26



T-1753
I-5
II-8
II-27



T-1754
I-5
II-8
II-28



T-1755
I-5
II-8
II-29



T-1756
I-5
II-9
II-11



T-1757
I-5
II-9
II-12



T-1758
I-5
II-9
II-13



T-1759
I-5
II-9
II-14



T-1760
I-5
II-9
II-15



T-1761
I-5
II-9
II-18



T-1762
I-5
II-9
II-19



T-1763
I-5
II-9
II-20



T-1764
I-5
II-9
II-21



T-1765
I-5
II-9
II-22



T-1766
I-5
II-9
II-23



T-1767
I-5
II-9
II-24



T-1768
I-5
II-9
II-25



T-1769
I-5
II-9
II-26



T-1770
I-5
II-9
II-27



T-1771
I-5
II-9
II-28



T-1772
I-5
II-9
II-29



T-1773
I-5
II-10
II-1



T-1774
I-5
II-10
II-2



T-1775
I-5
II-10
II-3



T-1776
I-5
II-10
II-6



T-1777
I-5
II-10
II-7



T-1778
I-5
II-10
II-8



T-1779
I-5
II-10
II-9



T-1780
I-5
II-10
II-11



T-1781
I-5
II-10
II-12



T-1782
I-5
II-10
II-13



T-1783
I-5
II-10
II-14



T-1784
I-5
II-10
II-15



T-1785
I-5
II-10
II-18



T-1786
I-5
II-10
II-19



T-1787
I-5
II-10
II-20



T-1788
I-5
II-10
II-21



T-1789
I-5
II-10
II-22



T-1790
I-5
II-10
II-23



T-1791
I-5
II-10
II-24



T-1792
I-5
II-10
II-25



T-1793
I-5
II-10
II-26



T-1794
I-5
II-10
II-27



T-1795
I-5
II-10
II-28



T-1796
I-5
II-10
II-29



T-1797
I-5
II-11
II-12



T-1798
I-5
II-11
II-13



T-1799
I-5
II-11
II-14



T-1800
I-5
II-11
II-15



T-1801
I-5
II-11
II-18



T-1802
I-5
II-11
II-19



T-1803
I-5
II-11
II-20



T-1804
I-5
II-11
II-21



T-1805
I-5
II-11
II-22



T-1806
I-5
II-11
II-23



T-1807
I-5
II-11
II-24



T-1808
I-5
II-11
II-25



T-1809
I-5
II-11
II-26



T-1810
I-5
II-11
II-27



T-1811
I-5
II-11
II-28



T-1812
I-5
II-11
II-29



T-1813
I-5
II-12
II-13



T-1814
I-5
II-12
II-14



T-1815
I-5
II-12
II-15



T-1816
I-5
II-12
II-18



T-1817
I-5
II-12
II-19



T-1818
I-5
II-12
II-20



T-1819
I-5
II-12
II-21



T-1820
I-5
II-12
II-22



T-1821
I-5
II-12
II-23



T-1822
I-5
II-12
II-24



T-1823
I-5
II-12
II-25



T-1824
I-5
II-12
II-26



T-1825
I-5
II-12
II-27



T-1826
I-5
II-12
II-28



T-1827
I-5
II-12
II-29



T-1828
I-5
II-13
II-14



T-1829
I-5
II-13
II-15



T-1830
I-5
II-13
II-18



T-1831
I-5
II-13
II-19



T-1832
I-5
II-13
II-20



T-1833
I-5
II-13
II-21



T-1834
I-5
II-13
II-22



T-1835
I-5
II-13
II-23



T-1836
I-5
II-13
II-24



T-1837
I-5
II-13
II-25



T-1838
I-5
II-13
II-26



T-1839
I-5
II-13
II-27



T-1840
I-5
II-13
II-28



T-1841
I-5
II-13
II-29



T-1842
I-5
II-14
II-15



T-1843
I-5
II-14
II-18



T-1844
I-5
II-14
II-19



T-1845
I-5
II-14
II-20



T-1846
I-5
II-14
II-21



T-1847
I-5
II-14
II-22



T-1848
I-5
II-14
II-23



T-1849
I-5
II-14
II-24



T-1850
I-5
II-14
II-25



T-1851
I-5
II-14
II-26



T-1852
I-5
II-14
II-27



T-1853
I-5
II-14
II-28



T-1854
I-5
II-14
II-29



T-1855
I-5
II-15
II-18



T-1856
I-5
II-15
II-19



T-1857
I-5
II-15
II-20



T-1858
I-5
II-15
II-21



T-1859
I-5
II-15
II-22



T-1860
I-5
II-15
II-23



T-1861
I-5
II-15
II-24



T-1862
I-5
II-15
II-25



T-1863
I-5
II-15
II-26



T-1864
I-5
II-15
II-27



T-1865
I-5
II-15
II-28



T-1866
I-5
II-15
II-29



T-1867
I-5
II-16
II-1



T-1868
I-5
II-16
II-2



T-1869
I-5
II-16
II-3



T-1870
I-5
II-16
II-6



T-1871
I-5
II-16
II-7



T-1872
I-5
II-16
II-8



T-1873
I-5
II-16
II-9



T-1874
I-5
II-16
II-11



T-1875
I-5
II-16
II-12



T-1876
I-5
II-16
II-13



T-1877
I-5
II-16
II-14



T-1878
I-5
II-16
II-15



T-1879
I-5
II-16
II-18



T-1880
I-5
II-16
II-19



T-1881
I-5
II-16
II-20



T-1882
I-5
II-16
II-21



T-1883
I-5
II-16
II-22



T-1884
I-5
II-16
II-23



T-1885
I-5
II-16
II-24



T-1886
I-5
II-16
II-25



T-1887
I-5
II-16
II-26



T-1888
I-5
II-16
II-27



T-1889
I-5
II-16
II-28



T-1890
I-5
II-16
II-29



T-1891
I-5
II-17
II-1



T-1892
I-5
II-17
II-2



T-1893
I-5
II-17
II-3



T-1894
I-5
II-17
II-6



T-1895
I-5
II-17
II-7



T-1896
I-5
II-17
II-8



T-1897
I-5
II-17
II-9



T-1898
I-5
II-17
II-11



T-1899
I-5
II-17
II-12



T-1900
I-5
II-17
II-13



T-1901
I-5
II-17
II-14



T-1902
I-5
II-17
II-15



T-1903
I-5
II-17
II-18



T-1904
I-5
II-17
II-19



T-1905
I-5
II-17
II-20



T-1906
I-5
II-17
II-21



T-1907
I-5
II-17
II-22



T-1908
I-5
II-17
II-23



T-1909
I-5
II-17
II-24



T-1910
I-5
II-17
II-25



T-1911
I-5
II-17
II-26



T-1912
I-5
II-17
II-27



T-1913
I-5
II-17
II-28



T-1914
I-5
II-17
II-29



T-1915
I-5
II-18
II-19



T-1916
I-5
II-18
II-20



T-1917
I-5
II-18
II-21



T-1918
I-5
II-18
II-22



T-1919
I-5
II-18
II-23



T-1920
I-5
II-18
II-24



T-1921
I-5
II-18
II-25



T-1922
I-5
II-18
II-26



T-1923
I-5
II-18
II-27



T-1924
I-5
II-18
II-28



T-1925
I-5
II-18
II-29



T-1926
I-5
II-19
II-20



T-1927
I-5
II-19
II-21



T-1928
I-5
II-19
II-22



T-1929
I-5
II-19
II-23



T-1930
I-5
II-19
II-24



T-1931
I-5
II-19
II-25



T-1932
I-5
II-19
II-26



T-1933
I-5
II-19
II-27



T-1934
I-5
II-19
II-28



T-1935
I-5
II-19
II-29



T-1936
I-5
II-20
II-21



T-1937
I-5
II-20
II-22



T-1938
I-5
II-20
II-23



T-1939
I-5
II-20
II-24



T-1940
I-5
II-20
II-25



T-1941
I-5
II-20
II-26



T-1942
I-5
II-20
II-27



T-1943
I-5
II-20
II-28



T-1944
I-5
II-20
II-29



T-1945
I-5
II-21
II-22



T-1946
I-5
II-21
II-23



T-1947
I-5
II-21
II-24



T-1948
I-5
II-21
II-25



T-1949
I-5
II-21
II-26



T-1950
I-5
II-21
II-27



T-1951
I-5
II-21
II-28



T-1952
I-5
II-21
II-29



T-1953
I-5
II-22
II-23



T-1954
I-5
II-22
II-24



T-1955
I-5
II-22
II-25



T-1956
I-5
II-22
II-26



T-1957
I-5
II-22
II-27



T-1958
I-5
II-22
II-28



T-1959
I-5
II-22
II-29



T-1960
I-5
II-23
II-24



T-1961
I-5
II-23
II-25



T-1962
I-5
II-23
II-26



T-1963
I-5
II-23
II-27



T-1964
I-5
II-23
II-28



T-1965
I-5
II-23
II-29



T-1966
I-5
II-24
II-25



T-1967
I-5
II-24
II-26



T-1968
I-5
II-24
II-27



T-1969
I-5
II-24
II-28



T-1970
I-5
II-24
II-29



T-1971
I-5
II-25
II-26



T-1972
I-5
II-25
II-27



T-1973
I-5
II-25
II-28



T-1974
I-5
II-25
II-29



T-1975
I-5
II-26
II-27



T-1976
I-5
II-26
II-28



T-1977
I-5
II-26
II-29



T-1978
I-5
II-27
II-28



T-1979
I-5
II-27
II-29



T-1980
I-5
II-28
II-29



T-1981
I-6
II-1
II-2



T-1982
I-6
II-1
II-3



T-1983
I-6
II-1
II-6



T-1984
I-6
II-1
II-7



T-1985
I-6
II-1
II-8



T-1986
I-6
II-1
II-9



T-1987
I-6
II-1
II-11



T-1988
I-6
II-1
II-12



T-1989
I-6
II-1
II-13



T-1990
I-6
II-1
II-14



T-1991
I-6
II-1
II-15



T-1992
I-6
II-1
II-18



T-1993
I-6
II-1
II-19



T-1994
I-6
II-1
II-20



T-1995
I-6
II-1
II-21



T-1996
I-6
II-1
II-22



T-1997
I-6
II-1
II-23



T-1998
I-6
II-1
II-24



T-1999
I-6
II-1
II-25



T-2000
I-6
II-1
II-26



T-2001
I-6
II-1
II-27



T-2002
I-6
II-1
II-28



T-2003
I-6
II-1
II-29



T-2004
I-6
II-2
II-3



T-2005
I-6
II-2
II-6



T-2006
I-6
II-2
II-7



T-2007
I-6
II-2
II-8



T-2008
I-6
II-2
II-9



T-2009
I-6
II-2
II-11



T-2010
I-6
II-2
II-12



T-2011
I-6
II-2
II-13



T-2012
I-6
II-2
II-14



T-2013
I-6
II-2
II-15



T-2014
I-6
II-2
II-18



T-2015
I-6
II-2
II-19



T-2016
I-6
II-2
II-20



T-2017
I-6
II-2
II-21



T-2018
I-6
II-2
II-22



T-2019
I-6
II-2
II-23



T-2020
I-6
II-2
II-24



T-2021
I-6
II-2
II-25



T-2022
I-6
II-2
II-26



T-2023
I-6
II-2
II-27



T-2024
I-6
II-2
II-28



T-2025
I-6
II-2
II-29



T-2026
I-6
II-3
II-6



T-2027
I-6
II-3
II-7



T-2028
I-6
II-3
II-8



T-2029
I-6
II-3
II-9



T-2030
I-6
II-3
II-11



T-2031
I-6
II-3
II-12



T-2032
I-6
II-3
II-13



T-2033
I-6
II-3
II-14



T-2034
I-6
II-3
II-15



T-2035
I-6
II-3
II-18



T-2036
I-6
II-3
II-19



T-2037
I-6
II-3
II-20



T-2038
I-6
II-3
II-21



T-2039
I-6
II-3
II-22



T-2040
I-6
II-3
II-23



T-2041
I-6
II-3
II-24



T-2042
I-6
II-3
II-25



T-2043
I-6
II-3
II-26



T-2044
I-6
II-3
II-27



T-2045
I-6
II-3
II-28



T-2046
I-6
II-3
II-29



T-2047
I-6
II-4
II-1



T-2048
I-6
II-4
II-2



T-2049
I-6
II-4
II-3



T-2050
I-6
II-4
II-6



T-2051
I-6
II-4
II-7



T-2052
I-6
II-4
II-8



T-2053
I-6
II-4
II-9



T-2054
I-6
II-4
II-11



T-2055
I-6
II-4
II-12



T-2056
I-6
II-4
II-13



T-2057
I-6
II-4
II-14



T-2058
I-6
II-4
II-15



T-2059
I-6
II-4
II-18



T-2060
I-6
II-4
II-19



T-2061
I-6
II-4
II-20



T-2062
I-6
II-4
II-21



T-2063
I-6
II-4
II-22



T-2064
I-6
II-4
II-23



T-2065
I-6
II-4
II-24



T-2066
I-6
II-4
II-25



T-2067
I-6
II-4
II-26



T-2068
I-6
II-4
II-27



T-2069
I-6
II-4
II-28



T-2070
I-6
II-4
II-29



T-2071
I-6
II-5
II-1



T-2072
I-6
II-5
II-2



T-2073
I-6
II-5
II-3



T-2074
I-6
II-5
II-6



T-2075
I-6
II-5
II-7



T-2076
I-6
II-5
II-8



T-2077
I-6
II-5
II-9



T-2078
I-6
II-5
II-11



T-2079
I-6
II-5
II-12



T-2080
I-6
II-5
II-13



T-2081
I-6
II-5
II-14



T-2082
I-6
II-5
II-15



T-2083
I-6
II-5
II-18



T-2084
I-6
II-5
II-19



T-2085
I-6
II-5
II-20



T-2086
I-6
II-5
II-21



T-2087
I-6
II-5
II-22



T-2088
I-6
II-5
II-23



T-2089
I-6
II-5
II-24



T-2090
I-6
II-5
II-25



T-2091
I-6
II-5
II-26



T-2092
I-6
II-5
II-27



T-2093
I-6
II-5
II-28



T-2094
I-6
II-5
II-29



T-2095
I-6
II-6
II-7



T-2096
I-6
II-6
II-8



T-2097
I-6
II-6
II-9



T-2098
I-6
II-6
II-11



T-2099
I-6
II-6
II-12



T-2100
I-6
II-6
II-13



T-2101
I-6
II-6
II-14



T-2102
I-6
II-6
II-15



T-2103
I-6
II-6
II-18



T-2104
I-6
II-6
II-19



T-2105
I-6
II-6
II-20



T-2106
I-6
II-6
II-21



T-2107
I-6
II-6
II-22



T-2108
I-6
II-6
II-23



T-2109
I-6
II-6
II-24



T-2110
I-6
II-6
II-25



T-2111
I-6
II-6
II-26



T-2112
I-6
II-6
II-27



T-2113
I-6
II-6
II-28



T-2114
I-6
II-6
II-29



T-2115
I-6
II-7
II-8



T-2116
I-6
II-7
II-9



T-2117
I-6
II-7
II-11



T-2118
I-6
II-7
II-12



T-2119
I-6
II-7
II-13



T-2120
I-6
II-7
II-14



T-2121
I-6
II-7
II-15



T-2122
I-6
II-7
II-18



T-2123
I-6
II-7
II-19



T-2124
I-6
II-7
II-20



T-2125
I-6
II-7
II-21



T-2126
I-6
II-7
II-22



T-2127
I-6
II-7
II-23



T-2128
I-6
II-7
II-24



T-2129
I-6
II-7
II-25



T-2130
I-6
II-7
II-26



T-2131
I-6
II-7
II-27



T-2132
I-6
II-7
II-28



T-2133
I-6
II-7
II-29



T-2134
I-6
II-8
II-9



T-2135
I-6
II-8
II-11



T-2136
I-6
II-8
II-12



T-2137
I-6
II-8
II-13



T-2138
I-6
II-8
II-14



T-2139
I-6
II-8
II-15



T-2140
I-6
II-8
II-18



T-2141
I-6
II-8
II-19



T-2142
I-6
II-8
II-20



T-2143
I-6
II-8
II-21



T-2144
I-6
II-8
II-22



T-2145
I-6
II-8
II-23



T-2146
I-6
II-8
II-24



T-2147
I-6
II-8
II-25



T-2148
I-6
II-8
II-26



T-2149
I-6
II-8
II-27



T-2150
I-6
II-8
II-28



T-2151
I-6
II-8
II-29



T-2152
I-6
II-9
II-11



T-2153
I-6
II-9
II-12



T-2154
I-6
II-9
II-13



T-2155
I-6
II-9
II-14



T-2156
I-6
II-9
II-15



T-2157
I-6
II-9
II-18



T-2158
I-6
II-9
II-19



T-2159
I-6
II-9
II-20



T-2160
I-6
II-9
II-21



T-2161
I-6
II-9
II-22



T-2162
I-6
II-9
II-23



T-2163
I-6
II-9
II-24



T-2164
I-6
II-9
II-25



T-2165
I-6
II-9
II-26



T-2166
I-6
II-9
II-27



T-2167
I-6
II-9
II-28



T-2168
I-6
II-9
II-29



T-2169
I-6
II-10
II-1



T-2170
I-6
II-10
II-2



T-2171
I-6
II-10
II-3



T-2172
I-6
II-10
II-6



T-2173
I-6
II-10
II-7



T-2174
I-6
II-10
II-8



T-2175
I-6
II-10
II-9



T-2176
I-6
II-10
II-11



T-2177
I-6
II-10
II-12



T-2178
I-6
II-10
II-13



T-2179
I-6
II-10
II-14



T-2180
I-6
II-10
II-15



T-2181
I-6
II-10
II-18



T-2182
I-6
II-10
II-19



T-2183
I-6
II-10
II-20



T-2184
I-6
II-10
II-21



T-2185
I-6
II-10
II-22



T-2186
I-6
II-10
II-23



T-2187
I-6
II-10
II-24



T-2188
I-6
II-10
II-25



T-2189
I-6
II-10
II-26



T-2190
I-6
II-10
II-27



T-2191
I-6
II-10
II-28



T-2192
I-6
II-10
II-29



T-2193
I-6
II-11
II-12



T-2194
I-6
II-11
II-13



T-2195
I-6
II-11
II-14



T-2196
I-6
II-11
II-15



T-2197
I-6
II-11
II-18



T-2198
I-6
II-11
II-19



T-2199
I-6
II-11
II-20



T-2200
I-6
II-11
II-21



T-2201
I-6
II-11
II-22



T-2202
I-6
II-11
II-23



T-2203
I-6
II-11
II-24



T-2204
I-6
II-11
II-25



T-2205
I-6
II-11
II-26



T-2206
I-6
II-11
II-27



T-2207
I-6
II-11
II-28



T-2208
I-6
II-11
II-29



T-2209
I-6
II-12
II-13



T-2210
I-6
II-12
II-14



T-2211
I-6
II-12
II-15



T-2212
I-6
II-12
II-18



T-2213
I-6
II-12
II-19



T-2214
I-6
II-12
II-20



T-2215
I-6
II-12
II-21



T-2216
I-6
II-12
II-22



T-2217
I-6
II-12
II-23



T-2218
I-6
II-12
II-24



T-2219
I-6
II-12
II-25



T-2220
I-6
II-12
II-26



T-2221
I-6
II-12
II-27



T-2222
I-6
II-12
II-28



T-2223
I-6
II-12
II-29



T-2224
I-6
II-13
II-14



T-2225
I-6
II-13
II-15



T-2226
I-6
II-13
II-18



T-2227
I-6
II-13
II-19



T-2228
I-6
II-13
II-20



T-2229
I-6
II-13
II-21



T-2230
I-6
II-13
II-22



T-2231
I-6
II-13
II-23



T-2232
I-6
II-13
II-24



T-2233
I-6
II-13
II-25



T-2234
I-6
II-13
II-26



T-2235
I-6
II-13
II-27



T-2236
I-6
II-13
II-28



T-2237
I-6
II-13
II-29



T-2238
I-6
II-14
II-15



T-2239
I-6
II-14
II-18



T-2240
I-6
II-14
II-19



T-2241
I-6
II-14
II-20



T-2242
I-6
II-14
II-21



T-2243
I-6
II-14
II-22



T-2244
I-6
II-14
II-23



T-2245
I-6
II-14
II-24



T-2246
I-6
II-14
II-25



T-2247
I-6
II-14
II-26



T-2248
I-6
II-14
II-27



T-2249
I-6
II-14
II-28



T-2250
I-6
II-14
II-29



T-2251
I-6
II-15
II-18



T-2252
I-6
II-15
II-19



T-2253
I-6
II-15
II-20



T-2254
I-6
II-15
II-21



T-2255
I-6
II-15
II-22



T-2256
I-6
II-15
II-23



T-2257
I-6
II-15
II-24



T-2258
I-6
II-15
II-25



T-2259
I-6
II-15
II-26



T-2260
I-6
II-15
II-27



T-2261
I-6
II-15
II-28



T-2262
I-6
II-15
II-29



T-2263
I-6
II-16
II-1



T-2264
I-6
II-16
II-2



T-2265
I-6
II-16
II-3



T-2266
I-6
II-16
II-6



T-2267
I-6
II-16
II-7



T-2268
I-6
II-16
II-8



T-2269
I-6
II-16
II-9



T-2270
I-6
II-16
II-11



T-2271
I-6
II-16
II-12



T-2272
I-6
II-16
II-13



T-2273
I-6
II-16
II-14



T-2274
I-6
II-16
II-15



T-2275
I-6
II-16
II-18



T-2276
I-6
II-16
II-19



T-2277
I-6
II-16
II-20



T-2278
I-6
II-16
II-21



T-2279
I-6
II-16
II-22



T-2280
I-6
II-16
II-23



T-2281
I-6
II-16
II-24



T-2282
I-6
II-16
II-25



T-2283
I-6
II-16
II-26



T-2284
I-6
II-16
II-27



T-2285
I-6
II-16
II-28



T-2286
I-6
II-16
II-29



T-2287
I-6
II-17
II-1



T-2288
I-6
II-17
II-2



T-2289
I-6
II-17
II-3



T-2290
I-6
II-17
II-6



T-2291
I-6
II-17
II-7



T-2292
I-6
II-17
II-8



T-2293
I-6
II-17
II-9



T-2294
I-6
II-17
II-11



T-2295
I-6
II-17
II-12



T-2296
I-6
II-17
II-13



T-2297
I-6
II-17
II-14



T-2298
I-6
II-17
II-15



T-2299
I-6
II-17
II-18



T-2300
I-6
II-17
II-19



T-2301
I-6
II-17
II-20



T-2302
I-6
II-17
II-21



T-2303
I-6
II-17
II-22



T-2304
I-6
II-17
II-23



T-2305
I-6
II-17
II-24



T-2306
I-6
II-17
II-25



T-2307
I-6
II-17
II-26



T-2308
I-6
II-17
II-27



T-2309
I-6
II-17
II-28



T-2310
I-6
II-17
II-29



T-2311
I-6
II-18
II-19



T-2312
I-6
II-18
II-20



T-2313
I-6
II-18
II-21



T-2314
I-6
II-18
II-22



T-2315
I-6
II-18
II-23



T-2316
I-6
II-18
II-24



T-2317
I-6
II-18
II-25



T-2318
I-6
II-18
II-26



T-2319
I-6
II-18
II-27



T-2320
I-6
II-18
II-28



T-2321
I-6
II-18
II-29



T-2322
I-6
II-19
II-20



T-2323
I-6
II-19
II-21



T-2324
I-6
II-19
II-22



T-2325
I-6
II-19
II-23



T-2326
I-6
II-19
II-24



T-2327
I-6
II-19
II-25



T-2328
I-6
II-19
II-26



T-2329
I-6
II-19
II-27



T-2330
I-6
II-19
II-28



T-2331
I-6
II-19
II-29



T-2332
I-6
II-20
II-21



T-2333
I-6
II-20
II-22



T-2334
I-6
II-20
II-23



T-2335
I-6
II-20
II-24



T-2336
I-6
II-20
II-25



T-2337
I-6
II-20
II-26



T-2338
I-6
II-20
II-27



T-2339
I-6
II-20
II-28



T-2340
I-6
II-20
II-29



T-2341
I-6
II-21
II-22



T-2342
I-6
II-21
II-23



T-2343
I-6
II-21
II-24



T-2344
I-6
II-21
II-25



T-2345
I-6
II-21
II-26



T-2346
I-6
II-21
II-27



T-2347
I-6
II-21
II-28



T-2348
I-6
II-21
II-29



T-2349
I-6
II-22
II-23



T-2350
I-6
II-22
II-24



T-2351
I-6
II-22
II-25



T-2352
I-6
II-22
II-26



T-2353
I-6
II-22
II-27



T-2354
I-6
II-22
II-28



T-2355
I-6
II-22
II-29



T-2356
I-6
II-23
II-24



T-2357
I-6
II-23
II-25



T-2358
I-6
II-23
II-26



T-2359
I-6
II-23
II-27



T-2360
I-6
II-23
II-28



T-2361
I-6
II-23
II-29



T-2362
I-6
II-24
II-25



T-2363
I-6
II-24
II-26



T-2364
I-6
II-24
II-27



T-2365
I-6
II-24
II-28



T-2366
I-6
II-24
II-29



T-2367
I-6
II-25
II-26



T-2368
I-6
II-25
II-27



T-2369
I-6
II-25
II-28



T-2370
I-6
II-25
II-29



T-2371
I-6
II-26
II-27



T-2372
I-6
II-26
II-28



T-2373
I-6
II-26
II-29



T-2374
I-6
II-27
II-28



T-2375
I-6
II-27
II-29



T-2376
I-6
II-28
II-29



T-2377
I-7
II-1
II-2



T-2378
I-7
II-1
II-3



T-2379
I-7
II-1
II-6



T-2380
I-7
II-1
II-7



T-2381
I-7
II-1
II-8



T-2382
I-7
II-1
II-9



T-2383
I-7
II-1
II-11



T-2384
I-7
II-1
II-12



T-2385
I-7
II-1
II-13



T-2386
I-7
II-1
II-14



T-2387
I-7
II-1
II-15



T-2388
I-7
II-1
II-18



T-2389
I-7
II-1
II-19



T-2390
I-7
II-1
II-20



T-2391
I-7
II-1
II-21



T-2392
I-7
II-1
II-22



T-2393
I-7
II-1
II-23



T-2394
I-7
II-1
II-24



T-2395
I-7
II-1
II-25



T-2396
I-7
II-1
II-26



T-2397
I-7
II-1
II-27



T-2398
I-7
II-1
II-28



T-2399
I-7
II-1
II-29



T-2400
I-7
II-2
II-3



T-2401
I-7
II-2
II-6



T-2402
I-7
II-2
II-7



T-2403
I-7
II-2
II-8



T-2404
I-7
II-2
II-9



T-2405
I-7
II-2
II-11



T-2406
I-7
II-2
II-12



T-2407
I-7
II-2
II-13



T-2408
I-7
II-2
II-14



T-2409
I-7
II-2
II-15



T-2410
I-7
II-2
II-18



T-2411
I-7
II-2
II-19



T-2412
I-7
II-2
II-20



T-2413
I-7
II-2
II-21



T-2414
I-7
II-2
II-22



T-2415
I-7
II-2
II-23



T-2416
I-7
II-2
II-24



T-2417
I-7
II-2
II-25



T-2418
I-7
II-2
II-26



T-2419
I-7
II-2
II-27



T-2420
I-7
II-2
II-28



T-2421
I-7
II-2
II-29



T-2422
I-7
II-3
II-6



T-2423
I-7
II-3
II-7



T-2424
I-7
II-3
II-8



T-2425
I-7
II-3
II-9



T-2426
I-7
II-3
II-11



T-2427
I-7
II-3
II-12



T-2428
I-7
II-3
II-13



T-2429
I-7
II-3
II-14



T-2430
I-7
II-3
II-15



T-2431
I-7
II-3
II-18



T-2432
I-7
II-3
II-19



T-2433
I-7
II-3
II-20



T-2434
I-7
II-3
II-21



T-2435
I-7
II-3
II-22



T-2436
I-7
II-3
II-23



T-2437
I-7
II-3
II-24



T-2438
I-7
II-3
II-25



T-2439
I-7
II-3
II-26



T-2440
I-7
II-3
II-27



T-2441
I-7
II-3
II-28



T-2442
I-7
II-3
II-29



T-2443
I-7
II-4
II-1



T-2444
I-7
II-4
II-2



T-2445
I-7
II-4
II-3



T-2446
I-7
II-4
II-6



T-2447
I-7
II-4
II-7



T-2448
I-7
II-4
II-8



T-2449
I-7
II-4
II-9



T-2450
I-7
II-4
II-11



T-2451
I-7
II-4
II-12



T-2452
I-7
II-4
II-13



T-2453
I-7
II-4
II-14



T-2454
I-7
II-4
II-15



T-2455
I-7
II-4
II-18



T-2456
I-7
II-4
II-19



T-2457
I-7
II-4
II-20



T-2458
I-7
II-4
II-21



T-2459
I-7
II-4
II-22



T-2460
I-7
II-4
II-23



T-2461
I-7
II-4
II-24



T-2462
I-7
II-4
II-25



T-2463
I-7
II-4
II-26



T-2464
I-7
II-4
II-27



T-2465
I-7
II-4
II-28



T-2466
I-7
II-4
II-29



T-2467
I-7
II-5
II-1



T-2468
I-7
II-5
II-2



T-2469
I-7
II-5
II-3



T-2470
I-7
II-5
II-6



T-2471
I-7
II-5
II-7



T-2472
I-7
II-5
II-8



T-2473
I-7
II-5
II-9



T-2474
I-7
II-5
II-11



T-2475
I-7
II-5
II-12



T-2476
I-7
II-5
II-13



T-2477
I-7
II-5
II-14



T-2478
I-7
II-5
II-15



T-2479
I-7
II-5
II-18



T-2480
I-7
II-5
II-19



T-2481
I-7
II-5
II-20



T-2482
I-7
II-5
II-21



T-2483
I-7
II-5
II-22



T-2484
I-7
II-5
II-23



T-2485
I-7
II-5
II-24



T-2486
I-7
II-5
II-25



T-2487
I-7
II-5
II-26



T-2488
I-7
II-5
II-27



T-2489
I-7
II-5
II-28



T-2490
I-7
II-5
II-29



T-2491
I-7
II-6
II-7



T-2492
I-7
II-6
II-8



T-2493
I-7
II-6
II-9



T-2494
I-7
II-6
II-11



T-2495
I-7
II-6
II-12



T-2496
I-7
II-6
II-13



T-2497
I-7
II-6
II-14



T-2498
I-7
II-6
II-15



T-2499
I-7
II-6
II-18



T-2500
I-7
II-6
II-19



T-2501
I-7
II-6
II-20



T-2502
I-7
II-6
II-21



T-2503
I-7
II-6
II-22



T-2504
I-7
II-6
II-23



T-2505
I-7
II-6
II-24



T-2506
I-7
II-6
II-25



T-2507
I-7
II-6
II-26



T-2508
I-7
II-6
II-27



T-2509
I-7
II-6
II-28



T-2510
I-7
II-6
II-29



T-2511
I-7
II-7
II-8



T-2512
I-7
II-7
II-9



T-2513
I-7
II-7
II-11



T-2514
I-7
II-7
II-12



T-2515
I-7
II-7
II-13



T-2516
I-7
II-7
II-14



T-2517
I-7
II-7
II-15



T-2518
I-7
II-7
II-18



T-2519
I-7
II-7
II-19



T-2520
I-7
II-7
II-20



T-2521
I-7
II-7
II-21



T-2522
I-7
II-7
II-22



T-2523
I-7
II-7
II-23



T-2524
I-7
II-7
II-24



T-2525
I-7
II-7
II-25



T-2526
I-7
II-7
II-26



T-2527
I-7
II-7
II-27



T-2528
I-7
II-7
II-28



T-2529
I-7
II-7
II-29



T-2530
I-7
II-8
II-9



T-2531
I-7
II-8
II-11



T-2532
I-7
II-8
II-12



T-2533
I-7
II-8
II-13



T-2534
I-7
II-8
II-14



T-2535
I-7
II-8
II-15



T-2536
I-7
II-8
II-18



T-2537
I-7
II-8
II-19



T-2538
I-7
II-8
II-20



T-2539
I-7
II-8
II-21



T-2540
I-7
II-8
II-22



T-2541
I-7
II-8
II-23



T-2542
I-7
II-8
II-24



T-2543
I-7
II-8
II-25



T-2544
I-7
II-8
II-26



T-2545
I-7
II-8
II-27



T-2546
I-7
II-8
II-28



T-2547
I-7
II-8
II-29



T-2548
I-7
II-9
II-11



T-2549
I-7
II-9
II-12



T-2550
I-7
II-9
II-13



T-2551
I-7
II-9
II-14



T-2552
I-7
II-9
II-15



T-2553
I-7
II-9
II-18



T-2554
I-7
II-9
II-19



T-2555
I-7
II-9
II-20



T-2556
I-7
II-9
II-21



T-2557
I-7
II-9
II-22



T-2558
I-7
II-9
II-23



T-2559
I-7
II-9
II-24



T-2560
I-7
II-9
II-25



T-2561
I-7
II-9
II-26



T-2562
I-7
II-9
II-27



T-2563
I-7
II-9
II-28



T-2564
I-7
II-9
II-29



T-2565
I-7
II-10
II-1



T-2566
I-7
II-10
II-2



T-2567
I-7
II-10
II-3



T-2568
I-7
II-10
II-6



T-2569
I-7
II-10
II-7



T-2570
I-7
II-10
II-8



T-2571
I-7
II-10
II-9



T-2572
I-7
II-10
II-11



T-2573
I-7
II-10
II-12



T-2574
I-7
II-10
II-13



T-2575
I-7
II-10
II-14



T-2576
I-7
II-10
II-15



T-2577
I-7
II-10
II-18



T-2578
I-7
II-10
II-19



T-2579
I-7
II-10
II-20



T-2580
I-7
II-10
II-21



T-2581
I-7
II-10
II-22



T-2582
I-7
II-10
II-23



T-2583
I-7
II-10
II-24



T-2584
I-7
II-10
II-25



T-2585
I-7
II-10
II-26



T-2586
I-7
II-10
II-27



T-2587
I-7
II-10
II-28



T-2588
I-7
II-10
II-29



T-2589
I-7
II-11
II-12



T-2590
I-7
II-11
II-13



T-2591
I-7
II-11
II-14



T-2592
I-7
II-11
II-15



T-2593
I-7
II-11
II-18



T-2594
I-7
II-11
II-19



T-2595
I-7
II-11
II-20



T-2596
I-7
II-11
II-21



T-2597
I-7
II-11
II-22



T-2598
I-7
II-11
II-23



T-2599
I-7
II-11
II-24



T-2600
I-7
II-11
II-25



T-2601
I-7
II-11
II-26



T-2602
I-7
II-11
II-27



T-2603
I-7
II-11
II-28



T-2604
I-7
II-11
II-29



T-2605
I-7
II-12
II-13



T-2606
I-7
II-12
II-14



T-2607
I-7
II-12
II-15



T-2608
I-7
II-12
II-18



T-2609
I-7
II-12
II-19



T-2610
I-7
II-12
II-20



T-2611
I-7
II-12
II-21



T-2612
I-7
II-12
II-22



T-2613
I-7
II-12
II-23



T-2614
I-7
II-12
II-24



T-2615
I-7
II-12
II-25



T-2616
I-7
II-12
II-26



T-2617
I-7
II-12
II-27



T-2618
I-7
II-12
II-28



T-2619
I-7
II-12
II-29



T-2620
I-7
II-13
II-14



T-2621
I-7
II-13
II-15



T-2622
I-7
II-13
II-18



T-2623
I-7
II-13
II-19



T-2624
I-7
II-13
II-20



T-2625
I-7
II-13
II-21



T-2626
I-7
II-13
II-22



T-2627
I-7
II-13
II-23



T-2628
I-7
II-13
II-24



T-2629
I-7
II-13
II-25



T-2630
I-7
II-13
II-26



T-2631
I-7
II-13
II-27



T-2632
I-7
II-13
II-28



T-2633
I-7
II-13
II-29



T-2634
I-7
II-14
II-15



T-2635
I-7
II-14
II-18



T-2636
I-7
II-14
II-19



T-2637
I-7
II-14
II-20



T-2638
I-7
II-14
II-21



T-2639
I-7
II-14
II-22



T-2640
I-7
II-14
II-23



T-2641
I-7
II-14
II-24



T-2642
I-7
II-14
II-25



T-2643
I-7
II-14
II-26



T-2644
I-7
II-14
II-27



T-2645
I-7
II-14
II-28



T-2646
I-7
II-14
II-29



T-2647
I-7
II-15
II-18



T-2648
I-7
II-15
II-19



T-2649
I-7
II-15
II-20



T-2650
I-7
II-15
II-21



T-2651
I-7
II-15
II-22



T-2652
I-7
II-15
II-23



T-2653
I-7
II-15
II-24



T-2654
I-7
II-15
II-25



T-2655
I-7
II-15
II-26



T-2656
I-7
II-15
II-27



T-2657
I-7
II-15
II-28



T-2658
I-7
II-15
II-29



T-2659
I-7
II-16
II-1



T-2660
I-7
II-16
II-2



T-2661
I-7
II-16
II-3



T-2662
I-7
II-16
II-6



T-2663
I-7
II-16
II-7



T-2664
I-7
II-16
II-8



T-2665
I-7
II-16
II-9



T-2666
I-7
II-16
II-11



T-2667
I-7
II-16
II-12



T-2668
I-7
II-16
II-13



T-2669
I-7
II-16
II-14



T-2670
I-7
II-16
II-15



T-2671
I-7
II-16
II-18



T-2672
I-7
II-16
II-19



T-2673
I-7
II-16
II-20



T-2674
I-7
II-16
II-21



T-2675
I-7
II-16
II-22



T-2676
I-7
II-16
II-23



T-2677
I-7
II-16
II-24



T-2678
I-7
II-16
II-25



T-2679
I-7
II-16
II-26



T-2680
I-7
II-16
II-27



T-2681
I-7
II-16
II-28



T-2682
I-7
II-16
II-29



T-2683
I-7
II-17
II-1



T-2684
I-7
II-17
II-2



T-2685
I-7
II-17
II-3



T-2686
I-7
II-17
II-6



T-2687
I-7
II-17
II-7



T-2688
I-7
II-17
II-8



T-2689
I-7
II-17
II-9



T-2690
I-7
II-17
II-11



T-2691
I-7
II-17
II-12



T-2692
I-7
II-17
II-13



T-2693
I-7
II-17
II-14



T-2694
I-7
II-17
II-15



T-2695
I-7
II-17
II-18



T-2696
I-7
II-17
II-19



T-2697
I-7
II-17
II-20



T-2698
I-7
II-17
II-21



T-2699
I-7
II-17
II-22



T-2700
I-7
II-17
II-23



T-2701
I-7
II-17
II-24



T-2702
I-7
II-17
II-25



T-2703
I-7
II-17
II-26



T-2704
I-7
II-17
II-27



T-2705
I-7
II-17
II-28



T-2706
I-7
II-17
II-29



T-2707
I-7
II-18
II-19



T-2708
I-7
II-18
II-20



T-2709
I-7
II-18
II-21



T-2710
I-7
II-18
II-22



T-2711
I-7
II-18
II-23



T-2712
I-7
II-18
II-24



T-2713
I-7
II-18
II-25



T-2714
I-7
II-18
II-26



T-2715
I-7
II-18
II-27



T-2716
I-7
II-18
II-28



T-2717
I-7
II-18
II-29



T-2718
I-7
II-19
II-20



T-2719
I-7
II-19
II-21



T-2720
I-7
II-19
II-22



T-2721
I-7
II-19
II-23



T-2722
I-7
II-19
II-24



T-2723
I-7
II-19
II-25



T-2724
I-7
II-19
II-26



T-2725
I-7
II-19
II-27



T-2726
I-7
II-19
II-28



T-2727
I-7
II-19
II-29



T-2728
I-7
II-20
II-21



T-2729
I-7
II-20
II-22



T-2730
I-7
II-20
II-23



T-2731
I-7
II-20
II-24



T-2732
I-7
II-20
II-25



T-2733
I-7
II-20
II-26



T-2734
I-7
II-20
II-27



T-2735
I-7
II-20
II-28



T-2736
I-7
II-20
II-29



T-2737
I-7
II-21
II-22



T-2738
I-7
II-21
II-23



T-2739
I-7
II-21
II-24



T-2740
I-7
II-21
II-25



T-2741
I-7
II-21
II-26



T-2742
I-7
II-21
II-27



T-2743
I-7
II-21
II-28



T-2744
I-7
II-21
II-29



T-2745
I-7
II-22
II-23



T-2746
I-7
II-22
II-24



T-2747
I-7
II-22
II-25



T-2748
I-7
II-22
II-26



T-2749
I-7
II-22
II-27



T-2750
I-7
II-22
II-28



T-2751
I-7
II-22
II-29



T-2752
I-7
II-23
II-24



T-2753
I-7
II-23
II-25



T-2754
I-7
II-23
II-26



T-2755
I-7
II-23
II-27



T-2756
I-7
II-23
II-28



T-2757
I-7
II-23
II-29



T-2758
I-7
II-24
II-25



T-2759
I-7
II-24
II-26



T-2760
I-7
II-24
II-27



T-2761
I-7
II-24
II-28



T-2762
I-7
II-24
II-29



T-2763
I-7
II-25
II-26



T-2764
I-7
II-25
II-27



T-2765
I-7
II-25
II-28



T-2766
I-7
II-25
II-29



T-2767
I-7
II-26
II-27



T-2768
I-7
II-26
II-28



T-2769
I-7
II-26
II-29



T-2770
I-7
II-27
II-28



T-2771
I-7
II-27
II-29



T-2772
I-7
II-28
II-29



T-2773
I-8
II-1
II-2



T-2774
I-8
II-1
II-3



T-2775
I-8
II-1
II-6



T-2776
I-8
II-1
II-7



T-2777
I-8
II-1
II-8



T-2778
I-8
II-1
II-9



T-2779
I-8
II-1
II-11



T-2780
I-8
II-1
II-12



T-2781
I-8
II-1
II-13



T-2782
I-8
II-1
II-14



T-2783
I-8
II-1
II-15



T-2784
I-8
II-1
II-18



T-2785
I-8
II-1
II-19



T-2786
I-8
II-1
II-20



T-2787
I-8
II-1
II-21



T-2788
I-8
II-1
II-22



T-2789
I-8
II-1
II-23



T-2790
I-8
II-1
II-24



T-2791
I-8
II-1
II-25



T-2792
I-8
II-1
II-26



T-2793
I-8
II-1
II-27



T-2794
I-8
II-1
II-28



T-2795
I-8
II-1
II-29



T-2796
I-8
II-2
II-3



T-2797
I-8
II-2
II-6



T-2798
I-8
II-2
II-7



T-2799
I-8
II-2
II-8



T-2800
I-8
II-2
II-9



T-2801
I-8
II-2
II-11



T-2802
I-8
II-2
II-12



T-2803
I-8
II-2
II-13



T-2804
I-8
II-2
II-14



T-2805
I-8
II-2
II-15



T-2806
I-8
II-2
II-18



T-2807
I-8
II-2
II-19



T-2808
I-8
II-2
II-20



T-2809
I-8
II-2
II-21



T-2810
I-8
II-2
II-22



T-2811
I-8
II-2
II-23



T-2812
I-8
II-2
II-24



T-2813
I-8
II-2
II-25



T-2814
I-8
II-2
II-26



T-2815
I-8
II-2
II-27



T-2816
I-8
II-2
II-28



T-2817
I-8
II-2
II-29



T-2818
I-8
II-3
II-6



T-2819
I-8
II-3
II-7



T-2820
I-8
II-3
II-8



T-2821
I-8
II-3
II-9



T-2822
I-8
II-3
II-11



T-2823
I-8
II-3
II-12



T-2824
I-8
II-3
II-13



T-2825
I-8
II-3
II-14



T-2826
I-8
II-3
II-15



T-2827
I-8
II-3
II-18



T-2828
I-8
II-3
II-19



T-2829
I-8
II-3
II-20



T-2830
I-8
II-3
II-21



T-2831
I-8
II-3
II-22



T-2832
I-8
II-3
II-23



T-2833
I-8
II-3
II-24



T-2834
I-8
II-3
II-25



T-2835
I-8
II-3
II-26



T-2836
I-8
II-3
II-27



T-2837
I-8
II-3
II-28



T-2838
I-8
II-3
II-29



T-2839
I-8
II-4
II-1



T-2840
I-8
II-4
II-2



T-2841
I-8
II-4
II-3



T-2842
I-8
II-4
II-6



T-2843
I-8
II-4
II-7



T-2844
I-8
II-4
II-8



T-2845
I-8
II-4
II-9



T-2846
I-8
II-4
II-11



T-2847
I-8
II-4
II-12



T-2848
I-8
II-4
II-13



T-2849
I-8
II-4
II-14



T-2850
I-8
II-4
II-15



T-2851
I-8
II-4
II-18



T-2852
I-8
II-4
II-19



T-2853
I-8
II-4
II-20



T-2854
I-8
II-4
II-21



T-2855
I-8
II-4
II-22



T-2856
I-8
II-4
II-23



T-2857
I-8
II-4
II-24



T-2858
I-8
II-4
II-25



T-2859
I-8
II-4
II-26



T-2860
I-8
II-4
II-27



T-2861
I-8
II-4
II-28



T-2862
I-8
II-4
II-29



T-2863
I-8
II-5
II-1



T-2864
I-8
II-5
II-2



T-2865
I-8
II-5
II-3



T-2866
I-8
II-5
II-6



T-2867
I-8
II-5
II-7



T-2868
I-8
II-5
II-8



T-2869
I-8
II-5
II-9



T-2870
I-8
II-5
II-11



T-2871
I-8
II-5
II-12



T-2872
I-8
II-5
II-13



T-2873
I-8
II-5
II-14



T-2874
I-8
II-5
II-15



T-2875
I-8
II-5
II-18



T-2876
I-8
II-5
II-19



T-2877
I-8
II-5
II-20



T-2878
I-8
II-5
II-21



T-2879
I-8
II-5
II-22



T-2880
I-8
II-5
II-23



T-2881
I-8
II-5
II-24



T-2882
I-8
II-5
II-25



T-2883
I-8
II-5
II-26



T-2884
I-8
II-5
II-27



T-2885
I-8
II-5
II-28



T-2886
I-8
II-5
II-29



T-2887
I-8
II-6
II-7



T-2888
I-8
II-6
II-8



T-2889
I-8
II-6
II-9



T-2890
I-8
II-6
II-11



T-2891
I-8
II-6
II-12



T-2892
I-8
II-6
II-13



T-2893
I-8
II-6
II-14



T-2894
I-8
II-6
II-15



T-2895
I-8
II-6
II-18



T-2896
I-8
II-6
II-19



T-2897
I-8
II-6
II-20



T-2898
I-8
II-6
II-21



T-2899
I-8
II-6
II-22



T-2900
I-8
II-6
II-23



T-2901
I-8
II-6
II-24



T-2902
I-8
II-6
II-25



T-2903
I-8
II-6
II-26



T-2904
I-8
II-6
II-27



T-2905
I-8
II-6
II-28



T-2906
I-8
II-6
II-29



T-2907
I-8
II-7
II-8



T-2908
I-8
II-7
II-9



T-2909
I-8
II-7
II-11



T-2910
I-8
II-7
II-12



T-2911
I-8
II-7
II-13



T-2912
I-8
II-7
II-14



T-2913
I-8
II-7
II-15



T-2914
I-8
II-7
II-18



T-2915
I-8
II-7
II-19



T-2916
I-8
II-7
II-20



T-2917
I-8
II-7
II-21



T-2918
I-8
II-7
II-22



T-2919
I-8
II-7
II-23



T-2920
I-8
II-7
II-24



T-2921
I-8
II-7
II-25



T-2922
I-8
II-7
II-26



T-2923
I-8
II-7
II-27



T-2924
I-8
II-7
II-28



T-2925
I-8
II-7
II-29



T-2926
I-8
II-8
II-9



T-2927
I-8
II-8
II-11



T-2928
I-8
II-8
II-12



T-2929
I-8
II-8
II-13



T-2930
I-8
II-8
II-14



T-2931
I-8
II-8
II-15



T-2932
I-8
II-8
II-18



T-2933
I-8
II-8
II-19



T-2934
I-8
II-8
II-20



T-2935
I-8
II-8
II-21



T-2936
I-8
II-8
II-22



T-2937
I-8
II-8
II-23



T-2938
I-8
II-8
II-24



T-2939
I-8
II-8
II-25



T-2940
I-8
II-8
II-26



T-2941
I-8
II-8
II-27



T-2942
I-8
II-8
II-28



T-2943
I-8
II-8
II-29



T-2944
I-8
II-9
II-11



T-2945
I-8
II-9
II-12



T-2946
I-8
II-9
II-13



T-2947
I-8
II-9
II-14



T-2948
I-8
II-9
II-15



T-2949
I-8
II-9
II-18



T-2950
I-8
II-9
II-19



T-2951
I-8
II-9
II-20



T-2952
I-8
II-9
II-21



T-2953
I-8
II-9
II-22



T-2954
I-8
II-9
II-23



T-2955
I-8
II-9
II-24



T-2956
I-8
II-9
II-25



T-2957
I-8
II-9
II-26



T-2958
I-8
II-9
II-27



T-2959
I-8
II-9
II-28



T-2960
I-8
II-9
II-29



T-2961
I-8
II-10
II-1



T-2962
I-8
II-10
II-2



T-2963
I-8
II-10
II-3



T-2964
I-8
II-10
II-6



T-2965
I-8
II-10
II-7



T-2966
I-8
II-10
II-8



T-2967
I-8
II-10
II-9



T-2968
I-8
II-10
II-11



T-2969
I-8
II-10
II-12



T-2970
I-8
II-10
II-13



T-2971
I-8
II-10
II-14



T-2972
I-8
II-10
II-15



T-2973
I-8
II-10
II-18



T-2974
I-8
II-10
II-19



T-2975
I-8
II-10
II-20



T-2976
I-8
II-10
II-21



T-2977
I-8
II-10
II-22



T-2978
I-8
II-10
II-23



T-2979
I-8
II-10
II-24



T-2980
I-8
II-10
II-25



T-2981
I-8
II-10
II-26



T-2982
I-8
II-10
II-27



T-2983
I-8
II-10
II-28



T-2984
I-8
II-10
II-29



T-2985
I-8
II-11
II-12



T-2986
I-8
II-11
II-13



T-2987
I-8
II-11
II-14



T-2988
I-8
II-11
II-15



T-2989
I-8
II-11
II-18



T-2990
I-8
II-11
II-19



T-2991
I-8
II-11
II-20



T-2992
I-8
II-11
II-21



T-2993
I-8
II-11
II-22



T-2994
I-8
II-11
II-23



T-2995
I-8
II-11
II-24



T-2996
I-8
II-11
II-25



T-2997
I-8
II-11
II-26



T-2998
I-8
II-11
II-27



T-2999
I-8
II-11
II-28



T-3000
I-8
II-11
II-29



T-3001
I-8
II-12
II-13



T-3002
I-8
II-12
II-14



T-3003
I-8
II-12
II-15



T-3004
I-8
II-12
II-18



T-3005
I-8
II-12
II-19



T-3006
I-8
II-12
II-20



T-3007
I-8
II-12
II-21



T-3008
I-8
II-12
II-22



T-3009
I-8
II-12
II-23



T-3010
I-8
II-12
II-24



T-3011
I-8
II-12
II-25



T-3012
I-8
II-12
II-26



T-3013
I-8
II-12
II-27



T-3014
I-8
II-12
II-28



T-3015
I-8
II-12
II-29



T-3016
I-8
II-13
II-14



T-3017
I-8
II-13
II-15



T-3018
I-8
II-13
II-18



T-3019
I-8
II-13
II-19



T-3020
I-8
II-13
II-20



T-3021
I-8
II-13
II-21



T-3022
I-8
II-13
II-22



T-3023
I-8
II-13
II-23



T-3024
I-8
II-13
II-24



T-3025
I-8
II-13
II-25



T-3026
I-8
II-13
II-26



T-3027
I-8
II-13
II-27



T-3028
I-8
II-13
II-28



T-3029
I-8
II-13
II-29



T-3030
I-8
II-14
II-15



T-3031
I-8
II-14
II-18



T-3032
I-8
II-14
II-19



T-3033
I-8
II-14
II-20



T-3034
I-8
II-14
II-21



T-3035
I-8
II-14
II-22



T-3036
I-8
II-14
II-23



T-3037
I-8
II-14
II-24



T-3038
I-8
II-14
II-25



T-3039
I-8
II-14
II-26



T-3040
I-8
II-14
II-27



T-3041
I-8
II-14
II-28



T-3042
I-8
II-14
II-29



T-3043
I-8
II-15
II-18



T-3044
I-8
II-15
II-19



T-3045
I-8
II-15
II-20



T-3046
I-8
II-15
II-21



T-3047
I-8
II-15
II-22



T-3048
I-8
II-15
II-23



T-3049
I-8
II-15
II-24



T-3050
I-8
II-15
II-25



T-3051
I-8
II-15
II-26



T-3052
I-8
II-15
II-27



T-3053
I-8
II-15
II-28



T-3054
I-8
II-15
II-29



T-3055
I-8
II-16
II-1



T-3056
I-8
II-16
II-2



T-3057
I-8
II-16
II-3



T-3058
I-8
II-16
II-6



T-3059
I-8
II-16
II-7



T-3060
I-8
II-16
II-8



T-3061
I-8
II-16
II-9



T-3062
I-8
II-16
II-11



T-3063
I-8
II-16
II-12



T-3064
I-8
II-16
II-13



T-3065
I-8
II-16
II-14



T-3066
I-8
II-16
II-15



T-3067
I-8
II-16
II-18



T-3068
I-8
II-16
II-19



T-3069
I-8
II-16
II-20



T-3070
I-8
II-16
II-21



T-3071
I-8
II-16
II-22



T-3072
I-8
II-16
II-23



T-3073
I-8
II-16
II-24



T-3074
I-8
II-16
II-25



T-3075
I-8
II-16
II-26



T-3076
I-8
II-16
II-27



T-3077
I-8
II-16
II-28



T-3078
I-8
II-16
II-29



T-3079
I-8
II-17
II-1



T-3080
I-8
II-17
II-2



T-3081
I-8
II-17
II-3



T-3082
I-8
II-17
II-6



T-3083
I-8
II-17
II-7



T-3084
I-8
II-17
II-8



T-3085
I-8
II-17
II-9



T-3086
I-8
II-17
II-11



T-3087
I-8
II-17
II-12



T-3088
I-8
II-17
II-13



T-3089
I-8
II-17
II-14



T-3090
I-8
II-17
II-15



T-3091
I-8
II-17
II-18



T-3092
I-8
II-17
II-19



T-3093
I-8
II-17
II-20



T-3094
I-8
II-17
II-21



T-3095
I-8
II-17
II-22



T-3096
I-8
II-17
II-23



T-3097
I-8
II-17
II-24



T-3098
I-8
II-17
II-25



T-3099
I-8
II-17
II-26



T-3100
I-8
II-17
II-27



T-3101
I-8
II-17
II-28



T-3102
I-8
II-17
II-29



T-3103
I-8
II-18
II-19



T-3104
I-8
II-18
II-20



T-3105
I-8
II-18
II-21



T-3106
I-8
II-18
II-22



T-3107
I-8
II-18
II-23



T-3108
I-8
II-18
II-24



T-3109
I-8
II-18
II-25



T-3110
I-8
II-18
II-26



T-3111
I-8
II-18
II-27



T-3112
I-8
II-18
II-28



T-3113
I-8
II-18
II-29



T-3114
I-8
II-19
II-20



T-3115
I-8
II-19
II-21



T-3116
I-8
II-19
II-22



T-3117
I-8
II-19
II-23



T-3118
I-8
II-19
II-24



T-3119
I-8
II-19
II-25



T-3120
I-8
II-19
II-26



T-3121
I-8
II-19
II-27



T-3122
I-8
II-19
II-28



T-3123
I-8
II-19
II-29



T-3124
I-8
II-20
II-21



T-3125
I-8
II-20
II-22



T-3126
I-8
II-20
II-23



T-3127
I-8
II-20
II-24



T-3128
I-8
II-20
II-25



T-3129
I-8
II-20
II-26



T-3130
I-8
II-20
II-27



T-3131
I-8
II-20
II-28



T-3132
I-8
II-20
II-29



T-3133
I-8
II-21
II-22



T-3134
I-8
II-21
II-23



T-3135
I-8
II-21
II-24



T-3136
I-8
II-21
II-25



T-3137
I-8
II-21
II-26



T-3138
I-8
II-21
II-27



T-3139
I-8
II-21
II-28



T-3140
I-8
II-21
II-29



T-3141
I-8
II-22
II-23



T-3142
I-8
II-22
II-24



T-3143
I-8
II-22
II-25



T-3144
I-8
II-22
II-26



T-3145
I-8
II-22
II-27



T-3146
I-8
II-22
II-28



T-3147
I-8
II-22
II-29



T-3148
I-8
II-23
II-24



T-3149
I-8
II-23
II-25



T-3150
I-8
II-23
II-26



T-3151
I-8
II-23
II-27



T-3152
I-8
II-23
II-28



T-3153
I-8
II-23
II-29



T-3154
I-8
II-24
II-25



T-3155
I-8
II-24
II-26



T-3156
I-8
II-24
II-27



T-3157
I-8
II-24
II-28



T-3158
I-8
II-24
II-29



T-3159
I-8
II-25
II-26



T-3160
I-8
II-25
II-27



T-3161
I-8
II-25
II-28



T-3162
I-8
II-25
II-29



T-3163
I-8
II-26
II-27



T-3164
I-8
II-26
II-28



T-3165
I-8
II-26
II-29



T-3166
I-8
II-27
II-28



T-3167
I-8
II-27
II-29



T-3168
I-8
II-28
II-29



T-3169
I-9
II-1
II-2



T-3170
I-9
II-1
II-3



T-3171
I-9
II-1
II-6



T-3172
I-9
II-1
II-7



T-3173
I-9
II-1
II-8



T-3174
I-9
II-1
II-9



T-3175
I-9
II-1
II-11



T-3176
I-9
II-1
II-12



T-3177
I-9
II-1
II-13



T-3178
I-9
II-1
II-14



T-3179
I-9
II-1
II-15



T-3180
I-9
II-1
II-18



T-3181
I-9
II-1
II-19



T-3182
I-9
II-1
II-20



T-3183
I-9
II-1
II-21



T-3184
I-9
II-1
II-22



T-3185
I-9
II-1
II-23



T-3186
I-9
II-1
II-24



T-3187
I-9
II-1
II-25



T-3188
I-9
II-1
II-26



T-3189
I-9
II-1
II-27



T-3190
I-9
II-1
II-28



T-3191
I-9
II-1
II-29



T-3192
I-9
II-2
II-3



T-3193
I-9
II-2
II-6



T-3194
I-9
II-2
II-7



T-3195
I-9
II-2
II-8



T-3196
I-9
II-2
II-9



T-3197
I-9
II-2
II-11



T-3198
I-9
II-2
II-12



T-3199
I-9
II-2
II-13



T-3200
I-9
II-2
II-14



T-3201
I-9
II-2
II-15



T-3202
I-9
II-2
II-18



T-3203
I-9
II-2
II-19



T-3204
I-9
II-2
II-20



T-3205
I-9
II-2
II-21



T-3206
I-9
II-2
II-22



T-3207
I-9
II-2
II-23



T-3208
I-9
II-2
II-24



T-3209
I-9
II-2
II-25



T-3210
I-9
II-2
II-26



T-3211
I-9
II-2
II-27



T-3212
I-9
II-2
II-28



T-3213
I-9
II-2
II-29



T-3214
I-9
II-3
II-6



T-3215
I-9
II-3
II-7



T-3216
I-9
II-3
II-8



T-3217
I-9
II-3
II-9



T-3218
I-9
II-3
II-11



T-3219
I-9
II-3
II-12



T-3220
I-9
II-3
II-13



T-3221
I-9
II-3
II-14



T-3222
I-9
II-3
II-15



T-3223
I-9
II-3
II-18



T-3224
I-9
II-3
II-19



T-3225
I-9
II-3
II-20



T-3226
I-9
II-3
II-21



T-3227
I-9
II-3
II-22



T-3228
I-9
II-3
II-23



T-3229
I-9
II-3
II-24



T-3230
I-9
II-3
II-25



T-3231
I-9
II-3
II-26



T-3232
I-9
II-3
II-27



T-3233
I-9
II-3
II-28



T-3234
I-9
II-3
II-29



T-3235
I-9
II-4
II-1



T-3236
I-9
II-4
II-2



T-3237
I-9
II-4
II-3



T-3238
I-9
II-4
II-6



T-3239
I-9
II-4
II-7



T-3240
I-9
II-4
II-8



T-3241
I-9
II-4
II-9



T-3242
I-9
II-4
II-11



T-3243
I-9
II-4
II-12



T-3244
I-9
II-4
II-13



T-3245
I-9
II-4
II-14



T-3246
I-9
II-4
II-15



T-3247
I-9
II-4
II-18



T-3248
I-9
II-4
II-19



T-3249
I-9
II-4
II-20



T-3250
I-9
II-4
II-21



T-3251
I-9
II-4
II-22



T-3252
I-9
II-4
II-23



T-3253
I-9
II-4
II-24



T-3254
I-9
II-4
II-25



T-3255
I-9
II-4
II-26



T-3256
I-9
II-4
II-27



T-3257
I-9
II-4
II-28



T-3258
I-9
II-4
II-29



T-3259
I-9
II-5
II-1



T-3260
I-9
II-5
II-2



T-3261
I-9
II-5
II-3



T-3262
I-9
II-5
II-6



T-3263
I-9
II-5
II-7



T-3264
I-9
II-5
II-8



T-3265
I-9
II-5
II-9



T-3266
I-9
II-5
II-11



T-3267
I-9
II-5
II-12



T-3268
I-9
II-5
II-13



T-3269
I-9
II-5
II-14



T-3270
I-9
II-5
II-15



T-3271
I-9
II-5
II-18



T-3272
I-9
II-5
II-19



T-3273
I-9
II-5
II-20



T-3274
I-9
II-5
II-21



T-3275
I-9
II-5
II-22



T-3276
I-9
II-5
II-23



T-3277
I-9
II-5
II-24



T-3278
I-9
II-5
II-25



T-3279
I-9
II-5
II-26



T-3280
I-9
II-5
II-27



T-3281
I-9
II-5
II-28



T-3282
I-9
II-5
II-29



T-3283
I-9
II-6
II-7



T-3284
I-9
II-6
II-8



T-3285
I-9
II-6
II-9



T-3286
I-9
II-6
II-11



T-3287
I-9
II-6
II-12



T-3288
I-9
II-6
II-13



T-3289
I-9
II-6
II-14



T-3290
I-9
II-6
II-15



T-3291
I-9
II-6
II-18



T-3292
I-9
II-6
II-19



T-3293
I-9
II-6
II-20



T-3294
I-9
II-6
II-21



T-3295
I-9
II-6
II-22



T-3296
I-9
II-6
II-23



T-3297
I-9
II-6
II-24



T-3298
I-9
II-6
II-25



T-3299
I-9
II-6
II-26



T-3300
I-9
II-6
II-27



T-3301
I-9
II-6
II-28



T-3302
I-9
II-6
II-29



T-3303
I-9
II-7
II-8



T-3304
I-9
II-7
II-9



T-3305
I-9
II-7
II-11



T-3306
I-9
II-7
II-12



T-3307
I-9
II-7
II-13



T-3308
I-9
II-7
II-14



T-3309
I-9
II-7
II-15



T-3310
I-9
II-7
II-18



T-3311
I-9
II-7
II-19



T-3312
I-9
II-7
II-20



T-3313
I-9
II-7
II-21



T-3314
I-9
II-7
II-22



T-3315
I-9
II-7
II-23



T-3316
I-9
II-7
II-24



T-3317
I-9
II-7
II-25



T-3318
I-9
II-7
II-26



T-3319
I-9
II-7
II-27



T-3320
I-9
II-7
II-28



T-3321
I-9
II-7
II-29



T-3322
I-9
II-8
II-9



T-3323
I-9
II-8
II-11



T-3324
I-9
II-8
II-12



T-3325
I-9
II-8
II-13



T-3326
I-9
II-8
II-14



T-3327
I-9
II-8
II-15



T-3328
I-9
II-8
II-18



T-3329
I-9
II-8
II-19



T-3330
I-9
II-8
II-20



T-3331
I-9
II-8
II-21



T-3332
I-9
II-8
II-22



T-3333
I-9
II-8
II-23



T-3334
I-9
II-8
II-24



T-3335
I-9
II-8
II-25



T-3336
I-9
II-8
II-26



T-3337
I-9
II-8
II-27



T-3338
I-9
II-8
II-28



T-3339
I-9
II-8
II-29



T-3340
I-9
II-9
II-11



T-3341
I-9
II-9
II-12



T-3342
I-9
II-9
II-13



T-3343
I-9
II-9
II-14



T-3344
I-9
II-9
II-15



T-3345
I-9
II-9
II-18



T-3346
I-9
II-9
II-19



T-3347
I-9
II-9
II-20



T-3348
I-9
II-9
II-21



T-3349
I-9
II-9
II-22



T-3350
I-9
II-9
II-23



T-3351
I-9
II-9
II-24



T-3352
I-9
II-9
II-25



T-3353
I-9
II-9
II-26



T-3354
I-9
II-9
II-27



T-3355
I-9
II-9
II-28



T-3356
I-9
II-9
II-29



T-3357
I-9
II-10
II-1



T-3358
I-9
II-10
II-2



T-3359
I-9
II-10
II-3



T-3360
I-9
II-10
II-6



T-3361
I-9
II-10
II-7



T-3362
I-9
II-10
II-8



T-3363
I-9
II-10
II-9



T-3364
I-9
II-10
II-11



T-3365
I-9
II-10
II-12



T-3366
I-9
II-10
II-13



T-3367
I-9
II-10
II-14



T-3368
I-9
II-10
II-15



T-3369
I-9
II-10
II-18



T-3370
I-9
II-10
II-19



T-3371
I-9
II-10
II-20



T-3372
I-9
II-10
II-21



T-3373
I-9
II-10
II-22



T-3374
I-9
II-10
II-23



T-3375
I-9
II-10
II-24



T-3376
I-9
II-10
II-25



T-3377
I-9
II-10
II-26



T-3378
I-9
II-10
II-27



T-3379
I-9
II-10
II-28



T-3380
I-9
II-10
II-29



T-3381
I-9
II-11
II-12



T-3382
I-9
II-11
II-13



T-3383
I-9
II-11
II-14



T-3384
I-9
II-11
II-15



T-3385
I-9
II-11
II-18



T-3386
I-9
II-11
II-19



T-3387
I-9
II-11
II-20



T-3388
I-9
II-11
II-21



T-3389
I-9
II-11
II-22



T-3390
I-9
II-11
II-23



T-3391
I-9
II-11
II-24



T-3392
I-9
II-11
II-25



T-3393
I-9
II-11
II-26



T-3394
I-9
II-11
II-27



T-3395
I-9
II-11
II-28



T-3396
I-9
II-11
II-29



T-3397
I-9
II-12
II-13



T-3398
I-9
II-12
II-14



T-3399
I-9
II-12
II-15



T-3400
I-9
II-12
II-18



T-3401
I-9
II-12
II-19



T-3402
I-9
II-12
II-20



T-3403
I-9
II-12
II-21



T-3404
I-9
II-12
II-22



T-3405
I-9
II-12
II-23



T-3406
I-9
II-12
II-24



T-3407
I-9
II-12
II-25



T-3408
I-9
II-12
II-26



T-3409
I-9
II-12
II-27



T-3410
I-9
II-12
II-28



T-3411
I-9
II-12
II-29



T-3412
I-9
II-13
II-14



T-3413
I-9
II-13
II-15



T-3414
I-9
II-13
II-18



T-3415
I-9
II-13
II-19



T-3416
I-9
II-13
II-20



T-3417
I-9
II-13
II-21



T-3418
I-9
II-13
II-22



T-3419
I-9
II-13
II-23



T-3420
I-9
II-13
II-24



T-3421
I-9
II-13
II-25



T-3422
I-9
II-13
II-26



T-3423
I-9
II-13
II-27



T-3424
I-9
II-13
II-28



T-3425
I-9
II-13
II-29



T-3426
I-9
II-14
II-15



T-3427
I-9
II-14
II-18



T-3428
I-9
II-14
II-19



T-3429
I-9
II-14
II-20



T-3430
I-9
II-14
II-21



T-3431
I-9
II-14
II-22



T-3432
I-9
II-14
II-23



T-3433
I-9
II-14
II-24



T-3434
I-9
II-14
II-25



T-3435
I-9
II-14
II-26



T-3436
I-9
II-14
II-27



T-3437
I-9
II-14
II-28



T-3438
I-9
II-14
II-29



T-3439
I-9
II-15
II-18



T-3440
I-9
II-15
II-19



T-3441
I-9
II-15
II-20



T-3442
I-9
II-15
II-21



T-3443
I-9
II-15
II-22



T-3444
I-9
II-15
II-23



T-3445
I-9
II-15
II-24



T-3446
I-9
II-15
II-25



T-3447
I-9
II-15
II-26



T-3448
I-9
II-15
II-27



T-3449
I-9
II-15
II-28



T-3450
I-9
II-15
II-29



T-3451
I-9
II-16
II-1



T-3452
I-9
II-16
II-2



T-3453
I-9
II-16
II-3



T-3454
I-9
II-16
II-6



T-3455
I-9
II-16
II-7



T-3456
I-9
II-16
II-8



T-3457
I-9
II-16
II-9



T-3458
I-9
II-16
II-11



T-3459
I-9
II-16
II-12



T-3460
I-9
II-16
II-13



T-3461
I-9
II-16
II-14



T-3462
I-9
II-16
II-15



T-3463
I-9
II-16
II-18



T-3464
I-9
II-16
II-19



T-3465
I-9
II-16
II-20



T-3466
I-9
II-16
II-21



T-3467
I-9
II-16
II-22



T-3468
I-9
II-16
II-23



T-3469
I-9
II-16
II-24



T-3470
I-9
II-16
II-25



T-3471
I-9
II-16
II-26



T-3472
I-9
II-16
II-27



T-3473
I-9
II-16
II-28



T-3474
I-9
II-16
II-29



T-3475
I-9
II-17
II-1



T-3476
I-9
II-17
II-2



T-3477
I-9
II-17
II-3



T-3478
I-9
II-17
II-6



T-3479
I-9
II-17
II-7



T-3480
I-9
II-17
II-8



T-3481
I-9
II-17
II-9



T-3482
I-9
II-17
II-11



T-3483
I-9
II-17
II-12



T-3484
I-9
II-17
II-13



T-3485
I-9
II-17
II-14



T-3486
I-9
II-17
II-15



T-3487
I-9
II-17
II-18



T-3488
I-9
II-17
II-19



T-3489
I-9
II-17
II-20



T-3490
I-9
II-17
II-21



T-3491
I-9
II-17
II-22



T-3492
I-9
II-17
II-23



T-3493
I-9
II-17
II-24



T-3494
I-9
II-17
II-25



T-3495
I-9
II-17
II-26



T-3496
I-9
II-17
II-27



T-3497
I-9
II-17
II-28



T-3498
I-9
II-17
II-29



T-3499
I-9
II-18
II-19



T-3500
I-9
II-18
II-20



T-3501
I-9
II-18
II-21



T-3502
I-9
II-18
II-22



T-3503
I-9
II-18
II-23



T-3504
I-9
II-18
II-24



T-3505
I-9
II-18
II-25



T-3506
I-9
II-18
II-26



T-3507
I-9
II-18
II-27



T-3508
I-9
II-18
II-28



T-3509
I-9
II-18
II-29



T-3510
I-9
II-19
II-20



T-3511
I-9
II-19
II-21



T-3512
I-9
II-19
II-22



T-3513
I-9
II-19
II-23



T-3514
I-9
II-19
II-24



T-3515
I-9
II-19
II-25



T-3516
I-9
II-19
II-26



T-3517
I-9
II-19
II-27



T-3518
I-9
II-19
II-28



T-3519
I-9
II-19
II-29



T-3520
I-9
II-20
II-21



T-3521
I-9
II-20
II-22



T-3522
I-9
II-20
II-23



T-3523
I-9
II-20
II-24



T-3524
I-9
II-20
II-25



T-3525
I-9
II-20
II-26



T-3526
I-9
II-20
II-27



T-3527
I-9
II-20
II-28



T-3528
I-9
II-20
II-29



T-3529
I-9
II-21
II-22



T-3530
I-9
II-21
II-23



T-3531
I-9
II-21
II-24



T-3532
I-9
II-21
II-25



T-3533
I-9
II-21
II-26



T-3534
I-9
II-21
II-27



T-3535
I-9
II-21
II-28



T-3536
I-9
II-21
II-29



T-3537
I-9
II-22
II-23



T-3538
I-9
II-22
II-24



T-3539
I-9
II-22
II-25



T-3540
I-9
II-22
II-26



T-3541
I-9
II-22
II-27



T-3542
I-9
II-22
II-28



T-3543
I-9
II-22
II-29



T-3544
I-9
II-23
II-24



T-3545
I-9
II-23
II-25



T-3546
I-9
II-23
II-26



T-3547
I-9
II-23
II-27



T-3548
I-9
II-23
II-28



T-3549
I-9
II-23
II-29



T-3550
I-9
II-24
II-25



T-3551
I-9
II-24
II-26



T-3552
I-9
II-24
II-27



T-3553
I-9
II-24
II-28



T-3554
I-9
II-24
II-29



T-3555
I-9
II-25
II-26



T-3556
I-9
II-25
II-27



T-3557
I-9
II-25
II-28



T-3558
I-9
II-25
II-29



T-3559
I-9
II-26
II-27



T-3560
I-9
II-26
II-28



T-3561
I-9
II-26
II-29



T-3562
I-9
II-27
II-28



T-3563
I-9
II-27
II-29



T-3564
I-9
II-28
II-29







“C” denotes “component”.






According to a further embodiment, preference is given to mixtures comprising a component 1, a component 2 and a component 3, where preference is given in particular to those mixtures in which component 2 is a compound II selected from the group of the compounds II-1 to II-29, II-34, II-46 to and II-57 (see above), and component 3 is a compound II selected from the compounds

    • II-34 dimoxystrobin
    • II-46 prochloraz
    • II-47 dithianon
    • II-48 difenoconazole
    • II-49 azoxystrobin
    • II-50 trifloxystrobin
    • II-51 penthiopyrad
    • II-56 picoxystrobin
    • II-57 fluoxastrobin


      with the proviso that component 2 and component 3 are not identical.


Such mixtures according to the invention are listed explicitly in Table T1. According to a specific embodiment, these are ternary mixtures comprising, as active compounds, in each case only these three components.









TABLE T1







Mixtures T1-1 to T1-1188, comprising, as component 1, the compound


I, a component 2 selected from the active compounds preferred for


component 2 and a component 3 selected from the active compounds


preferred for component 3. In the table below, in each case one row


of a mixture according to the invention corresponds to the respective


mixture components 1 to 3 listed in the row in question.












M
C1
C2
C3







T1-1
I-1
II-1
II-34



T1-2
I-1
II-1
II-46



T1-3
I-1
II-1
II-47



T1-4
I-1
II-1
II-48



T1-5
I-1
II-1
II-49



T1-6
I-1
II-1
II-50



T1-7
I-1
II-1
II-51



T1-8
I-1
II-1
II-56



T1-9
I-1
II-1
II-57



T1-10
I-1
II-2
II-34



T1-11
I-1
II-2
II-46



T1-12
I-1
II-2
II-47



T1-13
I-1
II-2
II-48



T1-14
I-1
II-2
II-49



T1-15
I-1
II-2
II-50



T1-16
I-1
II-2
II-51



T1-17
I-1
II-2
II-56



T1-18
I-1
II-2
II-57



T1-19
I-1
II-3
II-34



T1-20
I-1
II-3
II-46



T1-21
I-1
II-3
II-47



T1-22
I-1
II-3
II-48



T1-23
I-1
II-3
II-49



T1-24
I-1
II-3
II-50



T1-25
I-1
II-3
II-51



T1-26
I-1
II-3
II-57



T1-27
I-1
II-3
II-58



T1-28
I-1
II-4
II-34



T1-29
I-1
II-4
II-46



T1-30
I-1
II-4
II-47



T1-31
I-1
II-4
II-48



T1-32
I-1
II-4
II-49



T1-33
I-1
II-4
II-50



T1-34
I-1
II-4
II-51



T1-35
I-1
II-4
II-56



T1-36
I-1
II-4
II-57



T1-37
I-1
II-5
II-34



T1-38
I-1
II-5
II-46



T1-39
I-1
II-5
II-47



T1-40
I-1
II-5
II-48



T1-41
I-1
II-5
II-49



T1-42
I-1
II-5
II-50



T1-43
I-1
II-5
II-51



T1-44
I-1
II-5
II-56



T1-45
I-1
II-5
II-57



T1-46
I-1
II-6
II-34



T1-47
I-1
II-6
II-46



T1-48
I-1
II-6
II-47



T1-49
I-1
II-6
II-48



T1-50
I-1
II-6
II-49



T1-51
I-1
II-6
II-50



T1-52
I-1
II-6
II-51



T1-53
I-1
II-6
II-56



T1-54
I-1
II-6
II-57



T1-55
I-1
II-7
II-34



T1-56
I-1
II-7
II-46



T1-57
I-1
II-7
II-47



T1-58
I-1
II-7
II-48



T1-59
I-1
II-7
II-49



T1-60
I-1
II-7
II-50



T1-61
I-1
II-7
II-51



T1-62
I-1
II-7
II-56



T1-63
I-1
II-7
II-57



T1-64
I-1
II-8
II-34



T1-65
I-1
II-8
II-46



T1-66
I-1
II-8
II-47



T1-67
I-1
II-8
II-48



T1-68
I-1
II-8
II-49



T1-69
I-1
II-8
II-50



T1-70
I-1
II-8
II-51



T1-71
I-1
II-8
II-56



T1-72
I-1
II-8
II-57



T1-73
I-1
II-9
II-34



T1-74
I-1
II-9
II-46



T1-75
I-1
II-9
II-47



T1-76
I-1
II-9
II-48



T1-77
I-1
II-9
II-49



T1-78
I-1
II-9
II-50



T1-79
I-1
II-9
II-51



T1-80
I-1
II-9
II-56



T1-81
I-1
II-9
II-57



T1-82
I-1
II-10
II-34



T1-83
I-1
II-10
II-46



T1-84
I-1
II-10
II-47



T1-85
I-1
II-10
II-48



T1-86
I-1
II-10
II-49



T1-87
I-1
II-10
II-50



T1-88
I-1
II-10
II-51



T1-89
I-1
II-10
II-56



T1-90
I-1
II-10
II-57



T1-91
I-1
II-11
II-34



T1-92
I-1
II-11
II-46



T1-93
I-1
II-11
II-47



T1-94
I-1
II-11
II-48



T1-95
I-1
II-11
II-49



T1-96
I-1
II-11
II-50



T1-97
I-1
II-11
II-51



T1-98
I-1
II-11
II-56



T1-99
I-1
II-11
II-57



T1-100
I-1
II-12
II-34



T1-101
I-1
II-12
II-46



T1-102
I-1
II-12
II-47



T1-103
I-1
II-12
II-48



T1-104
I-1
II-12
II-49



T1-105
I-1
II-12
II-50



T1-106
I-1
II-12
II-51



T1-107
I-1
II-12
II-56



T1-108
I-1
II-12
II-57



T1-109
I-1
II-13
II-34



T1-110
I-1
II-13
II-46



T1-111
I-1
II-13
II-47



T1-112
I-1
II-13
II-48



T1-113
I-1
II-13
II-49



T1-114
I-1
II-13
II-50



T1-115
I-1
II-13
II-51



T1-116
I-1
II-13
II-56



T1-117
I-1
II-13
II-57



T1-118
I-1
II-14
II-34



T1-119
I-1
II-14
II-46



T1-120
I-1
II-14
II-47



T1-121
I-1
II-14
II-48



T1-122
I-1
II-14
II-49



T1-123
I-1
II-14
II-50



T1-124
I-1
II-14
II-51



T1-125
I-1
II-14
II-56



T1-126
I-1
II-14
II-57



T1-127
I-1
II-15
II-34



T1-128
I-1
II-15
II-46



T1-129
I-1
II-15
II-47



T1-130
I-1
II-15
II-48



T1-131
I-1
II-15
II-49



T1-132
I-1
II-15
II-50



T1-133
I-1
II-15
II-51



T1-134
I-1
II-15
II-56



T1-135
I-1
II-15
II-57



T1-136
I-1
II-16
II-34



T1-137
I-1
II-16
II-46



T1-138
I-1
II-16
II-47



T1-139
I-1
II-16
II-48



T1-140
I-1
II-16
II-49



T1-141
I-1
II-16
II-50



T1-142
I-1
II-16
II-51



T1-143
I-1
II-16
II-56



T1-144
I-1
II-16
II-57



T1-145
I-1
II-17
II-34



T1-146
I-1
II-17
II-46



T1-147
I-1
II-17
II-47



T1-148
I-1
II-17
II-48



T1-149
I-1
II-17
II-49



T1-150
I-1
II-17
II-50



T1-151
I-1
II-17
II-51



T1-152
I-1
II-17
II-56



T1-153
I-1
II-17
II-57



T1-154
I-1
II-18
II-34



T1-155
I-1
II-18
II-46



T1-156
I-1
II-18
II-47



T1-157
I-1
II-18
II-48



T1-158
I-1
II-18
II-49



T1-159
I-1
II-18
II-50



T1-160
I-1
II-18
II-51



T1-161
I-1
II-18
II-56



T1-162
I-1
II-18
II-57



T1-163
I-1
II-19
II-34



T1-164
I-1
II-19
II-46



T1-165
I-1
II-19
II-47



T1-166
I-1
II-19
II-48



T1-167
I-1
II-19
II-49



T1-168
I-1
II-19
II-50



T1-169
I-1
II-19
II-51



T1-170
I-1
II-19
II-56



T1-171
I-1
II-19
II-57



T1-172
I-1
II-20
II-34



T1-173
I-1
II-20
II-46



T1-174
I-1
II-20
II-47



T1-175
I-1
II-20
II-48



T1-176
I-1
II-20
II-49



T1-177
I-1
II-20
II-50



T1-178
I-1
II-20
II-51



T1-179
I-1
II-20
II-56



T1-180
I-1
II-20
II-57



T1-181
I-1
II-21
II-34



T1-182
I-1
II-21
II-46



T1-183
I-1
II-21
II-47



T1-184
I-1
II-21
II-48



T1-185
I-1
II-21
II-49



T1-186
I-1
II-21
II-50



T1-187
I-1
II-21
II-51



T1-188
I-1
II-21
II-56



T1-189
I-1
II-21
II-57



T1-190
I-1
II-22
II-34



T1-191
I-1
II-22
II-46



T1-192
I-1
II-22
II-47



T1-193
I-1
II-22
II-48



T1-194
I-1
II-22
II-49



T1-195
I-1
II-22
II-50



T1-196
I-1
II-22
II-51



T1-197
I-1
II-22
II-56



T1-198
I-1
II-22
II-57



T1-199
I-1
II-23
II-34



T1-200
I-1
II-23
II-46



T1-201
I-1
II-23
II-47



T1-202
I-1
II-23
II-48



T1-203
I-1
II-23
II-49



T1-204
I-1
II-23
II-50



T1-205
I-1
II-23
II-51



T1-206
I-1
II-23
II-56



T1-207
I-1
II-23
II-57



T1-208
I-1
II-24
II-34



T1-209
I-1
II-24
II-46



T1-210
I-1
II-24
II-47



T1-211
I-1
II-24
II-48



T1-212
I-1
II-24
II-49



T1-213
I-1
II-24
II-50



T1-214
I-1
II-24
II-51



T1-215
I-1
II-24
II-56



T1-216
I-1
II-24
II-57



T1-217
I-1
II-25
II-34



T1-218
I-1
II-25
II-46



T1-219
I-1
II-25
II-47



T1-220
I-1
II-25
II-48



T1-221
I-1
II-25
II-49



T1-222
I-1
II-25
II-50



T1-223
I-1
II-25
II-51



T1-224
I-1
II-25
II-56



T1-225
I-1
II-25
II-57



T1-226
I-1
II-26
II-34



T1-227
I-1
II-26
II-46



T1-228
I-1
II-26
II-47



T1-229
I-1
II-26
II-48



T1-230
I-1
II-26
II-49



T1-231
I-1
II-26
II-50



T1-232
I-1
II-26
II-51



T1-233
I-1
II-26
II-56



T1-234
I-1
II-26
II-57



T1-235
I-1
II-27
II-34



T1-236
I-1
II-27
II-46



T1-237
I-1
II-27
II-47



T1-238
I-1
II-27
II-48



T1-239
I-1
II-27
II-49



T1-240
I-1
II-27
II-50



T1-241
I-1
II-27
II-51



T1-242
I-1
II-27
II-56



T1-243
I-1
II-27
II-57



T1-244
I-1
II-28
II-34



T1-245
I-1
II-28
II-46



T1-246
I-1
II-28
II-47



T1-247
I-1
II-28
II-48



T1-248
I-1
II-28
II-49



T1-249
I-1
II-28
II-50



T1-250
I-1
II-28
II-51



T1-251
I-1
II-28
II-56



T1-252
I-1
II-28
II-57



T1-253
I-1
II-29
II-34



T1-254
I-1
II-29
II-46



T1-255
I-1
II-29
II-47



T1-256
I-1
II-29
II-48



T1-257
I-1
II-29
II-49



T1-258
I-1
II-29
II-50



T1-259
I-1
II-29
II-51



T1-260
I-1
II-29
II-56



T1-261
I-1
II-29
II-57



T1-262
I-1
II-34
II-46



T1-263
I-1
II-34
II-47



T1-264
I-1
II-34
II-48



T1-265
I-1
II-34
II-49



T1-266
I-1
II-34
II-50



T1-267
I-1
II-34
II-51



T1-268
I-1
II-34
II-56



T1-269
I-1
II-34
II-57



T1-270
I-1
II-46
II-47



T1-271
I-1
II-46
II-48



T1-272
I-1
II-46
II-49



T1-273
I-1
II-46
II-50



T1-274
I-1
II-46
II-51



T1-275
I-1
II-46
II-56



T1-276
I-1
II-46
II-57



T1-277
I-1
II-47
II-48



T1-278
I-1
II-47
II-49



T1-279
I-1
II-47
II-50



T1-280
I-1
II-47
II-51



T1-281
I-1
II-47
II-56



T1-282
I-1
II-47
II-57



T1-283
I-1
II-48
II-49



T1-284
I-1
II-48
II-50



T1-285
I-1
II-48
II-51



T1-286
I-1
II-48
II-56



T1-287
I-1
II-48
II-57



T1-288
I-1
II-49
II-50



T1-289
I-1
II-49
II-51



T1-290
I-1
II-49
II-56



T1-291
I-1
II-49
II-57



T1-292
I-1
II-50
II-51



T1-293
I-1
II-50
II-56



T1-294
I-1
II-50
II-57



T1-295
I-1
II-51
II-56



T1-296
I-1
II-51
II-57



T1-297
I-1
II-56
II-57



T1-298
I-3
II-1
II-34



T1-299
I-3
II-1
II-46



T1-300
I-3
II-1
II-47



T1-301
I-3
II-1
II-48



T1-302
I-3
II-1
II-49



T1-303
I-3
II-1
II-50



T1-304
I-3
II-1
II-51



T1-305
I-3
II-1
II-56



T1-306
I-3
II-1
II-57



T1-307
I-3
II-2
II-34



T1-308
I-3
II-2
II-46



T1-309
I-3
II-2
II-47



T1-310
I-3
II-2
II-48



T1-311
I-3
II-2
II-49



T1-312
I-3
II-2
II-50



T1-313
I-3
II-2
II-51



T1-314
I-3
II-2
II-56



T1-315
I-3
II-2
II-57



T1-316
I-3
II-3
II-34



T1-317
I-3
II-3
II-46



T1-318
I-3
II-3
II-47



T1-319
I-3
II-3
II-48



T1-320
I-3
II-3
II-49



T1-321
I-3
II-3
II-50



T1-322
I-3
II-3
II-51



T1-323
I-3
II-3
II-57



T1-324
I-3
II-3
II-58



T1-325
I-3
II-4
II-34



T1-326
I-3
II-4
II-46



T1-327
I-3
II-4
II-47



T1-328
I-3
II-4
II-48



T1-329
I-3
II-4
II-49



T1-330
I-3
II-4
II-50



T1-331
I-3
II-4
II-51



T1-332
I-3
II-4
II-56



T1-333
I-3
II-4
II-57



T1-334
I-3
II-5
II-34



T1-335
I-3
II-5
II-46



T1-336
I-3
II-5
II-47



T1-337
I-3
II-5
II-48



T1-338
I-3
II-5
II-49



T1-339
I-3
II-5
II-50



T1-340
I-3
II-5
II-51



T1-341
I-3
II-5
II-56



T1-342
I-3
II-5
II-57



T1-343
I-3
II-6
II-34



T1-344
I-3
II-6
II-46



T1-345
I-3
II-6
II-47



T1-346
I-3
II-6
II-48



T1-347
I-3
II-6
II-49



T1-348
I-3
II-6
II-50



T1-349
I-3
II-6
II-51



T1-350
I-3
II-6
II-56



T1-351
I-3
II-6
II-57



T1-352
I-3
II-7
II-34



T1-353
I-3
II-7
II-46



T1-354
I-3
II-7
II-47



T1-355
I-3
II-7
II-48



T1-356
I-3
II-7
II-49



T1-357
I-3
II-7
II-50



T1-358
I-3
II-7
II-51



T1-359
I-3
II-7
II-56



T1-360
I-3
II-7
II-57



T1-361
I-3
II-8
II-34



T1-362
I-3
II-8
II-46



T1-363
I-3
II-8
II-47



T1-364
I-3
II-8
II-48



T1-365
I-3
II-8
II-49



T1-366
I-3
II-8
II-50



T1-367
I-3
II-8
II-51



T1-368
I-3
II-8
II-56



T1-369
I-3
II-8
II-57



T1-370
I-3
II-9
II-34



T1-371
I-3
II-9
II-46



T1-372
I-3
II-9
II-47



T1-373
I-3
II-9
II-48



T1-374
I-3
II-9
II-49



T1-375
I-3
II-9
II-50



T1-376
I-3
II-9
II-51



T1-377
I-3
II-9
II-56



T1-378
I-3
II-9
II-57



T1-379
I-3
II-10
II-34



T1-380
I-3
II-10
II-46



T1-381
I-3
II-10
II-47



T1-382
I-3
II-10
II-48



T1-383
I-3
II-10
II-49



T1-384
I-3
II-10
II-50



T1-385
I-3
II-10
II-51



T1-386
I-3
II-10
II-56



T1-387
I-3
II-10
II-57



T1-388
I-3
II-11
II-34



T1-389
I-3
II-11
II-46



T1-390
I-3
II-11
II-47



T1-391
I-3
II-11
II-48



T1-392
I-3
II-11
II-49



T1-393
I-3
II-11
II-50



T1-394
I-3
II-11
II-51



T1-395
I-3
II-11
II-56



T1-396
I-3
II-11
II-57



T1-397
I-3
II-12
II-34



T1-398
I-3
II-12
II-46



T1-399
I-3
II-12
II-47



T1-400
I-3
II-12
II-48



T1-401
I-3
II-12
II-49



T1-402
I-3
II-12
II-50



T1-403
I-3
II-12
II-51



T1-404
I-3
II-12
II-56



T1-405
I-3
II-12
II-57



T1-406
I-3
II-13
II-34



T1-407
I-3
II-13
II-46



T1-408
I-3
II-13
II-47



T1-409
I-3
II-13
II-48



T1-410
I-3
II-13
II-49



T1-411
I-3
II-13
II-50



T1-412
I-3
II-13
II-51



T1-413
I-3
II-13
II-56



T1-414
I-3
II-13
II-57



T1-415
I-3
II-14
II-34



T1-416
I-3
II-14
II-46



T1-417
I-3
II-14
II-47



T1-418
I-3
II-14
II-48



T1-419
I-3
II-14
II-49



T1-420
I-3
II-14
II-50



T1-421
I-3
II-14
II-51



T1-422
I-3
II-14
II-56



T1-423
I-3
II-14
II-57



T1-424
I-3
II-15
II-34



T1-425
I-3
II-15
II-46



T1-426
I-3
II-15
II-47



T1-427
I-3
II-15
II-48



T1-428
I-3
II-15
II-49



T1-429
I-3
II-15
II-50



T1-430
I-3
II-15
II-51



T1-431
I-3
II-15
II-56



T1-432
I-3
II-15
II-57



T1-433
I-3
II-16
II-34



T1-434
I-3
II-16
II-46



T1-435
I-3
II-16
II-47



T1-436
I-3
II-16
II-48



T1-437
I-3
II-16
II-49



T1-438
I-3
II-16
II-50



T1-439
I-3
II-16
II-51



T1-440
I-3
II-16
II-56



T1-441
I-3
II-16
II-57



T1-442
I-3
II-17
II-34



T1-443
I-3
II-17
II-46



T1-444
I-3
II-17
II-47



T1-445
I-3
II-17
II-48



T1-446
I-3
II-17
II-49



T1-447
I-3
II-17
II-50



T1-448
I-3
II-17
II-51



T1-449
I-3
II-17
II-56



T1-450
I-3
II-17
II-57



T1-451
I-3
II-18
II-34



T1-452
I-3
II-18
II-46



T1-453
I-3
II-18
II-47



T1-454
I-3
II-18
II-48



T1-455
I-3
II-18
II-49



T1-456
I-3
II-18
II-50



T1-457
I-3
II-18
II-51



T1-458
I-3
II-18
II-56



T1-459
I-3
II-18
II-57



T1-460
I-3
II-19
II-34



T1-461
I-3
II-19
II-46



T1-462
I-3
II-19
II-47



T1-463
I-3
II-19
II-48



T1-464
I-3
II-19
II-49



T1-465
I-3
II-19
II-50



T1-466
I-3
II-19
II-51



T1-467
I-3
II-19
II-56



T1-468
I-3
II-19
II-57



T1-469
I-3
II-20
II-34



T1-470
I-3
II-20
II-46



T1-471
I-3
II-20
II-47



T1-472
I-3
II-20
II-48



T1-473
I-3
II-20
II-49



T1-474
I-3
II-20
II-50



T1-475
I-3
II-20
II-51



T1-476
I-3
II-20
II-56



T1-477
I-3
II-20
II-57



T1-478
I-3
II-21
II-34



T1-479
I-3
II-21
II-46



T1-480
I-3
II-21
II-47



T1-481
I-3
II-21
II-48



T1-482
I-3
II-21
II-49



T1-483
I-3
II-21
II-50



T1-484
I-3
II-21
II-51



T1-485
I-3
II-21
II-56



T1-486
I-3
II-21
II-57



T1-487
I-3
II-22
II-34



T1-488
I-3
II-22
II-46



T1-489
I-3
II-22
II-47



T1-490
I-3
II-22
II-48



T1-491
I-3
II-22
II-49



T1-492
I-3
II-22
II-50



T1-493
I-3
II-22
II-51



T1-494
I-3
II-22
II-56



T1-495
I-3
II-22
II-57



T1-496
I-3
II-23
II-34



T1-497
I-3
II-23
II-46



T1-498
I-3
II-23
II-47



T1-499
I-3
II-23
II-48



T1-500
I-3
II-23
II-49



T1-501
I-3
II-23
II-50



T1-502
I-3
II-23
II-51



T1-503
I-3
II-23
II-56



T1-504
I-3
II-23
II-57



T1-505
I-3
II-24
II-34



T1-506
I-3
II-24
II-46



T1-507
I-3
II-24
II-47



T1-508
I-3
II-24
II-48



T1-509
I-3
II-24
II-49



T1-510
I-3
II-24
II-50



T1-511
I-3
II-24
II-51



T1-512
I-3
II-24
II-56



T1-513
I-3
II-24
II-57



T1-514
I-3
II-25
II-34



T1-515
I-3
II-25
II-46



T1-516
I-3
II-25
II-47



T1-517
I-3
II-25
II-48



T1-518
I-3
II-25
II-49



T1-519
I-3
II-25
II-50



T1-520
I-3
II-25
II-51



T1-521
I-3
II-25
II-56



T1-522
I-3
II-25
II-57



T1-523
I-3
II-26
II-34



T1-524
I-3
II-26
II-46



T1-525
I-3
II-26
II-47



T1-526
I-3
II-26
II-48



T1-527
I-3
II-26
II-49



T1-528
I-3
II-26
II-50



T1-529
I-3
II-26
II-51



T1-530
I-3
II-26
II-56



T1-531
I-3
II-26
II-57



T1-532
I-3
II-27
II-34



T1-533
I-3
II-27
II-46



T1-534
I-3
II-27
II-47



T1-535
I-3
II-27
II-48



T1-536
I-3
II-27
II-49



T1-537
I-3
II-27
II-50



T1-538
I-3
II-27
II-51



T1-539
I-3
II-27
II-56



T1-540
I-3
II-27
II-57



T1-541
I-3
II-28
II-34



T1-542
I-3
II-28
II-46



T1-543
I-3
II-28
II-47



T1-544
I-3
II-28
II-48



T1-545
I-3
II-28
II-49



T1-546
I-3
II-28
II-50



T1-547
I-3
II-28
II-51



T1-548
I-3
II-28
II-56



T1-549
I-3
II-28
II-57



T1-550
I-3
II-29
II-34



T1-551
I-3
II-29
II-46



T1-552
I-3
II-29
II-47



T1-553
I-3
II-29
II-48



T1-554
I-3
II-29
II-49



T1-555
I-3
II-29
II-50



T1-556
I-3
II-29
II-51



T1-557
I-3
II-29
II-56



T1-558
I-3
II-29
II-57



T1-559
I-3
II-34
II-46



T1-560
I-3
II-34
II-47



T1-561
I-3
II-34
II-48



T1-562
I-3
II-34
II-49



T1-563
I-3
II-34
II-50



T1-564
I-3
II-34
II-51



T1-565
I-3
II-34
II-56



T1-566
I-3
II-34
II-57



T1-567
I-3
II-46
II-47



T1-568
I-3
II-46
II-48



T1-569
I-3
II-46
II-49



T1-570
I-3
II-46
II-50



T1-571
I-3
II-46
II-51



T1-572
I-3
II-46
II-56



T1-573
I-3
II-46
II-57



T1-574
I-3
II-47
II-48



T1-575
I-3
II-47
II-49



T1-576
I-3
II-47
II-50



T1-577
I-3
II-47
II-51



T1-578
I-3
II-47
II-56



T1-579
I-3
II-47
II-57



T1-580
I-3
II-48
II-49



T1-581
I-3
II-48
II-50



T1-582
I-3
II-48
II-51



T1-583
I-3
II-48
II-56



T1-584
I-3
II-48
II-57



T1-585
I-3
II-49
II-50



T1-586
I-3
II-49
II-51



T1-587
I-3
II-49
II-56



T1-588
I-3
II-49
II-57



T1-589
I-3
II-50
II-51



T1-590
I-3
II-50
II-56



T1-591
I-3
II-50
II-57



T1-592
I-3
II-51
II-56



T1-593
I-3
II-51
II-57



T1-594
I-3
II-56
II-57



T1-595
I-7
II-1
II-34



T1-596
I-7
II-1
II-46



T1-597
I-7
II-1
II-47



T1-598
I-7
II-1
II-48



T1-599
I-7
II-1
II-49



T1-600
I-7
II-1
II-50



T1-601
I-7
II-1
II-51



T1-602
I-7
II-1
II-56



T1-603
I-7
II-1
II-57



T1-604
I-7
II-2
II-34



T1-605
I-7
II-2
II-46



T1-606
I-7
II-2
II-47



T1-607
I-7
II-2
II-48



T1-608
I-7
II-2
II-49



T1-609
I-7
II-2
II-50



T1-610
I-7
II-2
II-51



T1-611
I-7
II-2
II-56



T1-612
I-7
II-2
II-57



T1-613
I-7
II-3
II-34



T1-614
I-7
II-3
II-46



T1-615
I-7
II-3
II-47



T1-616
I-7
II-3
II-48



T1-617
I-7
II-3
II-49



T1-618
I-7
II-3
II-50



T1-619
I-7
II-3
II-51



T1-620
I-7
II-3
II-57



T1-621
I-7
II-3
II-58



T1-622
I-7
II-4
II-34



T1-623
I-7
II-4
II-46



T1-624
I-7
II-4
II-47



T1-625
I-7
II-4
II-48



T1-626
I-7
II-4
II-49



T1-627
I-7
II-4
II-50



T1-628
I-7
II-4
II-51



T1-629
I-7
II-4
II-56



T1-630
I-7
II-4
II-57



T1-631
I-7
II-5
II-34



T1-632
I-7
II-5
II-46



T1-633
I-7
II-5
II-47



T1-634
I-7
II-5
II-48



T1-635
I-7
II-5
II-49



T1-636
I-7
II-5
II-50



T1-637
I-7
II-5
II-51



T1-638
I-7
II-5
II-56



T1-639
I-7
II-5
II-57



T1-640
I-7
II-6
II-34



T1-641
I-7
II-6
II-46



T1-642
I-7
II-6
II-47



T1-643
I-7
II-6
II-48



T1-644
I-7
II-6
II-49



T1-645
I-7
II-6
II-50



T1-646
I-7
II-6
II-51



T1-647
I-7
II-6
II-56



T1-648
I-7
II-6
II-57



T1-649
I-7
II-7
II-34



T1-650
I-7
II-7
II-46



T1-651
I-7
II-7
II-47



T1-652
I-7
II-7
II-48



T1-653
I-7
II-7
II-49



T1-654
I-7
II-7
II-50



T1-655
I-7
II-7
II-51



T1-656
I-7
II-7
II-56



T1-657
I-7
II-7
II-57



T1-658
I-7
II-8
II-34



T1-659
I-7
II-8
II-46



T1-660
I-7
II-8
II-47



T1-661
I-7
II-8
II-48



T1-662
I-7
II-8
II-49



T1-663
I-7
II-8
II-50



T1-664
I-7
II-8
II-51



T1-665
I-7
II-8
II-56



T1-666
I-7
II-8
II-57



T1-667
I-7
II-9
II-34



T1-668
I-7
II-9
II-46



T1-669
I-7
II-9
II-47



T1-670
I-7
II-9
II-48



T1-671
I-7
II-9
II-49



T1-672
I-7
II-9
II-50



T1-673
I-7
II-9
II-51



T1-674
I-7
II-9
II-56



T1-675
I-7
II-9
II-57



T1-676
I-7
II-10
II-34



T1-677
I-7
II-10
II-46



T1-678
I-7
II-10
II-47



T1-679
I-7
II-10
II-48



T1-680
I-7
II-10
II-49



T1-681
I-7
II-10
II-50



T1-682
I-7
II-10
II-51



T1-683
I-7
II-10
II-56



T1-684
I-7
II-10
II-57



T1-685
I-7
II-11
II-34



T1-686
I-7
II-11
II-46



T1-687
I-7
II-11
II-47



T1-688
I-7
II-11
II-48



T1-689
I-7
II-11
II-49



T1-690
I-7
II-11
II-50



T1-691
I-7
II-11
II-51



T1-692
I-7
II-11
II-56



T1-693
I-7
II-11
II-57



T1-694
I-7
II-12
II-34



T1-695
I-7
II-12
II-46



T1-696
I-7
II-12
II-47



T1-697
I-7
II-12
II-48



T1-698
I-7
II-12
II-49



T1-699
I-7
II-12
II-50



T1-700
I-7
II-12
II-51



T1-701
I-7
II-12
II-56



T1-702
I-7
II-12
II-57



T1-703
I-7
II-13
II-34



T1-704
I-7
II-13
II-46



T1-705
I-7
II-13
II-47



T1-706
I-7
II-13
II-48



T1-707
I-7
II-13
II-49



T1-708
I-7
II-13
II-50



T1-709
I-7
II-13
II-51



T1-710
I-7
II-13
II-56



T1-711
I-7
II-13
II-57



T1-712
I-7
II-14
II-34



T1-713
I-7
II-14
II-46



T1-714
I-7
II-14
II-47



T1-715
I-7
II-14
II-48



T1-716
I-7
II-14
II-49



T1-717
I-7
II-14
II-50



T1-718
I-7
II-14
II-51



T1-719
I-7
II-14
II-56



T1-720
I-7
II-14
II-57



T1-721
I-7
II-15
II-34



T1-722
I-7
II-15
II-46



T1-723
I-7
II-15
II-47



T1-724
I-7
II-15
II-48



T1-725
I-7
II-15
II-49



T1-726
I-7
II-15
II-50



T1-727
I-7
II-15
II-51



T1-728
I-7
II-15
II-56



T1-729
I-7
II-15
II-57



T1-730
I-7
II-16
II-34



T1-731
I-7
II-16
II-46



T1-732
I-7
II-16
II-47



T1-733
I-7
II-16
II-48



T1-734
I-7
II-16
II-49



T1-735
I-7
II-16
II-50



T1-736
I-7
II-16
II-51



T1-737
I-7
II-16
II-56



T1-738
I-7
II-16
II-57



T1-739
I-7
II-17
II-34



T1-740
I-7
II-17
II-46



T1-741
I-7
II-17
II-47



T1-742
I-7
II-17
II-48



T1-743
I-7
II-17
II-49



T1-744
I-7
II-17
II-50



T1-745
I-7
II-17
II-51



T1-746
I-7
II-17
II-56



T1-747
I-7
II-17
II-57



T1-748
I-7
II-18
II-34



T1-749
I-7
II-18
II-46



T1-750
I-7
II-18
II-47



T1-751
I-7
II-18
II-48



T1-752
I-7
II-18
II-49



T1-753
I-7
II-18
II-50



T1-754
I-7
II-18
II-51



T1-755
I-7
II-18
II-56



T1-756
I-7
II-18
II-57



T1-757
I-7
II-19
II-34



T1-758
I-7
II-19
II-46



T1-759
I-7
II-19
II-47



T1-760
I-7
II-19
II-48



T1-761
I-7
II-19
II-49



T1-762
I-7
II-19
II-50



T1-763
I-7
II-19
II-51



T1-764
I-7
II-19
II-56



T1-765
I-7
II-19
II-57



T1-766
I-7
II-20
II-34



T1-767
I-7
II-20
II-46



T1-768
I-7
II-20
II-47



T1-769
I-7
II-20
II-48



T1-770
I-7
II-20
II-49



T1-771
I-7
II-20
II-50



T1-772
I-7
II-20
II-51



T1-773
I-7
II-20
II-56



T1-774
I-7
II-20
II-57



T1-775
I-7
II-21
II-34



T1-776
I-7
II-21
II-46



T1-777
I-7
II-21
II-47



T1-778
I-7
II-21
II-48



T1-779
I-7
II-21
II-49



T1-780
I-7
II-21
II-50



T1-781
I-7
II-21
II-51



T1-782
I-7
II-21
II-56



T1-783
I-7
II-21
II-57



T1-784
I-7
II-22
II-34



T1-785
I-7
II-22
II-46



T1-786
I-7
II-22
II-47



T1-787
I-7
II-22
II-48



T1-788
I-7
II-22
II-49



T1-789
I-7
II-22
II-50



T1-790
I-7
II-22
II-51



T1-791
I-7
II-22
II-56



T1-792
I-7
II-22
II-57



T1-793
I-7
II-23
II-34



T1-794
I-7
II-23
II-46



T1-795
I-7
II-23
II-47



T1-796
I-7
II-23
II-48



T1-797
I-7
II-23
II-49



T1-798
I-7
II-23
II-50



T1-799
I-7
II-23
II-51



T1-800
I-7
II-23
II-56



T1-801
I-7
II-23
II-57



T1-802
I-7
II-24
II-34



T1-803
I-7
II-24
II-46



T1-804
I-7
II-24
II-47



T1-805
I-7
II-24
II-48



T1-806
I-7
II-24
II-49



T1-807
I-7
II-24
II-50



T1-808
I-7
II-24
II-51



T1-809
I-7
II-24
II-56



T1-810
I-7
II-24
II-57



T1-811
I-7
II-25
II-34



T1-812
I-7
II-25
II-46



T1-813
I-7
II-25
II-47



T1-814
I-7
II-25
II-48



T1-815
I-7
II-25
II-49



T1-816
I-7
II-25
II-50



T1-817
I-7
II-25
II-51



T1-818
I-7
II-25
II-56



T1-819
I-7
II-25
II-57



T1-820
I-7
II-26
II-34



T1-821
I-7
II-26
II-46



T1-822
I-7
II-26
II-47



T1-823
I-7
II-26
II-48



T1-824
I-7
II-26
II-49



T1-825
I-7
II-26
II-50



T1-826
I-7
II-26
II-51



T1-827
I-7
II-26
II-56



T1-828
I-7
II-26
II-57



T1-829
I-7
II-27
II-34



T1-830
I-7
II-27
II-46



T1-831
I-7
II-27
II-47



T1-832
I-7
II-27
II-48



T1-833
I-7
II-27
II-49



T1-834
I-7
II-27
II-50



T1-835
I-7
II-27
II-51



T1-836
I-7
II-27
II-56



T1-837
I-7
II-27
II-57



T1-838
I-7
II-28
II-34



T1-839
I-7
II-28
II-46



T1-840
I-7
II-28
II-47



T1-841
I-7
II-28
II-48



T1-842
I-7
II-28
II-49



T1-843
I-7
II-28
II-50



T1-844
I-7
II-28
II-51



T1-845
I-7
II-28
II-56



T1-846
I-7
II-28
II-57



T1-847
I-7
II-29
II-34



T1-848
I-7
II-29
II-46



T1-849
I-7
II-29
II-47



T1-850
I-7
II-29
II-48



T1-851
I-7
II-29
II-49



T1-852
I-7
II-29
II-50



T1-853
I-7
II-29
II-51



T1-854
I-7
II-29
II-56



T1-855
I-7
II-29
II-57



T1-856
I-7
II-34
II-46



T1-857
I-7
II-34
II-47



T1-858
I-7
II-34
II-48



T1-859
I-7
II-34
II-49



T1-860
I-7
II-34
II-50



T1-861
I-7
II-34
II-51



T1-862
I-7
II-34
II-56



T1-863
I-7
II-34
II-57



T1-864
I-7
II-46
II-47



T1-865
I-7
II-46
II-48



T1-866
I-7
II-46
II-49



T1-867
I-7
II-46
II-50



T1-868
I-7
II-46
II-51



T1-869
I-7
II-46
II-56



T1-870
I-7
II-46
II-57



T1-871
I-7
II-47
II-48



T1-872
I-7
II-47
II-49



T1-873
I-7
II-47
II-50



T1-874
I-7
II-47
II-51



T1-875
I-7
II-47
II-56



T1-876
I-7
II-47
II-57



T1-877
I-7
II-48
II-49



T1-878
I-7
II-48
II-50



T1-879
I-7
II-48
II-51



T1-880
I-7
II-48
II-56



T1-881
I-7
II-48
II-57



T1-882
I-7
II-49
II-50



T1-883
I-7
II-49
II-51



T1-884
I-7
II-49
II-56



T1-885
I-7
II-49
II-57



T1-886
I-7
II-50
II-51



T1-887
I-7
II-50
II-56



T1-888
I-7
II-50
II-57



T1-889
I-7
II-51
II-56



T1-890
I-7
II-51
II-57



T1-891
I-7
II-56
II-57



T1-892
I-8
II-1
II-34



T1-893
I-8
II-1
II-46



T1-894
I-8
II-1
II-47



T1-895
I-8
II-1
II-48



T1-896
I-8
II-1
II-49



T1-897
I-8
II-1
II-50



T1-898
I-8
II-1
II-51



T1-899
I-8
II-1
II-56



T1-900
I-8
II-1
II-57



T1-901
I-8
II-2
II-34



T1-902
I-8
II-2
II-46



T1-903
I-8
II-2
II-47



T1-904
I-8
II-2
II-48



T1-905
I-8
II-2
II-49



T1-906
I-8
II-2
II-50



T1-907
I-8
II-2
II-51



T1-908
I-8
II-2
II-56



T1-909
I-8
II-2
II-57



T1-910
I-8
II-3
II-34



T1-911
I-8
II-3
II-46



T1-912
I-8
II-3
II-47



T1-913
I-8
II-3
II-48



T1-914
I-8
II-3
II-49



T1-915
I-8
II-3
II-50



T1-916
I-8
II-3
II-51



T1-917
I-8
II-3
II-57



T1-918
I-8
II-3
II-58



T1-919
I-8
II-4
II-34



T1-920
I-8
II-4
II-46



T1-921
I-8
II-4
II-47



T1-922
I-8
II-4
II-48



T1-923
I-8
II-4
II-49



T1-924
I-8
II-4
II-50



T1-925
I-8
II-4
II-51



T1-926
I-8
II-4
II-56



T1-927
I-8
II-4
II-57



T1-928
I-8
II-5
II-34



T1-929
I-8
II-5
II-46



T1-930
I-8
II-5
II-47



T1-931
I-8
II-5
II-48



T1-932
I-8
II-5
II-49



T1-933
I-8
II-5
II-50



T1-934
I-8
II-5
II-51



T1-935
I-8
II-5
II-56



T1-936
I-8
II-5
II-57



T1-937
I-8
II-6
II-34



T1-938
I-8
II-6
II-46



T1-939
I-8
II-6
II-47



T1-940
I-8
II-6
II-48



T1-941
I-8
II-6
II-49



T1-942
I-8
II-6
II-50



T1-943
I-8
II-6
II-51



T1-944
I-8
II-6
II-56



T1-945
I-8
II-6
II-57



T1-946
I-8
II-7
II-34



T1-947
I-8
II-7
II-46



T1-948
I-8
II-7
II-47



T1-949
I-8
II-7
II-48



T1-950
I-8
II-7
II-49



T1-951
I-8
II-7
II-50



T1-952
I-8
II-7
II-51



T1-953
I-8
II-7
II-56



T1-954
I-8
II-7
II-57



T1-955
I-8
II-8
II-34



T1-956
I-8
II-8
II-46



T1-957
I-8
II-8
II-47



T1-958
I-8
II-8
II-48



T1-959
I-8
II-8
II-49



T1-960
I-8
II-8
II-50



T1-961
I-8
II-8
II-51



T1-962
I-8
II-8
II-56



T1-963
I-8
II-8
II-57



T1-964
I-8
II-9
II-34



T1-965
I-8
II-9
II-46



T1-966
I-8
II-9
II-47



T1-967
I-8
II-9
II-48



T1-968
I-8
II-9
II-49



T1-969
I-8
II-9
II-50



T1-970
I-8
II-9
II-51



T1-971
I-8
II-9
II-56



T1-972
I-8
II-9
II-57



T1-973
I-8
II-10
II-34



T1-974
I-8
II-10
II-46



T1-975
I-8
II-10
II-47



T1-976
I-8
II-10
II-48



T1-977
I-8
II-10
II-49



T1-978
I-8
II-10
II-50



T1-979
I-8
II-10
II-51



T1-980
I-8
II-10
II-56



T1-981
I-8
II-10
II-57



T1-982
I-8
II-11
II-34



T1-983
I-8
II-11
II-46



T1-984
I-8
II-11
II-47



T1-985
I-8
II-11
II-48



T1-986
I-8
II-11
II-49



T1-987
I-8
II-11
II-50



T1-988
I-8
II-11
II-51



T1-989
I-8
II-11
II-56



T1-990
I-8
II-11
II-57



T1-991
I-8
II-12
II-34



T1-992
I-8
II-12
II-46



T1-993
I-8
II-12
II-47



T1-994
I-8
II-12
II-48



T1-995
I-8
II-12
II-49



T1-996
I-8
II-12
II-50



T1-997
I-8
II-12
II-51



T1-998
I-8
II-12
II-56



T1-999
I-8
II-12
II-57



T1-1000
I-8
II-13
II-34



T1-1001
I-8
II-13
II-46



T1-1002
I-8
II-13
II-47



T1-1003
I-8
II-13
II-48



T1-1004
I-8
II-13
II-49



T1-1005
I-8
II-13
II-50



T1-1006
I-8
II-13
II-51



T1-1007
I-8
II-13
II-56



T1-1008
I-8
II-13
II-57



T1-1009
I-8
II-14
II-34



T1-1010
I-8
II-14
II-46



T1-1011
I-8
II-14
II-47



T1-1012
I-8
II-14
II-48



T1-1013
I-8
II-14
II-49



T1-1014
I-8
II-14
II-50



T1-1015
I-8
II-14
II-51



T1-1016
I-8
II-14
II-56



T1-1017
I-8
II-14
II-57



T1-1018
I-8
II-15
II-34



T1-1019
I-8
II-15
II-46



T1-1020
I-8
II-15
II-47



T1-1021
I-8
II-15
II-48



T1-1022
I-8
II-15
II-49



T1-1023
I-8
II-15
II-50



T1-1024
I-8
II-15
II-51



T1-1025
I-8
II-15
II-56



T1-1026
I-8
II-15
II-57



T1-1027
I-8
II-16
II-34



T1-1028
I-8
II-16
II-46



T1-1029
I-8
II-16
II-47



T1-1030
I-8
II-16
II-48



T1-1031
I-8
II-16
II-49



T1-1032
I-8
II-16
II-50



T1-1033
I-8
II-16
II-51



T1-1034
I-8
II-16
II-56



T1-1035
I-8
II-16
II-57



T1-1036
I-8
II-17
II-34



T1-1037
I-8
II-17
II-46



T1-1038
I-8
II-17
II-47



T1-1039
I-8
II-17
II-48



T1-1040
I-8
II-17
II-49



T1-1041
I-8
II-17
II-50



T1-1042
I-8
II-17
II-51



T1-1043
I-8
II-17
II-56



T1-1044
I-8
II-17
II-57



T1-1045
I-8
II-18
II-34



T1-1046
I-8
II-18
II-46



T1-1047
I-8
II-18
II-47



T1-1048
I-8
II-18
II-48



T1-1049
I-8
II-18
II-49



T1-1050
I-8
II-18
II-50



T1-1051
I-8
II-18
II-51



T1-1052
I-8
II-18
II-56



T1-1053
I-8
II-18
II-57



T1-1054
I-8
II-19
II-34



T1-1055
I-8
II-19
II-46



T1-1056
I-8
II-19
II-47



T1-1057
I-8
II-19
II-48



T1-1058
I-8
II-19
II-49



T1-1059
I-8
II-19
II-50



T1-1060
I-8
II-19
II-51



T1-1061
I-8
II-19
II-56



T1-1062
I-8
II-19
II-57



T1-1063
I-8
II-20
II-34



T1-1064
I-8
II-20
II-46



T1-1065
I-8
II-20
II-47



T1-1066
I-8
II-20
II-48



T1-1067
I-8
II-20
II-49



T1-1068
I-8
II-20
II-50



T1-1069
I-8
II-20
II-51



T1-1070
I-8
II-20
II-56



T1-1071
I-8
II-20
II-57



T1-1072
I-8
II-21
II-34



T1-1073
I-8
II-21
II-46



T1-1074
I-8
II-21
II-47



T1-1075
I-8
II-21
II-48



T1-1076
I-8
II-21
II-49



T1-1077
I-8
II-21
II-50



T1-1078
I-8
II-21
II-51



T1-1079
I-8
II-21
II-56



T1-1080
I-8
II-21
II-57



T1-1081
I-8
II-22
II-34



T1-1082
I-8
II-22
II-46



T1-1083
I-8
II-22
II-47



T1-1084
I-8
II-22
II-48



T1-1085
I-8
II-22
II-49



T1-1086
I-8
II-22
II-50



T1-1087
I-8
II-22
II-51



T1-1088
I-8
II-22
II-56



T1-1089
I-8
II-22
II-57



T1-1090
I-8
II-23
II-34



T1-1091
I-8
II-23
II-46



T1-1092
I-8
II-23
II-47



T1-1093
I-8
II-23
II-48



T1-1094
I-8
II-23
II-49



T1-1095
I-8
II-23
II-50



T1-1096
I-8
II-23
II-51



T1-1097
I-8
II-23
II-56



T1-1098
I-8
II-23
II-57



T1-1099
I-8
II-24
II-34



T1-1100
I-8
II-24
II-46



T1-1101
I-8
II-24
II-47



T1-1102
I-8
II-24
II-48



T1-1103
I-8
II-24
II-49



T1-1104
I-8
II-24
II-50



T1-1105
I-8
II-24
II-51



T1-1106
I-8
II-24
II-56



T1-1107
I-8
II-24
II-57



T1-1108
I-8
II-25
II-34



T1-1109
I-8
II-25
II-46



T1-1110
I-8
II-25
II-47



T1-1111
I-8
II-25
II-48



T1-1112
I-8
II-25
II-49



T1-1113
I-8
II-25
II-50



T1-1114
I-8
II-25
II-51



T1-1115
I-8
II-25
II-56



T1-1116
I-8
II-25
II-57



T1-1117
I-8
II-26
II-34



T1-1118
I-8
II-26
II-46



T1-1119
I-8
II-26
II-47



T1-1120
I-8
II-26
II-48



T1-1121
I-8
II-26
II-49



T1-1122
I-8
II-26
II-50



T1-1123
I-8
II-26
II-51



T1-1124
I-8
II-26
II-56



T1-1125
I-8
II-26
II-57



T1-1126
I-8
II-27
II-34



T1-1127
I-8
II-27
II-46



T1-1128
I-8
II-27
II-47



T1-1129
I-8
II-27
II-48



T1-1130
I-8
II-27
II-49



T1-1131
I-8
II-27
II-50



T1-1132
I-8
II-27
II-51



T1-1133
I-8
II-27
II-56



T1-1134
I-8
II-27
II-57



T1-1135
I-8
II-28
II-34



T1-1136
I-8
II-28
II-46



T1-1137
I-8
II-28
II-47



T1-1138
I-8
II-28
II-48



T1-1139
I-8
II-28
II-49



T1-1140
I-8
II-28
II-50



T1-1141
I-8
II-28
II-51



T1-1142
I-8
II-28
II-56



T1-1143
I-8
II-28
II-57



T1-1144
I-8
II-29
II-34



T1-1145
I-8
II-29
II-46



T1-1146
I-8
II-29
II-47



T1-1147
I-8
II-29
II-48



T1-1148
I-8
II-29
II-49



T1-1149
I-8
II-29
II-50



T1-1150
I-8
II-29
II-51



T1-1151
I-8
II-29
II-56



T1-1152
I-8
II-29
II-57



T1-1153
I-8
II-34
II-46



T1-1154
I-8
II-34
II-47



T1-1155
I-8
II-34
II-48



T1-1156
I-8
II-34
II-49



T1-1157
I-8
II-34
II-50



T1-1158
I-8
II-34
II-51



T1-1159
I-8
II-34
II-56



T1-1160
I-8
II-34
II-57



T1-1161
I-8
II-46
II-47



T1-1162
I-8
II-46
II-48



T1-1163
I-8
II-46
II-49



T1-1164
I-8
II-46
II-50



T1-1165
I-8
II-46
II-51



T1-1166
I-8
II-46
II-56



T1-1167
I-8
II-46
II-57



T1-1168
I-8
II-47
II-48



T1-1169
I-8
II-47
II-49



T1-1170
I-8
II-47
II-50



T1-1171
I-8
II-47
II-51



T1-1172
I-8
II-47
II-56



T1-1173
I-8
II-47
II-57



T1-1174
I-8
II-48
II-49



T1-1175
I-8
II-48
II-50



T1-1176
I-8
II-48
II-51



T1-1177
I-8
II-48
II-56



T1-1178
I-8
II-48
II-57



T1-1179
I-8
II-49
II-50



T1-1180
I-8
II-49
II-51



T1-1181
I-8
II-49
II-56



T1-1182
I-8
II-49
II-57



T1-1183
I-8
II-50
II-51



T1-1184
I-8
II-50
II-56



T1-1185
I-8
II-50
II-57



T1-1186
I-8
II-51
II-56



T1-1187
I-8
II-51
II-57



T1-1188
I-8
II-56
II-57







“C” denotes “component”, “M” denotes “mixture”.






According to a further embodiment, preference is given to mixtures comprising a component 1, a component 2 and a component 3, where preference is given in particular to those mixtures in which component 2 is a compound II selected from the group of the compounds II-1 to II-29, II-46 to II-49 to II-51 and II-52 to II-55 (see above), and component 3 is a compound II selected from the compounds II-52 mepiquat chloride

    • II-53 chlormequat chloride
    • II-54 trinexapac-ethyl
    • II-55 prohexadione-calcium of group G),


      with the proviso that component 2 and component 3 are not identical.


Such mixtures according to the invention are listed explicitly in Table T2. According to a specific embodiment, these are ternary mixtures comprising, as active compounds, in each case only these three components.









TABLE T2







Mixtures T2-1 to T2-583, comprising, as component 1, the compound I,


a component 2 selected from the active compounds preferred for


component 2 and a component 3 selected from the active compounds


preferred for component 3. In the table below, in each case one row of a


mixture according to the invention corresponds to the respective mixture


components 1 to 3 listed in the row in question.












M
C1
C2
C3







T2-1
I-1
II-1
II-52



T2-2
I-1
II-1
II-53



T2-3
I-1
II-1
II-54



T2-4
I-1
II-1
II-55



T2-5
I-1
II-2
II-52



T2-6
I-1
II-2
II-53



T2-7
I-1
II-2
II-54



T2-8
I-1
II-2
II-55



T2-9
I-1
II-3
II-52



T2-10
I-1
II-3
II-53



T2-11
I-1
II-3
II-54



T2-12
I-1
II-3
II-55



T2-13
I-1
II-4
II-52



T2-14
I-1
II-4
II-53



T2-15
I-1
II-4
II-54



T2-16
I-1
II-4
II-55



T2-17
I-1
II-5
II-52



T2-18
I-1
II-5
II-53



T2-19
I-1
II-5
II-54



T2-20
I-1
II-5
II-55



T2-21
I-1
II-6
II-52



T2-22
I-1
II-6
II-53



T2-23
I-1
II-6
II-54



T2-24
I-1
II-6
II-55



T2-25
I-1
II-7
II-52



T2-26
I-1
II-7
II-53



T2-27
I-1
II-7
II-54



T2-28
I-1
II-7
II-55



T2-29
I-1
II-8
II-52



T2-30
I-1
II-8
II-53



T2-31
I-1
II-8
II-54



T2-32
I-1
II-8
II-55



T2-33
I-1
II-9
II-52



T2-34
I-1
II-9
II-53



T2-35
I-1
II-9
II-54



T2-36
I-1
II-9
II-55



T2-37
I-1
II-10
II-52



T2-38
I-1
II-10
II-53



T2-39
I-1
II-10
II-54



T2-40
I-1
II-10
II-55



T2-41
I-1
II-11
II-52



T2-42
I-1
II-11
II-53



T2-43
I-1
II-11
II-54



T2-44
I-1
II-11
II-55



T2-45
I-1
II-12
II-52



T2-46
I-1
II-12
II-53



T2-47
I-1
II-12
II-54



T2-48
I-1
II-12
II-55



T2-49
I-1
II-13
II-52



T2-50
I-1
II-13
II-53



T2-51
I-1
II-13
II-54



T2-52
I-1
II-13
II-55



T2-53
I-1
II-14
II-52



T2-54
I-1
II-14
II-53



T2-55
I-1
II-14
II-54



T2-56
I-1
II-14
II-55



T2-57
I-1
II-15
II-52



T2-58
I-1
II-15
II-53



T2-59
I-1
II-15
II-54



T2-60
I-1
II-15
II-55



T2-61
I-1
II-16
II-52



T2-62
I-1
II-16
II-53



T2-63
I-1
II-16
II-54



T2-64
I-1
II-16
II-55



T2-65
I-1
II-17
II-52



T2-66
I-1
II-17
II-53



T2-67
I-1
II-17
II-54



T2-68
I-1
II-17
II-55



T2-69
I-1
II-18
II-52



T2-70
I-1
II-18
II-53



T2-71
I-1
II-18
II-54



T2-72
I-1
II-18
II-55



T2-73
I-1
II-19
II-52



T2-74
I-1
II-19
II-53



T2-75
I-1
II-19
II-54



T2-76
I-1
II-19
II-55



T2-77
I-1
II-20
II-52



T2-78
I-1
II-20
II-53



T2-79
I-1
II-20
II-54



T2-80
I-1
II-20
II-55



T2-81
I-1
II-21
II-52



T2-82
I-1
II-21
II-53



T2-83
I-1
II-21
II-54



T2-84
I-1
II-21
II-55



T2-85
I-1
II-22
II-52



T2-86
I-1
II-22
II-53



T2-87
I-1
II-22
II-54



T2-88
I-1
II-22
II-55



T2-89
I-1
II-23
II-52



T2-90
I-1
II-23
II-53



T2-91
I-1
II-23
II-54



T2-92
I-1
II-23
II-55



T2-93
I-1
II-24
II-52



T2-94
I-1
II-24
II-53



T2-95
I-1
II-24
II-54



T2-96
I-1
II-24
II-55



T2-97
I-1
II-25
II-52



T2-98
I-1
II-25
II-53



T2-99
I-1
II-25
II-54



T2-100
I-1
II-25
II-55



T2-101
I-1
II-26
II-52



T2-102
I-1
II-26
II-53



T2-103
I-1
II-26
II-54



T2-104
I-1
II-26
II-55



T2-105
I-1
II-27
II-52



T2-106
I-1
II-27
II-53



T2-107
I-1
II-27
II-54



T2-108
I-1
II-27
II-55



T2-109
I-1
II-28
II-52



T2-110
I-1
II-28
II-53



T2-111
I-1
II-28
II-54



T2-112
I-1
II-28
II-55



T2-113
I-1
II-29
II-52



T2-114
I-1
II-29
II-53



T2-115
I-1
II-29
II-54



T2-116
I-1
II-29
II-55



T2-117
I-1
II-46
II-52



T2-118
I-1
II-46
II-53



T2-119
I-1
II-46
II-54



T2-120
I-1
II-46
II-55



T2-121
I-1
II-47
II-52



T2-122
I-1
II-47
II-53



T2-123
I-1
II-47
II-54



T2-124
I-1
II-47
II-55



T2-125
I-1
II-48
II-52



T2-126
I-1
II-48
II-53



T2-127
I-1
II-48
II-54



T2-128
I-1
II-49
II-52



T2-129
I-1
II-49
II-53



T2-130
I-1
II-49
II-54



T2-131
I-1
II-49
II-55



T2-132
I-1
II-50
II-52



T2-133
I-1
II-50
II-53



T2-134
I-1
II-50
II-54



T2-135
I-1
II-50
II-55



T2-136
I-1
II-51
II-52



T2-137
I-1
II-51
II-53



T2-138
I-1
II-51
II-54



T2-139
I-1
II-51
II-55



T2-140
I-1
II-52
II-53



T2-141
I-1
II-52
II-54



T2-142
I-1
II-52
II-55



T2-143
I-1
II-53
II-54



T2-144
I-1
II-53
II-55



T2-145
I-1
II-54
II-55



T2-146
I-3
II-1
II-52



T2-147
I-3
II-1
II-53



T2-148
I-3
II-1
II-54



T2-149
I-3
II-1
II-55



T2-150
I-3
II-2
II-52



T2-151
I-3
II-2
II-53



T2-152
I-3
II-2
II-54



T2-153
I-3
II-2
II-55



T2-154
I-3
II-3
II-52



T2-155
I-3
II-3
II-53



T2-156
I-3
II-3
II-54



T2-157
I-3
II-3
II-55



T2-158
I-3
II-4
II-52



T2-159
I-3
II-4
II-53



T2-160
I-3
II-4
II-54



T2-161
I-3
II-4
II-55



T2-162
I-3
II-5
II-52



T2-163
I-3
II-5
II-53



T2-164
I-3
II-5
II-54



T2-165
I-3
II-5
II-55



T2-166
I-3
II-6
II-52



T2-167
I-3
II-6
II-53



T2-168
I-3
II-6
II-54



T2-169
I-3
II-6
II-55



T2-170
I-3
II-7
II-52



T2-171
I-3
II-7
II-53



T2-172
I-3
II-7
II-54



T2-173
I-3
II-7
II-55



T2-174
I-3
II-8
II-52



T2-175
I-3
II-8
II-53



T2-176
I-3
II-8
II-54



T2-177
I-3
II-8
II-55



T2-178
I-3
II-9
II-52



T2-179
I-3
II-9
II-53



T2-180
I-3
II-9
II-54



T2-181
I-3
II-9
II-55



T2-182
I-3
II-10
II-52



T2-183
I-3
II-10
II-53



T2-184
I-3
II-10
II-54



T2-185
I-3
II-10
II-55



T2-186
I-3
II-11
II-52



T2-187
I-3
II-11
II-53



T2-188
I-3
II-11
II-54



T2-189
I-3
II-11
II-55



T2-190
I-3
II-12
II-52



T2-191
I-3
II-12
II-53



T2-192
I-3
II-12
II-54



T2-193
I-3
II-12
II-55



T2-194
I-3
II-13
II-52



T2-195
I-3
II-13
II-53



T2-196
I-3
II-13
II-54



T2-197
I-3
II-13
II-55



T2-198
I-3
II-14
II-52



T2-199
I-3
II-14
II-53



T2-200
I-3
II-14
II-54



T2-201
I-3
II-14
II-55



T2-202
I-3
II-15
II-52



T2-203
I-3
II-15
II-53



T2-204
I-3
II-15
II-54



T2-205
I-3
II-15
II-55



T2-206
I-3
II-16
II-52



T2-207
I-3
II-16
II-53



T2-208
I-3
II-16
II-54



T2-209
I-3
II-16
II-55



T2-210
I-3
II-17
II-52



T2-211
I-3
II-17
II-53



T2-212
I-3
II-17
II-54



T2-213
I-3
II-17
II-55



T2-214
I-3
II-18
II-52



T2-215
I-3
II-18
II-53



T2-216
I-3
II-18
II-54



T2-217
I-3
II-18
II-55



T2-218
I-3
II-19
II-52



T2-219
I-3
II-19
II-53



T2-220
I-3
II-19
II-54



T2-221
I-3
II-19
II-55



T2-222
I-3
II-20
II-52



T2-223
I-3
II-20
II-53



T2-224
I-3
II-20
II-54



T2-225
I-3
II-20
II-55



T2-226
I-3
II-21
II-52



T2-227
I-3
II-21
II-53



T2-228
I-3
II-21
II-54



T2-229
I-3
II-21
II-55



T2-230
I-3
II-22
II-52



T2-231
I-3
II-22
II-53



T2-232
I-3
II-22
II-54



T2-233
I-3
II-22
II-55



T2-234
I-3
II-23
II-52



T2-235
I-3
II-23
II-53



T2-236
I-3
II-23
II-54



T2-237
I-3
II-23
II-55



T2-238
I-3
II-24
II-52



T2-239
I-3
II-24
II-53



T2-240
I-3
II-24
II-54



T2-241
I-3
II-24
II-55



T2-242
I-3
II-25
II-52



T2-243
I-3
II-25
II-53



T2-244
I-3
II-25
II-54



T2-245
I-3
II-25
II-55



T2-246
I-3
II-26
II-52



T2-247
I-3
II-26
II-53



T2-248
I-3
II-26
II-54



T2-249
I-3
II-26
II-55



T2-250
I-3
II-27
II-52



T2-251
I-3
II-27
II-53



T2-252
I-3
II-27
II-54



T2-253
I-3
II-27
II-55



T2-254
I-3
II-28
II-52



T2-255
I-3
II-28
II-53



T2-256
I-3
II-28
II-54



T2-257
I-3
II-28
II-55



T2-258
I-3
II-29
II-52



T2-259
I-3
II-29
II-53



T2-260
I-3
II-29
II-54



T2-261
I-3
II-29
II-55



T2-262
I-3
II-46
II-52



T2-263
I-3
II-46
II-53



T2-264
I-3
II-46
II-54



T2-265
I-3
II-46
II-55



T2-266
I-3
II-47
II-52



T2-267
I-3
II-47
II-53



T2-268
I-3
II-47
II-54



T2-269
I-3
II-47
II-55



T2-270
I-3
II-48
II-52



T2-271
I-3
II-48
II-53



T2-272
I-3
II-48
II-54



T2-273
I-3
II-48
II-55



T2-274
I-3
II-49
II-52



T2-275
I-3
II-49
II-53



T2-276
I-3
II-49
II-54



T2-277
I-3
II-49
II-55



T2-278
I-3
II-50
II-52



T2-279
I-3
II-50
II-53



T2-280
I-3
II-50
II-54



T2-281
I-3
II-50
II-55



T2-282
I-3
II-51
II-52



T2-283
I-3
II-51
II-53



T2-284
I-3
II-51
II-54



T2-285
I-3
II-51
II-55



T2-286
I-3
II-52
II-53



T2-287
I-3
II-52
II-54



T2-288
I-3
II-52
II-55



T2-289
I-3
II-53
II-54



T2-290
I-3
II-53
II-55



T2-291
I-3
II-54
II-55



T2-292
I-7
II-1
II-52



T2-293
I-7
II-1
II-53



T2-294
I-7
II-1
II-54



T2-295
I-7
II-1
II-55



T2-296
I-7
II-2
II-52



T2-297
I-7
II-2
II-53



T2-298
I-7
II-2
II-54



T2-299
I-7
II-2
II-55



T2-300
I-7
II-3
II-52



T2-301
I-7
II-3
II-53



T2-302
I-7
II-3
II-54



T2-303
I-7
II-3
II-55



T2-304
I-7
II-4
II-52



T2-305
I-7
II-4
II-53



T2-306
I-7
II-4
II-54



T2-307
I-7
II-4
II-55



T2-308
I-7
II-5
II-52



T2-309
I-7
II-5
II-53



T2-310
I-7
II-5
II-54



T2-311
I-7
II-5
II-55



T2-312
I-7
II-6
II-52



T2-313
I-7
II-6
II-53



T2-314
I-7
II-6
II-54



T2-315
I-7
II-6
II-55



T2-316
I-7
II-7
II-52



T2-317
I-7
II-7
II-53



T2-318
I-7
II-7
II-54



T2-319
I-7
II-7
II-55



T2-320
I-7
II-8
II-52



T2-321
I-7
II-8
II-53



T2-322
I-7
II-8
II-54



T2-323
I-7
II-8
II-55



T2-324
I-7
II-9
II-52



T2-325
I-7
II-9
II-53



T2-326
I-7
II-9
II-54



T2-327
I-7
II-9
II-55



T2-328
I-7
II-10
II-52



T2-329
I-7
II-10
II-53



T2-330
I-7
II-10
II-54



T2-331
I-7
II-10
II-55



T2-332
I-7
II-11
II-52



T2-333
I-7
II-11
II-53



T2-334
I-7
II-11
II-54



T2-335
I-7
II-11
II-55



T2-336
I-7
II-12
II-52



T2-337
I-7
II-12
II-53



T2-338
I-7
II-12
II-54



T2-339
I-7
II-12
II-55



T2-340
I-7
II-13
II-52



T2-341
I-7
II-13
II-53



T2-342
I-7
II-13
II-54



T2-343
I-7
II-13
II-55



T2-344
I-7
II-14
II-52



T2-345
I-7
II-14
II-53



T2-346
I-7
II-14
II-54



T2-347
I-7
II-14
II-55



T2-348
I-7
II-15
II-52



T2-349
I-7
II-15
II-53



T2-350
I-7
II-15
II-54



T2-351
I-7
II-15
II-55



T2-352
I-7
II-16
II-52



T2-353
I-7
II-16
II-53



T2-354
I-7
II-16
II-54



T2-355
I-7
II-16
II-55



T2-356
I-7
II-17
II-52



T2-357
I-7
II-17
II-53



T2-358
I-7
II-17
II-54



T2-359
I-7
II-17
II-55



T2-360
I-7
II-18
II-52



T2-361
I-7
II-18
II-53



T2-362
I-7
II-18
II-54



T2-363
I-7
II-18
II-55



T2-364
I-7
II-19
II-52



T2-365
I-7
II-19
II-53



T2-366
I-7
II-19
II-54



T2-367
I-7
II-19
II-55



T2-368
I-7
II-20
II-52



T2-369
I-7
II-20
II-53



T2-370
I-7
II-20
II-54



T2-371
I-7
II-20
II-55



T2-372
I-7
II-21
II-52



T2-373
I-7
II-21
II-53



T2-374
I-7
II-21
II-54



T2-375
I-7
II-21
II-55



T2-376
I-7
II-22
II-52



T2-377
I-7
II-22
II-53



T2-378
I-7
II-22
II-54



T2-379
I-7
II-22
II-55



T2-380
I-7
II-23
II-52



T2-381
I-7
II-23
II-53



T2-382
I-7
II-23
II-54



T2-383
I-7
II-23
II-55



T2-384
I-7
II-24
II-52



T2-385
I-7
II-24
II-53



T2-386
I-7
II-24
II-54



T2-387
I-7
II-24
II-55



T2-388
I-7
II-25
II-52



T2-389
I-7
II-25
II-53



T2-390
I-7
II-25
II-54



T2-391
I-7
II-25
II-55



T2-392
I-7
II-26
II-52



T2-393
I-7
II-26
II-53



T2-394
I-7
II-26
II-54



T2-395
I-7
II-26
II-55



T2-396
I-7
II-27
II-52



T2-397
I-7
II-27
II-53



T2-398
I-7
II-27
II-54



T2-399
I-7
II-27
II-55



T2-400
I-7
II-28
II-52



T2-401
I-7
II-28
II-53



T2-402
I-7
II-28
II-54



T2-403
I-7
II-28
II-55



T2-404
I-7
II-29
II-52



T2-405
I-7
II-29
II-53



T2-406
I-7
II-29
II-54



T2-407
I-7
II-29
II-55



T2-408
I-7
II-46
II-52



T2-409
I-7
II-46
II-53



T2-410
I-7
II-46
II-54



T2-411
I-7
II-46
II-55



T2-412
I-7
II-47
II-52



T2-413
I-7
II-47
II-53



T2-414
I-7
II-47
II-54



T2-415
I-7
II-47
II-55



T2-416
I-7
II-48
II-52



T2-417
I-7
II-48
II-53



T2-418
I-7
II-48
II-54



T2-419
I-7
II-48
II-55



T2-420
I-7
II-49
II-52



T2-421
I-7
II-49
II-53



T2-422
I-7
II-49
II-54



T2-423
I-7
II-49
II-55



T2-424
I-7
II-50
II-52



T2-425
I-7
II-50
II-53



T2-426
I-7
II-50
II-54



T2-427
I-7
II-50
II-55



T2-428
I-7
II-51
II-52



T2-429
I-7
II-51
II-53



T2-430
I-7
II-51
II-54



T2-431
I-7
II-51
II-55



T2-432
I-7
II-52
II-53



T2-433
I-7
II-52
II-54



T2-434
I-7
II-52
II-55



T2-435
I-7
II-53
II-54



T2-436
I-7
II-53
II-55



T2-437
I-7
II-54
II-55



T2-438
I-8
II-1
II-52



T2-439
I-8
II-1
II-53



T2-440
I-8
II-1
II-54



T2-441
I-8
II-1
II-55



T2-442
I-8
II-2
II-52



T2-443
I-8
II-2
II-53



T2-444
I-8
II-2
II-54



T2-445
I-8
II-2
II-55



T2-446
I-8
II-3
II-52



T2-447
I-8
II-3
II-53



T2-448
I-8
II-3
II-54



T2-449
I-8
II-3
II-55



T2-450
I-8
II-4
II-52



T2-451
I-8
II-4
II-53



T2-452
I-8
II-4
II-54



T2-453
I-8
II-4
II-55



T2-454
I-8
II-5
II-52



T2-455
I-8
II-5
II-53



T2-456
I-8
II-5
II-54



T2-457
I-8
II-5
II-55



T2-458
I-8
II-6
II-52



T2-459
I-8
II-6
II-53



T2-460
I-8
II-6
II-54



T2-461
I-8
II-6
II-55



T2-462
I-8
II-7
II-52



T2-463
I-8
II-7
II-53



T2-464
I-8
II-7
II-54



T2-465
I-8
II-7
II-55



T2-466
I-8
II-8
II-52



T2-467
I-8
II-8
II-53



T2-468
I-8
II-8
II-54



T2-469
I-8
II-8
II-55



T2-470
I-8
II-9
II-52



T2-471
I-8
II-9
II-53



T2-472
I-8
II-9
II-54



T2-473
I-8
II-9
II-55



T2-474
I-8
II-10
II-52



T2-475
I-8
II-10
II-53



T2-476
I-8
II-10
II-54



T2-477
I-8
II-10
II-55



T2-478
I-8
II-11
II-52



T2-479
I-8
II-11
II-53



T2-480
I-8
II-11
II-54



T2-481
I-8
II-11
II-55



T2-482
I-8
II-12
II-52



T2-483
I-8
II-12
II-53



T2-484
I-8
II-12
II-54



T2-485
I-8
II-12
II-55



T2-486
I-8
II-13
II-52



T2-487
I-8
II-13
II-53



T2-488
I-8
II-13
II-54



T2-489
I-8
II-13
II-55



T2-490
I-8
II-14
II-52



T2-491
I-8
II-14
II-53



T2-492
I-8
II-14
II-54



T2-493
I-8
II-14
II-55



T2-494
I-8
II-15
II-52



T2-495
I-8
II-15
II-53



T2-496
I-8
II-15
II-54



T2-497
I-8
II-15
II-55



T2-498
I-8
II-16
II-52



T2-499
I-8
II-16
II-53



T2-500
I-8
II-16
II-54



T2-501
I-8
II-16
II-55



T2-502
I-8
II-17
II-52



T2-503
I-8
II-17
II-53



T2-504
I-8
II-17
II-54



T2-505
I-8
II-17
II-55



T2-506
I-8
II-18
II-52



T2-507
I-8
II-18
II-53



T2-508
I-8
II-18
II-54



T2-509
I-8
II-18
II-55



T2-510
I-8
II-19
II-52



T2-511
I-8
II-19
II-53



T2-512
I-8
II-19
II-54



T2-513
I-8
II-19
II-55



T2-514
I-8
II-20
II-52



T2-515
I-8
II-20
II-53



T2-516
I-8
II-20
II-54



T2-517
I-8
II-20
II-55



T2-518
I-8
II-21
II-52



T2-519
I-8
II-21
II-53



T2-520
I-8
II-21
II-54



T2-521
I-8
II-21
II-55



T2-522
I-8
II-22
II-52



T2-523
I-8
II-22
II-53



T2-524
I-8
II-22
II-54



T2-525
I-8
II-22
II-55



T2-526
I-8
II-23
II-52



T2-527
I-8
II-23
II-53



T2-528
I-8
II-23
II-54



T2-529
I-8
II-23
II-55



T2-530
I-8
II-24
II-52



T2-531
I-8
II-24
II-53



T2-532
I-8
II-24
II-54



T2-533
I-8
II-24
II-55



T2-534
I-8
II-25
II-52



T2-535
I-8
II-25
II-53



T2-536
I-8
II-25
II-54



T2-537
I-8
II-25
II-55



T2-538
I-8
II-26
II-52



T2-539
I-8
II-26
II-53



T2-540
I-8
II-26
II-54



T2-541
I-8
II-26
II-55



T2-542
I-8
II-27
II-52



T2-543
I-8
II-27
II-53



T2-544
I-8
II-27
II-54



T2-545
I-8
II-27
II-55



T2-546
I-8
II-28
II-52



T2-547
I-8
II-28
II-53



T2-548
I-8
II-28
II-54



T2-549
I-8
II-28
II-55



T2-550
I-8
II-29
II-52



T2-551
I-8
II-29
II-53



T2-552
I-8
II-29
II-54



T2-553
I-8
II-29
II-55



T2-554
I-8
II-46
II-52



T2-555
I-8
II-46
II-53



T2-556
I-8
II-46
II-54



T2-557
I-8
II-46
II-55



T2-558
I-8
II-47
II-52



T2-559
I-8
II-47
II-53



T2-560
I-8
II-47
II-54



T2-561
I-8
II-47
II-55



T2-562
I-8
II-48
II-52



T2-563
I-8
II-48
II-53



T2-564
I-8
II-48
II-54



T2-565
I-8
II-48
II-55



T2-566
I-8
II-49
II-52



T2-567
I-8
II-49
II-53



T2-568
I-8
II-49
II-54



T2-569
I-8
II-49
II-55



T2-570
I-8
II-50
II-52



T2-571
I-8
II-50
II-53



T2-572
I-8
II-50
II-54



T2-573
I-8
II-50
II-55



T2-574
I-8
II-51
II-52



T2-575
I-8
II-51
II-53



T2-576
I-8
II-51
II-54



T2-577
I-8
II-51
II-55



T2-578
I-8
II-52
II-53



T2-579
I-8
II-52
II-54



T2-580
I-8
II-52
II-55



T2-581
I-8
II-53
II-54



T2-582
I-8
II-53
II-55



T2-583
I-8
II-54
II-55







“C” denotes “component”,



“M” denotes “mixture”.






According to a further embodiment, preference is given to mixtures comprising a component 1, a component 2 and a component 3, where preference is given in particular to those mixtures in which component 2 is a compound II selected from the group of the following compounds:

    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-28 fluopyram
    • II-29 penflufen
    • II-49 azoxystrobin
    • II-50 trifloxystrobin
    • II-51 penthiopyrad
    • and in which component 3 is a compound II selected from the group of the following compounds:
    • II-30a fipronil
    • II-32a clothianidin
    • II-34a imidacloprid
    • II-35a thiamethoxam


Such mixtures according to the invention are listed explicitly in Table T3. According to a specific embodiment, these are ternary mixtures comprising, as active compounds, in each case only these three components.









TABLE T3







Mixtures T3-1 to T3-144, comprising, as component 1, a preferred


compound I, a component 2 selected from the active compounds preferred


for component 2 and a component 3 selected from the active compounds


preferred for component 3. In the table below, in each case one row of a


mixture according to the invention corresponds to the respective mixture


components 1 to 3 listed in the row in question.












M
C1
C2
C3







T3-1
I-1
II-8
II-30a



T3-2
I-1
II-8
II-32a



T3-3
I-1
II-8
II-34a



T3-4
I-1
II-8
II-35a



T3-5
I-1
II-9
II-30a



T3-6
I-1
II-9
II-32a



T3-7
I-1
II-9
II-34a



T3-8
I-1
II-9
II-35a



T3-9
I-1
II-25
II-30a



T3-10
I-1
II-25
II-32a



T3-11
I-1
II-25
II-34a



T3-12
I-1
II-25
II-35a



T3-13
I-1
II-26
II-30a



T3-14
I-1
II-26
II-32a



T3-15
I-1
II-26
II-34a



T3-16
I-1
II-26
II-35a



T3-17
I-1
II-28
II-30a



T3-18
I-1
II-28
II-32a



T3-19
I-1
II-28
II-34a



T3-20
I-1
II-28
II-35a



T3-21
I-1
II-29
II-30a



T3-22
I-1
II-29
II-32a



T3-23
I-1
II-29
II-34a



T3-24
I-1
II-29
II-35a



T3-25
I-1
II-49
II-30a



T3-26
I-1
II-49
II-32a



T3-27
I-1
II-49
II-34a



T3-28
I-1
II-49
II-35a



T3-29
I-1
II-50
II-30a



T3-30
I-1
II-50
II-32a



T3-31
I-1
II-50
II-34a



T3-32
I-1
II-50
II-35a



T3-33
I-1
II-51
II-30a



T3-34
I-1
II-51
II-32a



T3-35
I-1
II-51
II-34a



T3-36
I-1
II-51
II-35a



T3-37
I-3
II-8
II-30a



T3-38
I-3
II-8
II-32a



T3-39
I-3
II-8
II-34a



T3-40
I-3
II-8
II-35a



T3-41
I-3
II-9
II-30a



T3-42
I-3
II-9
II-32a



T3-43
I-3
II-9
II-34a



T3-44
I-3
II-9
II-35a



T3-45
I-3
II-25
II-30a



T3-46
I-3
II-25
II-32a



T3-47
I-3
II-25
II-34a



T3-48
I-3
II-25
II-35a



T3-49
I-3
II-26
II-30a



T3-50
I-3
II-26
II-32a



T3-51
I-3
II-26
II-34a



T3-52
I-3
II-26
II-35a



T3-53
I-3
II-28
II-30a



T3-54
I-3
II-28
II-32a



T3-55
I-3
II-28
II-34a



T3-56
I-3
II-28
II-35a



T3-57
I-3
II-29
II-30a



T3-58
I-3
II-29
II-32a



T3-59
I-3
II-29
II-34a



T3-60
I-3
II-29
II-35a



T3-61
I-3
II-49
II-30a



T3-62
I-3
II-49
II-32a



T3-63
I-3
II-49
II-34a



T3-64
I-3
II-49
II-35a



T3-65
I-3
II-50
II-30a



T3-66
I-3
II-50
II-32a



T3-67
I-3
II-50
II-34a



T3-68
I-3
II-50
II-35a



T3-69
I-3
II-51
II-30a



T3-70
I-3
II-51
II-32a



T3-71
I-3
II-51
II-34a



T3-72
I-3
II-51
II-35a



T3-73
I-7
II-8
II-30a



T3-74
I-7
II-8
II-32a



T3-75
I-7
II-8
II-34a



T3-76
I-7
II-8
II-35a



T3-77
I-7
II-9
II-30a



T3-78
I-7
II-9
II-32a



T3-79
I-7
II-9
II-34a



T3-80
I-7
II-9
II-35a



T3-81
I-7
II-25
II-30a



T3-82
I-7
II-25
II-32a



T3-83
I-7
II-25
II-34a



T3-84
I-7
II-25
II-35a



T3-85
I-7
II-26
II-30a



T3-86
I-7
II-26
II-32a



T3-87
I-7
II-26
II-34a



T3-88
I-7
II-26
II-35a



T3-89
I-7
II-28
II-30a



T3-90
I-7
II-28
II-32a



T3-91
I-7
II-28
II-34a



T3-92
I-7
II-28
II-35a



T3-93
I-7
II-29
II-30a



T3-94
I-7
II-29
II-32a



T3-95
I-7
II-29
II-34a



T3-96
I-7
II-29
II-35a



T3-97
I-7
II-49
II-30a



T3-98
I-7
II-49
II-32a



T3-99
I-7
II-49
II-34a



T3-100
I-7
II-49
II-35a



T3-101
I-7
II-50
II-30a



T3-102
I-7
II-50
II-32a



T3-103
I-7
II-50
II-34a



T3-104
I-7
II-50
II-35a



T3-105
I-7
II-51
II-30a



T3-106
I-7
II-51
II-32a



T3-107
I-7
II-51
II-34a



T3-108
I-7
II-51
II-35a



T3-109
I-8
II-8
II-30a



T3-110
I-8
II-8
II-32a



T3-111
I-8
II-8
II-34a



T3-112
I-8
II-8
II-35a



T3-113
I-8
II-9
II-30a



T3-114
I-8
II-9
II-32a



T3-115
I-8
II-9
II-34a



T3-116
I-8
II-9
II-35a



T3-117
I-8
II-25
II-30a



T3-118
I-8
II-25
II-32a



T3-119
I-8
II-25
II-34a



T3-120
I-8
II-25
II-35a



T3-121
I-8
II-26
II-30a



T3-122
I-8
II-26
II-32a



T3-123
I-8
II-26
II-34a



T3-124
I-8
II-26
II-35a



T3-125
I-8
II-28
II-30a



T3-126
I-8
II-28
II-32a



T3-127
I-8
II-28
II-34a



T3-128
I-8
II-28
II-35a



T3-129
I-8
II-29
II-30a



T3-130
I-8
II-29
II-32a



T3-131
I-8
II-29
II-34a



T3-132
I-8
II-29
II-35a



T3-133
I-8
II-49
II-30a



T3-134
I-8
II-49
II-32a



T3-135
I-8
II-49
II-34a



T3-136
I-8
II-49
II-35a



T3-137
I-8
II-50
II-30a



T3-138
I-8
II-50
II-32a



T3-139
I-8
II-50
II-34a



T3-140
I-8
II-50
II-35a



T3-141
I-8
II-51
II-30a



T3-142
I-8
II-51
II-32a



T3-143
I-8
II-51
II-34a



T3-144
I-8
II-51
II-35a







“C” denotes “component”,



“M” denotes “mixture”.






According to a further embodiment, preference is given to mixtures comprising a component 1, a component 2 and a component 3, where preference is given in particular to those mixtures in which component 2 is a compound II selected from the group of the following compounds:

    • II-32a clothianidin
    • II-34a imidacloprid
    • II-35a thiamethoxam,


      and component 3 is fipronil (compound II-30a).


Such mixtures according to the invention are listed explicitly in Table T4. According to a specific embodiment, these are ternary mixtures comprising, as active compounds, in each case only these three components.









TABLE T4







Mixtures T4-1 to T4-27 comprising, as component 1, a preferred


compound I and components selected from preferred active


compounds II of group I) and fipronil as third component. In the table


below, in each case one row corresponds to a mixture according to


the invention having the respective mixture components 1 to 3 given


in the row in question.












M
C1
C2
C3







T4-1
I-1
II-32a
II-30a



T4-2
I-1
II-34a
II-30a



T4-3
I-1
II-35a
II-30a



T4-4
I-2
II-32a
II-30a



T4-5
I-2
II-34a
II-30a



T4-6
I-2
II-35a
II-30a



T4-7
I-3
II-32a
II-30a



T4-8
I-3
II-34a
II-30a



T4-9
I-3
II-35a
II-30a



T4-10
I-4
II-32a
II-30a



T4-11
I-4
II-34a
II-30a



T4-12
I-4
II-35a
II-30a



T4-13
I-5
II-32a
II-30a



T4-14
I-5
II-34a
II-30a



T4-15
I-5
II-35a
II-30a



T4-16
I-6
II-32a
II-30a



T4-17
I-6
II-34a
II-30a



T4-18
I-6
II-35a
II-30a



T4-19
I-7
II-32a
II-30a



T4-20
I-7
II-34a
II-30a



T4-21
I-7
II-35a
II-30a



T4-22
I-8
II-32a
II-30a



T4-23
I-8
II-34a
II-30a



T4-24
I-8
II-35a
II-30a



T4-25
I-9
II-32a
II-30a



T4-26
I-9
II-34a
II-30a



T4-27
I-9
II-35a
II-30a







“C” denotes “component”,



“M” denotes “mixture”.






According to a further embodiment, preference is given to ternary mixtures comprising a component 1, a component 2 and a component 3, where preference is given in particular to those mixtures in which component 2 is a compound II selected from the group of the following compounds:

    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-28 fluopyram
    • II-29 penflufen
    • II-49 azoxystrobin
    • II-50 trifloxystrobin
    • II-51 penthiopyrad


      and component 3 is fipronil (compound II-30a).


Such mixtures are listed explicitly in Table T5 below. According to a specific embodiment, these are ternary mixtures comprising, as active compounds, in each case only these three components.









TABLE T5







Mixtures T5-1 to T5-81 comprising, as component 1, a preferred


compound I and components selected from preferred active


compounds II of group I) and fipronil as third component. In the table


below, in each case one row corresponds to a mixture according to


the invention having the respective mixture components 1 to 3 given


in the row in question.












M
C1
C2
C3







T5-1
I-1
II-8
II-30a



T5-2
I-1
II-9
II-30a



T5-3
I-1
II-25
II-30a



T5-4
I-1
II-26
II-30a



T5-5
I-1
II-28
II-30a



T5-6
I-1
II-29
II-30a



T5-7
I-1
II-49
II-30a



T5-8
I-1
II-50
II-30a



T5-9
I-1
II-51
II-30a



T5-10
I-2
II-8
II-30a



T5-11
I-2
II-9
II-30a



T5-12
I-2
II-25
II-30a



T5-13
I-2
II-26
II-30a



T5-14
I-2
II-28
II-30a



T5-15
I-2
II-29
II-30a



T5-16
I-2
II-49
II-30a



T5-17
I-2
II-50
II-30a



T5-18
I-2
II-51
II-30a



T5-19
I-3
II-8
II-30a



T5-20
I-3
II-9
II-30a



T5-21
I-3
II-25
II-30a



T5-22
I-3
II-26
II-30a



T5-23
I-3
II-28
II-30a



T5-24
I-3
II-29
II-30a



T5-25
I-3
II-49
II-30a



T5-26
I-3
II-50
II-30a



T5-27
I-3
II-51
II-30a



T5-28
I-4
II-8
II-30a



T5-29
I-4
II-9
II-30a



T5-30
I-4
II-25
II-30a



T5-31
I-4
II-26
II-30a



T5-32
I-4
II-28
II-30a



T5-33
I-4
II-29
II-30a



T5-34
I-4
II-49
II-30a



T5-35
I-4
II-50
II-30a



T5-36
I-4
II-51
II-30a



T5-37
I-5
II-8
II-30a



T5-38
I-5
II-9
II-30a



T5-39
I-5
II-25
II-30a



T5-40
I-5
II-26
II-30a



T5-41
I-5
II-28
II-30a



T5-42
I-5
II-29
II-30a



T5-43
I-5
II-49
II-30a



T5-44
I-5
II-50
II-30a



T5-45
I-5
II-51
II-30a



T5-46
I-6
II-8
II-30a



T5-47
I-6
II-9
II-30a



T5-48
I-6
II-25
II-30a



T5-49
I-6
II-26
II-30a



T5-50
I-6
II-28
II-30a



T5-51
I-6
II-29
II-30a



T5-52
I-6
II-49
II-30a



T5-53
I-6
II-50
II-30a



T5-54
I-6
II-51
II-30a



T5-55
I-7
II-8
II-30a



T5-56
I-7
II-9
II-30a



T5-57
I-7
II-25
II-30a



T5-58
I-7
II-26
II-30a



T5-59
I-7
II-28
II-30a



T5-60
I-7
II-29
II-30a



T5-61
I-7
II-49
II-30a



T5-62
I-7
II-50
II-30a



T5-63
I-7
II-51
II-30a



T5-64
I-8
II-8
II-30a



T5-65
I-8
II-9
II-30a



T5-66
I-8
II-25
II-30a



T5-67
I-8
II-26
II-30a



T5-68
I-8
II-28
II-30a



T5-69
I-8
II-29
II-30a



T5-70
I-8
II-49
II-30a



T5-71
I-8
II-50
II-30a



T5-72
I-8
II-51
II-30a



T5-73
I-9
II-8
II-30a



T5-74
I-9
II-9
II-30a



T5-75
I-9
II-25
II-30a



T5-76
I-9
II-26
II-30a



T5-77
I-9
II-28
II-30a



T5-78
I-9
II-29
II-30a



T5-79
I-9
II-49
II-30a



T5-80
I-9
II-50
II-30a



T5-81
I-9
II-51
II-30a







“C” denotes “component”,



“M” denotes “mixture”.






According to a further embodiment, the invention relates to mixtures comprising a component 1, a component 2, a component 3 and a component 4.


Particularly preferred components 4 are compounds II selected from the group of the following compounds:

    • II-1 epoxiconazole
    • II-2 metconazole
    • II-3 tebuconazole
    • II-6 triticonazole
    • II-7 prothioconazole
    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-11 dimethomorph
    • II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine
    • II-13 pyrimethanil
    • II-14 metalaxyl
    • II-15 fenpropimorph
    • II-18 mancozeb
    • II-19 metiram
    • II-20 thiophanate methyl
    • II-21 chlorothalonil
    • II-22 metrafenone
    • II-23 bixafen
    • II-24 boscalid
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-27 isopyrazam
    • II-28 fluopyram
    • II-29 penflufen


      with the proviso that the components 2, 3 and 4 are different active compounds.


Particularly preferred quarternary mixtures of the present invention are the mixtures listed in the tables below:









TABLE QI.1







The quarternary mixtures QI.1-1 to QI.1-3404 below, comprising as


component 1 the compound I.1, a component 2 selected from the


active compounds of groups A to I preferred for component 2,


a component 3 selected from the active compounds of groups A


to I preferred for component 3 and a component 4 selected from the


active compounds of groups A to I preferred for component 4.


In the table below, in each case one row corresponds to a


quaternary mixture of the invention having the mixing components


1 to 4 stated in each case in the row in question.










Components of the mixture














Mixture
1
2
3
4







QI.1-1
I-1
II-1
II-3
II-2



QI.1-2
I-1
II-1
II-6
II-2



QI.1-3
I-1
II-1
II-7
II-2



QI.1-4
I-1
II-1
II-8
II-2



QI.1-5
I-1
II-1
II-9
II-2



QI.1-6
I-1
II-1
II-11
II-2



QI.1-7
I-1
II-1
II-12
II-2



QI.1-8
I-1
II-1
II-13
II-2



QI.1-9
I-1
II-1
II-14
II-2



QI.1-10
I-1
II-1
II-15
II-2



QI.1-11
I-1
II-1
II-18
II-2



QI.1-12
I-1
II-1
II-19
II-2



QI.1-13
I-1
II-1
II-20
II-2



QI.1-14
I-1
II-1
II-21
II-2



QI.1-15
I-1
II-1
II-22
II-2



QI.1-16
I-1
II-1
II-23
II-2



QI.1-17
I-1
II-1
II-24
II-2



QI.1-18
I-1
II-1
II-25
II-2



QI.1-19
I-1
II-1
II-26
II-2



QI.1-20
I-1
II-1
II-27
II-2



QI.1-21
I-1
II-1
II-28
II-2



QI.1-22
I-1
II-1
II-29
II-2



QI.1-23
I-1
II-1
II-6
II-3



QI.1-24
I-1
II-1
II-7
II-3



QI.1-25
I-1
II-1
II-8
II-3



QI.1-26
I-1
II-1
II-9
II-3



QI.1-27
I-1
II-1
II-11
II-3



QI.1-28
I-1
II-1
II-12
II-3



QI.1-29
I-1
II-1
II-13
II-3



QI.1-30
I-1
II-1
II-14
II-3



QI.1-31
I-1
II-1
II-15
II-3



QI.1-32
I-1
II-1
II-18
II-3



QI.1-33
I-1
II-1
II-19
II-3



QI.1-34
I-1
II-1
II-20
II-3



QI.1-35
I-1
II-1
II-21
II-3



QI.1-36
I-1
II-1
II-22
II-3



QI.1-37
I-1
II-1
II-23
II-3



QI.1-38
I-1
II-1
II-24
II-3



QI.1-39
I-1
II-1
II-25
II-3



QI.1-40
I-1
II-1
II-26
II-3



QI.1-41
I-1
II-1
II-27
II-3



QI.1-42
I-1
II-1
II-28
II-3



QI.1-43
I-1
II-1
II-29
II-3



QI.1-44
I-1
II-1
II-7
II-6



QI.1-45
I-1
II-1
II-8
II-6



QI.1-46
I-1
II-1
II-9
II-6



QI.1-47
I-1
II-1
II-11
II-6



QI.1-48
I-1
II-1
II-12
II-6



QI.1-49
I-1
II-1
II-13
II-6



QI.1-50
I-1
II-1
II-14
II-6



QI.1-51
I-1
II-1
II-15
II-6



QI.1-52
I-1
II-1
II-18
II-6



QI.1-53
I-1
II-1
II-19
II-6



QI.1-54
I-1
II-1
II-20
II-6



QI.1-55
I-1
II-1
II-21
II-6



QI.1-56
I-1
II-1
II-22
II-6



QI.1-57
I-1
II-1
II-23
II-6



QI.1-58
I-1
II-1
II-24
II-6



QI.1-59
I-1
II-1
II-25
II-6



QI.1-60
I-1
II-1
II-26
II-6



QI.1-61
I-1
II-1
II-27
II-6



QI.1-62
I-1
II-1
II-28
II-6



QI.1-63
I-1
II-1
II-29
II-6



QI.1-64
I-1
II-1
II-8
II-7



QI.1-65
I-1
II-1
II-9
II-7



QI.1-66
I-1
II-1
II-11
II-7



QI.1-67
I-1
II-1
II-12
II-7



QI.1-68
I-1
II-1
II-13
II-7



QI.1-69
I-1
II-1
II-14
II-7



QI.1-70
I-1
II-1
II-15
II-7



QI.1-71
I-1
II-1
II-18
II-7



QI.1-72
I-1
II-1
II-19
II-7



QI.1-73
I-1
II-1
II-20
II-7



QI.1-74
I-1
II-1
II-21
II-7



QI.1-75
I-1
II-1
II-22
II-7



QI.1-76
I-1
II-1
II-23
II-7



QI.1-77
I-1
II-1
II-24
II-7



QI.1-78
I-1
II-1
II-25
II-7



QI.1-79
I-1
II-1
II-26
II-7



QI.1-80
I-1
II-1
II-27
II-7



QI.1-81
I-1
II-1
II-28
II-7



QI.1-82
I-1
II-1
II-29
II-7



QI.1-83
I-1
II-1
II-9
II-8



QI.1-84
I-1
II-1
II-11
II-8



QI.1-85
I-1
II-1
II-12
II-8



QI.1-86
I-1
II-1
II-13
II-8



QI.1-87
I-1
II-1
II-14
II-8



QI.1-88
I-1
II-1
II-15
II-8



QI.1-89
I-1
II-1
II-18
II-8



QI.1-90
I-1
II-1
II-19
II-8



QI.1-91
I-1
II-1
II-20
II-8



QI.1-92
I-1
II-1
II-21
II-8



QI.1-93
I-1
II-1
II-22
II-8



QI.1-94
I-1
II-1
II-23
II-8



QI.1-95
I-1
II-1
II-24
II-8



QI.1-96
I-1
II-1
II-25
II-8



QI.1-97
I-1
II-1
II-26
II-8



QI.1-98
I-1
II-1
II-27
II-8



QI.1-99
I-1
II-1
II-28
II-8



QI.1-100
I-1
II-1
II-29
II-8



QI.1-101
I-1
II-1
II-11
II-9



QI.1-102
I-1
II-1
II-12
II-9



QI.1-103
I-1
II-1
II-13
II-9



QI.1-104
I-1
II-1
II-14
II-9



QI.1-105
I-1
II-1
II-15
II-9



QI.1-106
I-1
II-1
II-18
II-9



QI.1-107
I-1
II-1
II-19
II-9



QI.1-108
I-1
II-1
II-20
II-9



QI.1-109
I-1
II-1
II-21
II-9



QI.1-110
I-1
II-1
II-22
II-9



QI.1-111
I-1
II-1
II-23
II-9



QI.1-112
I-1
II-1
II-24
II-9



QI.1-113
I-1
II-1
II-25
II-9



QI.1-114
I-1
II-1
II-26
II-9



QI.1-115
I-1
II-1
II-27
II-9



QI.1-116
I-1
II-1
II-28
II-9



QI.1-117
I-1
II-1
II-29
II-9



QI.1-118
I-1
II-1
II-12
II-11



QI.1-119
I-1
II-1
II-13
II-11



QI.1-120
I-1
II-1
II-14
II-11



QI.1-121
I-1
II-1
II-15
II-11



QI.1-122
I-1
II-1
II-18
II-11



QI.1-123
I-1
II-1
II-19
II-11



QI.1-124
I-1
II-1
II-20
II-11



QI.1-125
I-1
II-1
II-21
II-11



QI.1-126
I-1
II-1
II-22
II-11



QI.1-127
I-1
II-1
II-23
II-11



QI.1-128
I-1
II-1
II-24
II-11



QI.1-129
I-1
II-1
II-25
II-11



QI.1-130
I-1
II-1
II-26
II-11



QI.1-131
I-1
II-1
II-27
II-11



QI.1-132
I-1
II-1
II-28
II-11



QI.1-133
I-1
II-1
II-29
II-11



QI.1-134
I-1
II-1
II-13
II-12



QI.1-135
I-1
II-1
II-14
II-12



QI.1-136
I-1
II-1
II-15
II-12



QI.1-137
I-1
II-1
II-18
II-12



QI.1-138
I-1
II-1
II-19
II-12



QI.1-139
I-1
II-1
II-20
II-12



QI.1-140
I-1
II-1
II-21
II-12



QI.1-141
I-1
II-1
II-22
II-12



QI.1-142
I-1
II-1
II-23
II-12



QI.1-143
I-1
II-1
II-24
II-12



QI.1-144
I-1
II-1
II-25
II-12



QI.1-145
I-1
II-1
II-26
II-12



QI.1-146
I-1
II-1
II-27
II-12



QI.1-147
I-1
II-1
II-28
II-12



QI.1-148
I-1
II-1
II-29
II-12



QI.1-149
I-1
II-1
II-14
II-13



QI.1-150
I-1
II-1
II-15
II-13



QI.1-151
I-1
II-1
II-18
II-13



QI.1-152
I-1
II-1
II-19
II-13



QI.1-153
I-1
II-1
II-20
II-13



QI.1-154
I-1
II-1
II-21
II-13



QI.1-155
I-1
II-1
II-22
II-13



QI.1-156
I-1
II-1
II-23
II-13



QI.1-157
I-1
II-1
II-24
II-13



QI.1-158
I-1
II-1
II-25
II-13



QI.1-159
I-1
II-1
II-26
II-13



QI.1-160
I-1
II-1
II-27
II-13



QI.1-161
I-1
II-1
II-28
II-13



QI.1-162
I-1
II-1
II-29
II-13



QI.1-163
I-1
II-1
II-15
II-14



QI.1-164
I-1
II-1
II-18
II-14



QI.1-165
I-1
II-1
II-19
II-14



QI.1-166
I-1
II-1
II-20
II-14



QI.1-167
I-1
II-1
II-21
II-14



QI.1-168
I-1
II-1
II-22
II-14



QI.1-169
I-1
II-1
II-23
II-14



QI.1-170
I-1
II-1
II-24
II-14



QI.1-171
I-1
II-1
II-25
II-14



QI.1-172
I-1
II-1
II-26
II-14



QI.1-173
I-1
II-1
II-27
II-14



QI.1-174
I-1
II-1
II-28
II-14



QI.1-175
I-1
II-1
II-29
II-14



QI.1-176
I-1
II-1
II-18
II-15



QI.1-177
I-1
II-1
II-19
II-15



QI.1-178
I-1
II-1
II-20
II-15



QI.1-179
I-1
II-1
II-21
II-15



QI.1-180
I-1
II-1
II-22
II-15



QI.1-181
I-1
II-1
II-23
II-15



QI.1-182
I-1
II-1
II-24
II-15



QI.1-183
I-1
II-1
II-25
II-15



QI.1-184
I-1
II-1
II-26
II-15



QI.1-185
I-1
II-1
II-27
II-15



QI.1-186
I-1
II-1
II-28
II-15



QI.1-187
I-1
II-1
II-29
II-15



QI.1-188
I-1
II-1
II-19
II-18



QI.1-189
I-1
II-1
II-20
II-18



QI.1-190
I-1
II-1
II-21
II-18



QI.1-191
I-1
II-1
II-22
II-18



QI.1-192
I-1
II-1
II-23
II-18



QI.1-193
I-1
II-1
II-24
II-18



QI.1-194
I-1
II-1
II-25
II-18



QI.1-195
I-1
II-1
II-26
II-18



QI.1-196
I-1
II-1
II-27
II-18



QI.1-197
I-1
II-1
II-28
II-18



QI.1-198
I-1
II-1
II-29
II-18



QI.1-199
I-1
II-1
II-20
II-19



QI.1-200
I-1
II-1
II-21
II-19



QI.1-201
I-1
II-1
II-22
II-19



QI.1-202
I-1
II-1
II-23
II-19



QI.1-203
I-1
II-1
II-24
II-19



QI.1-204
I-1
II-1
II-25
II-19



QI.1-205
I-1
II-1
II-26
II-19



QI.1-206
I-1
II-1
II-27
II-19



QI.1-207
I-1
II-1
II-28
II-19



QI.1-208
I-1
II-1
II-29
II-19



QI.1-209
I-1
II-1
II-21
II-20



QI.1-210
I-1
II-1
II-22
II-20



QI.1-211
I-1
II-1
II-23
II-20



QI.1-212
I-1
II-1
II-24
II-20



QI.1-213
I-1
II-1
II-25
II-20



QI.1-214
I-1
II-1
II-26
II-20



QI.1-215
I-1
II-1
II-27
II-20



QI.1-216
I-1
II-1
II-28
II-20



QI.1-217
I-1
II-1
II-29
II-20



QI.1-218
I-1
II-1
II-22
II-21



QI.1-219
I-1
II-1
II-23
II-21



QI.1-220
I-1
II-1
II-24
II-21



QI.1-221
I-1
II-1
II-25
II-21



QI.1-222
I-1
II-1
II-26
II-21



QI.1-223
I-1
II-1
II-27
II-21



QI.1-224
I-1
II-1
II-28
II-21



QI.1-225
I-1
II-1
II-29
II-21



QI.1-226
I-1
II-1
II-23
II-22



QI.1-227
I-1
II-1
II-24
II-22



QI.1-228
I-1
II-1
II-25
II-22



QI.1-229
I-1
II-1
II-26
II-22



QI.1-230
I-1
II-1
II-27
II-22



QI.1-231
I-1
II-1
II-28
II-22



QI.1-232
I-1
II-1
II-29
II-22



QI.1-233
I-1
II-1
II-24
II-23



QI.1-234
I-1
II-1
II-25
II-23



QI.1-235
I-1
II-1
II-26
II-23



QI.1-236
I-1
II-1
II-27
II-23



QI.1-237
I-1
II-1
II-28
II-23



QI.1-238
I-1
II-1
II-29
II-23



QI.1-239
I-1
II-1
II-25
II-24



QI.1-240
I-1
II-1
II-26
II-24



QI.1-241
I-1
II-1
II-27
II-24



QI.1-242
I-1
II-1
II-28
II-24



QI.1-243
I-1
II-1
II-29
II-24



QI.1-244
I-1
II-1
II-26
II-25



QI.1-245
I-1
II-1
II-27
II-25



QI.1-246
I-1
II-1
II-28
II-25



QI.1-247
I-1
II-1
II-29
II-25



QI.1-248
I-1
II-1
II-27
II-26



QI.1-249
I-1
II-1
II-28
II-26



QI.1-250
I-1
II-1
II-29
II-26



QI.1-251
I-1
II-1
II-28
II-27



QI.1-252
I-1
II-1
II-29
II-27



QI.1-253
I-1
II-1
II-29
II-28



QI.1-254
I-1
II-2
II-6
II-3



QI.1-255
I-1
II-2
II-7
II-3



QI.1-256
I-1
II-2
II-8
II-3



QI.1-257
I-1
II-2
II-9
II-3



QI.1-258
I-1
II-2
II-11
II-3



QI.1-259
I-1
II-2
II-12
II-3



QI.1-260
I-1
II-2
II-13
II-3



QI.1-261
I-1
II-2
II-14
II-3



QI.1-262
I-1
II-2
II-15
II-3



QI.1-263
I-1
II-2
II-18
II-3



QI.1-264
I-1
II-2
II-19
II-3



QI.1-265
I-1
II-2
II-20
II-3



QI.1-266
I-1
II-2
II-21
II-3



QI.1-267
I-1
II-2
II-22
II-3



QI.1-268
I-1
II-2
II-23
II-3



QI.1-269
I-1
II-2
II-24
II-3



QI.1-270
I-1
II-2
II-25
II-3



QI.1-271
I-1
II-2
II-26
II-3



QI.1-272
I-1
II-2
II-27
II-3



QI.1-273
I-1
II-2
II-28
II-3



QI.1-274
I-1
II-2
II-29
II-3



QI.1-275
I-1
II-2
II-7
II-6



QI.1-276
I-1
II-2
II-8
II-6



QI.1-277
I-1
II-2
II-9
II-6



QI.1-278
I-1
II-2
II-11
II-6



QI.1-279
I-1
II-2
II-12
II-6



QI.1-280
I-1
II-2
II-13
II-6



QI.1-281
I-1
II-2
II-14
II-6



QI.1-282
I-1
II-2
II-15
II-6



QI.1-283
I-1
II-2
II-18
II-6



QI.1-284
I-1
II-2
II-19
II-6



QI.1-285
I-1
II-2
II-20
II-6



QI.1-286
I-1
II-2
II-21
II-6



QI.1-287
I-1
II-2
II-22
II-6



QI.1-288
I-1
II-2
II-23
II-6



QI.1-289
I-1
II-2
II-24
II-6



QI.1-290
I-1
II-2
II-25
II-6



QI.1-291
I-1
II-2
II-26
II-6



QI.1-292
I-1
II-2
II-27
II-6



QI.1-293
I-1
II-2
II-28
II-6



QI.1-294
I-1
II-2
II-29
II-6



QI.1-295
I-1
II-2
II-8
II-7



QI.1-296
I-1
II-2
II-9
II-7



QI.1-297
I-1
II-2
II-11
II-7



QI.1-298
I-1
II-2
II-12
II-7



QI.1-299
I-1
II-2
II-13
II-7



QI.1-300
I-1
II-2
II-14
II-7



QI.1-301
I-1
II-2
II-15
II-7



QI.1-302
I-1
II-2
II-18
II-7



QI.1-303
I-1
II-2
II-19
II-7



QI.1-304
I-1
II-2
II-20
II-7



QI.1-305
I-1
II-2
II-21
II-7



QI.1-306
I-1
II-2
II-22
II-7



QI.1-307
I-1
II-2
II-23
II-7



QI.1-308
I-1
II-2
II-24
II-7



QI.1-309
I-1
II-2
II-25
II-7



QI.1-310
I-1
II-2
II-26
II-7



QI.1-311
I-1
II-2
II-27
II-7



QI.1-312
I-1
II-2
II-28
II-7



QI.1-313
I-1
II-2
II-29
II-7



QI.1-314
I-1
II-2
II-9
II-8



QI.1-315
I-1
II-2
II-11
II-8



QI.1-316
I-1
II-2
II-12
II-8



QI.1-317
I-1
II-2
II-13
II-8



QI.1-318
I-1
II-2
II-14
II-8



QI.1-319
I-1
II-2
II-15
II-8



QI.1-320
I-1
II-2
II-18
II-8



QI.1-321
I-1
II-2
II-19
II-8



QI.1-322
I-1
II-2
II-20
II-8



QI.1-323
I-1
II-2
II-21
II-8



QI.1-324
I-1
II-2
II-22
II-8



QI.1-325
I-1
II-2
II-23
II-8



QI.1-326
I-1
II-2
II-24
II-8



QI.1-327
I-1
II-2
II-25
II-8



QI.1-328
I-1
II-2
II-26
II-8



QI.1-329
I-1
II-2
II-27
II-8



QI.1-330
I-1
II-2
II-28
II-8



QI.1-331
I-1
II-2
II-29
II-8



QI.1-332
I-1
II-2
II-11
II-9



QI.1-333
I-1
II-2
II-12
II-9



QI.1-334
I-1
II-2
II-13
II-9



QI.1-335
I-1
II-2
II-14
II-9



QI.1-336
I-1
II-2
II-15
II-9



QI.1-337
I-1
II-2
II-18
II-9



QI.1-338
I-1
II-2
II-19
II-9



QI.1-339
I-1
II-2
II-20
II-9



QI.1-340
I-1
II-2
II-21
II-9



QI.1-341
I-1
II-2
II-22
II-9



QI.1-342
I-1
II-2
II-23
II-9



QI.1-343
I-1
II-2
II-24
II-9



QI.1-344
I-1
II-2
II-25
II-9



QI.1-345
I-1
II-2
II-26
II-9



QI.1-346
I-1
II-2
II-27
II-9



QI.1-347
I-1
II-2
II-28
II-9



QI.1-348
I-1
II-2
II-29
II-9



QI.1-349
I-1
II-2
II-12
II-11



QI.1-350
I-1
II-2
II-13
II-11



QI.1-351
I-1
II-2
II-14
II-11



QI.1-352
I-1
II-2
II-15
II-11



QI.1-353
I-1
II-2
II-18
II-11



QI.1-354
I-1
II-2
II-19
II-11



QI.1-355
I-1
II-2
II-20
II-11



QI.1-356
I-1
II-2
II-21
II-11



QI.1-357
I-1
II-2
II-22
II-11



QI.1-358
I-1
II-2
II-23
II-11



QI.1-359
I-1
II-2
II-24
II-11



QI.1-360
I-1
II-2
II-25
II-11



QI.1-361
I-1
II-2
II-26
II-11



QI.1-362
I-1
II-2
II-27
II-11



QI.1-363
I-1
II-2
II-28
II-11



QI.1-364
I-1
II-2
II-29
II-11



QI.1-365
I-1
II-2
II-13
II-12



QI.1-366
I-1
II-2
II-14
II-12



QI.1-367
I-1
II-2
II-15
II-12



QI.1-368
I-1
II-2
II-18
II-12



QI.1-369
I-1
II-2
II-19
II-12



QI.1-370
I-1
II-2
II-20
II-12



QI.1-371
I-1
II-2
II-21
II-12



QI.1-372
I-1
II-2
II-22
II-12



QI.1-373
I-1
II-2
II-23
II-12



QI.1-374
I-1
II-2
II-24
II-12



QI.1-375
I-1
II-2
II-25
II-12



QI.1-376
I-1
II-2
II-26
II-12



QI.1-377
I-1
II-2
II-27
II-12



QI.1-378
I-1
II-2
II-28
II-12



QI.1-379
I-1
II-2
II-29
II-12



QI.1-380
I-1
II-2
II-14
II-13



QI.1-381
I-1
II-2
II-15
II-13



QI.1-382
I-1
II-2
II-18
II-13



QI.1-383
I-1
II-2
II-19
II-13



QI.1-384
I-1
II-2
II-20
II-13



QI.1-385
I-1
II-2
II-21
II-13



QI.1-386
I-1
II-2
II-22
II-13



QI.1-387
I-1
II-2
II-23
II-13



QI.1-388
I-1
II-2
II-24
II-13



QI.1-389
I-1
II-2
II-25
II-13



QI.1-390
I-1
II-2
II-26
II-13



QI.1-391
I-1
II-2
II-27
II-13



QI.1-392
I-1
II-2
II-28
II-13



QI.1-393
I-1
II-2
II-29
II-13



QI.1-394
I-1
II-2
II-15
II-14



QI.1-395
I-1
II-2
II-18
II-14



QI.1-396
I-1
II-2
II-19
II-14



QI.1-397
I-1
II-2
II-20
II-14



QI.1-398
I-1
II-2
II-21
II-14



QI.1-399
I-1
II-2
II-22
II-14



QI.1-400
I-1
II-2
II-23
II-14



QI.1-401
I-1
II-2
II-24
II-14



QI.1-402
I-1
II-2
II-25
II-14



QI.1-403
I-1
II-2
II-26
II-14



QI.1-404
I-1
II-2
II-27
II-14



QI.1-405
I-1
II-2
II-28
II-14



QI.1-406
I-1
II-2
II-29
II-14



QI.1-407
I-1
II-2
II-18
II-15



QI.1-408
I-1
II-2
II-19
II-15



QI.1-409
I-1
II-2
II-20
II-15



QI.1-410
I-1
II-2
II-21
II-15



QI.1-411
I-1
II-2
II-22
II-15



QI.1-412
I-1
II-2
II-23
II-15



QI.1-413
I-1
II-2
II-24
II-15



QI.1-414
I-1
II-2
II-25
II-15



QI.1-415
I-1
II-2
II-26
II-15



QI.1-416
I-1
II-2
II-27
II-15



QI.1-417
I-1
II-2
II-28
II-15



QI.1-418
I-1
II-2
II-29
II-15



QI.1-419
I-1
II-2
II-19
II-18



QI.1-420
I-1
II-2
II-20
II-18



QI.1-421
I-1
II-2
II-21
II-18



QI.1-422
I-1
II-2
II-22
II-18



QI.1-423
I-1
II-2
II-23
II-18



QI.1-424
I-1
II-2
II-24
II-18



QI.1-425
I-1
II-2
II-25
II-18



QI.1-426
I-1
II-2
II-26
II-18



QI.1-427
I-1
II-2
II-27
II-18



QI.1-428
I-1
II-2
II-28
II-18



QI.1-429
I-1
II-2
II-29
II-18



QI.1-430
I-1
II-2
II-20
II-19



QI.1-431
I-1
II-2
II-21
II-19



QI.1-432
I-1
II-2
II-22
II-19



QI.1-433
I-1
II-2
II-23
II-19



QI.1-434
I-1
II-2
II-24
II-19



QI.1-435
I-1
II-2
II-25
II-19



QI.1-436
I-1
II-2
II-26
II-19



QI.1-437
I-1
II-2
II-27
II-19



QI.1-438
I-1
II-2
II-28
II-19



QI.1-439
I-1
II-2
II-29
II-19



QI.1-440
I-1
II-2
II-21
II-20



QI.1-441
I-1
II-2
II-22
II-20



QI.1-442
I-1
II-2
II-23
II-20



QI.1-443
I-1
II-2
II-24
II-20



QI.1-444
I-1
II-2
II-25
II-20



QI.1-445
I-1
II-2
II-26
II-20



QI.1-446
I-1
II-2
II-27
II-20



QI.1-447
I-1
II-2
II-28
II-20



QI.1-448
I-1
II-2
II-29
II-20



QI.1-449
I-1
II-2
II-22
II-21



QI.1-450
I-1
II-2
II-23
II-21



QI.1-451
I-1
II-2
II-24
II-21



QI.1-452
I-1
II-2
II-25
II-21



QI.1-453
I-1
II-2
II-26
II-21



QI.1-454
I-1
II-2
II-27
II-21



QI.1-455
I-1
II-2
II-28
II-21



QI.1-456
I-1
II-2
II-29
II-21



QI.1-457
I-1
II-2
II-23
II-22



QI.1-458
I-1
II-2
II-24
II-22



QI.1-459
I-1
II-2
II-25
II-22



QI.1-460
I-1
II-2
II-26
II-22



QI.1-461
I-1
II-2
II-27
II-22



QI.1-462
I-1
II-2
II-28
II-22



QI.1-463
I-1
II-2
II-29
II-22



QI.1-464
I-1
II-2
II-24
II-23



QI.1-465
I-1
II-2
II-25
II-23



QI.1-466
I-1
II-2
II-26
II-23



QI.1-467
I-1
II-2
II-27
II-23



QI.1-468
I-1
II-2
II-28
II-23



QI.1-469
I-1
II-2
II-29
II-23



QI.1-470
I-1
II-2
II-25
II-24



QI.1-471
I-1
II-2
II-26
II-24



QI.1-472
I-1
II-2
II-27
II-24



QI.1-473
I-1
II-2
II-28
II-24



QI.1-474
I-1
II-2
II-29
II-24



QI.1-475
I-1
II-2
II-26
II-25



QI.1-476
I-1
II-2
II-27
II-25



QI.1-477
I-1
II-2
II-28
II-25



QI.1-478
I-1
II-2
II-29
II-25



QI.1-479
I-1
II-2
II-27
II-26



QI.1-480
I-1
II-2
II-28
II-26



QI.1-481
I-1
II-2
II-29
II-26



QI.1-482
I-1
II-2
II-28
II-27



QI.1-483
I-1
II-2
II-29
II-27



QI.1-484
I-1
II-2
II-29
II-28



QI.1-485
I-1
II-3
II-7
II-6



QI.1-486
I-1
II-3
II-8
II-6



QI.1-487
I-1
II-3
II-9
II-6



QI.1-488
I-1
II-3
II-11
II-6



QI.1-489
I-1
II-3
II-12
II-6



QI.1-490
I-1
II-3
II-13
II-6



QI.1-491
I-1
II-3
II-14
II-6



QI.1-492
I-1
II-3
II-15
II-6



QI.1-493
I-1
II-3
II-18
II-6



QI.1-494
I-1
II-3
II-19
II-6



QI.1-495
I-1
II-3
II-20
II-6



QI.1-496
I-1
II-3
II-21
II-6



QI.1-497
I-1
II-3
II-22
II-6



QI.1-498
I-1
II-3
II-23
II-6



QI.1-499
I-1
II-3
II-24
II-6



QI.1-500
I-1
II-3
II-25
II-6



QI.1-501
I-1
II-3
II-26
II-6



QI.1-502
I-1
II-3
II-27
II-6



QI.1-503
I-1
II-3
II-28
II-6



QI.1-504
I-1
II-3
II-29
II-6



QI.1-505
I-1
II-3
II-8
II-7



QI.1-506
I-1
II-3
II-9
II-7



QI.1-507
I-1
II-3
II-11
II-7



QI.1-508
I-1
II-3
II-12
II-7



QI.1-509
I-1
II-3
II-13
II-7



QI.1-510
I-1
II-3
II-14
II-7



QI.1-511
I-1
II-3
II-15
II-7



QI.1-512
I-1
II-3
II-18
II-7



QI.1-513
I-1
II-3
II-19
II-7



QI.1-514
I-1
II-3
II-20
II-7



QI.1-515
I-1
II-3
II-21
II-7



QI.1-516
I-1
II-3
II-22
II-7



QI.1-517
I-1
II-3
II-23
II-7



QI.1-518
I-1
II-3
II-24
II-7



QI.1-519
I-1
II-3
II-25
II-7



QI.1-520
I-1
II-3
II-26
II-7



QI.1-521
I-1
II-3
II-27
II-7



QI.1-522
I-1
II-3
II-28
II-7



QI.1-523
I-1
II-3
II-29
II-7



QI.1-524
I-1
II-3
II-9
II-8



QI.1-525
I-1
II-3
II-11
II-8



QI.1-526
I-1
II-3
II-12
II-8



QI.1-527
I-1
II-3
II-13
II-8



QI.1-528
I-1
II-3
II-14
II-8



QI.1-529
I-1
II-3
II-15
II-8



QI.1-530
I-1
II-3
II-18
II-8



QI.1-531
I-1
II-3
II-19
II-8



QI.1-532
I-1
II-3
II-20
II-8



QI.1-533
I-1
II-3
II-21
II-8



QI.1-534
I-1
II-3
II-22
II-8



QI.1-535
I-1
II-3
II-23
II-8



QI.1-536
I-1
II-3
II-24
II-8



QI.1-537
I-1
II-3
II-25
II-8



QI.1-538
I-1
II-3
II-26
II-8



QI.1-539
I-1
II-3
II-27
II-8



QI.1-540
I-1
II-3
II-28
II-8



QI.1-541
I-1
II-3
II-29
II-8



QI.1-542
I-1
II-3
II-11
II-9



QI.1-543
I-1
II-3
II-12
II-9



QI.1-544
I-1
II-3
II-13
II-9



QI.1-545
I-1
II-3
II-14
II-9



QI.1-546
I-1
II-3
II-15
II-9



QI.1-547
I-1
II-3
II-18
II-9



QI.1-548
I-1
II-3
II-19
II-9



QI.1-549
I-1
II-3
II-20
II-9



QI.1-550
I-1
II-3
II-21
II-9



QI.1-551
I-1
II-3
II-22
II-9



QI.1-552
I-1
II-3
II-23
II-9



QI.1-553
I-1
II-3
II-24
II-9



QI.1-554
I-1
II-3
II-25
II-9



QI.1-555
I-1
II-3
II-26
II-9



QI.1-556
I-1
II-3
II-27
II-9



QI.1-557
I-1
II-3
II-28
II-9



QI.1-558
I-1
II-3
II-29
II-9



QI.1-559
I-1
II-3
II-12
II-11



QI.1-560
I-1
II-3
II-13
II-11



QI.1-561
I-1
II-3
II-14
II-11



QI.1-562
I-1
II-3
II-15
II-11



QI.1-563
I-1
II-3
II-18
II-11



QI.1-564
I-1
II-3
II-19
II-11



QI.1-565
I-1
II-3
II-20
II-11



QI.1-566
I-1
II-3
II-21
II-11



QI.1-567
I-1
II-3
II-22
II-11



QI.1-568
I-1
II-3
II-23
II-11



QI.1-569
I-1
II-3
II-24
II-11



QI.1-570
I-1
II-3
II-25
II-11



QI.1-571
I-1
II-3
II-26
II-11



QI.1-572
I-1
II-3
II-27
II-11



QI.1-573
I-1
II-3
II-28
II-11



QI.1-574
I-1
II-3
II-29
II-11



QI.1-575
I-1
II-3
II-13
II-12



QI.1-576
I-1
II-3
II-14
II-12



QI.1-577
I-1
II-3
II-15
II-12



QI.1-578
I-1
II-3
II-18
II-12



QI.1-579
I-1
II-3
II-19
II-12



QI.1-580
I-1
II-3
II-20
II-12



QI.1-581
I-1
II-3
II-21
II-12



QI.1-582
I-1
II-3
II-22
II-12



QI.1-583
I-1
II-3
II-23
II-12



QI.1-584
I-1
II-3
II-24
II-12



QI.1-585
I-1
II-3
II-25
II-12



QI.1-586
I-1
II-3
II-26
II-12



QI.1-587
I-1
II-3
II-27
II-12



QI.1-588
I-1
II-3
II-28
II-12



QI.1-589
I-1
II-3
II-29
II-12



QI.1-590
I-1
II-3
II-14
II-13



QI.1-591
I-1
II-3
II-15
II-13



QI.1-592
I-1
II-3
II-18
II-13



QI.1-593
I-1
II-3
II-19
II-13



QI.1-594
I-1
II-3
II-20
II-13



QI.1-595
I-1
II-3
II-21
II-13



QI.1-596
I-1
II-3
II-22
II-13



QI.1-597
I-1
II-3
II-23
II-13



QI.1-598
I-1
II-3
II-24
II-13



QI.1-599
I-1
II-3
II-25
II-13



QI.1-600
I-1
II-3
II-26
II-13



QI.1-601
I-1
II-3
II-27
II-13



QI.1-602
I-1
II-3
II-28
II-13



QI.1-603
I-1
II-3
II-29
II-13



QI.1-604
I-1
II-3
II-15
II-14



QI.1-605
I-1
II-3
II-18
II-14



QI.1-606
I-1
II-3
II-19
II-14



QI.1-607
I-1
II-3
II-20
II-14



QI.1-608
I-1
II-3
II-21
II-14



QI.1-609
I-1
II-3
II-22
II-14



QI.1-610
I-1
II-3
II-23
II-14



QI.1-611
I-1
II-3
II-24
II-14



QI.1-612
I-1
II-3
II-25
II-14



QI.1-613
I-1
II-3
II-26
II-14



QI.1-614
I-1
II-3
II-27
II-14



QI.1-615
I-1
II-3
II-28
II-14



QI.1-616
I-1
II-3
II-29
II-14



QI.1-617
I-1
II-3
II-18
II-15



QI.1-618
I-1
II-3
II-19
II-15



QI.1-619
I-1
II-3
II-20
II-15



QI.1-620
I-1
II-3
II-21
II-15



QI.1-621
I-1
II-3
II-22
II-15



QI.1-622
I-1
II-3
II-23
II-15



QI.1-623
I-1
II-3
II-24
II-15



QI.1-624
I-1
II-3
II-25
II-15



QI.1-625
I-1
II-3
II-26
II-15



QI.1-626
I-1
II-3
II-27
II-15



QI.1-627
I-1
II-3
II-28
II-15



QI.1-628
I-1
II-3
II-29
II-15



QI.1-629
I-1
II-3
II-19
II-18



QI.1-630
I-1
II-3
II-20
II-18



QI.1-631
I-1
II-3
II-21
II-18



QI.1-632
I-1
II-3
II-22
II-18



QI.1-633
I-1
II-3
II-23
II-18



QI.1-634
I-1
II-3
II-24
II-18



QI.1-635
I-1
II-3
II-25
II-18



QI.1-636
I-1
II-3
II-26
II-18



QI.1-637
I-1
II-3
II-27
II-18



QI.1-638
I-1
II-3
II-28
II-18



QI.1-639
I-1
II-3
II-29
II-18



QI.1-640
I-1
II-3
II-20
II-19



QI.1-641
I-1
II-3
II-21
II-19



QI.1-642
I-1
II-3
II-22
II-19



QI.1-643
I-1
II-3
II-23
II-19



QI.1-644
I-1
II-3
II-24
II-19



QI.1-645
I-1
II-3
II-25
II-19



QI.1-646
I-1
II-3
II-26
II-19



QI.1-647
I-1
II-3
II-27
II-19



QI.1-648
I-1
II-3
II-28
II-19



QI.1-649
I-1
II-3
II-29
II-19



QI.1-650
I-1
II-3
II-21
II-20



QI.1-651
I-1
II-3
II-22
II-20



QI.1-652
I-1
II-3
II-23
II-20



QI.1-653
I-1
II-3
II-24
II-20



QI.1-654
I-1
II-3
II-25
II-20



QI.1-655
I-1
II-3
II-26
II-20



QI.1-656
I-1
II-3
II-27
II-20



QI.1-657
I-1
II-3
II-28
II-20



QI.1-658
I-1
II-3
II-29
II-20



QI.1-659
I-1
II-3
II-22
II-21



QI.1-660
I-1
II-3
II-23
II-21



QI.1-661
I-1
II-3
II-24
II-21



QI.1-662
I-1
II-3
II-25
II-21



QI.1-663
I-1
II-3
II-26
II-21



QI.1-664
I-1
II-3
II-27
II-21



QI.1-665
I-1
II-3
II-28
II-21



QI.1-666
I-1
II-3
II-29
II-21



QI.1-667
I-1
II-3
II-23
II-22



QI.1-668
I-1
II-3
II-24
II-22



QI.1-669
I-1
II-3
II-25
II-22



QI.1-670
I-1
II-3
II-26
II-22



QI.1-671
I-1
II-3
II-27
II-22



QI.1-672
I-1
II-3
II-28
II-22



QI.1-673
I-1
II-3
II-29
II-22



QI.1-674
I-1
II-3
II-24
II-23



QI.1-675
I-1
II-3
II-25
II-23



QI.1-676
I-1
II-3
II-26
II-23



QI.1-677
I-1
II-3
II-27
II-23



QI.1-678
I-1
II-3
II-28
II-23



QI.1-679
I-1
II-3
II-29
II-23



QI.1-680
I-1
II-3
II-25
II-24



QI.1-681
I-1
II-3
II-26
II-24



QI.1-682
I-1
II-3
II-27
II-24



QI.1-683
I-1
II-3
II-28
II-24



QI.1-684
I-1
II-3
II-29
II-24



QI.1-685
I-1
II-3
II-26
II-25



QI.1-686
I-1
II-3
II-27
II-25



QI.1-687
I-1
II-3
II-28
II-25



QI.1-688
I-1
II-3
II-29
II-25



QI.1-689
I-1
II-3
II-27
II-26



QI.1-690
I-1
II-3
II-28
II-26



QI.1-691
I-1
II-3
II-29
II-26



QI.1-692
I-1
II-3
II-28
II-27



QI.1-693
I-1
II-3
II-29
II-27



QI.1-694
I-1
II-3
II-29
II-28



QI.1-695
I-1
II-4
II-2
II-1



QI.1-696
I-1
II-4
II-3
II-1



QI.1-697
I-1
II-4
II-6
II-1



QI.1-698
I-1
II-4
II-7
II-1



QI.1-699
I-1
II-4
II-8
II-1



QI.1-700
I-1
II-4
II-9
II-1



QI.1-701
I-1
II-4
II-11
II-1



QI.1-702
I-1
II-4
II-12
II-1



QI.1-703
I-1
II-4
II-13
II-1



QI.1-704
I-1
II-4
II-14
II-1



QI.1-705
I-1
II-4
II-15
II-1



QI.1-706
I-1
II-4
II-18
II-1



QI.1-707
I-1
II-4
II-19
II-1



QI.1-708
I-1
II-4
II-20
II-1



QI.1-709
I-1
II-4
II-21
II-1



QI.1-710
I-1
II-4
II-22
II-1



QI.1-711
I-1
II-4
II-23
II-1



QI.1-712
I-1
II-4
II-24
II-1



QI.1-713
I-1
II-4
II-25
II-1



QI.1-714
I-1
II-4
II-26
II-1



QI.1-715
I-1
II-4
II-27
II-1



QI.1-716
I-1
II-4
II-28
II-1



QI.1-717
I-1
II-4
II-29
II-1



QI.1-718
I-1
II-4
II-3
II-2



QI.1-719
I-1
II-4
II-6
II-2



QI.1-720
I-1
II-4
II-7
II-2



QI.1-721
I-1
II-4
II-8
II-2



QI.1-722
I-1
II-4
II-9
II-2



QI.1-723
I-1
II-4
II-11
II-2



QI.1-724
I-1
II-4
II-12
II-2



QI.1-725
I-1
II-4
II-13
II-2



QI.1-726
I-1
II-4
II-14
II-2



QI.1-727
I-1
II-4
II-15
II-2



QI.1-728
I-1
II-4
II-18
II-2



QI.1-729
I-1
II-4
II-19
II-2



QI.1-730
I-1
II-4
II-20
II-2



QI.1-731
I-1
II-4
II-21
II-2



QI.1-732
I-1
II-4
II-22
II-2



QI.1-733
I-1
II-4
II-23
II-2



QI.1-734
I-1
II-4
II-24
II-2



QI.1-735
I-1
II-4
II-25
II-2



QI.1-736
I-1
II-4
II-26
II-2



QI.1-737
I-1
II-4
II-27
II-2



QI.1-738
I-1
II-4
II-28
II-2



QI.1-739
I-1
II-4
II-29
II-2



QI.1-740
I-1
II-4
II-6
II-3



QI.1-741
I-1
II-4
II-7
II-3



QI.1-742
I-1
II-4
II-8
II-3



QI.1-743
I-1
II-4
II-9
II-3



QI.1-744
I-1
II-4
II-11
II-3



QI.1-745
I-1
II-4
II-12
II-3



QI.1-746
I-1
II-4
II-13
II-3



QI.1-747
I-1
II-4
II-14
II-3



QI.1-748
I-1
II-4
II-15
II-3



QI.1-749
I-1
II-4
II-18
II-3



QI.1-750
I-1
II-4
II-19
II-3



QI.1-751
I-1
II-4
II-20
II-3



QI.1-752
I-1
II-4
II-21
II-3



QI.1-753
I-1
II-4
II-22
II-3



QI.1-754
I-1
II-4
II-23
II-3



QI.1-755
I-1
II-4
II-24
II-3



QI.1-756
I-1
II-4
II-25
II-3



QI.1-757
I-1
II-4
II-26
II-3



QI.1-758
I-1
II-4
II-27
II-3



QI.1-759
I-1
II-4
II-28
II-3



QI.1-760
I-1
II-4
II-29
II-3



QI.1-761
I-1
II-4
II-7
II-6



QI.1-762
I-1
II-4
II-8
II-6



QI.1-763
I-1
II-4
II-9
II-6



QI.1-764
I-1
II-4
II-11
II-6



QI.1-765
I-1
II-4
II-12
II-6



QI.1-766
I-1
II-4
II-13
II-6



QI.1-767
I-1
II-4
II-14
II-6



QI.1-768
I-1
II-4
II-15
II-6



QI.1-769
I-1
II-4
II-18
II-6



QI.1-770
I-1
II-4
II-19
II-6



QI.1-771
I-1
II-4
II-20
II-6



QI.1-772
I-1
II-4
II-21
II-6



QI.1-773
I-1
II-4
II-22
II-6



QI.1-774
I-1
II-4
II-23
II-6



QI.1-775
I-1
II-4
II-24
II-6



QI.1-776
I-1
II-4
II-25
II-6



QI.1-777
I-1
II-4
II-26
II-6



QI.1-778
I-1
II-4
II-27
II-6



QI.1-779
I-1
II-4
II-28
II-6



QI.1-780
I-1
II-4
II-29
II-6



QI.1-781
I-1
II-4
II-8
II-7



QI.1-782
I-1
II-4
II-9
II-7



QI.1-783
I-1
II-4
II-11
II-7



QI.1-784
I-1
II-4
II-12
II-7



QI.1-785
I-1
II-4
II-13
II-7



QI.1-786
I-1
II-4
II-14
II-7



QI.1-787
I-1
II-4
II-15
II-7



QI.1-788
I-1
II-4
II-18
II-7



QI.1-789
I-1
II-4
II-19
II-7



QI.1-790
I-1
II-4
II-20
II-7



QI.1-791
I-1
II-4
II-21
II-7



QI.1-792
I-1
II-4
II-22
II-7



QI.1-793
I-1
II-4
II-23
II-7



QI.1-794
I-1
II-4
II-24
II-7



QI.1-795
I-1
II-4
II-25
II-7



QI.1-796
I-1
II-4
II-26
II-7



QI.1-797
I-1
II-4
II-27
II-7



QI.1-798
I-1
II-4
II-28
II-7



QI.1-799
I-1
II-4
II-29
II-7



QI.1-800
I-1
II-4
II-9
II-8



QI.1-801
I-1
II-4
II-11
II-8



QI.1-802
I-1
II-4
II-12
II-8



QI.1-803
I-1
II-4
II-13
II-8



QI.1-804
I-1
II-4
II-14
II-8



QI.1-805
I-1
II-4
II-15
II-8



QI.1-806
I-1
II-4
II-18
II-8



QI.1-807
I-1
II-4
II-19
II-8



QI.1-808
I-1
II-4
II-20
II-8



QI.1-809
I-1
II-4
II-21
II-8



QI.1-810
I-1
II-4
II-22
II-8



QI.1-811
I-1
II-4
II-23
II-8



QI.1-812
I-1
II-4
II-24
II-8



QI.1-813
I-1
II-4
II-25
II-8



QI.1-814
I-1
II-4
II-26
II-8



QI.1-815
I-1
II-4
II-27
II-8



QI.1-816
I-1
II-4
II-28
II-8



QI.1-817
I-1
II-4
II-29
II-8



QI.1-818
I-1
II-4
II-11
II-9



QI.1-819
I-1
II-4
II-12
II-9



QI.1-820
I-1
II-4
II-13
II-9



QI.1-821
I-1
II-4
II-14
II-9



QI.1-822
I-1
II-4
II-15
II-9



QI.1-823
I-1
II-4
II-18
II-9



QI.1-824
I-1
II-4
II-19
II-9



QI.1-825
I-1
II-4
II-20
II-9



QI.1-826
I-1
II-4
II-21
II-9



QI.1-827
I-1
II-4
II-22
II-9



QI.1-828
I-1
II-4
II-23
II-9



QI.1-829
I-1
II-4
II-24
II-9



QI.1-830
I-1
II-4
II-25
II-9



QI.1-831
I-1
II-4
II-26
II-9



QI.1-832
I-1
II-4
II-27
II-9



QI.1-833
I-1
II-4
II-28
II-9



QI.1-834
I-1
II-4
II-29
II-9



QI.1-835
I-1
II-4
II-12
II-11



QI.1-836
I-1
II-4
II-13
II-11



QI.1-837
I-1
II-4
II-14
II-11



QI.1-838
I-1
II-4
II-15
II-11



QI.1-839
I-1
II-4
II-18
II-11



QI.1-840
I-1
II-4
II-19
II-11



QI.1-841
I-1
II-4
II-20
II-11



QI.1-842
I-1
II-4
II-21
II-11



QI.1-843
I-1
II-4
II-22
II-11



QI.1-844
I-1
II-4
II-23
II-11



QI.1-845
I-1
II-4
II-24
II-11



QI.1-846
I-1
II-4
II-25
II-11



QI.1-847
I-1
II-4
II-26
II-11



QI.1-848
I-1
II-4
II-27
II-11



QI.1-849
I-1
II-4
II-28
II-11



QI.1-850
I-1
II-4
II-29
II-11



QI.1-851
I-1
II-4
II-13
II-12



QI.1-852
I-1
II-4
II-14
II-12



QI.1-853
I-1
II-4
II-15
II-12



QI.1-854
I-1
II-4
II-18
II-12



QI.1-855
I-1
II-4
II-19
II-12



QI.1-856
I-1
II-4
II-20
II-12



QI.1-857
I-1
II-4
II-21
II-12



QI.1-858
I-1
II-4
II-22
II-12



QI.1-859
I-1
II-4
II-23
II-12



QI.1-860
I-1
II-4
II-24
II-12



QI.1-861
I-1
II-4
II-25
II-12



QI.1-862
I-1
II-4
II-26
II-12



QI.1-863
I-1
II-4
II-27
II-12



QI.1-864
I-1
II-4
II-28
II-12



QI.1-865
I-1
II-4
II-29
II-12



QI.1-866
I-1
II-4
II-14
II-13



QI.1-867
I-1
II-4
II-15
II-13



QI.1-868
I-1
II-4
II-18
II-13



QI.1-869
I-1
II-4
II-19
II-13



QI.1-870
I-1
II-4
II-20
II-13



QI.1-871
I-1
II-4
II-21
II-13



QI.1-872
I-1
II-4
II-22
II-13



QI.1-873
I-1
II-4
II-23
II-13



QI.1-874
I-1
II-4
II-24
II-13



QI.1-875
I-1
II-4
II-25
II-13



QI.1-876
I-1
II-4
II-26
II-13



QI.1-877
I-1
II-4
II-27
II-13



QI.1-878
I-1
II-4
II-28
II-13



QI.1-879
I-1
II-4
II-29
II-13



QI.1-880
I-1
II-4
II-15
II-14



QI.1-881
I-1
II-4
II-18
II-14



QI.1-882
I-1
II-4
II-19
II-14



QI.1-883
I-1
II-4
II-20
II-14



QI.1-884
I-1
II-4
II-21
II-14



QI.1-885
I-1
II-4
II-22
II-14



QI.1-886
I-1
II-4
II-23
II-14



QI.1-887
I-1
II-4
II-24
II-14



QI.1-888
I-1
II-4
II-25
II-14



QI.1-889
I-1
II-4
II-26
II-14



QI.1-890
I-1
II-4
II-27
II-14



QI.1-891
I-1
II-4
II-28
II-14



QI.1-892
I-1
II-4
II-29
II-14



QI.1-893
I-1
II-4
II-18
II-15



QI.1-894
I-1
II-4
II-19
II-15



QI.1-895
I-1
II-4
II-20
II-15



QI.1-896
I-1
II-4
II-21
II-15



QI.1-897
I-1
II-4
II-22
II-15



QI.1-898
I-1
II-4
II-23
II-15



QI.1-899
I-1
II-4
II-24
II-15



QI.1-900
I-1
II-4
II-25
II-15



QI.1-901
I-1
II-4
II-26
II-15



QI.1-902
I-1
II-4
II-27
II-15



QI.1-903
I-1
II-4
II-28
II-15



QI.1-904
I-1
II-4
II-29
II-15



QI.1-905
I-1
II-4
II-19
II-18



QI.1-906
I-1
II-4
II-20
II-18



QI.1-907
I-1
II-4
II-21
II-18



QI.1-908
I-1
II-4
II-22
II-18



QI.1-909
I-1
II-4
II-23
II-18



QI.1-910
I-1
II-4
II-24
II-18



QI.1-911
I-1
II-4
II-25
II-18



QI.1-912
I-1
II-4
II-26
II-18



QI.1-913
I-1
II-4
II-27
II-18



QI.1-914
I-1
II-4
II-28
II-18



QI.1-915
I-1
II-4
II-29
II-18



QI.1-916
I-1
II-4
II-20
II-19



QI.1-917
I-1
II-4
II-21
II-19



QI.1-918
I-1
II-4
II-22
II-19



QI.1-919
I-1
II-4
II-23
II-19



QI.1-920
I-1
II-4
II-24
II-19



QI.1-921
I-1
II-4
II-25
II-19



QI.1-922
I-1
II-4
II-26
II-19



QI.1-923
I-1
II-4
II-27
II-19



QI.1-924
I-1
II-4
II-28
II-19



QI.1-925
I-1
II-4
II-29
II-19



QI.1-926
I-1
II-4
II-21
II-20



QI.1-927
I-1
II-4
II-22
II-20



QI.1-928
I-1
II-4
II-23
II-20



QI.1-929
I-1
II-4
II-24
II-20



QI.1-930
I-1
II-4
II-25
II-20



QI.1-931
I-1
II-4
II-26
II-20



QI.1-932
I-1
II-4
II-27
II-20



QI.1-933
I-1
II-4
II-28
II-20



QI.1-934
I-1
II-4
II-29
II-20



QI.1-935
I-1
II-4
II-22
II-21



QI.1-936
I-1
II-4
II-23
II-21



QI.1-937
I-1
II-4
II-24
II-21



QI.1-938
I-1
II-4
II-25
II-21



QI.1-939
I-1
II-4
II-26
II-21



QI.1-940
I-1
II-4
II-27
II-21



QI.1-941
I-1
II-4
II-28
II-21



QI.1-942
I-1
II-4
II-29
II-21



QI.1-943
I-1
II-4
II-23
II-22



QI.1-944
I-1
II-4
II-24
II-22



QI.1-945
I-1
II-4
II-25
II-22



QI.1-946
I-1
II-4
II-26
II-22



QI.1-947
I-1
II-4
II-27
II-22



QI.1-948
I-1
II-4
II-28
II-22



QI.1-949
I-1
II-4
II-29
II-22



QI.1-950
I-1
II-4
II-24
II-23



QI.1-951
I-1
II-4
II-25
II-23



QI.1-952
I-1
II-4
II-26
II-23



QI.1-953
I-1
II-4
II-27
II-23



QI.1-954
I-1
II-4
II-28
II-23



QI.1-955
I-1
II-4
II-29
II-23



QI.1-956
I-1
II-4
II-25
II-24



QI.1-957
I-1
II-4
II-26
II-24



QI.1-958
I-1
II-4
II-27
II-24



QI.1-959
I-1
II-4
II-28
II-24



QI.1-960
I-1
II-4
II-29
II-24



QI.1-961
I-1
II-4
II-26
II-25



QI.1-962
I-1
II-4
II-27
II-25



QI.1-963
I-1
II-4
II-28
II-25



QI.1-964
I-1
II-4
II-29
II-25



QI.1-965
I-1
II-4
II-27
II-26



QI.1-966
I-1
II-4
II-28
II-26



QI.1-967
I-1
II-4
II-29
II-26



QI.1-968
I-1
II-4
II-28
II-27



QI.1-969
I-1
II-4
II-29
II-27



QI.1-970
I-1
II-4
II-29
II-28



QI.1-971
I-1
II-5
II-2
II-1



QI.1-972
I-1
II-5
II-3
II-1



QI.1-973
I-1
II-5
II-6
II-1



QI.1-974
I-1
II-5
II-7
II-1



QI.1-975
I-1
II-5
II-8
II-1



QI.1-976
I-1
II-5
II-9
II-1



QI.1-977
I-1
II-5
II-11
II-1



QI.1-978
I-1
II-5
II-12
II-1



QI.1-979
I-1
II-5
II-13
II-1



QI.1-980
I-1
II-5
II-14
II-1



QI.1-981
I-1
II-5
II-15
II-1



QI.1-982
I-1
II-5
II-18
II-1



QI.1-983
I-1
II-5
II-19
II-1



QI.1-984
I-1
II-5
II-20
II-1



QI.1-985
I-1
II-5
II-21
II-1



QI.1-986
I-1
II-5
II-22
II-1



QI.1-987
I-1
II-5
II-23
II-1



QI.1-988
I-1
II-5
II-24
II-1



QI.1-989
I-1
II-5
II-25
II-1



QI.1-990
I-1
II-5
II-26
II-1



QI.1-991
I-1
II-5
II-27
II-1



QI.1-992
I-1
II-5
II-28
II-1



QI.1-993
I-1
II-5
II-29
II-1



QI.1-994
I-1
II-5
II-3
II-2



QI.1-995
I-1
II-5
II-6
II-2



QI.1-996
I-1
II-5
II-7
II-2



QI.1-997
I-1
II-5
II-8
II-2



QI.1-998
I-1
II-5
II-9
II-2



QI.1-999
I-1
II-5
II-11
II-2



QI.1-1000
I-1
II-5
II-12
II-2



QI.1-1001
I-1
II-5
II-13
II-2



QI.1-1002
I-1
II-5
II-14
II-2



QI.1-1003
I-1
II-5
II-15
II-2



QI.1-1004
I-1
II-5
II-18
II-2



QI.1-1005
I-1
II-5
II-19
II-2



QI.1-1006
I-1
II-5
II-20
II-2



QI.1-1007
I-1
II-5
II-21
II-2



QI.1-1008
I-1
II-5
II-22
II-2



QI.1-1009
I-1
II-5
II-23
II-2



QI.1-1010
I-1
II-5
II-24
II-2



QI.1-1011
I-1
II-5
II-25
II-2



QI.1-1012
I-1
II-5
II-26
II-2



QI.1-1013
I-1
II-5
II-27
II-2



QI.1-1014
I-1
II-5
II-28
II-2



QI.1-1015
I-1
II-5
II-29
II-2



QI.1-1016
I-1
II-5
II-6
II-3



QI.1-1017
I-1
II-5
II-7
II-3



QI.1-1018
I-1
II-5
II-8
II-3



QI.1-1019
I-1
II-5
II-9
II-3



QI.1-1020
I-1
II-5
II-11
II-3



QI.1-1021
I-1
II-5
II-12
II-3



QI.1-1022
I-1
II-5
II-13
II-3



QI.1-1023
I-1
II-5
II-14
II-3



QI.1-1024
I-1
II-5
II-15
II-3



QI.1-1025
I-1
II-5
II-18
II-3



QI.1-1026
I-1
II-5
II-19
II-3



QI.1-1027
I-1
II-5
II-20
II-3



QI.1-1028
I-1
II-5
II-21
II-3



QI.1-1029
I-1
II-5
II-22
II-3



QI.1-1030
I-1
II-5
II-23
II-3



QI.1-1031
I-1
II-5
II-24
II-3



QI.1-1032
I-1
II-5
II-25
II-3



QI.1-1033
I-1
II-5
II-26
II-3



QI.1-1034
I-1
II-5
II-27
II-3



QI.1-1035
I-1
II-5
II-28
II-3



QI.1-1036
I-1
II-5
II-29
II-3



QI.1-1037
I-1
II-5
II-7
II-6



QI.1-1038
I-1
II-5
II-8
II-6



QI.1-1039
I-1
II-5
II-9
II-6



QI.1-1040
I-1
II-5
II-11
II-6



QI.1-1041
I-1
II-5
II-12
II-6



QI.1-1042
I-1
II-5
II-13
II-6



QI.1-1043
I-1
II-5
II-14
II-6



QI.1-1044
I-1
II-5
II-15
II-6



QI.1-1045
I-1
II-5
II-18
II-6



QI.1-1046
I-1
II-5
II-19
II-6



QI.1-1047
I-1
II-5
II-20
II-6



QI.1-1048
I-1
II-5
II-21
II-6



QI.1-1049
I-1
II-5
II-22
II-6



QI.1-1050
I-1
II-5
II-23
II-6



QI.1-1051
I-1
II-5
II-24
II-6



QI.1-1052
I-1
II-5
II-25
II-6



QI.1-1053
I-1
II-5
II-26
II-6



QI.1-1054
I-1
II-5
II-27
II-6



QI.1-1055
I-1
II-5
II-28
II-6



QI.1-1056
I-1
II-5
II-29
II-6



QI.1-1057
I-1
II-5
II-8
II-7



QI.1-1058
I-1
II-5
II-9
II-7



QI.1-1059
I-1
II-5
II-11
II-7



QI.1-1060
I-1
II-5
II-12
II-7



QI.1-1061
I-1
II-5
II-13
II-7



QI.1-1062
I-1
II-5
II-14
II-7



QI.1-1063
I-1
II-5
II-15
II-7



QI.1-1064
I-1
II-5
II-18
II-7



QI.1-1065
I-1
II-5
II-19
II-7



QI.1-1066
I-1
II-5
II-20
II-7



QI.1-1067
I-1
II-5
II-21
II-7



QI.1-1068
I-1
II-5
II-22
II-7



QI.1-1069
I-1
II-5
II-23
II-7



QI.1-1070
I-1
II-5
II-24
II-7



QI.1-1071
I-1
II-5
II-25
II-7



QI.1-1072
I-1
II-5
II-26
II-7



QI.1-1073
I-1
II-5
II-27
II-7



QI.1-1074
I-1
II-5
II-28
II-7



QI.1-1075
I-1
II-5
II-29
II-7



QI.1-1076
I-1
II-5
II-9
II-8



QI.1-1077
I-1
II-5
II-11
II-8



QI.1-1078
I-1
II-5
II-12
II-8



QI.1-1079
I-1
II-5
II-13
II-8



QI.1-1080
I-1
II-5
II-14
II-8



QI.1-1081
I-1
II-5
II-15
II-8



QI.1-1082
I-1
II-5
II-18
II-8



QI.1-1083
I-1
II-5
II-19
II-8



QI.1-1084
I-1
II-5
II-20
II-8



QI.1-1085
I-1
II-5
II-21
II-8



QI.1-1086
I-1
II-5
II-22
II-8



QI.1-1087
I-1
II-5
II-23
II-8



QI.1-1088
I-1
II-5
II-24
II-8



QI.1-1089
I-1
II-5
II-25
II-8



QI.1-1090
I-1
II-5
II-26
II-8



QI.1-1091
I-1
II-5
II-27
II-8



QI.1-1092
I-1
II-5
II-28
II-8



QI.1-1093
I-1
II-5
II-29
II-8



QI.1-1094
I-1
II-5
II-11
II-9



QI.1-1095
I-1
II-5
II-12
II-9



QI.1-1096
I-1
II-5
II-13
II-9



QI.1-1097
I-1
II-5
II-14
II-9



QI.1-1098
I-1
II-5
II-15
II-9



QI.1-1099
I-1
II-5
II-18
II-9



QI.1-1100
I-1
II-5
II-19
II-9



QI.1-1101
I-1
II-5
II-20
II-9



QI.1-1102
I-1
II-5
II-21
II-9



QI.1-1103
I-1
II-5
II-22
II-9



QI.1-1104
I-1
II-5
II-23
II-9



QI.1-1105
I-1
II-5
II-24
II-9



QI.1-1106
I-1
II-5
II-25
II-9



QI.1-1107
I-1
II-5
II-26
II-9



QI.1-1108
I-1
II-5
II-27
II-9



QI.1-1109
I-1
II-5
II-28
II-9



QI.1-1110
I-1
II-5
II-29
II-9



QI.1-1111
I-1
II-5
II-12
II-11



QI.1-1112
I-1
II-5
II-13
II-11



QI.1-1113
I-1
II-5
II-14
II-11



QI.1-1114
I-1
II-5
II-15
II-11



QI.1-1115
I-1
II-5
II-18
II-11



QI.1-1116
I-1
II-5
II-19
II-11



QI.1-1117
I-1
II-5
II-20
II-11



QI.1-1118
I-1
II-5
II-21
II-11



QI.1-1119
I-1
II-5
II-22
II-11



QI.1-1120
I-1
II-5
II-23
II-11



QI.1-1121
I-1
II-5
II-24
II-11



QI.1-1122
I-1
II-5
II-25
II-11



QI.1-1123
I-1
II-5
II-26
II-11



QI.1-1124
I-1
II-5
II-27
II-11



QI.1-1125
I-1
II-5
II-28
II-11



QI.1-1126
I-1
II-5
II-29
II-11



QI.1-1127
I-1
II-5
II-13
II-12



QI.1-1128
I-1
II-5
II-14
II-12



QI.1-1129
I-1
II-5
II-15
II-12



QI.1-1130
I-1
II-5
II-18
II-12



QI.1-1131
I-1
II-5
II-19
II-12



QI.1-1132
I-1
II-5
II-20
II-12



QI.1-1133
I-1
II-5
II-21
II-12



QI.1-1134
I-1
II-5
II-22
II-12



QI.1-1135
I-1
II-5
II-23
II-12



QI.1-1136
I-1
II-5
II-24
II-12



QI.1-1137
I-1
II-5
II-25
II-12



QI.1-1138
I-1
II-5
II-26
II-12



QI.1-1139
I-1
II-5
II-27
II-12



QI.1-1140
I-1
II-5
II-28
II-12



QI.1-1141
I-1
II-5
II-29
II-12



QI.1-1142
I-1
II-5
II-14
II-13



QI.1-1143
I-1
II-5
II-15
II-13



QI.1-1144
I-1
II-5
II-18
II-13



QI.1-1145
I-1
II-5
II-19
II-13



QI.1-1146
I-1
II-5
II-20
II-13



QI.1-1147
I-1
II-5
II-21
II-13



QI.1-1148
I-1
II-5
II-22
II-13



QI.1-1149
I-1
II-5
II-23
II-13



QI.1-1150
I-1
II-5
II-24
II-13



QI.1-1151
I-1
II-5
II-25
II-13



QI.1-1152
I-1
II-5
II-26
II-13



QI.1-1153
I-1
II-5
II-27
II-13



QI.1-1154
I-1
II-5
II-28
II-13



QI.1-1155
I-1
II-5
II-29
II-13



QI.1-1156
I-1
II-5
II-15
II-14



QI.1-1157
I-1
II-5
II-18
II-14



QI.1-1158
I-1
II-5
II-19
II-14



QI.1-1159
I-1
II-5
II-20
II-14



QI.1-1160
I-1
II-5
II-21
II-14



QI.1-1161
I-1
II-5
II-22
II-14



QI.1-1162
I-1
II-5
II-23
II-14



QI.1-1163
I-1
II-5
II-24
II-14



QI.1-1164
I-1
II-5
II-25
II-14



QI.1-1165
I-1
II-5
II-26
II-14



QI.1-1166
I-1
II-5
II-27
II-14



QI.1-1167
I-1
II-5
II-28
II-14



QI.1-1168
I-1
II-5
II-29
II-14



QI.1-1169
I-1
II-5
II-18
II-15



QI.1-1170
I-1
II-5
II-19
II-15



QI.1-1171
I-1
II-5
II-20
II-15



QI.1-1172
I-1
II-5
II-21
II-15



QI.1-1173
I-1
II-5
II-22
II-15



QI.1-1174
I-1
II-5
II-23
II-15



QI.1-1175
I-1
II-5
II-24
II-15



QI.1-1176
I-1
II-5
II-25
II-15



QI.1-1177
I-1
II-5
II-26
II-15



QI.1-1178
I-1
II-5
II-27
II-15



QI.1-1179
I-1
II-5
II-28
II-15



QI.1-1180
I-1
II-5
II-29
II-15



QI.1-1181
I-1
II-5
II-19
II-18



QI.1-1182
I-1
II-5
II-20
II-18



QI.1-1183
I-1
II-5
II-21
II-18



QI.1-1184
I-1
II-5
II-22
II-18



QI.1-1185
I-1
II-5
II-23
II-18



QI.1-1186
I-1
II-5
II-24
II-18



QI.1-1187
I-1
II-5
II-25
II-18



QI.1-1188
I-1
II-5
II-26
II-18



QI.1-1189
I-1
II-5
II-27
II-18



QI.1-1190
I-1
II-5
II-28
II-18



QI.1-1191
I-1
II-5
II-29
II-18



QI.1-1192
I-1
II-5
II-20
II-19



QI.1-1193
I-1
II-5
II-21
II-19



QI.1-1194
I-1
II-5
II-22
II-19



QI.1-1195
I-1
II-5
II-23
II-19



QI.1-1196
I-1
II-5
II-24
II-19



QI.1-1197
I-1
II-5
II-25
II-19



QI.1-1198
I-1
II-5
II-26
II-19



QI.1-1199
I-1
II-5
II-27
II-19



QI.1-1200
I-1
II-5
II-28
II-19



QI.1-1201
I-1
II-5
II-29
II-19



QI.1-1202
I-1
II-5
II-21
II-20



QI.1-1203
I-1
II-5
II-22
II-20



QI.1-1204
I-1
II-5
II-23
II-20



QI.1-1205
I-1
II-5
II-24
II-20



QI.1-1206
I-1
II-5
II-25
II-20



QI.1-1207
I-1
II-5
II-26
II-20



QI.1-1208
I-1
II-5
II-27
II-20



QI.1-1209
I-1
II-5
II-28
II-20



QI.1-1210
I-1
II-5
II-29
II-20



QI.1-1211
I-1
II-5
II-22
II-21



QI.1-1212
I-1
II-5
II-23
II-21



QI.1-1213
I-1
II-5
II-24
II-21



QI.1-1214
I-1
II-5
II-25
II-21



QI.1-1215
I-1
II-5
II-26
II-21



QI.1-1216
I-1
II-5
II-27
II-21



QI.1-1217
I-1
II-5
II-28
II-21



QI.1-1218
I-1
II-5
II-29
II-21



QI.1-1219
I-1
II-5
II-23
II-22



QI.1-1220
I-1
II-5
II-24
II-22



QI.1-1221
I-1
II-5
II-25
II-22



QI.1-1222
I-1
II-5
II-26
II-22



QI.1-1223
I-1
II-5
II-27
II-22



QI.1-1224
I-1
II-5
II-28
II-22



QI.1-1225
I-1
II-5
II-29
II-22



QI.1-1226
I-1
II-5
II-24
II-23



QI.1-1227
I-1
II-5
II-25
II-23



QI.1-1228
I-1
II-5
II-26
II-23



QI.1-1229
I-1
II-5
II-27
II-23



QI.1-1230
I-1
II-5
II-28
II-23



QI.1-1231
I-1
II-5
II-29
II-23



QI.1-1232
I-1
II-5
II-25
II-24



QI.1-1233
I-1
II-5
II-26
II-24



QI.1-1234
I-1
II-5
II-27
II-24



QI.1-1235
I-1
II-5
II-28
II-24



QI.1-1236
I-1
II-5
II-29
II-24



QI.1-1237
I-1
II-5
II-26
II-25



QI.1-1238
I-1
II-5
II-27
II-25



QI.1-1239
I-1
II-5
II-28
II-25



QI.1-1240
I-1
II-5
II-29
II-25



QI.1-1241
I-1
II-5
II-27
II-26



QI.1-1242
I-1
II-5
II-28
II-26



QI.1-1243
I-1
II-5
II-29
II-26



QI.1-1244
I-1
II-5
II-28
II-27



QI.1-1245
I-1
II-5
II-29
II-27



QI.1-1246
I-1
II-5
II-29
II-28



QI.1-1247
I-1
II-6
II-8
II-7



QI.1-1248
I-1
II-6
II-9
II-7



QI.1-1249
I-1
II-6
II-11
II-7



QI.1-1250
I-1
II-6
II-12
II-7



QI.1-1251
I-1
II-6
II-13
II-7



QI.1-1252
I-1
II-6
II-14
II-7



QI.1-1253
I-1
II-6
II-15
II-7



QI.1-1254
I-1
II-6
II-18
II-7



QI.1-1255
I-1
II-6
II-19
II-7



QI.1-1256
I-1
II-6
II-20
II-7



QI.1-1257
I-1
II-6
II-21
II-7



QI.1-1258
I-1
II-6
II-22
II-7



QI.1-1259
I-1
II-6
II-23
II-7



QI.1-1260
I-1
II-6
II-24
II-7



QI.1-1261
I-1
II-6
II-25
II-7



QI.1-1262
I-1
II-6
II-26
II-7



QI.1-1263
I-1
II-6
II-27
II-7



QI.1-1264
I-1
II-6
II-28
II-7



QI.1-1265
I-1
II-6
II-29
II-7



QI.1-1266
I-1
II-6
II-9
II-8



QI.1-1267
I-1
II-6
II-11
II-8



QI.1-1268
I-1
II-6
II-12
II-8



QI.1-1269
I-1
II-6
II-13
II-8



QI.1-1270
I-1
II-6
II-14
II-8



QI.1-1271
I-1
II-6
II-15
II-8



QI.1-1272
I-1
II-6
II-18
II-8



QI.1-1273
I-1
II-6
II-19
II-8



QI.1-1274
I-1
II-6
II-20
II-8



QI.1-1275
I-1
II-6
II-21
II-8



QI.1-1276
I-1
II-6
II-22
II-8



QI.1-1277
I-1
II-6
II-23
II-8



QI.1-1278
I-1
II-6
II-24
II-8



QI.1-1279
I-1
II-6
II-25
II-8



QI.1-1280
I-1
II-6
II-26
II-8



QI.1-1281
I-1
II-6
II-27
II-8



QI.1-1282
I-1
II-6
II-28
II-8



QI.1-1283
I-1
II-6
II-29
II-8



QI.1-1284
I-1
II-6
II-11
II-9



QI.1-1285
I-1
II-6
II-12
II-9



QI.1-1286
I-1
II-6
II-13
II-9



QI.1-1287
I-1
II-6
II-14
II-9



QI.1-1288
I-1
II-6
II-15
II-9



QI.1-1289
I-1
II-6
II-18
II-9



QI.1-1290
I-1
II-6
II-19
II-9



QI.1-1291
I-1
II-6
II-20
II-9



QI.1-1292
I-1
II-6
II-21
II-9



QI.1-1293
I-1
II-6
II-22
II-9



QI.1-1294
I-1
II-6
II-23
II-9



QI.1-1295
I-1
II-6
II-24
II-9



QI.1-1296
I-1
II-6
II-25
II-9



QI.1-1297
I-1
II-6
II-26
II-9



QI.1-1298
I-1
II-6
II-27
II-9



QI.1-1299
I-1
II-6
II-28
II-9



QI.1-1300
I-1
II-6
II-29
II-9



QI.1-1301
I-1
II-6
II-12
II-11



QI.1-1302
I-1
II-6
II-13
II-11



QI.1-1303
I-1
II-6
II-14
II-11



QI.1-1304
I-1
II-6
II-15
II-11



QI.1-1305
I-1
II-6
II-18
II-11



QI.1-1306
I-1
II-6
II-19
II-11



QI.1-1307
I-1
II-6
II-20
II-11



QI.1-1308
I-1
II-6
II-21
II-11



QI.1-1309
I-1
II-6
II-22
II-11



QI.1-1310
I-1
II-6
II-23
II-11



QI.1-1311
I-1
II-6
II-24
II-11



QI.1-1312
I-1
II-6
II-25
II-11



QI.1-1313
I-1
II-6
II-26
II-11



QI.1-1314
I-1
II-6
II-27
II-11



QI.1-1315
I-1
II-6
II-28
II-11



QI.1-1316
I-1
II-6
II-29
II-11



QI.1-1317
I-1
II-6
II-13
II-12



QI.1-1318
I-1
II-6
II-14
II-12



QI.1-1319
I-1
II-6
II-15
II-12



QI.1-1320
I-1
II-6
II-18
II-12



QI.1-1321
I-1
II-6
II-19
II-12



QI.1-1322
I-1
II-6
II-20
II-12



QI.1-1323
I-1
II-6
II-21
II-12



QI.1-1324
I-1
II-6
II-22
II-12



QI.1-1325
I-1
II-6
II-23
II-12



QI.1-1326
I-1
II-6
II-24
II-12



QI.1-1327
I-1
II-6
II-25
II-12



QI.1-1328
I-1
II-6
II-26
II-12



QI.1-1329
I-1
II-6
II-27
II-12



QI.1-1330
I-1
II-6
II-28
II-12



QI.1-1331
I-1
II-6
II-29
II-12



QI.1-1332
I-1
II-6
II-14
II-13



QI.1-1333
I-1
II-6
II-15
II-13



QI.1-1334
I-1
II-6
II-18
II-13



QI.1-1335
I-1
II-6
II-19
II-13



QI.1-1336
I-1
II-6
II-20
II-13



QI.1-1337
I-1
II-6
II-21
II-13



QI.1-1338
I-1
II-6
II-22
II-13



QI.1-1339
I-1
II-6
II-23
II-13



QI.1-1340
I-1
II-6
II-24
II-13



QI.1-1341
I-1
II-6
II-25
II-13



QI.1-1342
I-1
II-6
II-26
II-13



QI.1-1343
I-1
II-6
II-27
II-13



QI.1-1344
I-1
II-6
II-28
II-13



QI.1-1345
I-1
II-6
II-29
II-13



QI.1-1346
I-1
II-6
II-15
II-14



QI.1-1347
I-1
II-6
II-18
II-14



QI.1-1348
I-1
II-6
II-19
II-14



QI.1-1349
I-1
II-6
II-20
II-14



QI.1-1350
I-1
II-6
II-21
II-14



QI.1-1351
I-1
II-6
II-22
II-14



QI.1-1352
I-1
II-6
II-23
II-14



QI.1-1353
I-1
II-6
II-24
II-14



QI.1-1354
I-1
II-6
II-25
II-14



QI.1-1355
I-1
II-6
II-26
II-14



QI.1-1356
I-1
II-6
II-27
II-14



QI.1-1357
I-1
II-6
II-28
II-14



QI.1-1358
I-1
II-6
II-29
II-14



QI.1-1359
I-1
II-6
II-18
II-15



QI.1-1360
I-1
II-6
II-19
II-15



QI.1-1361
I-1
II-6
II-20
II-15



QI.1-1362
I-1
II-6
II-21
II-15



QI.1-1363
I-1
II-6
II-22
II-15



QI.1-1364
I-1
II-6
II-23
II-15



QI.1-1365
I-1
II-6
II-24
II-15



QI.1-1366
I-1
II-6
II-25
II-15



QI.1-1367
I-1
II-6
II-26
II-15



QI.1-1368
I-1
II-6
II-27
II-15



QI.1-1369
I-1
II-6
II-28
II-15



QI.1-1370
I-1
II-6
II-29
II-15



QI.1-1371
I-1
II-6
II-19
II-18



QI.1-1372
I-1
II-6
II-20
II-18



QI.1-1373
I-1
II-6
II-21
II-18



QI.1-1374
I-1
II-6
II-22
II-18



QI.1-1375
I-1
II-6
II-23
II-18



QI.1-1376
I-1
II-6
II-24
II-18



QI.1-1377
I-1
II-6
II-25
II-18



QI.1-1378
I-1
II-6
II-26
II-18



QI.1-1379
I-1
II-6
II-27
II-18



QI.1-1380
I-1
II-6
II-28
II-18



QI.1-1381
I-1
II-6
II-29
II-18



QI.1-1382
I-1
II-6
II-20
II-19



QI.1-1383
I-1
II-6
II-21
II-19



QI.1-1384
I-1
II-6
II-22
II-19



QI.1-1385
I-1
II-6
II-23
II-19



QI.1-1386
I-1
II-6
II-24
II-19



QI.1-1387
I-1
II-6
II-25
II-19



QI.1-1388
I-1
II-6
II-26
II-19



QI.1-1389
I-1
II-6
II-27
II-19



QI.1-1390
I-1
II-6
II-28
II-19



QI.1-1391
I-1
II-6
II-29
II-19



QI.1-1392
I-1
II-6
II-21
II-20



QI.1-1393
I-1
II-6
II-22
II-20



QI.1-1394
I-1
II-6
II-23
II-20



QI.1-1395
I-1
II-6
II-24
II-20



QI.1-1396
I-1
II-6
II-25
II-20



QI.1-1397
I-1
II-6
II-26
II-20



QI.1-1398
I-1
II-6
II-27
II-20



QI.1-1399
I-1
II-6
II-28
II-20



QI.1-1400
I-1
II-6
II-29
II-20



QI.1-1401
I-1
II-6
II-22
II-21



QI.1-1402
I-1
II-6
II-23
II-21



QI.1-1403
I-1
II-6
II-24
II-21



QI.1-1404
I-1
II-6
II-25
II-21



QI.1-1405
I-1
II-6
II-26
II-21



QI.1-1406
I-1
II-6
II-27
II-21



QI.1-1407
I-1
II-6
II-28
II-21



QI.1-1408
I-1
II-6
II-29
II-21



QI.1-1409
I-1
II-6
II-23
II-22



QI.1-1410
I-1
II-6
II-24
II-22



QI.1-1411
I-1
II-6
II-25
II-22



QI.1-1412
I-1
II-6
II-26
II-22



QI.1-1413
I-1
II-6
II-27
II-22



QI.1-1414
I-1
II-6
II-28
II-22



QI.1-1415
I-1
II-6
II-29
II-22



QI.1-1416
I-1
II-6
II-24
II-23



QI.1-1417
I-1
II-6
II-25
II-23



QI.1-1418
I-1
II-6
II-26
II-23



QI.1-1419
I-1
II-6
II-27
II-23



QI.1-1420
I-1
II-6
II-28
II-23



QI.1-1421
I-1
II-6
II-29
II-23



QI.1-1422
I-1
II-6
II-25
II-24



QI.1-1423
I-1
II-6
II-26
II-24



QI.1-1424
I-1
II-6
II-27
II-24



QI.1-1425
I-1
II-6
II-28
II-24



QI.1-1426
I-1
II-6
II-29
II-24



QI.1-1427
I-1
II-6
II-26
II-25



QI.1-1428
I-1
II-6
II-27
II-25



QI.1-1429
I-1
II-6
II-28
II-25



QI.1-1430
I-1
II-6
II-29
II-25



QI.1-1431
I-1
II-6
II-27
II-26



QI.1-1432
I-1
II-6
II-28
II-26



QI.1-1433
I-1
II-6
II-29
II-26



QI.1-1434
I-1
II-6
II-28
II-27



QI.1-1435
I-1
II-6
II-29
II-27



QI.1-1436
I-1
II-6
II-29
II-28



QI.1-1437
I-1
II-7
II-9
II-8



QI.1-1438
I-1
II-7
II-11
II-8



QI.1-1439
I-1
II-7
II-12
II-8



QI.1-1440
I-1
II-7
II-13
II-8



QI.1-1441
I-1
II-7
II-14
II-8



QI.1-1442
I-1
II-7
II-15
II-8



QI.1-1443
I-1
II-7
II-18
II-8



QI.1-1444
I-1
II-7
II-19
II-8



QI.1-1445
I-1
II-7
II-20
II-8



QI.1-1446
I-1
II-7
II-21
II-8



QI.1-1447
I-1
II-7
II-22
II-8



QI.1-1448
I-1
II-7
II-23
II-8



QI.1-1449
I-1
II-7
II-24
II-8



QI.1-1450
I-1
II-7
II-25
II-8



QI.1-1451
I-1
II-7
II-26
II-8



QI.1-1452
I-1
II-7
II-27
II-8



QI.1-1453
I-1
II-7
II-28
II-8



QI.1-1454
I-1
II-7
II-29
II-8



QI.1-1455
I-1
II-7
II-11
II-9



QI.1-1456
I-1
II-7
II-12
II-9



QI.1-1457
I-1
II-7
II-13
II-9



QI.1-1458
I-1
II-7
II-14
II-9



QI.1-1459
I-1
II-7
II-15
II-9



QI.1-1460
I-1
II-7
II-18
II-9



QI.1-1461
I-1
II-7
II-19
II-9



QI.1-1462
I-1
II-7
II-20
II-9



QI.1-1463
I-1
II-7
II-21
II-9



QI.1-1464
I-1
II-7
II-22
II-9



QI.1-1465
I-1
II-7
II-23
II-9



QI.1-1466
I-1
II-7
II-24
II-9



QI.1-1467
I-1
II-7
II-25
II-9



QI.1-1468
I-1
II-7
II-26
II-9



QI.1-1469
I-1
II-7
II-27
II-9



QI.1-1470
I-1
II-7
II-28
II-9



QI.1-1471
I-1
II-7
II-29
II-9



QI.1-1472
I-1
II-7
II-12
II-11



QI.1-1473
I-1
II-7
II-13
II-11



QI.1-1474
I-1
II-7
II-14
II-11



QI.1-1475
I-1
II-7
II-15
II-11



QI.1-1476
I-1
II-7
II-18
II-11



QI.1-1477
I-1
II-7
II-19
II-11



QI.1-1478
I-1
II-7
II-20
II-11



QI.1-1479
I-1
II-7
II-21
II-11



QI.1-1480
I-1
II-7
II-22
II-11



QI.1-1481
I-1
II-7
II-23
II-11



QI.1-1482
I-1
II-7
II-24
II-11



QI.1-1483
I-1
II-7
II-25
II-11



QI.1-1484
I-1
II-7
II-26
II-11



QI.1-1485
I-1
II-7
II-27
II-11



QI.1-1486
I-1
II-7
II-28
II-11



QI.1-1487
I-1
II-7
II-29
II-11



QI.1-1488
I-1
II-7
II-13
II-12



QI.1-1489
I-1
II-7
II-14
II-12



QI.1-1490
I-1
II-7
II-15
II-12



QI.1-1491
I-1
II-7
II-18
II-12



QI.1-1492
I-1
II-7
II-19
II-12



QI.1-1493
I-1
II-7
II-20
II-12



QI.1-1494
I-1
II-7
II-21
II-12



QI.1-1495
I-1
II-7
II-22
II-12



QI.1-1496
I-1
II-7
II-23
II-12



QI.1-1497
I-1
II-7
II-24
II-12



QI.1-1498
I-1
II-7
II-25
II-12



QI.1-1499
I-1
II-7
II-26
II-12



QI.1-1500
I-1
II-7
II-27
II-12



QI.1-1501
I-1
II-7
II-28
II-12



QI.1-1502
I-1
II-7
II-29
II-12



QI.1-1503
I-1
II-7
II-14
II-13



QI.1-1504
I-1
II-7
II-15
II-13



QI.1-1505
I-1
II-7
II-18
II-13



QI.1-1506
I-1
II-7
II-19
II-13



QI.1-1507
I-1
II-7
II-20
II-13



QI.1-1508
I-1
II-7
II-21
II-13



QI.1-1509
I-1
II-7
II-22
II-13



QI.1-1510
I-1
II-7
II-23
II-13



QI.1-1511
I-1
II-7
II-24
II-13



QI.1-1512
I-1
II-7
II-25
II-13



QI.1-1513
I-1
II-7
II-26
II-13



QI.1-1514
I-1
II-7
II-27
II-13



QI.1-1515
I-1
II-7
II-28
II-13



QI.1-1516
I-1
II-7
II-29
II-13



QI.1-1517
I-1
II-7
II-15
II-14



QI.1-1518
I-1
II-7
II-18
II-14



QI.1-1519
I-1
II-7
II-19
II-14



QI.1-1520
I-1
II-7
II-20
II-14



QI.1-1521
I-1
II-7
II-21
II-14



QI.1-1522
I-1
II-7
II-22
II-14



QI.1-1523
I-1
II-7
II-23
II-14



QI.1-1524
I-1
II-7
II-24
II-14



QI.1-1525
I-1
II-7
II-25
II-14



QI.1-1526
I-1
II-7
II-26
II-14



QI.1-1527
I-1
II-7
II-27
II-14



QI.1-1528
I-1
II-7
II-28
II-14



QI.1-1529
I-1
II-7
II-29
II-14



QI.1-1530
I-1
II-7
II-18
II-15



QI.1-1531
I-1
II-7
II-19
II-15



QI.1-1532
I-1
II-7
II-20
II-15



QI.1-1533
I-1
II-7
II-21
II-15



QI.1-1534
I-1
II-7
II-22
II-15



QI.1-1535
I-1
II-7
II-23
II-15



QI.1-1536
I-1
II-7
II-24
II-15



QI.1-1537
I-1
II-7
II-25
II-15



QI.1-1538
I-1
II-7
II-26
II-15



QI.1-1539
I-1
II-7
II-27
II-15



QI.1-1540
I-1
II-7
II-28
II-15



QI.1-1541
I-1
II-7
II-29
II-15



QI.1-1542
I-1
II-7
II-19
II-18



QI.1-1543
I-1
II-7
II-20
II-18



QI.1-1544
I-1
II-7
II-21
II-18



QI.1-1545
I-1
II-7
II-22
II-18



QI.1-1546
I-1
II-7
II-23
II-18



QI.1-1547
I-1
II-7
II-24
II-18



QI.1-1548
I-1
II-7
II-25
II-18



QI.1-1549
I-1
II-7
II-26
II-18



QI.1-1550
I-1
II-7
II-27
II-18



QI.1-1551
I-1
II-7
II-28
II-18



QI.1-1552
I-1
II-7
II-29
II-18



QI.1-1553
I-1
II-7
II-20
II-19



QI.1-1554
I-1
II-7
II-21
II-19



QI.1-1555
I-1
II-7
II-22
II-19



QI.1-1556
I-1
II-7
II-23
II-19



QI.1-1557
I-1
II-7
II-24
II-19



QI.1-1558
I-1
II-7
II-25
II-19



QI.1-1559
I-1
II-7
II-26
II-19



QI.1-1560
I-1
II-7
II-27
II-19



QI.1-1561
I-1
II-7
II-28
II-19



QI.1-1562
I-1
II-7
II-29
II-19



QI.1-1563
I-1
II-7
II-21
II-20



QI.1-1564
I-1
II-7
II-22
II-20



QI.1-1565
I-1
II-7
II-23
II-20



QI.1-1566
I-1
II-7
II-24
II-20



QI.1-1567
I-1
II-7
II-25
II-20



QI.1-1568
I-1
II-7
II-26
II-20



QI.1-1569
I-1
II-7
II-27
II-20



QI.1-1570
I-1
II-7
II-28
II-20



QI.1-1571
I-1
II-7
II-29
II-20



QI.1-1572
I-1
II-7
II-22
II-21



QI.1-1573
I-1
II-7
II-23
II-21



QI.1-1574
I-1
II-7
II-24
II-21



QI.1-1575
I-1
II-7
II-25
II-21



QI.1-1576
I-1
II-7
II-26
II-21



QI.1-1577
I-1
II-7
II-27
II-21



QI.1-1578
I-1
II-7
II-28
II-21



QI.1-1579
I-1
II-7
II-29
II-21



QI.1-1580
I-1
II-7
II-23
II-22



QI.1-1581
I-1
II-7
II-24
II-22



QI.1-1582
I-1
II-7
II-25
II-22



QI.1-1583
I-1
II-7
II-26
II-22



QI.1-1584
I-1
II-7
II-27
II-22



QI.1-1585
I-1
II-7
II-28
II-22



QI.1-1586
I-1
II-7
II-29
II-22



QI.1-1587
I-1
II-7
II-24
II-23



QI.1-1588
I-1
II-7
II-25
II-23



QI.1-1589
I-1
II-7
II-26
II-23



QI.1-1590
I-1
II-7
II-27
II-23



QI.1-1591
I-1
II-7
II-28
II-23



QI.1-1592
I-1
II-7
II-29
II-23



QI.1-1593
I-1
II-7
II-25
II-24



QI.1-1594
I-1
II-7
II-26
II-24



QI.1-1595
I-1
II-7
II-27
II-24



QI.1-1596
I-1
II-7
II-28
II-24



QI.1-1597
I-1
II-7
II-29
II-24



QI.1-1598
I-1
II-7
II-26
II-25



QI.1-1599
I-1
II-7
II-27
II-25



QI.1-1600
I-1
II-7
II-28
II-25



QI.1-1601
I-1
II-7
II-29
II-25



QI.1-1602
I-1
II-7
II-27
II-26



QI.1-1603
I-1
II-7
II-28
II-26



QI.1-1604
I-1
II-7
II-29
II-26



QI.1-1605
I-1
II-7
II-28
II-27



QI.1-1606
I-1
II-7
II-29
II-27



QI.1-1607
I-1
II-7
II-29
II-28



QI.1-1608
I-1
II-8
II-11
II-9



QI.1-1609
I-1
II-8
II-12
II-9



QI.1-1610
I-1
II-8
II-13
II-9



QI.1-1611
I-1
II-8
II-14
II-9



QI.1-1612
I-1
II-8
II-15
II-9



QI.1-1613
I-1
II-8
II-18
II-9



QI.1-1614
I-1
II-8
II-19
II-9



QI.1-1615
I-1
II-8
II-20
II-9



QI.1-1616
I-1
II-8
II-21
II-9



QI.1-1617
I-1
II-8
II-22
II-9



QI.1-1618
I-1
II-8
II-23
II-9



QI.1-1619
I-1
II-8
II-24
II-9



QI.1-1620
I-1
II-8
II-25
II-9



QI.1-1621
I-1
II-8
II-26
II-9



QI.1-1622
I-1
II-8
II-27
II-9



QI.1-1623
I-1
II-8
II-28
II-9



QI.1-1624
I-1
II-8
II-29
II-9



QI.1-1625
I-1
II-8
II-12
II-11



QI.1-1626
I-1
II-8
II-13
II-11



QI.1-1627
I-1
II-8
II-14
II-11



QI.1-1628
I-1
II-8
II-15
II-11



QI.1-1629
I-1
II-8
II-18
II-11



QI.1-1630
I-1
II-8
II-19
II-11



QI.1-1631
I-1
II-8
II-20
II-11



QI.1-1632
I-1
II-8
II-21
II-11



QI.1-1633
I-1
II-8
II-22
II-11



QI.1-1634
I-1
II-8
II-23
II-11



QI.1-1635
I-1
II-8
II-24
II-11



QI.1-1636
I-1
II-8
II-25
II-11



QI.1-1637
I-1
II-8
II-26
II-11



QI.1-1638
I-1
II-8
II-27
II-11



QI.1-1639
I-1
II-8
II-28
II-11



QI.1-1640
I-1
II-8
II-29
II-11



QI.1-1641
I-1
II-8
II-13
II-12



QI.1-1642
I-1
II-8
II-14
II-12



QI.1-1643
I-1
II-8
II-15
II-12



QI.1-1644
I-1
II-8
II-18
II-12



QI.1-1645
I-1
II-8
II-19
II-12



QI.1-1646
I-1
II-8
II-20
II-12



QI.1-1647
I-1
II-8
II-21
II-12



QI.1-1648
I-1
II-8
II-22
II-12



QI.1-1649
I-1
II-8
II-23
II-12



QI.1-1650
I-1
II-8
II-24
II-12



QI.1-1651
I-1
II-8
II-25
II-12



QI.1-1652
I-1
II-8
II-26
II-12



QI.1-1653
I-1
II-8
II-27
II-12



QI.1-1654
I-1
II-8
II-28
II-12



QI.1-1655
I-1
II-8
II-29
II-12



QI.1-1656
I-1
II-8
II-14
II-13



QI.1-1657
I-1
II-8
II-15
II-13



QI.1-1658
I-1
II-8
II-18
II-13



QI.1-1659
I-1
II-8
II-19
II-13



QI.1-1660
I-1
II-8
II-20
II-13



QI.1-1661
I-1
II-8
II-21
II-13



QI.1-1662
I-1
II-8
II-22
II-13



QI.1-1663
I-1
II-8
II-23
II-13



QI.1-1664
I-1
II-8
II-24
II-13



QI.1-1665
I-1
II-8
II-25
II-13



QI.1-1666
I-1
II-8
II-26
II-13



QI.1-1667
I-1
II-8
II-27
II-13



QI.1-1668
I-1
II-8
II-28
II-13



QI.1-1669
I-1
II-8
II-29
II-13



QI.1-1670
I-1
II-8
II-15
II-14



QI.1-1671
I-1
II-8
II-18
II-14



QI.1-1672
I-1
II-8
II-19
II-14



QI.1-1673
I-1
II-8
II-20
II-14



QI.1-1674
I-1
II-8
II-21
II-14



QI.1-1675
I-1
II-8
II-22
II-14



QI.1-1676
I-1
II-8
II-23
II-14



QI.1-1677
I-1
II-8
II-24
II-14



QI.1-1678
I-1
II-8
II-25
II-14



QI.1-1679
I-1
II-8
II-26
II-14



QI.1-1680
I-1
II-8
II-27
II-14



QI.1-1681
I-1
II-8
II-28
II-14



QI.1-1682
I-1
II-8
II-29
II-14



QI.1-1683
I-1
II-8
II-18
II-15



QI.1-1684
I-1
II-8
II-19
II-15



QI.1-1685
I-1
II-8
II-20
II-15



QI.1-1686
I-1
II-8
II-21
II-15



QI.1-1687
I-1
II-8
II-22
II-15



QI.1-1688
I-1
II-8
II-23
II-15



QI.1-1689
I-1
II-8
II-24
II-15



QI.1-1690
I-1
II-8
II-25
II-15



QI.1-1691
I-1
II-8
II-26
II-15



QI.1-1692
I-1
II-8
II-27
II-15



QI.1-1693
I-1
II-8
II-28
II-15



QI.1-1694
I-1
II-8
II-29
II-15



QI.1-1695
I-1
II-8
II-19
II-18



QI.1-1696
I-1
II-8
II-20
II-18



QI.1-1697
I-1
II-8
II-21
II-18



QI.1-1698
I-1
II-8
II-22
II-18



QI.1-1699
I-1
II-8
II-23
II-18



QI.1-1700
I-1
II-8
II-24
II-18



QI.1-1701
I-1
II-8
II-25
II-18



QI.1-1702
I-1
II-8
II-26
II-18



QI.1-1703
I-1
II-8
II-27
II-18



QI.1-1704
I-1
II-8
II-28
II-18



QI.1-1705
I-1
II-8
II-29
II-18



QI.1-1706
I-1
II-8
II-20
II-19



QI.1-1707
I-1
II-8
II-21
II-19



QI.1-1708
I-1
II-8
II-22
II-19



QI.1-1709
I-1
II-8
II-23
II-19



QI.1-1710
I-1
II-8
II-24
II-19



QI.1-1711
I-1
II-8
II-25
II-19



QI.1-1712
I-1
II-8
II-26
II-19



QI.1-1713
I-1
II-8
II-27
II-19



QI.1-1714
I-1
II-8
II-28
II-19



QI.1-1715
I-1
II-8
II-29
II-19



QI.1-1716
I-1
II-8
II-21
II-20



QI.1-1717
I-1
II-8
II-22
II-20



QI.1-1718
I-1
II-8
II-23
II-20



QI.1-1719
I-1
II-8
II-24
II-20



QI.1-1720
I-1
II-8
II-25
II-20



QI.1-1721
I-1
II-8
II-26
II-20



QI.1-1722
I-1
II-8
II-27
II-20



QI.1-1723
I-1
II-8
II-28
II-20



QI.1-1724
I-1
II-8
II-29
II-20



QI.1-1725
I-1
II-8
II-22
II-21



QI.1-1726
I-1
II-8
II-23
II-21



QI.1-1727
I-1
II-8
II-24
II-21



QI.1-1728
I-1
II-8
II-25
II-21



QI.1-1729
I-1
II-8
II-26
II-21



QI.1-1730
I-1
II-8
II-27
II-21



QI.1-1731
I-1
II-8
II-28
II-21



QI.1-1732
I-1
II-8
II-29
II-21



QI.1-1733
I-1
II-8
II-23
II-22



QI.1-1734
I-1
II-8
II-24
II-22



QI.1-1735
I-1
II-8
II-25
II-22



QI.1-1736
I-1
II-8
II-26
II-22



QI.1-1737
I-1
II-8
II-27
II-22



QI.1-1738
I-1
II-8
II-28
II-22



QI.1-1739
I-1
II-8
II-29
II-22



QI.1-1740
I-1
II-8
II-24
II-23



QI.1-1741
I-1
II-8
II-25
II-23



QI.1-1742
I-1
II-8
II-26
II-23



QI.1-1743
I-1
II-8
II-27
II-23



QI.1-1744
I-1
II-8
II-28
II-23



QI.1-1745
I-1
II-8
II-29
II-23



QI.1-1746
I-1
II-8
II-25
II-24



QI.1-1747
I-1
II-8
II-26
II-24



QI.1-1748
I-1
II-8
II-27
II-24



QI.1-1749
I-1
II-8
II-28
II-24



QI.1-1750
I-1
II-8
II-29
II-24



QI.1-1751
I-1
II-8
II-26
II-25



QI.1-1752
I-1
II-8
II-27
II-25



QI.1-1753
I-1
II-8
II-28
II-25



QI.1-1754
I-1
II-8
II-29
II-25



QI.1-1755
I-1
II-8
II-27
II-26



QI.1-1756
I-1
II-8
II-28
II-26



QI.1-1757
I-1
II-8
II-29
II-26



QI.1-1758
I-1
II-8
II-28
II-27



QI.1-1759
I-1
II-8
II-29
II-27



QI.1-1760
I-1
II-8
II-29
II-28



QI.1-1761
I-1
II-9
II-12
II-11



QI.1-1762
I-1
II-9
II-13
II-11



QI.1-1763
I-1
II-9
II-14
II-11



QI.1-1764
I-1
II-9
II-15
II-11



QI.1-1765
I-1
II-9
II-18
II-11



QI.1-1766
I-1
II-9
II-19
II-11



QI.1-1767
I-1
II-9
II-20
II-11



QI.1-1768
I-1
II-9
II-21
II-11



QI.1-1769
I-1
II-9
II-22
II-11



QI.1-1770
I-1
II-9
II-23
II-11



QI.1-1771
I-1
II-9
II-24
II-11



QI.1-1772
I-1
II-9
II-25
II-11



QI.1-1773
I-1
II-9
II-26
II-11



QI.1-1774
I-1
II-9
II-27
II-11



QI.1-1775
I-1
II-9
II-28
II-11



QI.1-1776
I-1
II-9
II-29
II-11



QI.1-1777
I-1
II-9
II-13
II-12



QI.1-1778
I-1
II-9
II-14
II-12



QI.1-1779
I-1
II-9
II-15
II-12



QI.1-1780
I-1
II-9
II-18
II-12



QI.1-1781
I-1
II-9
II-19
II-12



QI.1-1782
I-1
II-9
II-20
II-12



QI.1-1783
I-1
II-9
II-21
II-12



QI.1-1784
I-1
II-9
II-22
II-12



QI.1-1785
I-1
II-9
II-23
II-12



QI.1-1786
I-1
II-9
II-24
II-12



QI.1-1787
I-1
II-9
II-25
II-12



QI.1-1788
I-1
II-9
II-26
II-12



QI.1-1789
I-1
II-9
II-27
II-12



QI.1-1790
I-1
II-9
II-28
II-12



QI.1-1791
I-1
II-9
II-29
II-12



QI.1-1792
I-1
II-9
II-14
II-13



QI.1-1793
I-1
II-9
II-15
II-13



QI.1-1794
I-1
II-9
II-18
II-13



QI.1-1795
I-1
II-9
II-19
II-13



QI.1-1796
I-1
II-9
II-20
II-13



QI.1-1797
I-1
II-9
II-21
II-13



QI.1-1798
I-1
II-9
II-22
II-13



QI.1-1799
I-1
II-9
II-23
II-13



QI.1-1800
I-1
II-9
II-24
II-13



QI.1-1801
I-1
II-9
II-25
II-13



QI.1-1802
I-1
II-9
II-26
II-13



QI.1-1803
I-1
II-9
II-27
II-13



QI.1-1804
I-1
II-9
II-28
II-13



QI.1-1805
I-1
II-9
II-29
II-13



QI.1-1806
I-1
II-9
II-15
II-14



QI.1-1807
I-1
II-9
II-18
II-14



QI.1-1808
I-1
II-9
II-19
II-14



QI.1-1809
I-1
II-9
II-20
II-14



QI.1-1810
I-1
II-9
II-21
II-14



QI.1-1811
I-1
II-9
II-22
II-14



QI.1-1812
I-1
II-9
II-23
II-14



QI.1-1813
I-1
II-9
II-24
II-14



QI.1-1814
I-1
II-9
II-25
II-14



QI.1-1815
I-1
II-9
II-26
II-14



QI.1-1816
I-1
II-9
II-27
II-14



QI.1-1817
I-1
II-9
II-28
II-14



QI.1-1818
I-1
II-9
II-29
II-14



QI.1-1819
I-1
II-9
II-18
II-15



QI.1-1820
I-1
II-9
II-19
II-15



QI.1-1821
I-1
II-9
II-20
II-15



QI.1-1822
I-1
II-9
II-21
II-15



QI.1-1823
I-1
II-9
II-22
II-15



QI.1-1824
I-1
II-9
II-23
II-15



QI.1-1825
I-1
II-9
II-24
II-15



QI.1-1826
I-1
II-9
II-25
II-15



QI.1-1827
I-1
II-9
II-26
II-15



QI.1-1828
I-1
II-9
II-27
II-15



QI.1-1829
I-1
II-9
II-28
II-15



QI.1-1830
I-1
II-9
II-29
II-15



QI.1-1831
I-1
II-9
II-19
II-18



QI.1-1832
I-1
II-9
II-20
II-18



QI.1-1833
I-1
II-9
II-21
II-18



QI.1-1834
I-1
II-9
II-22
II-18



QI.1-1835
I-1
II-9
II-23
II-18



QI.1-1836
I-1
II-9
II-24
II-18



QI.1-1837
I-1
II-9
II-25
II-18



QI.1-1838
I-1
II-9
II-26
II-18



QI.1-1839
I-1
II-9
II-27
II-18



QI.1-1840
I-1
II-9
II-28
II-18



QI.1-1841
I-1
II-9
II-29
II-18



QI.1-1842
I-1
II-9
II-20
II-19



QI.1-1843
I-1
II-9
II-21
II-19



QI.1-1844
I-1
II-9
II-22
II-19



QI.1-1845
I-1
II-9
II-23
II-19



QI.1-1846
I-1
II-9
II-24
II-19



QI.1-1847
I-1
II-9
II-25
II-19



QI.1-1848
I-1
II-9
II-26
II-19



QI.1-1849
I-1
II-9
II-27
II-19



QI.1-1850
I-1
II-9
II-28
II-19



QI.1-1851
I-1
II-9
II-29
II-19



QI.1-1852
I-1
II-9
II-21
II-20



QI.1-1853
I-1
II-9
II-22
II-20



QI.1-1854
I-1
II-9
II-23
II-20



QI.1-1855
I-1
II-9
II-24
II-20



QI.1-1856
I-1
II-9
II-25
II-20



QI.1-1857
I-1
II-9
II-26
II-20



QI.1-1858
I-1
II-9
II-27
II-20



QI.1-1859
I-1
II-9
II-28
II-20



QI.1-1860
I-1
II-9
II-29
II-20



QI.1-1861
I-1
II-9
II-22
II-21



QI.1-1862
I-1
II-9
II-23
II-21



QI.1-1863
I-1
II-9
II-24
II-21



QI.1-1864
I-1
II-9
II-25
II-21



QI.1-1865
I-1
II-9
II-26
II-21



QI.1-1866
I-1
II-9
II-27
II-21



QI.1-1867
I-1
II-9
II-28
II-21



QI.1-1868
I-1
II-9
II-29
II-21



QI.1-1869
I-1
II-9
II-23
II-22



QI.1-1870
I-1
II-9
II-24
II-22



QI.1-1871
I-1
II-9
II-25
II-22



QI.1-1872
I-1
II-9
II-26
II-22



QI.1-1873
I-1
II-9
II-27
II-22



QI.1-1874
I-1
II-9
II-28
II-22



QI.1-1875
I-1
II-9
II-29
II-22



QI.1-1876
I-1
II-9
II-24
II-23



QI.1-1877
I-1
II-9
II-25
II-23



QI.1-1878
I-1
II-9
II-26
II-23



QI.1-1879
I-1
II-9
II-27
II-23



QI.1-1880
I-1
II-9
II-28
II-23



QI.1-1881
I-1
II-9
II-29
II-23



QI.1-1882
I-1
II-9
II-25
II-24



QI.1-1883
I-1
II-9
II-26
II-24



QI.1-1884
I-1
II-9
II-27
II-24



QI.1-1885
I-1
II-9
II-28
II-24



QI.1-1886
I-1
II-9
II-29
II-24



QI.1-1887
I-1
II-9
II-26
II-25



QI.1-1888
I-1
II-9
II-27
II-25



QI.1-1889
I-1
II-9
II-28
II-25



QI.1-1890
I-1
II-9
II-29
II-25



QI.1-1891
I-1
II-9
II-27
II-26



QI.1-1892
I-1
II-9
II-28
II-26



QI.1-1893
I-1
II-9
II-29
II-26



QI.1-1894
I-1
II-9
II-28
II-27



QI.1-1895
I-1
II-9
II-29
II-27



QI.1-1896
I-1
II-9
II-29
II-28



QI.1-1897
I-1
II-10
II-2
II-1



QI.1-1898
I-1
II-10
II-3
II-1



QI.1-1899
I-1
II-10
II-6
II-1



QI.1-1900
I-1
II-10
II-7
II-1



QI.1-1901
I-1
II-10
II-8
II-1



QI.1-1902
I-1
II-10
II-9
II-1



QI.1-1903
I-1
II-10
II-11
II-1



QI.1-1904
I-1
II-10
II-12
II-1



QI.1-1905
I-1
II-10
II-13
II-1



QI.1-1906
I-1
II-10
II-14
II-1



QI.1-1907
I-1
II-10
II-15
II-1



QI.1-1908
I-1
II-10
II-18
II-1



QI.1-1909
I-1
II-10
II-19
II-1



QI.1-1910
I-1
II-10
II-20
II-1



QI.1-1911
I-1
II-10
II-21
II-1



QI.1-1912
I-1
II-10
II-22
II-1



QI.1-1913
I-1
II-10
II-23
II-1



QI.1-1914
I-1
II-10
II-24
II-1



QI.1-1915
I-1
II-10
II-25
II-1



QI.1-1916
I-1
II-10
II-26
II-1



QI.1-1917
I-1
II-10
II-27
II-1



QI.1-1918
I-1
II-10
II-28
II-1



QI.1-1919
I-1
II-10
II-29
II-1



QI.1-1920
I-1
II-10
II-3
II-2



QI.1-1921
I-1
II-10
II-6
II-2



QI.1-1922
I-1
II-10
II-7
II-2



QI.1-1923
I-1
II-10
II-8
II-2



QI.1-1924
I-1
II-10
II-9
II-2



QI.1-1925
I-1
II-10
II-11
II-2



QI.1-1926
I-1
II-10
II-12
II-2



QI.1-1927
I-1
II-10
II-13
II-2



QI.1-1928
I-1
II-10
II-14
II-2



QI.1-1929
I-1
II-10
II-15
II-2



QI.1-1930
I-1
II-10
II-18
II-2



QI.1-1931
I-1
II-10
II-19
II-2



QI.1-1932
I-1
II-10
II-20
II-2



QI.1-1933
I-1
II-10
II-21
II-2



QI.1-1934
I-1
II-10
II-22
II-2



QI.1-1935
I-1
II-10
II-23
II-2



QI.1-1936
I-1
II-10
II-24
II-2



QI.1-1937
I-1
II-10
II-25
II-2



QI.1-1938
I-1
II-10
II-26
II-2



QI.1-1939
I-1
II-10
II-27
II-2



QI.1-1940
I-1
II-10
II-28
II-2



QI.1-1941
I-1
II-10
II-29
II-2



QI.1-1942
I-1
II-10
II-6
II-3



QI.1-1943
I-1
II-10
II-7
II-3



QI.1-1944
I-1
II-10
II-8
II-3



QI.1-1945
I-1
II-10
II-9
II-3



QI.1-1946
I-1
II-10
II-11
II-3



QI.1-1947
I-1
II-10
II-12
II-3



QI.1-1948
I-1
II-10
II-13
II-3



QI.1-1949
I-1
II-10
II-14
II-3



QI.1-1950
I-1
II-10
II-15
II-3



QI.1-1951
I-1
II-10
II-18
II-3



QI.1-1952
I-1
II-10
II-19
II-3



QI.1-1953
I-1
II-10
II-20
II-3



QI.1-1954
I-1
II-10
II-21
II-3



QI.1-1955
I-1
II-10
II-22
II-3



QI.1-1956
I-1
II-10
II-23
II-3



QI.1-1957
I-1
II-10
II-24
II-3



QI.1-1958
I-1
II-10
II-25
II-3



QI.1-1959
I-1
II-10
II-26
II-3



QI.1-1960
I-1
II-10
II-27
II-3



QI.1-1961
I-1
II-10
II-28
II-3



QI.1-1962
I-1
II-10
II-29
II-3



QI.1-1963
I-1
II-10
II-7
II-6



QI.1-1964
I-1
II-10
II-8
II-6



QI.1-1965
I-1
II-10
II-9
II-6



QI.1-1966
I-1
II-10
II-11
II-6



QI.1-1967
I-1
II-10
II-12
II-6



QI.1-1968
I-1
II-10
II-13
II-6



QI.1-1969
I-1
II-10
II-14
II-6



QI.1-1970
I-1
II-10
II-15
II-6



QI.1-1971
I-1
II-10
II-18
II-6



QI.1-1972
I-1
II-10
II-19
II-6



QI.1-1973
I-1
II-10
II-20
II-6



QI.1-1974
I-1
II-10
II-21
II-6



QI.1-1975
I-1
II-10
II-22
II-6



QI.1-1976
I-1
II-10
II-23
II-6



QI.1-1977
I-1
II-10
II-24
II-6



QI.1-1978
I-1
II-10
II-25
II-6



QI.1-1979
I-1
II-10
II-26
II-6



QI.1-1980
I-1
II-10
II-27
II-6



QI.1-1981
I-1
II-10
II-28
II-6



QI.1-1982
I-1
II-10
II-29
II-6



QI.1-1983
I-1
II-10
II-8
II-7



QI.1-1984
I-1
II-10
II-9
II-7



QI.1-1985
I-1
II-10
II-11
II-7



QI.1-1986
I-1
II-10
II-12
II-7



QI.1-1987
I-1
II-10
II-13
II-7



QI.1-1988
I-1
II-10
II-14
II-7



QI.1-1989
I-1
II-10
II-15
II-7



QI.1-1990
I-1
II-10
II-18
II-7



QI.1-1991
I-1
II-10
II-19
II-7



QI.1-1992
I-1
II-10
II-20
II-7



QI.1-1993
I-1
II-10
II-21
II-7



QI.1-1994
I-1
II-10
II-22
II-7



QI.1-1995
I-1
II-10
II-23
II-7



QI.1-1996
I-1
II-10
II-24
II-7



QI.1-1997
I-1
II-10
II-25
II-7



QI.1-1998
I-1
II-10
II-26
II-7



QI.1-1999
I-1
II-10
II-27
II-7



QI.1-2000
I-1
II-10
II-28
II-7



QI.1-2001
I-1
II-10
II-29
II-7



QI.1-2002
I-1
II-10
II-9
II-8



QI.1-2003
I-1
II-10
II-11
II-8



QI.1-2004
I-1
II-10
II-12
II-8



QI.1-2005
I-1
II-10
II-13
II-8



QI.1-2006
I-1
II-10
II-14
II-8



QI.1-2007
I-1
II-10
II-15
II-8



QI.1-2008
I-1
II-10
II-18
II-8



QI.1-2009
I-1
II-10
II-19
II-8



QI.1-2010
I-1
II-10
II-20
II-8



QI.1-2011
I-1
II-10
II-21
II-8



QI.1-2012
I-1
II-10
II-22
II-8



QI.1-2013
I-1
II-10
II-23
II-8



QI.1-2014
I-1
II-10
II-24
II-8



QI.1-2015
I-1
II-10
II-25
II-8



QI.1-2016
I-1
II-10
II-26
II-8



QI.1-2017
I-1
II-10
II-27
II-8



QI.1-2018
I-1
II-10
II-28
II-8



QI.1-2019
I-1
II-10
II-29
II-8



QI.1-2020
I-1
II-10
II-11
II-9



QI.1-2021
I-1
II-10
II-12
II-9



QI.1-2022
I-1
II-10
II-13
II-9



QI.1-2023
I-1
II-10
II-14
II-9



QI.1-2024
I-1
II-10
II-15
II-9



QI.1-2025
I-1
II-10
II-18
II-9



QI.1-2026
I-1
II-10
II-19
II-9



QI.1-2027
I-1
II-10
II-20
II-9



QI.1-2028
I-1
II-10
II-21
II-9



QI.1-2029
I-1
II-10
II-22
II-9



QI.1-2030
I-1
II-10
II-23
II-9



QI.1-2031
I-1
II-10
II-24
II-9



QI.1-2032
I-1
II-10
II-25
II-9



QI.1-2033
I-1
II-10
II-26
II-9



QI.1-2034
I-1
II-10
II-27
II-9



QI.1-2035
I-1
II-10
II-28
II-9



QI.1-2036
I-1
II-10
II-29
II-9



QI.1-2037
I-1
II-10
II-12
II-11



QI.1-2038
I-1
II-10
II-13
II-11



QI.1-2039
I-1
II-10
II-14
II-11



QI.1-2040
I-1
II-10
II-15
II-11



QI.1-2041
I-1
II-10
II-18
II-11



QI.1-2042
I-1
II-10
II-19
II-11



QI.1-2043
I-1
II-10
II-20
II-11



QI.1-2044
I-1
II-10
II-21
II-11



QI.1-2045
I-1
II-10
II-22
II-11



QI.1-2046
I-1
II-10
II-23
II-11



QI.1-2047
I-1
II-10
II-24
II-11



QI.1-2048
I-1
II-10
II-25
II-11



QI.1-2049
I-1
II-10
II-26
II-11



QI.1-2050
I-1
II-10
II-27
II-11



QI.1-2051
I-1
II-10
II-28
II-11



QI.1-2052
I-1
II-10
II-29
II-11



QI.1-2053
I-1
II-10
II-13
II-12



QI.1-2054
I-1
II-10
II-14
II-12



QI.1-2055
I-1
II-10
II-15
II-12



QI.1-2056
I-1
II-10
II-18
II-12



QI.1-2057
I-1
II-10
II-19
II-12



QI.1-2058
I-1
II-10
II-20
II-12



QI.1-2059
I-1
II-10
II-21
II-12



QI.1-2060
I-1
II-10
II-22
II-12



QI.1-2061
I-1
II-10
II-23
II-12



QI.1-2062
I-1
II-10
II-24
II-12



QI.1-2063
I-1
II-10
II-25
II-12



QI.1-2064
I-1
II-10
II-26
II-12



QI.1-2065
I-1
II-10
II-27
II-12



QI.1-2066
I-1
II-10
II-28
II-12



QI.1-2067
I-1
II-10
II-29
II-12



QI.1-2068
I-1
II-10
II-14
II-13



QI.1-2069
I-1
II-10
II-15
II-13



QI.1-2070
I-1
II-10
II-18
II-13



QI.1-2071
I-1
II-10
II-19
II-13



QI.1-2072
I-1
II-10
II-20
II-13



QI.1-2073
I-1
II-10
II-21
II-13



QI.1-2074
I-1
II-10
II-22
II-13



QI.1-2075
I-1
II-10
II-23
II-13



QI.1-2076
I-1
II-10
II-24
II-13



QI.1-2077
I-1
II-10
II-25
II-13



QI.1-2078
I-1
II-10
II-26
II-13



QI.1-2079
I-1
II-10
II-27
II-13



QI.1-2080
I-1
II-10
II-28
II-13



QI.1-2081
I-1
II-10
II-29
II-13



QI.1-2082
I-1
II-10
II-15
II-14



QI.1-2083
I-1
II-10
II-18
II-14



QI.1-2084
I-1
II-10
II-19
II-14



QI.1-2085
I-1
II-10
II-20
II-14



QI.1-2086
I-1
II-10
II-21
II-14



QI.1-2087
I-1
II-10
II-22
II-14



QI.1-2088
I-1
II-10
II-23
II-14



QI.1-2089
I-1
II-10
II-24
II-14



QI.1-2090
I-1
II-10
II-25
II-14



QI.1-2091
I-1
II-10
II-26
II-14



QI.1-2092
I-1
II-10
II-27
II-14



QI.1-2093
I-1
II-10
II-28
II-14



QI.1-2094
I-1
II-10
II-29
II-14



QI.1-2095
I-1
II-10
II-18
II-15



QI.1-2096
I-1
II-10
II-19
II-15



QI.1-2097
I-1
II-10
II-20
II-15



QI.1-2098
I-1
II-10
II-21
II-15



QI.1-2099
I-1
II-10
II-22
II-15



QI.1-2100
I-1
II-10
II-23
II-15



QI.1-2101
I-1
II-10
II-24
II-15



QI.1-2102
I-1
II-10
II-25
II-15



QI.1-2103
I-1
II-10
II-26
II-15



QI.1-2104
I-1
II-10
II-27
II-15



QI.1-2105
I-1
II-10
II-28
II-15



QI.1-2106
I-1
II-10
II-29
II-15



QI.1-2107
I-1
II-10
II-19
II-18



QI.1-2108
I-1
II-10
II-20
II-18



QI.1-2109
I-1
II-10
II-21
II-18



QI.1-2110
I-1
II-10
II-22
II-18



QI.1-2111
I-1
II-10
II-23
II-18



QI.1-2112
I-1
II-10
II-24
II-18



QI.1-2113
I-1
II-10
II-25
II-18



QI.1-2114
I-1
II-10
II-26
II-18



QI.1-2115
I-1
II-10
II-27
II-18



QI.1-2116
I-1
II-10
II-28
II-18



QI.1-2117
I-1
II-10
II-29
II-18



QI.1-2118
I-1
II-10
II-20
II-19



QI.1-2119
I-1
II-10
II-21
II-19



QI.1-2120
I-1
II-10
II-22
II-19



QI.1-2121
I-1
II-10
II-23
II-19



QI.1-2122
I-1
II-10
II-24
II-19



QI.1-2123
I-1
II-10
II-25
II-19



QI.1-2124
I-1
II-10
II-26
II-19



QI.1-2125
I-1
II-10
II-27
II-19



QI.1-2126
I-1
II-10
II-28
II-19



QI.1-2127
I-1
II-10
II-29
II-19



QI.1-2128
I-1
II-10
II-21
II-20



QI.1-2129
I-1
II-10
II-22
II-20



QI.1-2130
I-1
II-10
II-23
II-20



QI.1-2131
I-1
II-10
II-24
II-20



QI.1-2132
I-1
II-10
II-25
II-20



QI.1-2133
I-1
II-10
II-26
II-20



QI.1-2134
I-1
II-10
II-27
II-20



QI.1-2135
I-1
II-10
II-28
II-20



QI.1-2136
I-1
II-10
II-29
II-20



QI.1-2137
I-1
II-10
II-22
II-21



QI.1-2138
I-1
II-10
II-23
II-21



QI.1-2139
I-1
II-10
II-24
II-21



QI.1-2140
I-1
II-10
II-25
II-21



QI.1-2141
I-1
II-10
II-26
II-21



QI.1-2142
I-1
II-10
II-27
II-21



QI.1-2143
I-1
II-10
II-28
II-21



QI.1-2144
I-1
II-10
II-29
II-21



QI.1-2145
I-1
II-10
II-23
II-22



QI.1-2146
I-1
II-10
II-24
II-22



QI.1-2147
I-1
II-10
II-25
II-22



QI.1-2148
I-1
II-10
II-26
II-22



QI.1-2149
I-1
II-10
II-27
II-22



QI.1-2150
I-1
II-10
II-28
II-22



QI.1-2151
I-1
II-10
II-29
II-22



QI.1-2152
I-1
II-10
II-24
II-23



QI.1-2153
I-1
II-10
II-25
II-23



QI.1-2154
I-1
II-10
II-26
II-23



QI.1-2155
I-1
II-10
II-27
II-23



QI.1-2156
I-1
II-10
II-28
II-23



QI.1-2157
I-1
II-10
II-29
II-23



QI.1-2158
I-1
II-10
II-25
II-24



QI.1-2159
I-1
II-10
II-26
II-24



QI.1-2160
I-1
II-10
II-27
II-24



QI.1-2161
I-1
II-10
II-28
II-24



QI.1-2162
I-1
II-10
II-29
II-24



QI.1-2163
I-1
II-10
II-26
II-25



QI.1-2164
I-1
II-10
II-27
II-25



QI.1-2165
I-1
II-10
II-28
II-25



QI.1-2166
I-1
II-10
II-29
II-25



QI.1-2167
I-1
II-10
II-27
II-26



QI.1-2168
I-1
II-10
II-28
II-26



QI.1-2169
I-1
II-10
II-29
II-26



QI.1-2170
I-1
II-10
II-28
II-27



QI.1-2171
I-1
II-10
II-29
II-27



QI.1-2172
I-1
II-10
II-29
II-28



QI.1-2173
I-1
II-11
II-13
II-12



QI.1-2174
I-1
II-11
II-14
II-12



QI.1-2175
I-1
II-11
II-15
II-12



QI.1-2176
I-1
II-11
II-18
II-12



QI.1-2177
I-1
II-11
II-19
II-12



QI.1-2178
I-1
II-11
II-20
II-12



QI.1-2179
I-1
II-11
II-21
II-12



QI.1-2180
I-1
II-11
II-22
II-12



QI.1-2181
I-1
II-11
II-23
II-12



QI.1-2182
I-1
II-11
II-24
II-12



QI.1-2183
I-1
II-11
II-25
II-12



QI.1-2184
I-1
II-11
II-26
II-12



QI.1-2185
I-1
II-11
II-27
II-12



QI.1-2186
I-1
II-11
II-28
II-12



QI.1-2187
I-1
II-11
II-29
II-12



QI.1-2188
I-1
II-11
II-14
II-13



QI.1-2189
I-1
II-11
II-15
II-13



QI.1-2190
I-1
II-11
II-18
II-13



QI.1-2191
I-1
II-11
II-19
II-13



QI.1-2192
I-1
II-11
II-20
II-13



QI.1-2193
I-1
II-11
II-21
II-13



QI.1-2194
I-1
II-11
II-22
II-13



QI.1-2195
I-1
II-11
II-23
II-13



QI.1-2196
I-1
II-11
II-24
II-13



QI.1-2197
I-1
II-11
II-25
II-13



QI.1-2198
I-1
II-11
II-26
II-13



QI.1-2199
I-1
II-11
II-27
II-13



QI.1-2200
I-1
II-11
II-28
II-13



QI.1-2201
I-1
II-11
II-29
II-13



QI.1-2202
I-1
II-11
II-15
II-14



QI.1-2203
I-1
II-11
II-18
II-14



QI.1-2204
I-1
II-11
II-19
II-14



QI.1-2205
I-1
II-11
II-20
II-14



QI.1-2206
I-1
II-11
II-21
II-14



QI.1-2207
I-1
II-11
II-22
II-14



QI.1-2208
I-1
II-11
II-23
II-14



QI.1-2209
I-1
II-11
II-24
II-14



QI.1-2210
I-1
II-11
II-25
II-14



QI.1-2211
I-1
II-11
II-26
II-14



QI.1-2212
I-1
II-11
II-27
II-14



QI.1-2213
I-1
II-11
II-28
II-14



QI.1-2214
I-1
II-11
II-29
II-14



QI.1-2215
I-1
II-11
II-18
II-15



QI.1-2216
I-1
II-11
II-19
II-15



QI.1-2217
I-1
II-11
II-20
II-15



QI.1-2218
I-1
II-11
II-21
II-15



QI.1-2219
I-1
II-11
II-22
II-15



QI.1-2220
I-1
II-11
II-23
II-15



QI.1-2221
I-1
II-11
II-24
II-15



QI.1-2222
I-1
II-11
II-25
II-15



QI.1-2223
I-1
II-11
II-26
II-15



QI.1-2224
I-1
II-11
II-27
II-15



QI.1-2225
I-1
II-11
II-28
II-15



QI.1-2226
I-1
II-11
II-29
II-15



QI.1-2227
I-1
II-11
II-19
II-18



QI.1-2228
I-1
II-11
II-20
II-18



QI.1-2229
I-1
II-11
II-21
II-18



QI.1-2230
I-1
II-11
II-22
II-18



QI.1-2231
I-1
II-11
II-23
II-18



QI.1-2232
I-1
II-11
II-24
II-18



QI.1-2233
I-1
II-11
II-25
II-18



QI.1-2234
I-1
II-11
II-26
II-18



QI.1-2235
I-1
II-11
II-27
II-18



QI.1-2236
I-1
II-11
II-28
II-18



QI.1-2237
I-1
II-11
II-29
II-18



QI.1-2238
I-1
II-11
II-20
II-19



QI.1-2239
I-1
II-11
II-21
II-19



QI.1-2240
I-1
II-11
II-22
II-19



QI.1-2241
I-1
II-11
II-23
II-19



QI.1-2242
I-1
II-11
II-24
II-19



QI.1-2243
I-1
II-11
II-25
II-19



QI.1-2244
I-1
II-11
II-26
II-19



QI.1-2245
I-1
II-11
II-27
II-19



QI.1-2246
I-1
II-11
II-28
II-19



QI.1-2247
I-1
II-11
II-29
II-19



QI.1-2248
I-1
II-11
II-21
II-20



QI.1-2249
I-1
II-11
II-22
II-20



QI.1-2250
I-1
II-11
II-23
II-20



QI.1-2251
I-1
II-11
II-24
II-20



QI.1-2252
I-1
II-11
II-25
II-20



QI.1-2253
I-1
II-11
II-26
II-20



QI.1-2254
I-1
II-11
II-27
II-20



QI.1-2255
I-1
II-11
II-28
II-20



QI.1-2256
I-1
II-11
II-29
II-20



QI.1-2257
I-1
II-11
II-22
II-21



QI.1-2258
I-1
II-11
II-23
II-21



QI.1-2259
I-1
II-11
II-24
II-21



QI.1-2260
I-1
II-11
II-25
II-21



QI.1-2261
I-1
II-11
II-26
II-21



QI.1-2262
I-1
II-11
II-27
II-21



QI.1-2263
I-1
II-11
II-28
II-21



QI.1-2264
I-1
II-11
II-29
II-21



QI.1-2265
I-1
II-11
II-23
II-22



QI.1-2266
I-1
II-11
II-24
II-22



QI.1-2267
I-1
II-11
II-25
II-22



QI.1-2268
I-1
II-11
II-26
II-22



QI.1-2269
I-1
II-11
II-27
II-22



QI.1-2270
I-1
II-11
II-28
II-22



QI.1-2271
I-1
II-11
II-29
II-22



QI.1-2272
I-1
II-11
II-24
II-23



QI.1-2273
I-1
II-11
II-25
II-23



QI.1-2274
I-1
II-11
II-26
II-23



QI.1-2275
I-1
II-11
II-27
II-23



QI.1-2276
I-1
II-11
II-28
II-23



QI.1-2277
I-1
II-11
II-29
II-23



QI.1-2278
I-1
II-11
II-25
II-24



QI.1-2279
I-1
II-11
II-26
II-24



QI.1-2280
I-1
II-11
II-27
II-24



QI.1-2281
I-1
II-11
II-28
II-24



QI.1-2282
I-1
II-11
II-29
II-24



QI.1-2283
I-1
II-11
II-26
II-25



QI.1-2284
I-1
II-11
II-27
II-25



QI.1-2285
I-1
II-11
II-28
II-25



QI.1-2286
I-1
II-11
II-29
II-25



QI.1-2287
I-1
II-11
II-27
II-26



QI.1-2288
I-1
II-11
II-28
II-26



QI.1-2289
I-1
II-11
II-29
II-26



QI.1-2290
I-1
II-11
II-28
II-27



QI.1-2291
I-1
II-11
II-29
II-27



QI.1-2292
I-1
II-11
II-29
II-28



QI.1-2293
I-1
II-12
II-14
II-13



QI.1-2294
I-1
II-12
II-15
II-13



QI.1-2295
I-1
II-12
II-18
II-13



QI.1-2296
I-1
II-12
II-19
II-13



QI.1-2297
I-1
II-12
II-20
II-13



QI.1-2298
I-1
II-12
II-21
II-13



QI.1-2299
I-1
II-12
II-22
II-13



QI.1-2300
I-1
II-12
II-23
II-13



QI.1-2301
I-1
II-12
II-24
II-13



QI.1-2302
I-1
II-12
II-25
II-13



QI.1-2303
I-1
II-12
II-26
II-13



QI.1-2304
I-1
II-12
II-27
II-13



QI.1-2305
I-1
II-12
II-28
II-13



QI.1-2306
I-1
II-12
II-29
II-13



QI.1-2307
I-1
II-12
II-15
II-14



QI.1-2308
I-1
II-12
II-18
II-14



QI.1-2309
I-1
II-12
II-19
II-14



QI.1-2310
I-1
II-12
II-20
II-14



QI.1-2311
I-1
II-12
II-21
II-14



QI.1-2312
I-1
II-12
II-22
II-14



QI.1-2313
I-1
II-12
II-23
II-14



QI.1-2314
I-1
II-12
II-24
II-14



QI.1-2315
I-1
II-12
II-25
II-14



QI.1-2316
I-1
II-12
II-26
II-14



QI.1-2317
I-1
II-12
II-27
II-14



QI.1-2318
I-1
II-12
II-28
II-14



QI.1-2319
I-1
II-12
II-29
II-14



QI.1-2320
I-1
II-12
II-18
II-15



QI.1-2321
I-1
II-12
II-19
II-15



QI.1-2322
I-1
II-12
II-20
II-15



QI.1-2323
I-1
II-12
II-21
II-15



QI.1-2324
I-1
II-12
II-22
II-15



QI.1-2325
I-1
II-12
II-23
II-15



QI.1-2326
I-1
II-12
II-24
II-15



QI.1-2327
I-1
II-12
II-25
II-15



QI.1-2328
I-1
II-12
II-26
II-15



QI.1-2329
I-1
II-12
II-27
II-15



QI.1-2330
I-1
II-12
II-28
II-15



QI.1-2331
I-1
II-12
II-29
II-15



QI.1-2332
I-1
II-12
II-19
II-18



QI.1-2333
I-1
II-12
II-20
II-18



QI.1-2334
I-1
II-12
II-21
II-18



QI.1-2335
I-1
II-12
II-22
II-18



QI.1-2336
I-1
II-12
II-23
II-18



QI.1-2337
I-1
II-12
II-24
II-18



QI.1-2338
I-1
II-12
II-25
II-18



QI.1-2339
I-1
II-12
II-26
II-18



QI.1-2340
I-1
II-12
II-27
II-18



QI.1-2341
I-1
II-12
II-28
II-18



QI.1-2342
I-1
II-12
II-29
II-18



QI.1-2343
I-1
II-12
II-20
II-19



QI.1-2344
I-1
II-12
II-21
II-19



QI.1-2345
I-1
II-12
II-22
II-19



QI.1-2346
I-1
II-12
II-23
II-19



QI.1-2347
I-1
II-12
II-24
II-19



QI.1-2348
I-1
II-12
II-25
II-19



QI.1-2349
I-1
II-12
II-26
II-19



QI.1-2350
I-1
II-12
II-27
II-19



QI.1-2351
I-1
II-12
II-28
II-19



QI.1-2352
I-1
II-12
II-29
II-19



QI.1-2353
I-1
II-12
II-21
II-20



QI.1-2354
I-1
II-12
II-22
II-20



QI.1-2355
I-1
II-12
II-23
II-20



QI.1-2356
I-1
II-12
II-24
II-20



QI.1-2357
I-1
II-12
II-25
II-20



QI.1-2358
I-1
II-12
II-26
II-20



QI.1-2359
I-1
II-12
II-27
II-20



QI.1-2360
I-1
II-12
II-28
II-20



QI.1-2361
I-1
II-12
II-29
II-20



QI.1-2362
I-1
II-12
II-22
II-21



QI.1-2363
I-1
II-12
II-23
II-21



QI.1-2364
I-1
II-12
II-24
II-21



QI.1-2365
I-1
II-12
II-25
II-21



QI.1-2366
I-1
II-12
II-26
II-21



QI.1-2367
I-1
II-12
II-27
II-21



QI.1-2368
I-1
II-12
II-28
II-21



QI.1-2369
I-1
II-12
II-29
II-21



QI.1-2370
I-1
II-12
II-23
II-22



QI.1-2371
I-1
II-12
II-24
II-22



QI.1-2372
I-1
II-12
II-25
II-22



QI.1-2373
I-1
II-12
II-26
II-22



QI.1-2374
I-1
II-12
II-27
II-22



QI.1-2375
I-1
II-12
II-28
II-22



QI.1-2376
I-1
II-12
II-29
II-22



QI.1-2377
I-1
II-12
II-24
II-23



QI.1-2378
I-1
II-12
II-25
II-23



QI.1-2379
I-1
II-12
II-26
II-23



QI.1-2380
I-1
II-12
II-27
II-23



QI.1-2381
I-1
II-12
II-28
II-23



QI.1-2382
I-1
II-12
II-29
II-23



QI.1-2383
I-1
II-12
II-25
II-24



QI.1-2384
I-1
II-12
II-26
II-24



QI.1-2385
I-1
II-12
II-27
II-24



QI.1-2386
I-1
II-12
II-28
II-24



QI.1-2387
I-1
II-12
II-29
II-24



QI.1-2388
I-1
II-12
II-26
II-25



QI.1-2389
I-1
II-12
II-27
II-25



QI.1-2390
I-1
II-12
II-28
II-25



QI.1-2391
I-1
II-12
II-29
II-25



QI.1-2392
I-1
II-12
II-27
II-26



QI.1-2393
I-1
II-12
II-28
II-26



QI.1-2394
I-1
II-12
II-29
II-26



QI.1-2395
I-1
II-12
II-28
II-27



QI.1-2396
I-1
II-12
II-29
II-27



QI.1-2397
I-1
II-12
II-29
II-28



QI.1-2398
I-1
II-13
II-15
II-14



QI.1-2399
I-1
II-13
II-18
II-14



QI.1-2400
I-1
II-13
II-19
II-14



QI.1-2401
I-1
II-13
II-20
II-14



QI.1-2402
I-1
II-13
II-21
II-14



QI.1-2403
I-1
II-13
II-22
II-14



QI.1-2404
I-1
II-13
II-23
II-14



QI.1-2405
I-1
II-13
II-24
II-14



QI.1-2406
I-1
II-13
II-25
II-14



QI.1-2407
I-1
II-13
II-26
II-14



QI.1-2408
I-1
II-13
II-27
II-14



QI.1-2409
I-1
II-13
II-28
II-14



QI.1-2410
I-1
II-13
II-29
II-14



QI.1-2411
I-1
II-13
II-18
II-15



QI.1-2412
I-1
II-13
II-19
II-15



QI.1-2413
I-1
II-13
II-20
II-15



QI.1-2414
I-1
II-13
II-21
II-15



QI.1-2415
I-1
II-13
II-22
II-15



QI.1-2416
I-1
II-13
II-23
II-15



QI.1-2417
I-1
II-13
II-24
II-15



QI.1-2418
I-1
II-13
II-25
II-15



QI.1-2419
I-1
II-13
II-26
II-15



QI.1-2420
I-1
II-13
II-27
II-15



QI.1-2421
I-1
II-13
II-28
II-15



QI.1-2422
I-1
II-13
II-29
II-15



QI.1-2423
I-1
II-13
II-19
II-18



QI.1-2424
I-1
II-13
II-20
II-18



QI.1-2425
I-1
II-13
II-21
II-18



QI.1-2426
I-1
II-13
II-22
II-18



QI.1-2427
I-1
II-13
II-23
II-18



QI.1-2428
I-1
II-13
II-24
II-18



QI.1-2429
I-1
II-13
II-25
II-18



QI.1-2430
I-1
II-13
II-26
II-18



QI.1-2431
I-1
II-13
II-27
II-18



QI.1-2432
I-1
II-13
II-28
II-18



QI.1-2433
I-1
II-13
II-29
II-18



QI.1-2434
I-1
II-13
II-20
II-19



QI.1-2435
I-1
II-13
II-21
II-19



QI.1-2436
I-1
II-13
II-22
II-19



QI.1-2437
I-1
II-13
II-23
II-19



QI.1-2438
I-1
II-13
II-24
II-19



QI.1-2439
I-1
II-13
II-25
II-19



QI.1-2440
I-1
II-13
II-26
II-19



QI.1-2441
I-1
II-13
II-27
II-19



QI.1-2442
I-1
II-13
II-28
II-19



QI.1-2443
I-1
II-13
II-29
II-19



QI.1-2444
I-1
II-13
II-21
II-20



QI.1-2445
I-1
II-13
II-22
II-20



QI.1-2446
I-1
II-13
II-23
II-20



QI.1-2447
I-1
II-13
II-24
II-20



QI.1-2448
I-1
II-13
II-25
II-20



QI.1-2449
I-1
II-13
II-26
II-20



QI.1-2450
I-1
II-13
II-27
II-20



QI.1-2451
I-1
II-13
II-28
II-20



QI.1-2452
I-1
II-13
II-29
II-20



QI.1-2453
I-1
II-13
II-22
II-21



QI.1-2454
I-1
II-13
II-23
II-21



QI.1-2455
I-1
II-13
II-24
II-21



QI.1-2456
I-1
II-13
II-25
II-21



QI.1-2457
I-1
II-13
II-26
II-21



QI.1-2458
I-1
II-13
II-27
II-21



QI.1-2459
I-1
II-13
II-28
II-21



QI.1-2460
I-1
II-13
II-29
II-21



QI.1-2461
I-1
II-13
II-23
II-22



QI.1-2462
I-1
II-13
II-24
II-22



QI.1-2463
I-1
II-13
II-25
II-22



QI.1-2464
I-1
II-13
II-26
II-22



QI.1-2465
I-1
II-13
II-27
II-22



QI.1-2466
I-1
II-13
II-28
II-22



QI.1-2467
I-1
II-13
II-29
II-22



QI.1-2468
I-1
II-13
II-24
II-23



QI.1-2469
I-1
II-13
II-25
II-23



QI.1-2470
I-1
II-13
II-26
II-23



QI.1-2471
I-1
II-13
II-27
II-23



QI.1-2472
I-1
II-13
II-28
II-23



QI.1-2473
I-1
II-13
II-29
II-23



QI.1-2474
I-1
II-13
II-25
II-24



QI.1-2475
I-1
II-13
II-26
II-24



QI.1-2476
I-1
II-13
II-27
II-24



QI.1-2477
I-1
II-13
II-28
II-24



QI.1-2478
I-1
II-13
II-29
II-24



QI.1-2479
I-1
II-13
II-26
II-25



QI.1-2480
I-1
II-13
II-27
II-25



QI.1-2481
I-1
II-13
II-28
II-25



QI.1-2482
I-1
II-13
II-29
II-25



QI.1-2483
I-1
II-13
II-27
II-26



QI.1-2484
I-1
II-13
II-28
II-26



QI.1-2485
I-1
II-13
II-29
II-26



QI.1-2486
I-1
II-13
II-28
II-27



QI.1-2487
I-1
II-13
II-29
II-27



QI.1-2488
I-1
II-13
II-29
II-28



QI.1-2489
I-1
II-14
II-18
II-15



QI.1-2490
I-1
II-14
II-19
II-15



QI.1-2491
I-1
II-14
II-20
II-15



QI.1-2492
I-1
II-14
II-21
II-15



QI.1-2493
I-1
II-14
II-22
II-15



QI.1-2494
I-1
II-14
II-23
II-15



QI.1-2495
I-1
II-14
II-24
II-15



QI.1-2496
I-1
II-14
II-25
II-15



QI.1-2497
I-1
II-14
II-26
II-15



QI.1-2498
I-1
II-14
II-27
II-15



QI.1-2499
I-1
II-14
II-28
II-15



QI.1-2500
I-1
II-14
II-29
II-15



QI.1-2501
I-1
II-14
II-19
II-18



QI.1-2502
I-1
II-14
II-20
II-18



QI.1-2503
I-1
II-14
II-21
II-18



QI.1-2504
I-1
II-14
II-22
II-18



QI.1-2505
I-1
II-14
II-23
II-18



QI.1-2506
I-1
II-14
II-24
II-18



QI.1-2507
I-1
II-14
II-25
II-18



QI.1-2508
I-1
II-14
II-26
II-18



QI.1-2509
I-1
II-14
II-27
II-18



QI.1-2510
I-1
II-14
II-28
II-18



QI.1-2511
I-1
II-14
II-29
II-18



QI.1-2512
I-1
II-14
II-20
II-19



QI.1-2513
I-1
II-14
II-21
II-19



QI.1-2514
I-1
II-14
II-22
II-19



QI.1-2515
I-1
II-14
II-23
II-19



QI.1-2516
I-1
II-14
II-24
II-19



QI.1-2517
I-1
II-14
II-25
II-19



QI.1-2518
I-1
II-14
II-26
II-19



QI.1-2519
I-1
II-14
II-27
II-19



QI.1-2520
I-1
II-14
II-28
II-19



QI.1-2521
I-1
II-14
II-29
II-19



QI.1-2522
I-1
II-14
II-21
II-20



QI.1-2523
I-1
II-14
II-22
II-20



QI.1-2524
I-1
II-14
II-23
II-20



QI.1-2525
I-1
II-14
II-24
II-20



QI.1-2526
I-1
II-14
II-25
II-20



QI.1-2527
I-1
II-14
II-26
II-20



QI.1-2528
I-1
II-14
II-27
II-20



QI.1-2529
I-1
II-14
II-28
II-20



QI.1-2530
I-1
II-14
II-29
II-20



QI.1-2531
I-1
II-14
II-22
II-21



QI.1-2532
I-1
II-14
II-23
II-21



QI.1-2533
I-1
II-14
II-24
II-21



QI.1-2534
I-1
II-14
II-25
II-21



QI.1-2535
I-1
II-14
II-26
II-21



QI.1-2536
I-1
II-14
II-27
II-21



QI.1-2537
I-1
II-14
II-28
II-21



QI.1-2538
I-1
II-14
II-29
II-21



QI.1-2539
I-1
II-14
II-23
II-22



QI.1-2540
I-1
II-14
II-24
II-22



QI.1-2541
I-1
II-14
II-25
II-22



QI.1-2542
I-1
II-14
II-26
II-22



QI.1-2543
I-1
II-14
II-27
II-22



QI.1-2544
I-1
II-14
II-28
II-22



QI.1-2545
I-1
II-14
II-29
II-22



QI.1-2546
I-1
II-14
II-24
II-23



QI.1-2547
I-1
II-14
II-25
II-23



QI.1-2548
I-1
II-14
II-26
II-23



QI.1-2549
I-1
II-14
II-27
II-23



QI.1-2550
I-1
II-14
II-28
II-23



QI.1-2551
I-1
II-14
II-29
II-23



QI.1-2552
I-1
II-14
II-25
II-24



QI.1-2553
I-1
II-14
II-26
II-24



QI.1-2554
I-1
II-14
II-27
II-24



QI.1-2555
I-1
II-14
II-28
II-24



QI.1-2556
I-1
II-14
II-29
II-24



QI.1-2557
I-1
II-14
II-26
II-25



QI.1-2558
I-1
II-14
II-27
II-25



QI.1-2559
I-1
II-14
II-28
II-25



QI.1-2560
I-1
II-14
II-29
II-25



QI.1-2561
I-1
II-14
II-27
II-26



QI.1-2562
I-1
II-14
II-28
II-26



QI.1-2563
I-1
II-14
II-29
II-26



QI.1-2564
I-1
II-14
II-28
II-27



QI.1-2565
I-1
II-14
II-29
II-27



QI.1-2566
I-1
II-14
II-29
II-28



QI.1-2567
I-1
II-15
II-19
II-18



QI.1-2568
I-1
II-15
II-20
II-18



QI.1-2569
I-1
II-15
II-21
II-18



QI.1-2570
I-1
II-15
II-22
II-18



QI.1-2571
I-1
II-15
II-23
II-18



QI.1-2572
I-1
II-15
II-24
II-18



QI.1-2573
I-1
II-15
II-25
II-18



QI.1-2574
I-1
II-15
II-26
II-18



QI.1-2575
I-1
II-15
II-27
II-18



QI.1-2576
I-1
II-15
II-28
II-18



QI.1-2577
I-1
II-15
II-29
II-18



QI.1-2578
I-1
II-15
II-20
II-19



QI.1-2579
I-1
II-15
II-21
II-19



QI.1-2580
I-1
II-15
II-22
II-19



QI.1-2581
I-1
II-15
II-23
II-19



QI.1-2582
I-1
II-15
II-24
II-19



QI.1-2583
I-1
II-15
II-25
II-19



QI.1-2584
I-1
II-15
II-26
II-19



QI.1-2585
I-1
II-15
II-27
II-19



QI.1-2586
I-1
II-15
II-28
II-19



QI.1-2587
I-1
II-15
II-29
II-19



QI.1-2588
I-1
II-15
II-21
II-20



QI.1-2589
I-1
II-15
II-22
II-20



QI.1-2590
I-1
II-15
II-23
II-20



QI.1-2591
I-1
II-15
II-24
II-20



QI.1-2592
I-1
II-15
II-25
II-20



QI.1-2593
I-1
II-15
II-26
II-20



QI.1-2594
I-1
II-15
II-27
II-20



QI.1-2595
I-1
II-15
II-28
II-20



QI.1-2596
I-1
II-15
II-29
II-20



QI.1-2597
I-1
II-15
II-22
II-21



QI.1-2598
I-1
II-15
II-23
II-21



QI.1-2599
I-1
II-15
II-24
II-21



QI.1-2600
I-1
II-15
II-25
II-21



QI.1-2601
I-1
II-15
II-26
II-21



QI.1-2602
I-1
II-15
II-27
II-21



QI.1-2603
I-1
II-15
II-28
II-21



QI.1-2604
I-1
II-15
II-29
II-21



QI.1-2605
I-1
II-15
II-23
II-22



QI.1-2606
I-1
II-15
II-24
II-22



QI.1-2607
I-1
II-15
II-25
II-22



QI.1-2608
I-1
II-15
II-26
II-22



QI.1-2609
I-1
II-15
II-27
II-22



QI.1-2610
I-1
II-15
II-28
II-22



QI.1-2611
I-1
II-15
II-29
II-22



QI.1-2612
I-1
II-15
II-24
II-23



QI.1-2613
I-1
II-15
II-25
II-23



QI.1-2614
I-1
II-15
II-26
II-23



QI.1-2615
I-1
II-15
II-27
II-23



QI.1-2616
I-1
II-15
II-28
II-23



QI.1-2617
I-1
II-15
II-29
II-23



QI.1-2618
I-1
II-15
II-25
II-24



QI.1-2619
I-1
II-15
II-26
II-24



QI.1-2620
I-1
II-15
II-27
II-24



QI.1-2621
I-1
II-15
II-28
II-24



QI.1-2622
I-1
II-15
II-29
II-24



QI.1-2623
I-1
II-15
II-26
II-25



QI.1-2624
I-1
II-15
II-27
II-25



QI.1-2625
I-1
II-15
II-28
II-25



QI.1-2626
I-1
II-15
II-29
II-25



QI.1-2627
I-1
II-15
II-27
II-26



QI.1-2628
I-1
II-15
II-28
II-26



QI.1-2629
I-1
II-15
II-29
II-26



QI.1-2630
I-1
II-15
II-28
II-27



QI.1-2631
I-1
II-15
II-29
II-27



QI.1-2632
I-1
II-15
II-29
II-28



QI.1-2633
I-1
II-16
II-2
II-1



QI.1-2634
I-1
II-16
II-3
II-1



QI.1-2635
I-1
II-16
II-6
II-1



QI.1-2636
I-1
II-16
II-7
II-1



QI.1-2637
I-1
II-16
II-8
II-1



QI.1-2638
I-1
II-16
II-9
II-1



QI.1-2639
I-1
II-16
II-11
II-1



QI.1-2640
I-1
II-16
II-12
II-1



QI.1-2641
I-1
II-16
II-13
II-1



QI.1-2642
I-1
II-16
II-14
II-1



QI.1-2643
I-1
II-16
II-15
II-1



QI.1-2644
I-1
II-16
II-18
II-1



QI.1-2645
I-1
II-16
II-19
II-1



QI.1-2646
I-1
II-16
II-20
II-1



QI.1-2647
I-1
II-16
II-21
II-1



QI.1-2648
I-1
II-16
II-22
II-1



QI.1-2649
I-1
II-16
II-23
II-1



QI.1-2650
I-1
II-16
II-24
II-1



QI.1-2651
I-1
II-16
II-25
II-1



QI.1-2652
I-1
II-16
II-26
II-1



QI.1-2653
I-1
II-16
II-27
II-1



QI.1-2654
I-1
II-16
II-28
II-1



QI.1-2655
I-1
II-16
II-29
II-1



QI.1-2656
I-1
II-16
II-3
II-2



QI.1-2657
I-1
II-16
II-6
II-2



QI.1-2658
I-1
II-16
II-7
II-2



QI.1-2659
I-1
II-16
II-8
II-2



QI.1-2660
I-1
II-16
II-9
II-2



QI.1-2661
I-1
II-16
II-11
II-2



QI.1-2662
I-1
II-16
II-12
II-2



QI.1-2663
I-1
II-16
II-13
II-2



QI.1-2664
I-1
II-16
II-14
II-2



QI.1-2665
I-1
II-16
II-15
II-2



QI.1-2666
I-1
II-16
II-18
II-2



QI.1-2667
I-1
II-16
II-19
II-2



QI.1-2668
I-1
II-16
II-20
II-2



QI.1-2669
I-1
II-16
II-21
II-2



QI.1-2670
I-1
II-16
II-22
II-2



QI.1-2671
I-1
II-16
II-23
II-2



QI.1-2672
I-1
II-16
II-24
II-2



QI.1-2673
I-1
II-16
II-25
II-2



QI.1-2674
I-1
II-16
II-26
II-2



QI.1-2675
I-1
II-16
II-27
II-2



QI.1-2676
I-1
II-16
II-28
II-2



QI.1-2677
I-1
II-16
II-29
II-2



QI.1-2678
I-1
II-16
II-6
II-3



QI.1-2679
I-1
II-16
II-7
II-3



QI.1-2680
I-1
II-16
II-8
II-3



QI.1-2681
I-1
II-16
II-9
II-3



QI.1-2682
I-1
II-16
II-11
II-3



QI.1-2683
I-1
II-16
II-12
II-3



QI.1-2684
I-1
II-16
II-13
II-3



QI.1-2685
I-1
II-16
II-14
II-3



QI.1-2686
I-1
II-16
II-15
II-3



QI.1-2687
I-1
II-16
II-18
II-3



QI.1-2688
I-1
II-16
II-19
II-3



QI.1-2689
I-1
II-16
II-20
II-3



QI.1-2690
I-1
II-16
II-21
II-3



QI.1-2691
I-1
II-16
II-22
II-3



QI.1-2692
I-1
II-16
II-23
II-3



QI.1-2693
I-1
II-16
II-24
II-3



QI.1-2694
I-1
II-16
II-25
II-3



QI.1-2695
I-1
II-16
II-26
II-3



QI.1-2696
I-1
II-16
II-27
II-3



QI.1-2697
I-1
II-16
II-28
II-3



QI.1-2698
I-1
II-16
II-29
II-3



QI.1-2699
I-1
II-16
II-7
II-6



QI.1-2700
I-1
II-16
II-8
II-6



QI.1-2701
I-1
II-16
II-9
II-6



QI.1-2702
I-1
II-16
II-11
II-6



QI.1-2703
I-1
II-16
II-12
II-6



QI.1-2704
I-1
II-16
II-13
II-6



QI.1-2705
I-1
II-16
II-14
II-6



QI.1-2706
I-1
II-16
II-15
II-6



QI.1-2707
I-1
II-16
II-18
II-6



QI.1-2708
I-1
II-16
II-19
II-6



QI.1-2709
I-1
II-16
II-20
II-6



QI.1-2710
I-1
II-16
II-21
II-6



QI.1-2711
I-1
II-16
II-22
II-6



QI.1-2712
I-1
II-16
II-23
II-6



QI.1-2713
I-1
II-16
II-24
II-6



QI.1-2714
I-1
II-16
II-25
II-6



QI.1-2715
I-1
II-16
II-26
II-6



QI.1-2716
I-1
II-16
II-27
II-6



QI.1-2717
I-1
II-16
II-28
II-6



QI.1-2718
I-1
II-16
II-29
II-6



QI.1-2719
I-1
II-16
II-8
II-7



QI.1-2720
I-1
II-16
II-9
II-7



QI.1-2721
I-1
II-16
II-11
II-7



QI.1-2722
I-1
II-16
II-12
II-7



QI.1-2723
I-1
II-16
II-13
II-7



QI.1-2724
I-1
II-16
II-14
II-7



QI.1-2725
I-1
II-16
II-15
II-7



QI.1-2726
I-1
II-16
II-18
II-7



QI.1-2727
I-1
II-16
II-19
II-7



QI.1-2728
I-1
II-16
II-20
II-7



QI.1-2729
I-1
II-16
II-21
II-7



QI.1-2730
I-1
II-16
II-22
II-7



QI.1-2731
I-1
II-16
II-23
II-7



QI.1-2732
I-1
II-16
II-24
II-7



QI.1-2733
I-1
II-16
II-25
II-7



QI.1-2734
I-1
II-16
II-26
II-7



QI.1-2735
I-1
II-16
II-27
II-7



QI.1-2736
I-1
II-16
II-28
II-7



QI.1-2737
I-1
II-16
II-29
II-7



QI.1-2738
I-1
II-16
II-9
II-8



QI.1-2739
I-1
II-16
II-11
II-8



QI.1-2740
I-1
II-16
II-12
II-8



QI.1-2741
I-1
II-16
II-13
II-8



QI.1-2742
I-1
II-16
II-14
II-8



QI.1-2743
I-1
II-16
II-15
II-8



QI.1-2744
I-1
II-16
II-18
II-8



QI.1-2745
I-1
II-16
II-19
II-8



QI.1-2746
I-1
II-16
II-20
II-8



QI.1-2747
I-1
II-16
II-21
II-8



QI.1-2748
I-1
II-16
II-22
II-8



QI.1-2749
I-1
II-16
II-23
II-8



QI.1-2750
I-1
II-16
II-24
II-8



QI.1-2751
I-1
II-16
II-25
II-8



QI.1-2752
I-1
II-16
II-26
II-8



QI.1-2753
I-1
II-16
II-27
II-8



QI.1-2754
I-1
II-16
II-28
II-8



QI.1-2755
I-1
II-16
II-29
II-8



QI.1-2756
I-1
II-16
II-11
II-9



QI.1-2757
I-1
II-16
II-12
II-9



QI.1-2758
I-1
II-16
II-13
II-9



QI.1-2759
I-1
II-16
II-14
II-9



QI.1-2760
I-1
II-16
II-15
II-9



QI.1-2761
I-1
II-16
II-18
II-9



QI.1-2762
I-1
II-16
II-19
II-9



QI.1-2763
I-1
II-16
II-20
II-9



QI.1-2764
I-1
II-16
II-21
II-9



QI.1-2765
I-1
II-16
II-22
II-9



QI.1-2766
I-1
II-16
II-23
II-9



QI.1-2767
I-1
II-16
II-24
II-9



QI.1-2768
I-1
II-16
II-25
II-9



QI.1-2769
I-1
II-16
II-26
II-9



QI.1-2770
I-1
II-16
II-27
II-9



QI.1-2771
I-1
II-16
II-28
II-9



QI.1-2772
I-1
II-16
II-29
II-9



QI.1-2773
I-1
II-16
II-12
II-11



QI.1-2774
I-1
II-16
II-13
II-11



QI.1-2775
I-1
II-16
II-14
II-11



QI.1-2776
I-1
II-16
II-15
II-11



QI.1-2777
I-1
II-16
II-18
II-11



QI.1-2778
I-1
II-16
II-19
II-11



QI.1-2779
I-1
II-16
II-20
II-11



QI.1-2780
I-1
II-16
II-21
II-11



QI.1-2781
I-1
II-16
II-22
II-11



QI.1-2782
I-1
II-16
II-23
II-11



QI.1-2783
I-1
II-16
II-24
II-11



QI.1-2784
I-1
II-16
II-25
II-11



QI.1-2785
I-1
II-16
II-26
II-11



QI.1-2786
I-1
II-16
II-27
II-11



QI.1-2787
I-1
II-16
II-28
II-11



QI.1-2788
I-1
II-16
II-29
II-11



QI.1-2789
I-1
II-16
II-13
II-12



QI.1-2790
I-1
II-16
II-14
II-12



QI.1-2791
I-1
II-16
II-15
II-12



QI.1-2792
I-1
II-16
II-18
II-12



QI.1-2793
I-1
II-16
II-19
II-12



QI.1-2794
I-1
II-16
II-20
II-12



QI.1-2795
I-1
II-16
II-21
II-12



QI.1-2796
I-1
II-16
II-22
II-12



QI.1-2797
I-1
II-16
II-23
II-12



QI.1-2798
I-1
II-16
II-24
II-12



QI.1-2799
I-1
II-16
II-25
II-12



QI.1-2800
I-1
II-16
II-26
II-12



QI.1-2801
I-1
II-16
II-27
II-12



QI.1-2802
I-1
II-16
II-28
II-12



QI.1-2803
I-1
II-16
II-29
II-12



QI.1-2804
I-1
II-16
II-14
II-13



QI.1-2805
I-1
II-16
II-15
II-13



QI.1-2806
I-1
II-16
II-18
II-13



QI.1-2807
I-1
II-16
II-19
II-13



QI.1-2808
I-1
II-16
II-20
II-13



QI.1-2809
I-1
II-16
II-21
II-13



QI.1-2810
I-1
II-16
II-22
II-13



QI.1-2811
I-1
II-16
II-23
II-13



QI.1-2812
I-1
II-16
II-24
II-13



QI.1-2813
I-1
II-16
II-25
II-13



QI.1-2814
I-1
II-16
II-26
II-13



QI.1-2815
I-1
II-16
II-27
II-13



QI.1-2816
I-1
II-16
II-28
II-13



QI.1-2817
I-1
II-16
II-29
II-13



QI.1-2818
I-1
II-16
II-15
II-14



QI.1-2819
I-1
II-16
II-18
II-14



QI.1-2820
I-1
II-16
II-19
II-14



QI.1-2821
I-1
II-16
II-20
II-14



QI.1-2822
I-1
II-16
II-21
II-14



QI.1-2823
I-1
II-16
II-22
II-14



QI.1-2824
I-1
II-16
II-23
II-14



QI.1-2825
I-1
II-16
II-24
II-14



QI.1-2826
I-1
II-16
II-25
II-14



QI.1-2827
I-1
II-16
II-26
II-14



QI.1-2828
I-1
II-16
II-27
II-14



QI.1-2829
I-1
II-16
II-28
II-14



QI.1-2830
I-1
II-16
II-29
II-14



QI.1-2831
I-1
II-16
II-18
II-15



QI.1-2832
I-1
II-16
II-19
II-15



QI.1-2833
I-1
II-16
II-20
II-15



QI.1-2834
I-1
II-16
II-21
II-15



QI.1-2835
I-1
II-16
II-22
II-15



QI.1-2836
I-1
II-16
II-23
II-15



QI.1-2837
I-1
II-16
II-24
II-15



QI.1-2838
I-1
II-16
II-25
II-15



QI.1-2839
I-1
II-16
II-26
II-15



QI.1-2840
I-1
II-16
II-27
II-15



QI.1-2841
I-1
II-16
II-28
II-15



QI.1-2842
I-1
II-16
II-29
II-15



QI.1-2843
I-1
II-16
II-19
II-18



QI.1-2844
I-1
II-16
II-20
II-18



QI.1-2845
I-1
II-16
II-21
II-18



QI.1-2846
I-1
II-16
II-22
II-18



QI.1-2847
I-1
II-16
II-23
II-18



QI.1-2848
I-1
II-16
II-24
II-18



QI.1-2849
I-1
II-16
II-25
II-18



QI.1-2850
I-1
II-16
II-26
II-18



QI.1-2851
I-1
II-16
II-27
II-18



QI.1-2852
I-1
II-16
II-28
II-18



QI.1-2853
I-1
II-16
II-29
II-18



QI.1-2854
I-1
II-16
II-20
II-19



QI.1-2855
I-1
II-16
II-21
II-19



QI.1-2856
I-1
II-16
II-22
II-19



QI.1-2857
I-1
II-16
II-23
II-19



QI.1-2858
I-1
II-16
II-24
II-19



QI.1-2859
I-1
II-16
II-25
II-19



QI.1-2860
I-1
II-16
II-26
II-19



QI.1-2861
I-1
II-16
II-27
II-19



QI.1-2862
I-1
II-16
II-28
II-19



QI.1-2863
I-1
II-16
II-29
II-19



QI.1-2864
I-1
II-16
II-21
II-20



QI.1-2865
I-1
II-16
II-22
II-20



QI.1-2866
I-1
II-16
II-23
II-20



QI.1-2867
I-1
II-16
II-24
II-20



QI.1-2868
I-1
II-16
II-25
II-20



QI.1-2869
I-1
II-16
II-26
II-20



QI.1-2870
I-1
II-16
II-27
II-20



QI.1-2871
I-1
II-16
II-28
II-20



QI.1-2872
I-1
II-16
II-29
II-20



QI.1-2873
I-1
II-16
II-22
II-21



QI.1-2874
I-1
II-16
II-23
II-21



QI.1-2875
I-1
II-16
II-24
II-21



QI.1-2876
I-1
II-16
II-25
II-21



QI.1-2877
I-1
II-16
II-26
II-21



QI.1-2878
I-1
II-16
II-27
II-21



QI.1-2879
I-1
II-16
II-28
II-21



QI.1-2880
I-1
II-16
II-29
II-21



QI.1-2881
I-1
II-16
II-23
II-22



QI.1-2882
I-1
II-16
II-24
II-22



QI.1-2883
I-1
II-16
II-25
II-22



QI.1-2884
I-1
II-16
II-26
II-22



QI.1-2885
I-1
II-16
II-27
II-22



QI.1-2886
I-1
II-16
II-28
II-22



QI.1-2887
I-1
II-16
II-29
II-22



QI.1-2888
I-1
II-16
II-24
II-23



QI.1-2889
I-1
II-16
II-25
II-23



QI.1-2890
I-1
II-16
II-26
II-23



QI.1-2891
I-1
II-16
II-27
II-23



QI.1-2892
I-1
II-16
II-28
II-23



QI.1-2893
I-1
II-16
II-29
II-23



QI.1-2894
I-1
II-16
II-25
II-24



QI.1-2895
I-1
II-16
II-26
II-24



QI.1-2896
I-1
II-16
II-27
II-24



QI.1-2897
I-1
II-16
II-28
II-24



QI.1-2898
I-1
II-16
II-29
II-24



QI.1-2899
I-1
II-16
II-26
II-25



QI.1-2900
I-1
II-16
II-27
II-25



QI.1-2901
I-1
II-16
II-28
II-25



QI.1-2902
I-1
II-16
II-29
II-25



QI.1-2903
I-1
II-16
II-27
II-26



QI.1-2904
I-1
II-16
II-28
II-26



QI.1-2905
I-1
II-16
II-29
II-26



QI.1-2906
I-1
II-16
II-28
II-27



QI.1-2907
I-1
II-16
II-29
II-27



QI.1-2908
I-1
II-16
II-29
II-28



QI.1-2909
I-1
II-17
II-2
II-1



QI.1-2910
I-1
II-17
II-3
II-1



QI.1-2911
I-1
II-17
II-6
II-1



QI.1-2912
I-1
II-17
II-7
II-1



QI.1-2913
I-1
II-17
II-8
II-1



QI.1-2914
I-1
II-17
II-9
II-1



QI.1-2915
I-1
II-17
II-11
II-1



QI.1-2916
I-1
II-17
II-12
II-1



QI.1-2917
I-1
II-17
II-13
II-1



QI.1-2918
I-1
II-17
II-14
II-1



QI.1-2919
I-1
II-17
II-15
II-1



QI.1-2920
I-1
II-17
II-18
II-1



QI.1-2921
I-1
II-17
II-19
II-1



QI.1-2922
I-1
II-17
II-20
II-1



QI.1-2923
I-1
II-17
II-21
II-1



QI.1-2924
I-1
II-17
II-22
II-1



QI.1-2925
I-1
II-17
II-23
II-1



QI.1-2926
I-1
II-17
II-24
II-1



QI.1-2927
I-1
II-17
II-25
II-1



QI.1-2928
I-1
II-17
II-26
II-1



QI.1-2929
I-1
II-17
II-27
II-1



QI.1-2930
I-1
II-17
II-28
II-1



QI.1-2931
I-1
II-17
II-29
II-1



QI.1-2932
I-1
II-17
II-3
II-2



QI.1-2933
I-1
II-17
II-6
II-2



QI.1-2934
I-1
II-17
II-7
II-2



QI.1-2935
I-1
II-17
II-8
II-2



QI.1-2936
I-1
II-17
II-9
II-2



QI.1-2937
I-1
II-17
II-11
II-2



QI.1-2938
I-1
II-17
II-12
II-2



QI.1-2939
I-1
II-17
II-13
II-2



QI.1-2940
I-1
II-17
II-14
II-2



QI.1-2941
I-1
II-17
II-15
II-2



QI.1-2942
I-1
II-17
II-18
II-2



QI.1-2943
I-1
II-17
II-19
II-2



QI.1-2944
I-1
II-17
II-20
II-2



QI.1-2945
I-1
II-17
II-21
II-2



QI.1-2946
I-1
II-17
II-22
II-2



QI.1-2947
I-1
II-17
II-23
II-2



QI.1-2948
I-1
II-17
II-24
II-2



QI.1-2949
I-1
II-17
II-25
II-2



QI.1-2950
I-1
II-17
II-26
II-2



QI.1-2951
I-1
II-17
II-27
II-2



QI.1-2952
I-1
II-17
II-28
II-2



QI.1-2953
I-1
II-17
II-29
II-2



QI.1-2954
I-1
II-17
II-6
II-3



QI.1-2955
I-1
II-17
II-7
II-3



QI.1-2956
I-1
II-17
II-8
II-3



QI.1-2957
I-1
II-17
II-9
II-3



QI.1-2958
I-1
II-17
II-11
II-3



QI.1-2959
I-1
II-17
II-12
II-3



QI.1-2960
I-1
II-17
II-13
II-3



QI.1-2961
I-1
II-17
II-14
II-3



QI.1-2962
I-1
II-17
II-15
II-3



QI.1-2963
I-1
II-17
II-18
II-3



QI.1-2964
I-1
II-17
II-19
II-3



QI.1-2965
I-1
II-17
II-20
II-3



QI.1-2966
I-1
II-17
II-21
II-3



QI.1-2967
I-1
II-17
II-22
II-3



QI.1-2968
I-1
II-17
II-23
II-3



QI.1-2969
I-1
II-17
II-24
II-3



QI.1-2970
I-1
II-17
II-25
II-3



QI.1-2971
I-1
II-17
II-26
II-3



QI.1-2972
I-1
II-17
II-27
II-3



QI.1-2973
I-1
II-17
II-28
II-3



QI.1-2974
I-1
II-17
II-29
II-3



QI.1-2975
I-1
II-17
II-7
II-6



QI.1-2976
I-1
II-17
II-8
II-6



QI.1-2977
I-1
II-17
II-9
II-6



QI.1-2978
I-1
II-17
II-11
II-6



QI.1-2979
I-1
II-17
II-12
II-6



QI.1-2980
I-1
II-17
II-13
II-6



QI.1-2981
I-1
II-17
II-14
II-6



QI.1-2982
I-1
II-17
II-15
II-6



QI.1-2983
I-1
II-17
II-18
II-6



QI.1-2984
I-1
II-17
II-19
II-6



QI.1-2985
I-1
II-17
II-20
II-6



QI.1-2986
I-1
II-17
II-21
II-6



QI.1-2987
I-1
II-17
II-22
II-6



QI.1-2988
I-1
II-17
II-23
II-6



QI.1-2989
I-1
II-17
II-24
II-6



QI.1-2990
I-1
II-17
II-25
II-6



QI.1-2991
I-1
II-17
II-26
II-6



QI.1-2992
I-1
II-17
II-27
II-6



QI.1-2993
I-1
II-17
II-28
II-6



QI.1-2994
I-1
II-17
II-29
II-6



QI.1-2995
I-1
II-17
II-8
II-7



QI.1-2996
I-1
II-17
II-9
II-7



QI.1-2997
I-1
II-17
II-11
II-7



QI.1-2998
I-1
II-17
II-12
II-7



QI.1-2999
I-1
II-17
II-13
II-7



QI.1-3000
I-1
II-17
II-14
II-7



QI.1-3001
I-1
II-17
II-15
II-7



QI.1-3002
I-1
II-17
II-18
II-7



QI.1-3003
I-1
II-17
II-19
II-7



QI.1-3004
I-1
II-17
II-20
II-7



QI.1-3005
I-1
II-17
II-21
II-7



QI.1-3006
I-1
II-17
II-22
II-7



QI.1-3007
I-1
II-17
II-23
II-7



QI.1-3008
I-1
II-17
II-24
II-7



QI.1-3009
I-1
II-17
II-25
II-7



QI.1-3010
I-1
II-17
II-26
II-7



QI.1-3011
I-1
II-17
II-27
II-7



QI.1-3012
I-1
II-17
II-28
II-7



QI.1-3013
I-1
II-17
II-29
II-7



QI.1-3014
I-1
II-17
II-9
II-8



QI.1-3015
I-1
II-17
II-11
II-8



QI.1-3016
I-1
II-17
II-12
II-8



QI.1-3017
I-1
II-17
II-13
II-8



QI.1-3018
I-1
II-17
II-14
II-8



QI.1-3019
I-1
II-17
II-15
II-8



QI.1-3020
I-1
II-17
II-18
II-8



QI.1-3021
I-1
II-17
II-19
II-8



QI.1-3022
I-1
II-17
II-20
II-8



QI.1-3023
I-1
II-17
II-21
II-8



QI.1-3024
I-1
II-17
II-22
II-8



QI.1-3025
I-1
II-17
II-23
II-8



QI.1-3026
I-1
II-17
II-24
II-8



QI.1-3027
I-1
II-17
II-25
II-8



QI.1-3028
I-1
II-17
II-26
II-8



QI.1-3029
I-1
II-17
II-27
II-8



QI.1-3030
I-1
II-17
II-28
II-8



QI.1-3031
I-1
II-17
II-29
II-8



QI.1-3032
I-1
II-17
II-11
II-9



QI.1-3033
I-1
II-17
II-12
II-9



QI.1-3034
I-1
II-17
II-13
II-9



QI.1-3035
I-1
II-17
II-14
II-9



QI.1-3036
I-1
II-17
II-15
II-9



QI.1-3037
I-1
II-17
II-18
II-9



QI.1-3038
I-1
II-17
II-19
II-9



QI.1-3039
I-1
II-17
II-20
II-9



QI.1-3040
I-1
II-17
II-21
II-9



QI.1-3041
I-1
II-17
II-22
II-9



QI.1-3042
I-1
II-17
II-23
II-9



QI.1-3043
I-1
II-17
II-24
II-9



QI.1-3044
I-1
II-17
II-25
II-9



QI.1-3045
I-1
II-17
II-26
II-9



QI.1-3046
I-1
II-17
II-27
II-9



QI.1-3047
I-1
II-17
II-28
II-9



QI.1-3048
I-1
II-17
II-29
II-9



QI.1-3049
I-1
II-17
II-12
II-11



QI.1-3050
I-1
II-17
II-13
II-11



QI.1-3051
I-1
II-17
II-14
II-11



QI.1-3052
I-1
II-17
II-15
II-11



QI.1-3053
I-1
II-17
II-18
II-11



QI.1-3054
I-1
II-17
II-19
II-11



QI.1-3055
I-1
II-17
II-20
II-11



QI.1-3056
I-1
II-17
II-21
II-11



QI.1-3057
I-1
II-17
II-22
II-11



QI.1-3058
I-1
II-17
II-23
II-11



QI.1-3059
I-1
II-17
II-24
II-11



QI.1-3060
I-1
II-17
II-25
II-11



QI.1-3061
I-1
II-17
II-26
II-11



QI.1-3062
I-1
II-17
II-27
II-11



QI.1-3063
I-1
II-17
II-28
II-11



QI.1-3064
I-1
II-17
II-29
II-11



QI.1-3065
I-1
II-17
II-13
II-12



QI.1-3066
I-1
II-17
II-14
II-12



QI.1-3067
I-1
II-17
II-15
II-12



QI.1-3068
I-1
II-17
II-18
II-12



QI.1-3069
I-1
II-17
II-19
II-12



QI.1-3070
I-1
II-17
II-20
II-12



QI.1-3071
I-1
II-17
II-21
II-12



QI.1-3072
I-1
II-17
II-22
II-12



QI.1-3073
I-1
II-17
II-23
II-12



QI.1-3074
I-1
II-17
II-24
II-12



QI.1-3075
I-1
II-17
II-25
II-12



QI.1-3076
I-1
II-17
II-26
II-12



QI.1-3077
I-1
II-17
II-27
II-12



QI.1-3078
I-1
II-17
II-28
II-12



QI.1-3079
I-1
II-17
II-29
II-12



QI.1-3080
I-1
II-17
II-14
II-13



QI.1-3081
I-1
II-17
II-15
II-13



QI.1-3082
I-1
II-17
II-18
II-13



QI.1-3083
I-1
II-17
II-19
II-13



QI.1-3084
I-1
II-17
II-20
II-13



QI.1-3085
I-1
II-17
II-21
II-13



QI.1-3086
I-1
II-17
II-22
II-13



QI.1-3087
I-1
II-17
II-23
II-13



QI.1-3088
I-1
II-17
II-24
II-13



QI.1-3089
I-1
II-17
II-25
II-13



QI.1-3090
I-1
II-17
II-26
II-13



QI.1-3091
I-1
II-17
II-27
II-13



QI.1-3092
I-1
II-17
II-28
II-13



QI.1-3093
I-1
II-17
II-29
II-13



QI.1-3094
I-1
II-17
II-15
II-14



QI.1-3095
I-1
II-17
II-18
II-14



QI.1-3096
I-1
II-17
II-19
II-14



QI.1-3097
I-1
II-17
II-20
II-14



QI.1-3098
I-1
II-17
II-21
II-14



QI.1-3099
I-1
II-17
II-22
II-14



QI.1-3100
I-1
II-17
II-23
II-14



QI.1-3101
I-1
II-17
II-24
II-14



QI.1-3102
I-1
II-17
II-25
II-14



QI.1-3103
I-1
II-17
II-26
II-14



QI.1-3104
I-1
II-17
II-27
II-14



QI.1-3105
I-1
II-17
II-28
II-14



QI.1-3106
I-1
II-17
II-29
II-14



QI.1-3107
I-1
II-17
II-18
II-15



QI.1-3108
I-1
II-17
II-19
II-15



QI.1-3109
I-1
II-17
II-20
II-15



QI.1-3110
I-1
II-17
II-21
II-15



QI.1-3111
I-1
II-17
II-22
II-15



QI.1-3112
I-1
II-17
II-23
II-15



QI.1-3113
I-1
II-17
II-24
II-15



QI.1-3114
I-1
II-17
II-25
II-15



QI.1-3115
I-1
II-17
II-26
II-15



QI.1-3116
I-1
II-17
II-27
II-15



QI.1-3117
I-1
II-17
II-28
II-15



QI.1-3118
I-1
II-17
II-29
II-15



QI.1-3119
I-1
II-17
II-19
II-18



QI.1-3120
I-1
II-17
II-20
II-18



QI.1-3121
I-1
II-17
II-21
II-18



QI.1-3122
I-1
II-17
II-22
II-18



QI.1-3123
I-1
II-17
II-23
II-18



QI.1-3124
I-1
II-17
II-24
II-18



QI.1-3125
I-1
II-17
II-25
II-18



QI.1-3126
I-1
II-17
II-26
II-18



QI.1-3127
I-1
II-17
II-27
II-18



QI.1-3128
I-1
II-17
II-28
II-18



QI.1-3129
I-1
II-17
II-29
II-18



QI.1-3130
I-1
II-17
II-20
II-19



QI.1-3131
I-1
II-17
II-21
II-19



QI.1-3132
I-1
II-17
II-22
II-19



QI.1-3133
I-1
II-17
II-23
II-19



QI.1-3134
I-1
II-17
II-24
II-19



QI.1-3135
I-1
II-17
II-25
II-19



QI.1-3136
I-1
II-17
II-26
II-19



QI.1-3137
I-1
II-17
II-27
II-19



QI.1-3138
I-1
II-17
II-28
II-19



QI.1-3139
I-1
II-17
II-29
II-19



QI.1-3140
I-1
II-17
II-21
II-20



QI.1-3141
I-1
II-17
II-22
II-20



QI.1-3142
I-1
II-17
II-23
II-20



QI.1-3143
I-1
II-17
II-24
II-20



QI.1-3144
I-1
II-17
II-25
II-20



QI.1-3145
I-1
II-17
II-26
II-20



QI.1-3146
I-1
II-17
II-27
II-20



QI.1-3147
I-1
II-17
II-28
II-20



QI.1-3148
I-1
II-17
II-29
II-20



QI.1-3149
I-1
II-17
II-22
II-21



QI.1-3150
I-1
II-17
II-23
II-21



QI.1-3151
I-1
II-17
II-24
II-21



QI.1-3152
I-1
II-17
II-25
II-21



QI.1-3153
I-1
II-17
II-26
II-21



QI.1-3154
I-1
II-17
II-27
II-21



QI.1-3155
I-1
II-17
II-28
II-21



QI.1-3156
I-1
II-17
II-29
II-21



QI.1-3157
I-1
II-17
II-23
II-22



QI.1-3158
I-1
II-17
II-24
II-22



QI.1-3159
I-1
II-17
II-25
II-22



QI.1-3160
I-1
II-17
II-26
II-22



QI.1-3161
I-1
II-17
II-27
II-22



QI.1-3162
I-1
II-17
II-28
II-22



QI.1-3163
I-1
II-17
II-29
II-22



QI.1-3164
I-1
II-17
II-24
II-23



QI.1-3165
I-1
II-17
II-25
II-23



QI.1-3166
I-1
II-17
II-26
II-23



QI.1-3167
I-1
II-17
II-27
II-23



QI.1-3168
I-1
II-17
II-28
II-23



QI.1-3169
I-1
II-17
II-29
II-23



QI.1-3170
I-1
II-17
II-25
II-24



QI.1-3171
I-1
II-17
II-26
II-24



QI.1-3172
I-1
II-17
II-27
II-24



QI.1-3173
I-1
II-17
II-28
II-24



QI.1-3174
I-1
II-17
II-29
II-24



QI.1-3175
I-1
II-17
II-26
II-25



QI.1-3176
I-1
II-17
II-27
II-25



QI.1-3177
I-1
II-17
II-28
II-25



QI.1-3178
I-1
II-17
II-29
II-25



QI.1-3179
I-1
II-17
II-27
II-26



QI.1-3180
I-1
II-17
II-28
II-26



QI.1-3181
I-1
II-17
II-29
II-26



QI.1-3182
I-1
II-17
II-28
II-27



QI.1-3183
I-1
II-17
II-29
II-27



QI.1-3184
I-1
II-17
II-29
II-28



QI.1-3185
I-1
II-18
II-20
II-19



QI.1-3186
I-1
II-18
II-21
II-19



QI.1-3187
I-1
II-18
II-22
II-19



QI.1-3188
I-1
II-18
II-23
II-19



QI.1-3189
I-1
II-18
II-24
II-19



QI.1-3190
I-1
II-18
II-25
II-19



QI.1-3191
I-1
II-18
II-26
II-19



QI.1-3192
I-1
II-18
II-27
II-19



QI.1-3193
I-1
II-18
II-28
II-19



QI.1-3194
I-1
II-18
II-29
II-19



QI.1-3195
I-1
II-18
II-21
II-20



QI.1-3196
I-1
II-18
II-22
II-20



QI.1-3197
I-1
II-18
II-23
II-20



QI.1-3198
I-1
II-18
II-24
II-20



QI.1-3199
I-1
II-18
II-25
II-20



QI.1-3200
I-1
II-18
II-26
II-20



QI.1-3201
I-1
II-18
II-27
II-20



QI.1-3202
I-1
II-18
II-28
II-20



QI.1-3203
I-1
II-18
II-29
II-20



QI.1-3204
I-1
II-18
II-22
II-21



QI.1-3205
I-1
II-18
II-23
II-21



QI.1-3206
I-1
II-18
II-24
II-21



QI.1-3207
I-1
II-18
II-25
II-21



QI.1-3208
I-1
II-18
II-26
II-21



QI.1-3209
I-1
II-18
II-27
II-21



QI.1-3210
I-1
II-18
II-28
II-21



QI.1-3211
I-1
II-18
II-29
II-21



QI.1-3212
I-1
II-18
II-23
II-22



QI.1-3213
I-1
II-18
II-24
II-22



QI.1-3214
I-1
II-18
II-25
II-22



QI.1-3215
I-1
II-18
II-26
II-22



QI.1-3216
I-1
II-18
II-27
II-22



QI.1-3217
I-1
II-18
II-28
II-22



QI.1-3218
I-1
II-18
II-29
II-22



QI.1-3219
I-1
II-18
II-24
II-23



QI.1-3220
I-1
II-18
II-25
II-23



QI.1-3221
I-1
II-18
II-26
II-23



QI.1-3222
I-1
II-18
II-27
II-23



QI.1-3223
I-1
II-18
II-28
II-23



QI.1-3224
I-1
II-18
II-29
II-23



QI.1-3225
I-1
II-18
II-25
II-24



QI.1-3226
I-1
II-18
II-26
II-24



QI.1-3227
I-1
II-18
II-27
II-24



QI.1-3228
I-1
II-18
II-28
II-24



QI.1-3229
I-1
II-18
II-29
II-24



QI.1-3230
I-1
II-18
II-26
II-25



QI.1-3231
I-1
II-18
II-27
II-25



QI.1-3232
I-1
II-18
II-28
II-25



QI.1-3233
I-1
II-18
II-29
II-25



QI.1-3234
I-1
II-18
II-27
II-26



QI.1-3235
I-1
II-18
II-28
II-26



QI.1-3236
I-1
II-18
II-29
II-26



QI.1-3237
I-1
II-18
II-28
II-27



QI.1-3238
I-1
II-18
II-29
II-27



QI.1-3239
I-1
II-18
II-29
II-28



QI.1-3240
I-1
II-19
II-21
II-20



QI.1-3241
I-1
II-19
II-22
II-20



QI.1-3242
I-1
II-19
II-23
II-20



QI.1-3243
I-1
II-19
II-24
II-20



QI.1-3244
I-1
II-19
II-25
II-20



QI.1-3245
I-1
II-19
II-26
II-20



QI.1-3246
I-1
II-19
II-27
II-20



QI.1-3247
I-1
II-19
II-28
II-20



QI.1-3248
I-1
II-19
II-29
II-20



QI.1-3249
I-1
II-19
II-22
II-21



QI.1-3250
I-1
II-19
II-23
II-21



QI.1-3251
I-1
II-19
II-24
II-21



QI.1-3252
I-1
II-19
II-25
II-21



QI.1-3253
I-1
II-19
II-26
II-21



QI.1-3254
I-1
II-19
II-27
II-21



QI.1-3255
I-1
II-19
II-28
II-21



QI.1-3256
I-1
II-19
II-29
II-21



QI.1-3257
I-1
II-19
II-23
II-22



QI.1-3258
I-1
II-19
II-24
II-22



QI.1-3259
I-1
II-19
II-25
II-22



QI.1-3260
I-1
II-19
II-26
II-22



QI.1-3261
I-1
II-19
II-27
II-22



QI.1-3262
I-1
II-19
II-28
II-22



QI.1-3263
I-1
II-19
II-29
II-22



QI.1-3264
I-1
II-19
II-24
II-23



QI.1-3265
I-1
II-19
II-25
II-23



QI.1-3266
I-1
II-19
II-26
II-23



QI.1-3267
I-1
II-19
II-27
II-23



QI.1-3268
I-1
II-19
II-28
II-23



QI.1-3269
I-1
II-19
II-29
II-23



QI.1-3270
I-1
II-19
II-25
II-24



QI.1-3271
I-1
II-19
II-26
II-24



QI.1-3272
I-1
II-19
II-27
II-24



QI.1-3273
I-1
II-19
II-28
II-24



QI.1-3274
I-1
II-19
II-29
II-24



QI.1-3275
I-1
II-19
II-26
II-25



QI.1-3276
I-1
II-19
II-27
II-25



QI.1-3277
I-1
II-19
II-28
II-25



QI.1-3278
I-1
II-19
II-29
II-25



QI.1-3279
I-1
II-19
II-27
II-26



QI.1-3280
I-1
II-19
II-28
II-26



QI.1-3281
I-1
II-19
II-29
II-26



QI.1-3282
I-1
II-19
II-28
II-27



QI.1-3283
I-1
II-19
II-29
II-27



QI.1-3284
I-1
II-19
II-29
II-28



QI.1-3285
I-1
II-20
II-22
II-21



QI.1-3286
I-1
II-20
II-23
II-21



QI.1-3287
I-1
II-20
II-24
II-21



QI.1-3288
I-1
II-20
II-25
II-21



QI.1-3289
I-1
II-20
II-26
II-21



QI.1-3290
I-1
II-20
II-27
II-21



QI.1-3291
I-1
II-20
II-28
II-21



QI.1-3292
I-1
II-20
II-29
II-21



QI.1-3293
I-1
II-20
II-23
II-22



QI.1-3294
I-1
II-20
II-24
II-22



QI.1-3295
I-1
II-20
II-25
II-22



QI.1-3296
I-1
II-20
II-26
II-22



QI.1-3297
I-1
II-20
II-27
II-22



QI.1-3298
I-1
II-20
II-28
II-22



QI.1-3299
I-1
II-20
II-29
II-22



QI.1-3300
I-1
II-20
II-24
II-23



QI.1-3301
I-1
II-20
II-25
II-23



QI.1-3302
I-1
II-20
II-26
II-23



QI.1-3303
I-1
II-20
II-27
II-23



QI.1-3304
I-1
II-20
II-28
II-23



QI.1-3305
I-1
II-20
II-29
II-23



QI.1-3306
I-1
II-20
II-25
II-24



QI.1-3307
I-1
II-20
II-26
II-24



QI.1-3308
I-1
II-20
II-27
II-24



QI.1-3309
I-1
II-20
II-28
II-24



QI.1-3310
I-1
II-20
II-29
II-24



QI.1-3311
I-1
II-20
II-26
II-25



QI.1-3312
I-1
II-20
II-27
II-25



QI.1-3313
I-1
II-20
II-28
II-25



QI.1-3314
I-1
II-20
II-29
II-25



QI.1-3315
I-1
II-20
II-27
II-26



QI.1-3316
I-1
II-20
II-28
II-26



QI.1-3317
I-1
II-20
II-29
II-26



QI.1-3318
I-1
II-20
II-28
II-27



QI.1-3319
I-1
II-20
II-29
II-27



QI.1-3320
I-1
II-20
II-29
II-28



QI.1-3321
I-1
II-21
II-23
II-22



QI.1-3322
I-1
II-21
II-24
II-22



QI.1-3323
I-1
II-21
II-25
II-22



QI.1-3324
I-1
II-21
II-26
II-22



QI.1-3325
I-1
II-21
II-27
II-22



QI.1-3326
I-1
II-21
II-28
II-22



QI.1-3327
I-1
II-21
II-29
II-22



QI.1-3328
I-1
II-21
II-24
II-23



QI.1-3329
I-1
II-21
II-25
II-23



QI.1-3330
I-1
II-21
II-26
II-23



QI.1-3331
I-1
II-21
II-27
II-23



QI.1-3332
I-1
II-21
II-28
II-23



QI.1-3333
I-1
II-21
II-29
II-23



QI.1-3334
I-1
II-21
II-25
II-24



QI.1-3335
I-1
II-21
II-26
II-24



QI.1-3336
I-1
II-21
II-27
II-24



QI.1-3337
I-1
II-21
II-28
II-24



QI.1-3338
I-1
II-21
II-29
II-24



QI.1-3339
I-1
II-21
II-26
II-25



QI.1-3340
I-1
II-21
II-27
II-25



QI.1-3341
I-1
II-21
II-28
II-25



QI.1-3342
I-1
II-21
II-29
II-25



QI.1-3343
I-1
II-21
II-27
II-26



QI.1-3344
I-1
II-21
II-28
II-26



QI.1-3345
I-1
II-21
II-29
II-26



QI.1-3346
I-1
II-21
II-28
II-27



QI.1-3347
I-1
II-21
II-29
II-27



QI.1-3348
I-1
II-21
II-29
II-28



QI.1-3349
I-1
II-22
II-24
II-23



QI.1-3350
I-1
II-22
II-25
II-23



QI.1-3351
I-1
II-22
II-26
II-23



QI.1-3352
I-1
II-22
II-27
II-23



QI.1-3353
I-1
II-22
II-28
II-23



QI.1-3354
I-1
II-22
II-29
II-23



QI.1-3355
I-1
II-22
II-25
II-24



QI.1-3356
I-1
II-22
II-26
II-24



QI.1-3357
I-1
II-22
II-27
II-24



QI.1-3358
I-1
II-22
II-28
II-24



QI.1-3359
I-1
II-22
II-29
II-24



QI.1-3360
I-1
II-22
II-26
II-25



QI.1-3361
I-1
II-22
II-27
II-25



QI.1-3362
I-1
II-22
II-28
II-25



QI.1-3363
I-1
II-22
II-29
II-25



QI.1-3364
I-1
II-22
II-27
II-26



QI.1-3365
I-1
II-22
II-28
II-26



QI.1-3366
I-1
II-22
II-29
II-26



QI.1-3367
I-1
II-22
II-28
II-27



QI.1-3368
I-1
II-22
II-29
II-27



QI.1-3369
I-1
II-22
II-29
II-28



QI.1-3370
I-1
II-23
II-25
II-24



QI.1-3371
I-1
II-23
II-26
II-24



QI.1-3372
I-1
II-23
II-27
II-24



QI.1-3373
I-1
II-23
II-28
II-24



QI.1-3374
I-1
II-23
II-29
II-24



QI.1-3375
I-1
II-23
II-26
II-25



QI.1-3376
I-1
II-23
II-27
II-25



QI.1-3377
I-1
II-23
II-28
II-25



QI.1-3378
I-1
II-23
II-29
II-25



QI.1-3379
I-1
II-23
II-27
II-26



QI.1-3380
I-1
II-23
II-28
II-26



QI.1-3381
I-1
II-23
II-29
II-26



QI.1-3382
I-1
II-23
II-28
II-27



QI.1-3383
I-1
II-23
II-29
II-27



QI.1-3384
I-1
II-23
II-29
II-28



QI.1-3385
I-1
II-24
II-26
II-25



QI.1-3386
I-1
II-24
II-27
II-25



QI.1-3387
I-1
II-24
II-28
II-25



QI.1-3388
I-1
II-24
II-29
II-25



QI.1-3389
I-1
II-24
II-27
II-26



QI.1-3390
I-1
II-24
II-28
II-26



QI.1-3391
I-1
II-24
II-29
II-26



QI.1-3392
I-1
II-24
II-28
II-27



QI.1-3393
I-1
II-24
II-29
II-27



QI.1-3394
I-1
II-24
II-29
II-28



QI.1-3395
I-1
II-25
II-27
II-26



QI.1-3396
I-1
II-25
II-28
II-26



QI.1-3397
I-1
II-25
II-29
II-26



QI.1-3398
I-1
II-25
II-28
II-27



QI.1-3399
I-1
II-25
II-29
II-27



QI.1-3400
I-1
II-25
II-29
II-28



QI.1-3401
I-1
II-26
II-28
II-27



QI.1-3402
I-1
II-26
II-29
II-27



QI.1-3403
I-1
II-26
II-29
II-28



QI.1-3404
I-1
II-27
II-29
II-28










Table QI.2: Quarternary mixtures QI.2-1 to QI.2-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-2 and therefore have the term “QI.2-” instead of “QI.1-” in front of the number.


Table QI.3: Quarternary mixtures QI.3-1 to QI.3-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-3 and therefore have the term “QI.3-” instead of “QI.1-” in front of the number.


Table QI.4: Quarternary mixtures QI.4-1 to QI.4-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-4 and therefore have the term “QI.4-” instead of “QI.1-” in front of the number.


Table QI.5: Quarternary mixtures QI.5-1 to QI.5-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-5 and therefore have the term “QI.5-” instead of “QI.1-” in front of the number.


Table QI.6: Quarternary mixtures QI.6-1 to QI.6-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-6 and therefore have the term “QI.6-” instead of “QI.1-” in front of the number.


Table QI.7: Quarternary mixtures QI.7-1 to QI.7-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-7 and therefore have the term “QI.7-” instead of “QI.1-” in front of the number.


Table QI.8: Quarternary mixtures QI.8-1 to QI.8-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-8 and therefore have the term “QI.8-” instead of “QI.1-” in front of the number.


Table QI.9: Quarternary mixtures QI.9-1 to QI.9-3404 which correspond to the quarternary mixtures QI.1-1 to QI.1-3404 having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-9 and therefore have the term “QI.9-” instead of “QI.1-” in front of the number.


According to a further embodiment of the invention, preference is given to mixtures comprising a component 1, a component 2, a component 3 and a component 4, where component 2 is selected from the group of the compounds II-1 to II-29 and II-46 to II-48 and II-52 to II-55 (see above), and components 3 and 4 are a compound II, in each case selected from the compounds II-46 to II-48 and II-52 to II-55, with the proviso that component 2 and component 3 are not identical.


Such mixtures are listed explicitly in Tables QII-1 to QII-9 below.









TABLE QII.1







The mixtures QII.1-1 to QI.1-1330 below comprise, as component 1, the


compound I-1, a component 2 selected from the active compounds II


preferred for component 2, a component 3 selected from the active


compounds preferred for component 3 and a component 4 selected from


the active compounds preferred for component 4. In the table below, in


each case one row corresponds to a mixture according to the invention


having the respective mixture components 1 to 4 listed in the row in


question.










Mixture components














Mixture
1
2
3
4







QII.1-1
I-1
II-1
II-2
II-15



QII.1-2
I-1
II-1
II-2
II-21



QII.1-3
I-1
II-1
II-2
II-22



QII.1-4
I-1
II-1
II-2
II-47



QII.1-5
I-1
II-1
II-2
II-52



QII.1-6
I-1
II-1
II-2
II-53



QII.1-7
I-1
II-1
II-2
II-55



QII.1-8
I-1
II-1
II-3
II-15



QII.1-9
I-1
II-1
II-3
II-21



QII.1-10
I-1
II-1
II-3
II-22



QII.1-11
I-1
II-1
II-3
II-47



QII.1-12
I-1
II-1
II-3
II-52



QII.1-13
I-1
II-1
II-3
II-53



QII.1-14
I-1
II-1
II-3
II-55



QII.1-15
I-1
II-1
II-7
II-15



QII.1-16
I-1
II-1
II-7
II-21



QII.1-17
I-1
II-1
II-7
II-22



QII.1-18
I-1
II-1
II-7
II-47



QII.1-19
I-1
II-1
II-7
II-52



QII.1-20
I-1
II-1
II-7
II-53



QII.1-21
I-1
II-1
II-7
II-55



QII.1-22
I-1
II-1
II-8
II-15



QII.1-23
I-1
II-1
II-8
II-21



QII.1-24
I-1
II-1
II-8
II-22



QII.1-25
I-1
II-1
II-8
II-47



QII.1-26
I-1
II-1
II-8
II-52



QII.1-27
I-1
II-1
II-8
II-53



QII.1-28
I-1
II-1
II-8
II-55



QII.1-29
I-1
II-1
II-9
II-15



QII.1-30
I-1
II-1
II-9
II-21



QII.1-31
I-1
II-1
II-9
II-22



QII.1-32
I-1
II-1
II-9
II-47



QII.1-33
I-1
II-1
II-9
II-52



QII.1-34
I-1
II-1
II-9
II-53



QII.1-35
I-1
II-1
II-9
II-55



QII.1-36
I-1
II-1
II-10
II-15



QII.1-37
I-1
II-1
II-10
II-21



QII.1-38
I-1
II-1
II-10
II-22



QII.1-39
I-1
II-1
II-10
II-47



QII.1-40
I-1
II-1
II-10
II-52



QII.1-41
I-1
II-1
II-10
II-53



QII.1-42
I-1
II-1
II-10
II-55



QII.1-43
I-1
II-1
II-23
II-15



QII.1-44
I-1
II-1
II-23
II-21



QII.1-45
I-1
II-1
II-23
II-22



QII.1-46
I-1
II-1
II-23
II-47



QII.1-47
I-1
II-1
II-23
II-52



QII.1-48
I-1
II-1
II-23
II-53



QII.1-49
I-1
II-1
II-23
II-55



QII.1-50
I-1
II-1
II-24
II-15



QII.1-51
I-1
II-1
II-24
II-21



QII.1-52
I-1
II-1
II-24
II-22



QII.1-53
I-1
II-1
II-24
II-47



QII.1-54
I-1
II-1
II-24
II-52



QII.1-55
I-1
II-1
II-24
II-53



QII.1-56
I-1
II-1
II-24
II-55



QII.1-57
I-1
II-1
II-25
II-15



QII.1-58
I-1
II-1
II-25
II-21



QII.1-59
I-1
II-1
II-25
II-22



QII.1-60
I-1
II-1
II-25
II-47



QII.1-61
I-1
II-1
II-25
II-52



QII.1-62
I-1
II-1
II-25
II-53



QII.1-63
I-1
II-1
II-25
II-55



QII.1-64
I-1
II-1
II-26
II-15



QII.1-65
I-1
II-1
II-26
II-21



QII.1-66
I-1
II-1
II-26
II-22



QII.1-67
I-1
II-1
II-26
II-47



QII.1-68
I-1
II-1
II-26
II-52



QII.1-69
I-1
II-1
II-26
II-53



QII.1-70
I-1
II-1
II-26
II-55



QII.1-71
I-1
II-1
II-27
II-15



QII.1-72
I-1
II-1
II-27
II-21



QII.1-73
I-1
II-1
II-27
II-22



QII.1-74
I-1
II-1
II-27
II-47



QII.1-75
I-1
II-1
II-27
II-52



QII.1-76
I-1
II-1
II-27
II-53



QII.1-77
I-1
II-1
II-27
II-55



QII.1-78
I-1
II-1
II-28
II-15



QII.1-79
I-1
II-1
II-28
II-21



QII.1-80
I-1
II-1
II-28
II-22



QII.1-81
I-1
II-1
II-28
II-47



QII.1-82
I-1
II-1
II-28
II-52



QII.1-83
I-1
II-1
II-28
II-53



QII.1-84
I-1
II-1
II-28
II-55



QII.1-85
I-1
II-1
II-29
II-15



QII.1-86
I-1
II-1
II-29
II-21



QII.1-87
I-1
II-1
II-29
II-22



QII.1-88
I-1
II-1
II-29
II-47



QII.1-89
I-1
II-1
II-29
II-52



QII.1-90
I-1
II-1
II-29
II-53



QII.1-91
I-1
II-1
II-29
II-55



QII.1-92
I-1
II-1
II-34
II-15



QII.1-93
I-1
II-1
II-34
II-21



QII.1-94
I-1
II-1
II-34
II-22



QII.1-95
I-1
II-1
II-34
II-47



QII.1-96
I-1
II-1
II-34
II-52



QII.1-97
I-1
II-1
II-34
II-53



QII.1-98
I-1
II-1
II-34
II-55



QII.1-99
I-1
II-1
II-46
II-15



QII.1-100
I-1
II-1
II-46
II-21



QII.1-101
I-1
II-1
II-46
II-22



QII.1-102
I-1
II-1
II-46
II-47



QII.1-103
I-1
II-1
II-46
II-52



QII.1-104
I-1
II-1
II-46
II-53



QII.1-105
I-1
II-1
II-46
II-55



QII.1-106
I-1
II-1
II-48
II-15



QII.1-107
I-1
II-1
II-48
II-21



QII.1-108
I-1
II-1
II-48
II-22



QII.1-109
I-1
II-1
II-48
II-47



QII.1-110
I-1
II-1
II-48
II-52



QII.1-111
I-1
II-1
II-48
II-53



QII.1-112
I-1
II-1
II-48
II-55



QII.1-113
I-1
II-1
II-49
II-15



QII.1-114
I-1
II-1
II-49
II-21



QII.1-115
I-1
II-1
II-49
II-22



QII.1-116
I-1
II-1
II-49
II-47



QII.1-117
I-1
II-1
II-49
II-52



QII.1-118
I-1
II-1
II-49
II-53



QII.1-119
I-1
II-1
II-49
II-55



QII.1-120
I-1
II-1
II-50
II-15



QII.1-121
I-1
II-1
II-50
II-21



QII.1-122
I-1
II-1
II-50
II-22



QII.1-123
I-1
II-1
II-50
II-47



QII.1-124
I-1
II-1
II-50
II-52



QII.1-125
I-1
II-1
II-50
II-53



QII.1-126
I-1
II-1
II-50
II-55



QII.1-127
I-1
II-1
II-51
II-15



QII.1-128
I-1
II-1
II-51
II-21



QII.1-129
I-1
II-1
II-51
II-22



QII.1-130
I-1
II-1
II-51
II-47



QII.1-131
I-1
II-1
II-51
II-52



QII.1-132
I-1
II-1
II-51
II-53



QII.1-133
I-1
II-1
II-51
II-55



QII.1-134
I-1
II-2
II-3
II-15



QII.1-135
I-1
II-2
II-3
II-21



QII.1-136
I-1
II-2
II-3
II-22



QII.1-137
I-1
II-2
II-3
II-47



QII.1-138
I-1
II-2
II-3
II-52



QII.1-139
I-1
II-2
II-3
II-53



QII.1-140
I-1
II-2
II-3
II-55



QII.1-141
I-1
II-2
II-7
II-15



QII.1-142
I-1
II-2
II-7
II-21



QII.1-143
I-1
II-2
II-7
II-22



QII.1-144
I-1
II-2
II-7
II-47



QII.1-145
I-1
II-2
II-7
II-52



QII.1-146
I-1
II-2
II-7
II-53



QII.1-147
I-1
II-2
II-7
II-55



QII.1-148
I-1
II-2
II-8
II-15



QII.1-149
I-1
II-2
II-8
II-21



QII.1-150
I-1
II-2
II-8
II-22



QII.1-151
I-1
II-2
II-8
II-47



QII.1-152
I-1
II-2
II-8
II-52



QII.1-153
I-1
II-2
II-8
II-53



QII.1-154
I-1
II-2
II-8
II-55



QII.1-155
I-1
II-2
II-9
II-15



QII.1-156
I-1
II-2
II-9
II-21



QII.1-157
I-1
II-2
II-9
II-22



QII.1-158
I-1
II-2
II-9
II-47



QII.1-159
I-1
II-2
II-9
II-52



QII.1-160
I-1
II-2
II-9
II-53



QII.1-161
I-1
II-2
II-9
II-55



QII.1-162
I-1
II-2
II-10
II-15



QII.1-163
I-1
II-2
II-10
II-21



QII.1-164
I-1
II-2
II-10
II-22



QII.1-165
I-1
II-2
II-10
II-47



QII.1-166
I-1
II-2
II-10
II-52



QII.1-167
I-1
II-2
II-10
II-53



QII.1-168
I-1
II-2
II-10
II-55



QII.1-169
I-1
II-2
II-23
II-15



QII.1-170
I-1
II-2
II-23
II-21



QII.1-171
I-1
II-2
II-23
II-22



QII.1-172
I-1
II-2
II-23
II-47



QII.1-173
I-1
II-2
II-23
II-52



QII.1-174
I-1
II-2
II-23
II-53



QII.1-175
I-1
II-2
II-23
II-55



QII.1-176
I-1
II-2
II-24
II-15



QII.1-177
I-1
II-2
II-24
II-21



QII.1-178
I-1
II-2
II-24
II-22



QII.1-179
I-1
II-2
II-24
II-47



QII.1-180
I-1
II-2
II-24
II-52



QII.1-181
I-1
II-2
II-24
II-53



QII.1-182
I-1
II-2
II-24
II-55



QII.1-183
I-1
II-2
II-25
II-15



QII.1-184
I-1
II-2
II-25
II-21



QII.1-185
I-1
II-2
II-25
II-22



QII.1-186
I-1
II-2
II-25
II-47



QII.1-187
I-1
II-2
II-25
II-52



QII.1-188
I-1
II-2
II-25
II-53



QII.1-189
I-1
II-2
II-25
II-55



QII.1-190
I-1
II-2
II-26
II-15



QII.1-191
I-1
II-2
II-26
II-21



QII.1-192
I-1
II-2
II-26
II-22



QII.1-193
I-1
II-2
II-26
II-47



QII.1-194
I-1
II-2
II-26
II-52



QII.1-195
I-1
II-2
II-26
II-53



QII.1-196
I-1
II-2
II-26
II-55



QII.1-197
I-1
II-2
II-27
II-15



QII.1-198
I-1
II-2
II-27
II-21



QII.1-199
I-1
II-2
II-27
II-22



QII.1-200
I-1
II-2
II-27
II-47



QII.1-201
I-1
II-2
II-27
II-52



QII.1-202
I-1
II-2
II-27
II-53



QII.1-203
I-1
II-2
II-27
II-55



QII.1-204
I-1
II-2
II-28
II-15



QII.1-205
I-1
II-2
II-28
II-21



QII.1-206
I-1
II-2
II-28
II-22



QII.1-207
I-1
II-2
II-28
II-47



QII.1-208
I-1
II-2
II-28
II-52



QII.1-209
I-1
II-2
II-28
II-53



QII.1-210
I-1
II-2
II-28
II-55



QII.1-211
I-1
II-2
II-29
II-15



QII.1-212
I-1
II-2
II-29
II-21



QII.1-213
I-1
II-2
II-29
II-22



QII.1-214
I-1
II-2
II-29
II-47



QII.1-215
I-1
II-2
II-29
II-52



QII.1-216
I-1
II-2
II-29
II-53



QII.1-217
I-1
II-2
II-29
II-55



QII.1-218
I-1
II-2
II-34
II-15



QII.1-219
I-1
II-2
II-34
II-21



QII.1-220
I-1
II-2
II-34
II-22



QII.1-221
I-1
II-2
II-34
II-47



QII.1-222
I-1
II-2
II-34
II-52



QII.1-223
I-1
II-2
II-34
II-53



QII.1-224
I-1
II-2
II-34
II-55



QII.1-225
I-1
II-2
II-46
II-15



QII.1-226
I-1
II-2
II-46
II-21



QII.1-227
I-1
II-2
II-46
II-22



QII.1-228
I-1
II-2
II-46
II-47



QII.1-229
I-1
II-2
II-46
II-52



QII.1-230
I-1
II-2
II-46
II-53



QII.1-231
I-1
II-2
II-46
II-55



QII.1-232
I-1
II-2
II-48
II-15



QII.1-233
I-1
II-2
II-48
II-21



QII.1-234
I-1
II-2
II-48
II-22



QII.1-235
I-1
II-2
II-48
II-47



QII.1-236
I-1
II-2
II-48
II-52



QII.1-237
I-1
II-2
II-48
II-53



QII.1-238
I-1
II-2
II-48
II-55



QII.1-239
I-1
II-2
II-49
II-15



QII.1-240
I-1
II-2
II-49
II-21



QII.1-241
I-1
II-2
II-49
II-22



QII.1-242
I-1
II-2
II-49
II-47



QII.1-243
I-1
II-2
II-49
II-52



QII.1-244
I-1
II-2
II-49
II-53



QII.1-245
I-1
II-2
II-49
II-55



QII.1-246
I-1
II-2
II-50
II-15



QII.1-247
I-1
II-2
II-50
II-21



QII.1-248
I-1
II-2
II-50
II-22



QII.1-249
I-1
II-2
II-50
II-47



QII.1-250
I-1
II-2
II-50
II-52



QII.1-251
I-1
II-2
II-50
II-53



QII.1-252
I-1
II-2
II-50
II-55



QII.1-253
I-1
II-2
II-51
II-15



QII.1-254
I-1
II-2
II-51
II-21



QII.1-255
I-1
II-2
II-51
II-22



QII.1-256
I-1
II-2
II-51
II-47



QII.1-257
I-1
II-2
II-51
II-52



QII.1-258
I-1
II-2
II-51
II-53



QII.1-259
I-1
II-2
II-51
II-55



QII.1-260
I-1
II-3
II-7
II-15



QII.1-261
I-1
II-3
II-7
II-21



QII.1-262
I-1
II-3
II-7
II-22



QII.1-263
I-1
II-3
II-7
II-47



QII.1-264
I-1
II-3
II-7
II-52



QII.1-265
I-1
II-3
II-7
II-53



QII.1-266
I-1
II-3
II-7
II-55



QII.1-267
I-1
II-3
II-8
II-15



QII.1-268
I-1
II-3
II-8
II-21



QII.1-269
I-1
II-3
II-8
II-22



QII.1-270
I-1
II-3
II-8
II-47



QII.1-271
I-1
II-3
II-8
II-52



QII.1-272
I-1
II-3
II-8
II-53



QII.1-273
I-1
II-3
II-8
II-55



QII.1-274
I-1
II-3
II-9
II-15



QII.1-275
I-1
II-3
II-9
II-21



QII.1-276
I-1
II-3
II-9
II-22



QII.1-277
I-1
II-3
II-9
II-47



QII.1-278
I-1
II-3
II-9
II-52



QII.1-279
I-1
II-3
II-9
II-53



QII.1-280
I-1
II-3
II-9
II-55



QII.1-281
I-1
II-3
II-10
II-15



QII.1-282
I-1
II-3
II-10
II-21



QII.1-283
I-1
II-3
II-10
II-22



QII.1-284
I-1
II-3
II-10
II-47



QII.1-285
I-1
II-3
II-10
II-52



QII.1-286
I-1
II-3
II-10
II-53



QII.1-287
I-1
II-3
II-10
II-55



QII.1-288
I-1
II-3
II-23
II-15



QII.1-289
I-1
II-3
II-23
II-21



QII.1-290
I-1
II-3
II-23
II-22



QII.1-291
I-1
II-3
II-23
II-47



QII.1-292
I-1
II-3
II-23
II-52



QII.1-293
I-1
II-3
II-23
II-53



QII.1-294
I-1
II-3
II-23
II-55



QII.1-295
I-1
II-3
II-24
II-15



QII.1-296
I-1
II-3
II-24
II-21



QII.1-297
I-1
II-3
II-24
II-22



QII.1-298
I-1
II-3
II-24
II-47



QII.1-299
I-1
II-3
II-24
II-52



QII.1-300
I-1
II-3
II-24
II-53



QII.1-301
I-1
II-3
II-24
II-55



QII.1-302
I-1
II-3
II-25
II-15



QII.1-303
I-1
II-3
II-25
II-21



QII.1-304
I-1
II-3
II-25
II-22



QII.1-305
I-1
II-3
II-25
II-47



QII.1-306
I-1
II-3
II-25
II-52



QII.1-307
I-1
II-3
II-25
II-53



QII.1-308
I-1
II-3
II-25
II-55



QII.1-309
I-1
II-3
II-26
II-15



QII.1-310
I-1
II-3
II-26
II-21



QII.1-311
I-1
II-3
II-26
II-22



QII.1-312
I-1
II-3
II-26
II-47



QII.1-313
I-1
II-3
II-26
II-52



QII.1-314
I-1
II-3
II-26
II-53



QII.1-315
I-1
II-3
II-26
II-55



QII.1-316
I-1
II-3
II-27
II-15



QII.1-317
I-1
II-3
II-27
II-21



QII.1-318
I-1
II-3
II-27
II-22



QII.1-319
I-1
II-3
II-27
II-47



QII.1-320
I-1
II-3
II-27
II-52



QII.1-321
I-1
II-3
II-27
II-53



QII.1-322
I-1
II-3
II-27
II-55



QII.1-323
I-1
II-3
II-28
II-15



QII.1-324
I-1
II-3
II-28
II-21



QII.1-325
I-1
II-3
II-28
II-22



QII.1-326
I-1
II-3
II-28
II-47



QII.1-327
I-1
II-3
II-28
II-52



QII.1-328
I-1
II-3
II-28
II-53



QII.1-329
I-1
II-3
II-28
II-55



QII.1-330
I-1
II-3
II-29
II-15



QII.1-331
I-1
II-3
II-29
II-21



QII.1-332
I-1
II-3
II-29
II-22



QII.1-333
I-1
II-3
II-29
II-47



QII.1-334
I-1
II-3
II-29
II-52



QII.1-335
I-1
II-3
II-29
II-53



QII.1-336
I-1
II-3
II-29
II-55



QII.1-337
I-1
II-3
II-34
II-15



QII.1-338
I-1
II-3
II-34
II-21



QII.1-339
I-1
II-3
II-34
II-22



QII.1-340
I-1
II-3
II-34
II-47



QII.1-341
I-1
II-3
II-34
II-52



QII.1-342
I-1
II-3
II-34
II-53



QII.1-343
I-1
II-3
II-34
II-55



QII.1-344
I-1
II-3
II-46
II-15



QII.1-345
I-1
II-3
II-46
II-21



QII.1-346
I-1
II-3
II-46
II-22



QII.1-347
I-1
II-3
II-46
II-47



QII.1-348
I-1
II-3
II-46
II-52



QII.1-349
I-1
II-3
II-46
II-53



QII.1-350
I-1
II-3
II-46
II-55



QII.1-351
I-1
II-3
II-48
II-15



QII.1-352
I-1
II-3
II-48
II-21



QII.1-353
I-1
II-3
II-48
II-22



QII.1-354
I-1
II-3
II-48
II-47



QII.1-355
I-1
II-3
II-48
II-52



QII.1-356
I-1
II-3
II-48
II-53



QII.1-357
I-1
II-3
II-48
II-55



QII.1-358
I-1
II-3
II-49
II-15



QII.1-359
I-1
II-3
II-49
II-21



QII.1-360
I-1
II-3
II-49
II-22



QII.1-361
I-1
II-3
II-49
II-47



QII.1-362
I-1
II-3
II-49
II-52



QII.1-363
I-1
II-3
II-49
II-53



QII.1-364
I-1
II-3
II-49
II-55



QII.1-365
I-1
II-3
II-50
II-15



QII.1-366
I-1
II-3
II-50
II-21



QII.1-367
I-1
II-3
II-50
II-22



QII.1-368
I-1
II-3
II-50
II-47



QII.1-369
I-1
II-3
II-50
II-52



QII.1-370
I-1
II-3
II-50
II-53



QII.1-371
I-1
II-3
II-50
II-55



QII.1-372
I-1
II-3
II-51
II-15



QII.1-373
I-1
II-3
II-51
II-21



QII.1-374
I-1
II-3
II-51
II-22



QII.1-375
I-1
II-3
II-51
II-47



QII.1-376
I-1
II-3
II-51
II-52



QII.1-377
I-1
II-3
II-51
II-53



QII.1-378
I-1
II-3
II-51
II-55



QII.1-379
I-1
II-7
II-8
II-15



QII.1-380
I-1
II-7
II-8
II-21



QII.1-381
I-1
II-7
II-8
II-22



QII.1-382
I-1
II-7
II-8
II-47



QII.1-383
I-1
II-7
II-8
II-52



QII.1-384
I-1
II-7
II-8
II-53



QII.1-385
I-1
II-7
II-8
II-55



QII.1-386
I-1
II-7
II-9
II-15



QII.1-387
I-1
II-7
II-9
II-21



QII.1-388
I-1
II-7
II-9
II-22



QII.1-389
I-1
II-7
II-9
II-47



QII.1-390
I-1
II-7
II-9
II-52



QII.1-391
I-1
II-7
II-9
II-53



QII.1-392
I-1
II-7
II-9
II-55



QII.1-393
I-1
II-7
II-10
II-15



QII.1-394
I-1
II-7
II-10
II-21



QII.1-395
I-1
II-7
II-10
II-22



QII.1-396
I-1
II-7
II-10
II-47



QII.1-397
I-1
II-7
II-10
II-52



QII.1-398
I-1
II-7
II-10
II-53



QII.1-399
I-1
II-7
II-10
II-55



QII.1-400
I-1
II-7
II-23
II-15



QII.1-401
I-1
II-7
II-23
II-21



QII.1-402
I-1
II-7
II-23
II-22



QII.1-403
I-1
II-7
II-23
II-47



QII.1-404
I-1
II-7
II-23
II-52



QII.1-405
I-1
II-7
II-23
II-53



QII.1-406
I-1
II-7
II-23
II-55



QII.1-407
I-1
II-7
II-24
II-15



QII.1-408
I-1
II-7
II-24
II-21



QII.1-409
I-1
II-7
II-24
II-22



QII.1-410
I-1
II-7
II-24
II-47



QII.1-411
I-1
II-7
II-24
II-52



QII.1-412
I-1
II-7
II-24
II-53



QII.1-413
I-1
II-7
II-24
II-55



QII.1-414
I-1
II-7
II-25
II-15



QII.1-415
I-1
II-7
II-25
II-21



QII.1-416
I-1
II-7
II-25
II-22



QII.1-417
I-1
II-7
II-25
II-47



QII.1-418
I-1
II-7
II-25
II-52



QII.1-419
I-1
II-7
II-25
II-53



QII.1-420
I-1
II-7
II-25
II-55



QII.1-421
I-1
II-7
II-26
II-15



QII.1-422
I-1
II-7
II-26
II-21



QII.1-423
I-1
II-7
II-26
II-22



QII.1-424
I-1
II-7
II-26
II-47



QII.1-425
I-1
II-7
II-26
II-52



QII.1-426
I-1
II-7
II-26
II-53



QII.1-427
I-1
II-7
II-26
II-55



QII.1-428
I-1
II-7
II-27
II-15



QII.1-429
I-1
II-7
II-27
II-21



QII.1-430
I-1
II-7
II-27
II-22



QII.1-431
I-1
II-7
II-27
II-47



QII.1-432
I-1
II-7
II-27
II-52



QII.1-433
I-1
II-7
II-27
II-53



QII.1-434
I-1
II-7
II-27
II-55



QII.1-435
I-1
II-7
II-28
II-15



QII.1-436
I-1
II-7
II-28
II-21



QII.1-437
I-1
II-7
II-28
II-22



QII.1-438
I-1
II-7
II-28
II-47



QII.1-439
I-1
II-7
II-28
II-52



QII.1-440
I-1
II-7
II-28
II-53



QII.1-441
I-1
II-7
II-28
II-55



QII.1-442
I-1
II-7
II-29
II-15



QII.1-443
I-1
II-7
II-29
II-21



QII.1-444
I-1
II-7
II-29
II-22



QII.1-445
I-1
II-7
II-29
II-47



QII.1-446
I-1
II-7
II-29
II-52



QII.1-447
I-1
II-7
II-29
II-53



QII.1-448
I-1
II-7
II-29
II-55



QII.1-449
I-1
II-7
II-34
II-15



QII.1-450
I-1
II-7
II-34
II-21



QII.1-451
I-1
II-7
II-34
II-22



QII.1-452
I-1
II-7
II-34
II-47



QII.1-453
I-1
II-7
II-34
II-52



QII.1-454
I-1
II-7
II-34
II-53



QII.1-455
I-1
II-7
II-34
II-55



QII.1-456
I-1
II-7
II-46
II-15



QII.1-457
I-1
II-7
II-46
II-21



QII.1-458
I-1
II-7
II-46
II-22



QII.1-459
I-1
II-7
II-46
II-47



QII.1-460
I-1
II-7
II-46
II-52



QII.1-461
I-1
II-7
II-46
II-53



QII.1-462
I-1
II-7
II-46
II-55



QII.1-463
I-1
II-7
II-48
II-15



QII.1-464
I-1
II-7
II-48
II-21



QII.1-465
I-1
II-7
II-48
II-22



QII.1-466
I-1
II-7
II-48
II-47



QII.1-467
I-1
II-7
II-48
II-52



QII.1-468
I-1
II-7
II-48
II-53



QII.1-469
I-1
II-7
II-48
II-55



QII.1-470
I-1
II-7
II-49
II-15



QII.1-471
I-1
II-7
II-49
II-21



QII.1-472
I-1
II-7
II-49
II-22



QII.1-473
I-1
II-7
II-49
II-47



QII.1-474
I-1
II-7
II-49
II-52



QII.1-475
I-1
II-7
II-49
II-53



QII.1-476
I-1
II-7
II-49
II-55



QII.1-477
I-1
II-7
II-50
II-15



QII.1-478
I-1
II-7
II-50
II-21



QII.1-479
I-1
II-7
II-50
II-22



QII.1-480
I-1
II-7
II-50
II-47



QII.1-481
I-1
II-7
II-50
II-52



QII.1-482
I-1
II-7
II-50
II-53



QII.1-483
I-1
II-7
II-50
II-55



QII.1-484
I-1
II-7
II-51
II-15



QII.1-485
I-1
II-7
II-51
II-21



QII.1-486
I-1
II-7
II-51
II-22



QII.1-487
I-1
II-7
II-51
II-47



QII.1-488
I-1
II-7
II-51
II-52



QII.1-489
I-1
II-7
II-51
II-53



QII.1-490
I-1
II-7
II-51
II-55



QII.1-491
I-1
II-8
II-9
II-15



QII.1-492
I-1
II-8
II-9
II-21



QII.1-493
I-1
II-8
II-9
II-22



QII.1-494
I-1
II-8
II-9
II-47



QII.1-495
I-1
II-8
II-9
II-52



QII.1-496
I-1
II-8
II-9
II-53



QII.1-497
I-1
II-8
II-9
II-55



QII.1-498
I-1
II-8
II-10
II-15



QII.1-499
I-1
II-8
II-10
II-21



QII.1-500
I-1
II-8
II-10
II-22



QII.1-501
I-1
II-8
II-10
II-47



QII.1-502
I-1
II-8
II-10
II-52



QII.1-503
I-1
II-8
II-10
II-53



QII.1-504
I-1
II-8
II-10
II-55



QII.1-505
I-1
II-8
II-23
II-15



QII.1-506
I-1
II-8
II-23
II-21



QII.1-507
I-1
II-8
II-23
II-22



QII.1-508
I-1
II-8
II-23
II-47



QII.1-509
I-1
II-8
II-23
II-52



QII.1-510
I-1
II-8
II-23
II-53



QII.1-511
I-1
II-8
II-23
II-55



QII.1-512
I-1
II-8
II-24
II-15



QII.1-513
I-1
II-8
II-24
II-21



QII.1-514
I-1
II-8
II-24
II-22



QII.1-515
I-1
II-8
II-24
II-47



QII.1-516
I-1
II-8
II-24
II-52



QII.1-517
I-1
II-8
II-24
II-53



QII.1-518
I-1
II-8
II-24
II-55



QII.1-519
I-1
II-8
II-25
II-15



QII.1-520
I-1
II-8
II-25
II-21



QII.1-521
I-1
II-8
II-25
II-22



QII.1-522
I-1
II-8
II-25
II-47



QII.1-523
I-1
II-8
II-25
II-52



QII.1-524
I-1
II-8
II-25
II-53



QII.1-525
I-1
II-8
II-25
II-55



QII.1-526
I-1
II-8
II-26
II-15



QII.1-527
I-1
II-8
II-26
II-21



QII.1-528
I-1
II-8
II-26
II-22



QII.1-529
I-1
II-8
II-26
II-47



QII.1-530
I-1
II-8
II-26
II-52



QII.1-531
I-1
II-8
II-26
II-53



QII.1-532
I-1
II-8
II-26
II-55



QII.1-533
I-1
II-8
II-27
II-15



QII.1-534
I-1
II-8
II-27
II-21



QII.1-535
I-1
II-8
II-27
II-22



QII.1-536
I-1
II-8
II-27
II-47



QII.1-537
I-1
II-8
II-27
II-52



QII.1-538
I-1
II-8
II-27
II-53



QII.1-539
I-1
II-8
II-27
II-55



QII.1-540
I-1
II-8
II-28
II-15



QII.1-541
I-1
II-8
II-28
II-21



QII.1-542
I-1
II-8
II-28
II-22



QII.1-543
I-1
II-8
II-28
II-47



QII.1-544
I-1
II-8
II-28
II-52



QII.1-545
I-1
II-8
II-28
II-53



QII.1-546
I-1
II-8
II-28
II-55



QII.1-547
I-1
II-8
II-29
II-15



QII.1-548
I-1
II-8
II-29
II-21



QII.1-549
I-1
II-8
II-29
II-22



QII.1-550
I-1
II-8
II-29
II-47



QII.1-551
I-1
II-8
II-29
II-52



QII.1-552
I-1
II-8
II-29
II-53



QII.1-553
I-1
II-8
II-29
II-55



QII.1-554
I-1
II-8
II-34
II-15



QII.1-555
I-1
II-8
II-34
II-21



QII.1-556
I-1
II-8
II-34
II-22



QII.1-557
I-1
II-8
II-34
II-47



QII.1-558
I-1
II-8
II-34
II-52



QII.1-559
I-1
II-8
II-34
II-53



QII.1-560
I-1
II-8
II-34
II-55



QII.1-561
I-1
II-8
II-46
II-15



QII.1-562
I-1
II-8
II-46
II-21



QII.1-563
I-1
II-8
II-46
II-22



QII.1-564
I-1
II-8
II-46
II-47



QII.1-565
I-1
II-8
II-46
II-52



QII.1-566
I-1
II-8
II-46
II-53



QII.1-567
I-1
II-8
II-46
II-55



QII.1-568
I-1
II-8
II-48
II-15



QII.1-569
I-1
II-8
II-48
II-21



QII.1-570
I-1
II-8
II-48
II-22



QII.1-571
I-1
II-8
II-48
II-47



QII.1-572
I-1
II-8
II-48
II-52



QII.1-573
I-1
II-8
II-48
II-53



QII.1-574
I-1
II-8
II-48
II-55



QII.1-575
I-1
II-8
II-49
II-15



QII.1-576
I-1
II-8
II-49
II-21



QII.1-577
I-1
II-8
II-49
II-22



QII.1-578
I-1
II-8
II-49
II-47



QII.1-579
I-1
II-8
II-49
II-52



QII.1-580
I-1
II-8
II-49
II-53



QII.1-581
I-1
II-8
II-49
II-55



QII.1-582
I-1
II-8
II-50
II-15



QII.1-583
I-1
II-8
II-50
II-21



QII.1-584
I-1
II-8
II-50
II-22



QII.1-585
I-1
II-8
II-50
II-47



QII.1-586
I-1
II-8
II-50
II-52



QII.1-587
I-1
II-8
II-50
II-53



QII.1-588
I-1
II-8
II-50
II-55



QII.1-589
I-1
II-8
II-51
II-15



QII.1-590
I-1
II-8
II-51
II-21



QII.1-591
I-1
II-8
II-51
II-22



QII.1-592
I-1
II-8
II-51
II-47



QII.1-593
I-1
II-8
II-51
II-52



QII.1-594
I-1
II-8
II-51
II-53



QII.1-595
I-1
II-8
II-51
II-55



QII.1-596
I-1
II-9
II-10
II-15



QII.1-597
I-1
II-9
II-10
II-21



QII.1-598
I-1
II-9
II-10
II-22



QII.1-599
I-1
II-9
II-10
II-47



QII.1-600
I-1
II-9
II-10
II-52



QII.1-601
I-1
II-9
II-10
II-53



QII.1-602
I-1
II-9
II-10
II-55



QII.1-603
I-1
II-9
II-23
II-15



QII.1-604
I-1
II-9
II-23
II-21



QII.1-605
I-1
II-9
II-23
II-22



QII.1-606
I-1
II-9
II-23
II-47



QII.1-607
I-1
II-9
II-23
II-52



QII.1-608
I-1
II-9
II-23
II-53



QII.1-609
I-1
II-9
II-23
II-55



QII.1-610
I-1
II-9
II-24
II-15



QII.1-611
I-1
II-9
II-24
II-21



QII.1-612
I-1
II-9
II-24
II-22



QII.1-613
I-1
II-9
II-24
II-47



QII.1-614
I-1
II-9
II-24
II-52



QII.1-615
I-1
II-9
II-24
II-53



QII.1-616
I-1
II-9
II-24
II-55



QII.1-617
I-1
II-9
II-25
II-15



QII.1-618
I-1
II-9
II-25
II-21



QII.1-619
I-1
II-9
II-25
II-22



QII.1-620
I-1
II-9
II-25
II-47



QII.1-621
I-1
II-9
II-25
II-52



QII.1-622
I-1
II-9
II-25
II-53



QII.1-623
I-1
II-9
II-25
II-55



QII.1-624
I-1
II-9
II-26
II-15



QII.1-625
I-1
II-9
II-26
II-21



QII.1-626
I-1
II-9
II-26
II-22



QII.1-627
I-1
II-9
II-26
II-47



QII.1-628
I-1
II-9
II-26
II-52



QII.1-629
I-1
II-9
II-26
II-53



QII.1-630
I-1
II-9
II-26
II-55



QII.1-631
I-1
II-9
II-27
II-15



QII.1-632
I-1
II-9
II-27
II-21



QII.1-633
I-1
II-9
II-27
II-22



QII.1-634
I-1
II-9
II-27
II-47



QII.1-635
I-1
II-9
II-27
II-52



QII.1-636
I-1
II-9
II-27
II-53



QII.1-637
I-1
II-9
II-27
II-55



QII.1-638
I-1
II-9
II-28
II-15



QII.1-639
I-1
II-9
II-28
II-21



QII.1-640
I-1
II-9
II-28
II-22



QII.1-641
I-1
II-9
II-28
II-47



QII.1-642
I-1
II-9
II-28
II-52



QII.1-643
I-1
II-9
II-28
II-53



QII.1-644
I-1
II-9
II-28
II-55



QII.1-645
I-1
II-9
II-29
II-15



QII.1-646
I-1
II-9
II-29
II-21



QII.1-647
I-1
II-9
II-29
II-22



QII.1-648
I-1
II-9
II-29
II-47



QII.1-649
I-1
II-9
II-29
II-52



QII.1-650
I-1
II-9
II-29
II-53



QII.1-651
I-1
II-9
II-29
II-55



QII.1-652
I-1
II-9
II-34
II-15



QII.1-653
I-1
II-9
II-34
II-21



QII.1-654
I-1
II-9
II-34
II-22



QII.1-655
I-1
II-9
II-34
II-47



QII.1-656
I-1
II-9
II-34
II-52



QII.1-657
I-1
II-9
II-34
II-53



QII.1-658
I-1
II-9
II-34
II-55



QII.1-659
I-1
II-9
II-46
II-15



QII.1-660
I-1
II-9
II-46
II-21



QII.1-661
I-1
II-9
II-46
II-22



QII.1-662
I-1
II-9
II-46
II-47



QII.1-663
I-1
II-9
II-46
II-52



QII.1-664
I-1
II-9
II-46
II-53



QII.1-665
I-1
II-9
II-46
II-55



QII.1-666
I-1
II-9
II-48
II-15



QII.1-667
I-1
II-9
II-48
II-21



QII.1-668
I-1
II-9
II-48
II-22



QII.1-669
I-1
II-9
II-48
II-47



QII.1-670
I-1
II-9
II-48
II-52



QII.1-671
I-1
II-9
II-48
II-53



QII.1-672
I-1
II-9
II-48
II-55



QII.1-673
I-1
II-9
II-49
II-15



QII.1-674
I-1
II-9
II-49
II-21



QII.1-675
I-1
II-9
II-49
II-22



QII.1-676
I-1
II-9
II-49
II-47



QII.1-677
I-1
II-9
II-49
II-52



QII.1-678
I-1
II-9
II-49
II-53



QII.1-679
I-1
II-9
II-49
II-55



QII.1-680
I-1
II-9
II-50
II-15



QII.1-681
I-1
II-9
II-50
II-21



QII.1-682
I-1
II-9
II-50
II-22



QII.1-683
I-1
II-9
II-50
II-47



QII.1-684
I-1
II-9
II-50
II-52



QII.1-685
I-1
II-9
II-50
II-53



QII.1-686
I-1
II-9
II-50
II-55



QII.1-687
I-1
II-9
II-51
II-15



QII.1-688
I-1
II-9
II-51
II-21



QII.1-689
I-1
II-9
II-51
II-22



QII.1-690
I-1
II-9
II-51
II-47



QII.1-691
I-1
II-9
II-51
II-52



QII.1-692
I-1
II-9
II-51
II-53



QII.1-693
I-1
II-9
II-51
II-55



QII.1-694
I-1
II-10
II-23
II-15



QII.1-695
I-1
II-10
II-23
II-21



QII.1-696
I-1
II-10
II-23
II-22



QII.1-697
I-1
II-10
II-23
II-47



QII.1-698
I-1
II-10
II-23
II-52



QII.1-699
I-1
II-10
II-23
II-53



QII.1-700
I-1
II-10
II-23
II-55



QII.1-701
I-1
II-10
II-24
II-15



QII.1-702
I-1
II-10
II-24
II-21



QII.1-703
I-1
II-10
II-24
II-22



QII.1-704
I-1
II-10
II-24
II-47



QII.1-705
I-1
II-10
II-24
II-52



QII.1-706
I-1
II-10
II-24
II-53



QII.1-707
I-1
II-10
II-24
II-55



QII.1-708
I-1
II-10
II-25
II-15



QII.1-709
I-1
II-10
II-25
II-21



QII.1-710
I-1
II-10
II-25
II-22



QII.1-711
I-1
II-10
II-25
II-47



QII.1-712
I-1
II-10
II-25
II-52



QII.1-713
I-1
II-10
II-25
II-53



QII.1-714
I-1
II-10
II-25
II-55



QII.1-715
I-1
II-10
II-26
II-15



QII.1-716
I-1
II-10
II-26
II-21



QII.1-717
I-1
II-10
II-26
II-22



QII.1-718
I-1
II-10
II-26
II-47



QII.1-719
I-1
II-10
II-26
II-52



QII.1-720
I-1
II-10
II-26
II-53



QII.1-721
I-1
II-10
II-26
II-55



QII.1-722
I-1
II-10
II-27
II-15



QII.1-723
I-1
II-10
II-27
II-21



QII.1-724
I-1
II-10
II-27
II-22



QII.1-725
I-1
II-10
II-27
II-47



QII.1-726
I-1
II-10
II-27
II-52



QII.1-727
I-1
II-10
II-27
II-53



QII.1-728
I-1
II-10
II-27
II-55



QII.1-729
I-1
II-10
II-28
II-15



QII.1-730
I-1
II-10
II-28
II-21



QII.1-731
I-1
II-10
II-28
II-22



QII.1-732
I-1
II-10
II-28
II-47



QII.1-733
I-1
II-10
II-28
II-52



QII.1-734
I-1
II-10
II-28
II-53



QII.1-735
I-1
II-10
II-28
II-55



QII.1-736
I-1
II-10
II-29
II-15



QII.1-737
I-1
II-10
II-29
II-21



QII.1-738
I-1
II-10
II-29
II-22



QII.1-739
I-1
II-10
II-29
II-47



QII.1-740
I-1
II-10
II-29
II-52



QII.1-741
I-1
II-10
II-29
II-53



QII.1-742
I-1
II-10
II-29
II-55



QII.1-743
I-1
II-10
II-34
II-15



QII.1-744
I-1
II-10
II-34
II-21



QII.1-745
I-1
II-10
II-34
II-22



QII.1-746
I-1
II-10
II-34
II-47



QII.1-747
I-1
II-10
II-34
II-52



QII.1-748
I-1
II-10
II-34
II-53



QII.1-749
I-1
II-10
II-34
II-55



QII.1-750
I-1
II-10
II-46
II-15



QII.1-751
I-1
II-10
II-46
II-21



QII.1-752
I-1
II-10
II-46
II-22



QII.1-753
I-1
II-10
II-46
II-47



QII.1-754
I-1
II-10
II-46
II-52



QII.1-755
I-1
II-10
II-46
II-53



QII.1-756
I-1
II-10
II-46
II-55



QII.1-757
I-1
II-10
II-48
II-15



QII.1-758
I-1
II-10
II-48
II-21



QII.1-759
I-1
II-10
II-48
II-22



QII.1-760
I-1
II-10
II-48
II-47



QII.1-761
I-1
II-10
II-48
II-52



QII.1-762
I-1
II-10
II-48
II-53



QII.1-763
I-1
II-10
II-48
II-55



QII.1-764
I-1
II-10
II-49
II-15



QII.1-765
I-1
II-10
II-49
II-21



QII.1-766
I-1
II-10
II-49
II-22



QII.1-767
I-1
II-10
II-49
II-47



QII.1-768
I-1
II-10
II-49
II-52



QII.1-769
I-1
II-10
II-49
II-53



QII.1-770
I-1
II-10
II-49
II-55



QII.1-771
I-1
II-10
II-50
II-15



QII.1-772
I-1
II-10
II-50
II-21



QII.1-773
I-1
II-10
II-50
II-22



QII.1-774
I-1
II-10
II-50
II-47



QII.1-775
I-1
II-10
II-50
II-52



QII.1-776
I-1
II-10
II-50
II-53



QII.1-777
I-1
II-10
II-50
II-55



QII.1-778
I-1
II-10
II-51
II-15



QII.1-779
I-1
II-10
II-51
II-21



QII.1-780
I-1
II-10
II-51
II-22



QII.1-781
I-1
II-10
II-51
II-47



QII.1-782
I-1
II-10
II-51
II-52



QII.1-783
I-1
II-10
II-51
II-53



QII.1-784
I-1
II-10
II-51
II-55



QII.1-785
I-1
II-23
II-24
II-15



QII.1-786
I-1
II-23
II-24
II-21



QII.1-787
I-1
II-23
II-24
II-22



QII.1-788
I-1
II-23
II-24
II-47



QII.1-789
I-1
II-23
II-24
II-52



QII.1-790
I-1
II-23
II-24
II-53



QII.1-791
I-1
II-23
II-24
II-55



QII.1-792
I-1
II-23
II-25
II-15



QII.1-793
I-1
II-23
II-25
II-21



QII.1-794
I-1
II-23
II-25
II-22



QII.1-795
I-1
II-23
II-25
II-47



QII.1-796
I-1
II-23
II-25
II-52



QII.1-797
I-1
II-23
II-25
II-53



QII.1-798
I-1
II-23
II-25
II-55



QII.1-799
I-1
II-23
II-26
II-15



QII.1-800
I-1
II-23
II-26
II-21



QII.1-801
I-1
II-23
II-26
II-22



QII.1-802
I-1
II-23
II-26
II-47



QII.1-803
I-1
II-23
II-26
II-52



QII.1-804
I-1
II-23
II-26
II-53



QII.1-805
I-1
II-23
II-26
II-55



QII.1-806
I-1
II-23
II-27
II-15



QII.1-807
I-1
II-23
II-27
II-21



QII.1-808
I-1
II-23
II-27
II-22



QII.1-809
I-1
II-23
II-27
II-47



QII.1-810
I-1
II-23
II-27
II-52



QII.1-811
I-1
II-23
II-27
II-53



QII.1-812
I-1
II-23
II-27
II-55



QII.1-813
I-1
II-23
II-28
II-15



QII.1-814
I-1
II-23
II-28
II-21



QII.1-815
I-1
II-23
II-28
II-22



QII.1-816
I-1
II-23
II-28
II-47



QII.1-817
I-1
II-23
II-28
II-52



QII.1-818
I-1
II-23
II-28
II-53



QII.1-819
I-1
II-23
II-28
II-55



QII.1-820
I-1
II-23
II-29
II-15



QII.1-821
I-1
II-23
II-29
II-21



QII.1-822
I-1
II-23
II-29
II-22



QII.1-823
I-1
II-23
II-29
II-47



QII.1-824
I-1
II-23
II-29
II-52



QII.1-825
I-1
II-23
II-29
II-53



QII.1-826
I-1
II-23
II-29
II-55



QII.1-827
I-1
II-23
II-34
II-15



QII.1-828
I-1
II-23
II-34
II-21



QII.1-829
I-1
II-23
II-34
II-22



QII.1-830
I-1
II-23
II-34
II-47



QII.1-831
I-1
II-23
II-34
II-52



QII.1-832
I-1
II-23
II-34
II-53



QII.1-833
I-1
II-23
II-34
II-55



QII.1-834
I-1
II-23
II-46
II-15



QII.1-835
I-1
II-23
II-46
II-21



QII.1-836
I-1
II-23
II-46
II-22



QII.1-837
I-1
II-23
II-46
II-47



QII.1-838
I-1
II-23
II-46
II-52



QII.1-839
I-1
II-23
II-46
II-53



QII.1-840
I-1
II-23
II-46
II-55



QII.1-841
I-1
II-23
II-48
II-15



QII.1-842
I-1
II-23
II-48
II-21



QII.1-843
I-1
II-23
II-48
II-22



QII.1-844
I-1
II-23
II-48
II-47



QII.1-845
I-1
II-23
II-48
II-52



QII.1-846
I-1
II-23
II-48
II-53



QII.1-847
I-1
II-23
II-48
II-55



QII.1-848
I-1
II-23
II-49
II-15



QII.1-849
I-1
II-23
II-49
II-21



QII.1-850
I-1
II-23
II-49
II-22



QII.1-851
I-1
II-23
II-49
II-47



QII.1-852
I-1
II-23
II-49
II-52



QII.1-853
I-1
II-23
II-49
II-53



QII.1-854
I-1
II-23
II-49
II-55



QII.1-855
I-1
II-23
II-50
II-15



QII.1-856
I-1
II-23
II-50
II-21



QII.1-857
I-1
II-23
II-50
II-22



QII.1-858
I-1
II-23
II-50
II-47



QII.1-859
I-1
II-23
II-50
II-52



QII.1-860
I-1
II-23
II-50
II-53



QII.1-861
I-1
II-23
II-50
II-55



QII.1-862
I-1
II-23
II-51
II-15



QII.1-863
I-1
II-23
II-51
II-21



QII.1-864
I-1
II-23
II-51
II-22



QII.1-865
I-1
II-23
II-51
II-47



QII.1-866
I-1
II-23
II-51
II-52



QII.1-867
I-1
II-23
II-51
II-53



QII.1-868
I-1
II-23
II-51
II-55



QII.1-869
I-1
II-24
II-25
II-15



QII.1-870
I-1
II-24
II-25
II-21



QII.1-871
I-1
II-24
II-25
II-22



QII.1-872
I-1
II-24
II-25
II-47



QII.1-873
I-1
II-24
II-25
II-52



QII.1-874
I-1
II-24
II-25
II-53



QII.1-875
I-1
II-24
II-25
II-55



QII.1-876
I-1
II-24
II-26
II-15



QII.1-877
I-1
II-24
II-26
II-21



QII.1-878
I-1
II-24
II-26
II-22



QII.1-879
I-1
II-24
II-26
II-47



QII.1-880
I-1
II-24
II-26
II-52



QII.1-881
I-1
II-24
II-26
II-53



QII.1-882
I-1
II-24
II-26
II-55



QII.1-883
I-1
II-24
II-27
II-15



QII.1-884
I-1
II-24
II-27
II-21



QII.1-885
I-1
II-24
II-27
II-22



QII.1-886
I-1
II-24
II-27
II-47



QII.1-887
I-1
II-24
II-27
II-52



QII.1-888
I-1
II-24
II-27
II-53



QII.1-889
I-1
II-24
II-27
II-55



QII.1-890
I-1
II-24
II-28
II-15



QII.1-891
I-1
II-24
II-28
II-21



QII.1-892
I-1
II-24
II-28
II-22



QII.1-893
I-1
II-24
II-28
II-47



QII.1-894
I-1
II-24
II-28
II-52



QII.1-895
I-1
II-24
II-28
II-53



QII.1-896
I-1
II-24
II-28
II-55



QII.1-897
I-1
II-24
II-29
II-15



QII.1-898
I-1
II-24
II-29
II-21



QII.1-899
I-1
II-24
II-29
II-22



QII.1-900
I-1
II-24
II-29
II-47



QII.1-901
I-1
II-24
II-29
II-52



QII.1-902
I-1
II-24
II-29
II-53



QII.1-903
I-1
II-24
II-29
II-55



QII.1-904
I-1
II-24
II-34
II-15



QII.1-905
I-1
II-24
II-34
II-21



QII.1-906
I-1
II-24
II-34
II-22



QII.1-907
I-1
II-24
II-34
II-47



QII.1-908
I-1
II-24
II-34
II-52



QII.1-909
I-1
II-24
II-34
II-53



QII.1-910
I-1
II-24
II-34
II-55



QII.1-911
I-1
II-24
II-46
II-15



QII.1-912
I-1
II-24
II-46
II-21



QII.1-913
I-1
II-24
II-46
II-22



QII.1-914
I-1
II-24
II-46
II-47



QII.1-915
I-1
II-24
II-46
II-52



QII.1-916
I-1
II-24
II-46
II-53



QII.1-917
I-1
II-24
II-46
II-55



QII.1-918
I-1
II-24
II-48
II-15



QII.1-919
I-1
II-24
II-48
II-21



QII.1-920
I-1
II-24
II-48
II-22



QII.1-921
I-1
II-24
II-48
II-47



QII.1-922
I-1
II-24
II-48
II-52



QII.1-923
I-1
II-24
II-48
II-53



QII.1-924
I-1
II-24
II-48
II-55



QII.1-925
I-1
II-24
II-49
II-15



QII.1-926
I-1
II-24
II-49
II-21



QII.1-927
I-1
II-24
II-49
II-22



QII.1-928
I-1
II-24
II-49
II-47



QII.1-929
I-1
II-24
II-49
II-52



QII.1-930
I-1
II-24
II-49
II-53



QII.1-931
I-1
II-24
II-49
II-55



QII.1-932
I-1
II-24
II-50
II-15



QII.1-933
I-1
II-24
II-50
II-21



QII.1-934
I-1
II-24
II-50
II-22



QII.1-935
I-1
II-24
II-50
II-47



QII.1-936
I-1
II-24
II-50
II-52



QII.1-937
I-1
II-24
II-50
II-53



QII.1-938
I-1
II-24
II-50
II-55



QII.1-939
I-1
II-24
II-51
II-15



QII.1-940
I-1
II-24
II-51
II-21



QII.1-941
I-1
II-24
II-51
II-22



QII.1-942
I-1
II-24
II-51
II-47



QII.1-943
I-1
II-24
II-51
II-52



QII.1-944
I-1
II-24
II-51
II-53



QII.1-945
I-1
II-24
II-51
II-55



QII.1-946
I-1
II-25
II-26
II-15



QII.1-947
I-1
II-25
II-26
II-21



QII.1-948
I-1
II-25
II-26
II-22



QII.1-949
I-1
II-25
II-26
II-47



QII.1-950
I-1
II-25
II-26
II-52



QII.1-951
I-1
II-25
II-26
II-53



QII.1-952
I-1
II-25
II-26
II-55



QII.1-953
I-1
II-25
II-27
II-15



QII.1-954
I-1
II-25
II-27
II-21



QII.1-955
I-1
II-25
II-27
II-22



QII.1-956
I-1
II-25
II-27
II-47



QII.1-957
I-1
II-25
II-27
II-52



QII.1-958
I-1
II-25
II-27
II-53



QII.1-959
I-1
II-25
II-27
II-55



QII.1-960
I-1
II-25
II-28
II-15



QII.1-961
I-1
II-25
II-28
II-21



QII.1-962
I-1
II-25
II-28
II-22



QII.1-963
I-1
II-25
II-28
II-47



QII.1-964
I-1
II-25
II-28
II-52



QII.1-965
I-1
II-25
II-28
II-53



QII.1-966
I-1
II-25
II-28
II-55



QII.1-967
I-1
II-25
II-29
II-15



QII.1-968
I-1
II-25
II-29
II-21



QII.1-969
I-1
II-25
II-29
II-22



QII.1-970
I-1
II-25
II-29
II-47



QII.1-971
I-1
II-25
II-29
II-52



QII.1-972
I-1
II-25
II-29
II-53



QII.1-973
I-1
II-25
II-29
II-55



QII.1-974
I-1
II-25
II-34
II-15



QII.1-975
I-1
II-25
II-34
II-21



QII.1-976
I-1
II-25
II-34
II-22



QII.1-977
I-1
II-25
II-34
II-47



QII.1-978
I-1
II-25
II-34
II-52



QII.1-979
I-1
II-25
II-34
II-53



QII.1-980
I-1
II-25
II-34
II-55



QII.1-981
I-1
II-25
II-46
II-15



QII.1-982
I-1
II-25
II-46
II-21



QII.1-983
I-1
II-25
II-46
II-22



QII.1-984
I-1
II-25
II-46
II-47



QII.1-985
I-1
II-25
II-46
II-52



QII.1-986
I-1
II-25
II-46
II-53



QII.1-987
I-1
II-25
II-46
II-55



QII.1-988
I-1
II-25
II-48
II-15



QII.1-989
I-1
II-25
II-48
II-21



QII.1-990
I-1
II-25
II-48
II-22



QII.1-991
I-1
II-25
II-48
II-47



QII.1-992
I-1
II-25
II-48
II-52



QII.1-993
I-1
II-25
II-48
II-53



QII.1-994
I-1
II-25
II-48
II-55



QII.1-995
I-1
II-25
II-49
II-15



QII.1-996
I-1
II-25
II-49
II-21



QII.1-997
I-1
II-25
II-49
II-22



QII.1-998
I-1
II-25
II-49
II-47



QII.1-999
I-1
II-25
II-49
II-52



QII.1-1000
I-1
II-25
II-49
II-53



QII.1-1001
I-1
II-25
II-49
II-55



QII.1-1002
I-1
II-25
II-50
II-15



QII.1-1003
I-1
II-25
II-50
II-21



QII.1-1004
I-1
II-25
II-50
II-22



QII.1-1005
I-1
II-25
II-50
II-47



QII.1-1006
I-1
II-25
II-50
II-52



QII.1-1007
I-1
II-25
II-50
II-53



QII.1-1008
I-1
II-25
II-50
II-55



QII.1-1009
I-1
II-25
II-51
II-15



QII.1-1010
I-1
II-25
II-51
II-21



QII.1-1011
I-1
II-25
II-51
II-22



QII.1-1012
I-1
II-25
II-51
II-47



QII.1-1013
I-1
II-25
II-51
II-52



QII.1-1014
I-1
II-25
II-51
II-53



QII.1-1015
I-1
II-25
II-51
II-55



QII.1-1016
I-1
II-26
II-27
II-15



QII.1-1017
I-1
II-26
II-27
II-21



QII.1-1018
I-1
II-26
II-27
II-22



QII.1-1019
I-1
II-26
II-27
II-47



QII.1-1020
I-1
II-26
II-27
II-52



QII.1-1021
I-1
II-26
II-27
II-53



QII.1-1022
I-1
II-26
II-27
II-55



QII.1-1023
I-1
II-26
II-28
II-15



QII.1-1024
I-1
II-26
II-28
II-21



QII.1-1025
I-1
II-26
II-28
II-22



QII.1-1026
I-1
II-26
II-28
II-47



QII.1-1027
I-1
II-26
II-28
II-52



QII.1-1028
I-1
II-26
II-28
II-53



QII.1-1029
I-1
II-26
II-28
II-55



QII.1-1030
I-1
II-26
II-29
II-15



QII.1-1031
I-1
II-26
II-29
II-21



QII.1-1032
I-1
II-26
II-29
II-22



QII.1-1033
I-1
II-26
II-29
II-47



QII.1-1034
I-1
II-26
II-29
II-52



QII.1-1035
I-1
II-26
II-29
II-53



QII.1-1036
I-1
II-26
II-29
II-55



QII.1-1037
I-1
II-26
II-34
II-15



QII.1-1038
I-1
II-26
II-34
II-21



QII.1-1039
I-1
II-26
II-34
II-22



QII.1-1040
I-1
II-26
II-34
II-47



QII.1-1041
I-1
II-26
II-34
II-52



QII.1-1042
I-1
II-26
II-34
II-53



QII.1-1043
I-1
II-26
II-34
II-55



QII.1-1044
I-1
II-26
II-46
II-15



QII.1-1045
I-1
II-26
II-46
II-21



QII.1-1046
I-1
II-26
II-46
II-22



QII.1-1047
I-1
II-26
II-46
II-47



QII.1-1048
I-1
II-26
II-46
II-52



QII.1-1049
I-1
II-26
II-46
II-53



QII.1-1050
I-1
II-26
II-46
II-55



QII.1-1051
I-1
II-26
II-48
II-15



QII.1-1052
I-1
II-26
II-48
II-21



QII.1-1053
I-1
II-26
II-48
II-22



QII.1-1054
I-1
II-26
II-48
II-47



QII.1-1055
I-1
II-26
II-48
II-52



QII.1-1056
I-1
II-26
II-48
II-53



QII.1-1057
I-1
II-26
II-48
II-55



QII.1-1058
I-1
II-26
II-49
II-15



QII.1-1059
I-1
II-26
II-49
II-21



QII.1-1060
I-1
II-26
II-49
II-22



QII.1-1061
I-1
II-26
II-49
II-47



QII.1-1062
I-1
II-26
II-49
II-52



QII.1-1063
I-1
II-26
II-49
II-53



QII.1-1064
I-1
II-26
II-49
II-55



QII.1-1065
I-1
II-26
II-50
II-15



QII.1-1066
I-1
II-26
II-50
II-21



QII.1-1067
I-1
II-26
II-50
II-22



QII.1-1068
I-1
II-26
II-50
II-47



QII.1-1069
I-1
II-26
II-50
II-52



QII.1-1070
I-1
II-26
II-50
II-53



QII.1-1071
I-1
II-26
II-50
II-55



QII.1-1072
I-1
II-26
II-51
II-15



QII.1-1073
I-1
II-26
II-51
II-21



QII.1-1074
I-1
II-26
II-51
II-22



QII.1-1075
I-1
II-26
II-51
II-47



QII.1-1076
I-1
II-26
II-51
II-52



QII.1-1077
I-1
II-26
II-51
II-53



QII.1-1078
I-1
II-26
II-51
II-55



QII.1-1079
I-1
II-27
II-28
II-15



QII.1-1080
I-1
II-27
II-28
II-21



QII.1-1081
I-1
II-27
II-28
II-22



QII.1-1082
I-1
II-27
II-28
II-47



QII.1-1083
I-1
II-27
II-28
II-52



QII.1-1084
I-1
II-27
II-28
II-53



QII.1-1085
I-1
II-27
II-28
II-55



QII.1-1086
I-1
II-27
II-29
II-15



QII.1-1087
I-1
II-27
II-29
II-21



QII.1-1088
I-1
II-27
II-29
II-22



QII.1-1089
I-1
II-27
II-29
II-47



QII.1-1090
I-1
II-27
II-29
II-52



QII.1-1091
I-1
II-27
II-29
II-53



QII.1-1092
I-1
II-27
II-29
II-55



QII.1-1093
I-1
II-27
II-34
II-15



QII.1-1094
I-1
II-27
II-34
II-21



QII.1-1095
I-1
II-27
II-34
II-22



QII.1-1096
I-1
II-27
II-34
II-47



QII.1-1097
I-1
II-27
II-34
II-52



QII.1-1098
I-1
II-27
II-34
II-53



QII.1-1099
I-1
II-27
II-34
II-55



QII.1-1100
I-1
II-27
II-46
II-15



QII.1-1101
I-1
II-27
II-46
II-21



QII.1-1102
I-1
II-27
II-46
II-22



QII.1-1103
I-1
II-27
II-46
II-47



QII.1-1104
I-1
II-27
II-46
II-52



QII.1-1105
I-1
II-27
II-46
II-53



QII.1-1106
I-1
II-27
II-46
II-55



QII.1-1107
I-1
II-27
II-48
II-15



QII.1-1108
I-1
II-27
II-48
II-21



QII.1-1109
I-1
II-27
II-48
II-22



QII.1-1110
I-1
II-27
II-48
II-47



QII.1-1111
I-1
II-27
II-48
II-52



QII.1-1112
I-1
II-27
II-48
II-53



QII.1-1113
I-1
II-27
II-48
II-55



QII.1-1114
I-1
II-27
II-49
II-15



QII.1-1115
I-1
II-27
II-49
II-21



QII.1-1116
I-1
II-27
II-49
II-22



QII.1-1117
I-1
II-27
II-49
II-47



QII.1-1118
I-1
II-27
II-49
II-52



QII.1-1119
I-1
II-27
II-49
II-53



QII.1-1120
I-1
II-27
II-49
II-55



QII.1-1121
I-1
II-27
II-50
II-15



QII.1-1122
I-1
II-27
II-50
II-21



QII.1-1123
I-1
II-27
II-50
II-22



QII.1-1124
I-1
II-27
II-50
II-47



QII.1-1125
I-1
II-27
II-50
II-52



QII.1-1126
I-1
II-27
II-50
II-53



QII.1-1127
I-1
II-27
II-50
II-55



QII.1-1128
I-1
II-27
II-51
II-15



QII.1-1129
I-1
II-27
II-51
II-21



QII.1-1130
I-1
II-27
II-51
II-22



QII.1-1131
I-1
II-27
II-51
II-47



QII.1-1132
I-1
II-27
II-51
II-52



QII.1-1133
I-1
II-27
II-51
II-53



QII.1-1134
I-1
II-27
II-51
II-55



QII.1-1135
I-1
II-28
II-29
II-15



QII.1-1136
I-1
II-28
II-29
II-21



QII.1-1137
I-1
II-28
II-29
II-22



QII.1-1138
I-1
II-28
II-29
II-47



QII.1-1139
I-1
II-28
II-29
II-52



QII.1-1140
I-1
II-28
II-29
II-53



QII.1-1141
I-1
II-28
II-29
II-55



QII.1-1142
I-1
II-28
II-34
II-15



QII.1-1143
I-1
II-28
II-34
II-21



QII.1-1144
I-1
II-28
II-34
II-22



QII.1-1145
I-1
II-28
II-34
II-47



QII.1-1146
I-1
II-28
II-34
II-52



QII.1-1147
I-1
II-28
II-34
II-53



QII.1-1148
I-1
II-28
II-34
II-55



QII.1-1149
I-1
II-28
II-46
II-15



QII.1-1150
I-1
II-28
II-46
II-21



QII.1-1151
I-1
II-28
II-46
II-22



QII.1-1152
I-1
II-28
II-46
II-47



QII.1-1153
I-1
II-28
II-46
II-52



QII.1-1154
I-1
II-28
II-46
II-53



QII.1-1155
I-1
II-28
II-46
II-55



QII.1-1156
I-1
II-28
II-48
II-15



QII.1-1157
I-1
II-28
II-48
II-21



QII.1-1158
I-1
II-28
II-48
II-22



QII.1-1159
I-1
II-28
II-48
II-47



QII.1-1160
I-1
II-28
II-48
II-52



QII.1-1161
I-1
II-28
II-48
II-53



QII.1-1162
I-1
II-28
II-48
II-55



QII.1-1163
I-1
II-28
II-49
II-15



QII.1-1164
I-1
II-28
II-49
II-21



QII.1-1165
I-1
II-28
II-49
II-22



QII.1-1166
I-1
II-28
II-49
II-47



QII.1-1167
I-1
II-28
II-49
II-52



QII.1-1168
I-1
II-28
II-49
II-53



QII.1-1169
I-1
II-28
II-49
II-55



QII.1-1170
I-1
II-28
II-50
II-15



QII.1-1171
I-1
II-28
II-50
II-21



QII.1-1172
I-1
II-28
II-50
II-22



QII.1-1173
I-1
II-28
II-50
II-47



QII.1-1174
I-1
II-28
II-50
II-52



QII.1-1175
I-1
II-28
II-50
II-53



QII.1-1176
I-1
II-28
II-50
II-55



QII.1-1177
I-1
II-28
II-51
II-15



QII.1-1178
I-1
II-28
II-51
II-21



QII.1-1179
I-1
II-28
II-51
II-22



QII.1-1180
I-1
II-28
II-51
II-47



QII.1-1181
I-1
II-28
II-51
II-52



QII.1-1182
I-1
II-28
II-51
II-53



QII.1-1183
I-1
II-28
II-51
II-55



QII.1-1184
I-1
II-29
II-34
II-15



QII.1-1185
I-1
II-29
II-34
II-21



QII.1-1186
I-1
II-29
II-34
II-22



QII.1-1187
I-1
II-29
II-34
II-47



QII.1-1188
I-1
II-29
II-34
II-52



QII.1-1189
I-1
II-29
II-34
II-53



QII.1-1190
I-1
II-29
II-34
II-55



QII.1-1191
I-1
II-29
II-46
II-15



QII.1-1192
I-1
II-29
II-46
II-21



QII.1-1193
I-1
II-29
II-46
II-22



QII.1-1194
I-1
II-29
II-46
II-47



QII.1-1195
I-1
II-29
II-46
II-52



QII.1-1196
I-1
II-29
II-46
II-53



QII.1-1197
I-1
II-29
II-46
II-55



QII.1-1198
I-1
II-29
II-48
II-15



QII.1-1199
I-1
II-29
II-48
II-21



QII.1-1200
I-1
II-29
II-48
II-22



QII.1-1201
I-1
II-29
II-48
II-47



QII.1-1202
I-1
II-29
II-48
II-52



QII.1-1203
I-1
II-29
II-48
II-53



QII.1-1204
I-1
II-29
II-48
II-55



QII.1-1205
I-1
II-29
II-49
II-15



QII.1-1206
I-1
II-29
II-49
II-21



QII.1-1207
I-1
II-29
II-49
II-22



QII.1-1208
I-1
II-29
II-49
II-47



QII.1-1209
I-1
II-29
II-49
II-52



QII.1-1210
I-1
II-29
II-49
II-53



QII.1-1211
I-1
II-29
II-49
II-55



QII.1-1212
I-1
II-29
II-50
II-15



QII.1-1213
I-1
II-29
II-50
II-21



QII.1-1214
I-1
II-29
II-50
II-22



QII.1-1215
I-1
II-29
II-50
II-47



QII.1-1216
I-1
II-29
II-50
II-52



QII.1-1217
I-1
II-29
II-50
II-53



QII.1-1218
I-1
II-29
II-50
II-55



QII.1-1219
I-1
II-29
II-51
II-15



QII.1-1220
I-1
II-29
II-51
II-21



QII.1-1221
I-1
II-29
II-51
II-22



QII.1-1222
I-1
II-29
II-51
II-47



QII.1-1223
I-1
II-29
II-51
II-52



QII.1-1224
I-1
II-29
II-51
II-53



QII.1-1225
I-1
II-29
II-51
II-55



QII.1-1226
I-1
II-34
II-46
II-15



QII.1-1227
I-1
II-34
II-46
II-21



QII.1-1228
I-1
II-34
II-46
II-22



QII.1-1229
I-1
II-34
II-46
II-47



QII.1-1230
I-1
II-34
II-46
II-52



QII.1-1231
I-1
II-34
II-46
II-53



QII.1-1232
I-1
II-34
II-46
II-55



QII.1-1233
I-1
II-34
II-48
II-15



QII.1-1234
I-1
II-34
II-48
II-21



QII.1-1235
I-1
II-34
II-48
II-22



QII.1-1236
I-1
II-34
II-48
II-47



QII.1-1237
I-1
II-34
II-48
II-52



QII.1-1238
I-1
II-34
II-48
II-53



QII.1-1239
I-1
II-34
II-48
II-55



QII.1-1240
I-1
II-34
II-49
II-15



QII.1-1241
I-1
II-34
II-49
II-21



QII.1-1242
I-1
II-34
II-49
II-22



QII.1-1243
I-1
II-34
II-49
II-47



QII.1-1244
I-1
II-34
II-49
II-52



QII.1-1245
I-1
II-34
II-49
II-53



QII.1-1246
I-1
II-34
II-49
II-55



QII.1-1247
I-1
II-34
II-50
II-15



QII.1-1248
I-1
II-34
II-50
II-21



QII.1-1249
I-1
II-34
II-50
II-22



QII.1-1250
I-1
II-34
II-50
II-47



QII.1-1251
I-1
II-34
II-50
II-52



QII.1-1252
I-1
II-34
II-50
II-53



QII.1-1253
I-1
II-34
II-50
II-55



QII.1-1254
I-1
II-34
II-51
II-15



QII.1-1255
I-1
II-34
II-51
II-21



QII.1-1256
I-1
II-34
II-51
II-22



QII.1-1257
I-1
II-34
II-51
II-47



QII.1-1258
I-1
II-34
II-51
II-52



QII.1-1259
I-1
II-34
II-51
II-53



QII.1-1260
I-1
II-34
II-51
II-55



QII.1-1261
I-1
II-46
II-48
II-15



QII.1-1262
I-1
II-46
II-48
II-21



QII.1-1263
I-1
II-46
II-48
II-22



QII.1-1264
I-1
II-46
II-48
II-47



QII.1-1265
I-1
II-46
II-48
II-52



QII.1-1266
I-1
II-46
II-48
II-53



QII.1-1267
I-1
II-46
II-48
II-55



QII.1-1268
I-1
II-46
II-49
II-15



QII.1-1269
I-1
II-46
II-49
II-21



QII.1-1270
I-1
II-46
II-49
II-22



QII.1-1271
I-1
II-46
II-49
II-47



QII.1-1272
I-1
II-46
II-49
II-52



QII.1-1273
I-1
II-46
II-49
II-53



QII.1-1274
I-1
II-46
II-49
II-55



QII.1-1275
I-1
II-46
II-50
II-15



QII.1-1276
I-1
II-46
II-50
II-21



QII.1-1277
I-1
II-46
II-50
II-22



QII.1-1278
I-1
II-46
II-50
II-47



QII.1-1279
I-1
II-46
II-50
II-52



QII.1-1280
I-1
II-46
II-50
II-53



QII.1-1281
I-1
II-46
II-50
II-55



QII.1-1282
I-1
II-46
II-51
II-15



QII.1-1283
I-1
II-46
II-51
II-21



QII.1-1284
I-1
II-46
II-51
II-22



QII.1-1285
I-1
II-46
II-51
II-47



QII.1-1286
I-1
II-46
II-51
II-52



QII.1-1287
I-1
II-46
II-51
II-53



QII.1-1288
I-1
II-46
II-51
II-55



QII.1-1289
I-1
II-48
II-49
II-15



QII.1-1290
I-1
II-48
II-49
II-21



QII.1-1291
I-1
II-48
II-49
II-22



QII.1-1292
I-1
II-48
II-49
II-47



QII.1-1293
I-1
II-48
II-49
II-52



QII.1-1294
I-1
II-48
II-49
II-53



QII.1-1295
I-1
II-48
II-49
II-55



QII.1-1296
I-1
II-48
II-50
II-15



QII.1-1297
I-1
II-48
II-50
II-21



QII.1-1298
I-1
II-48
II-50
II-22



QII.1-1299
I-1
II-48
II-50
II-47



QII.1-1300
I-1
II-48
II-50
II-52



QII.1-1301
I-1
II-48
II-50
II-53



QII.1-1302
I-1
II-48
II-50
II-55



QII.1-1303
I-1
II-48
II-51
II-15



QII.1-1304
I-1
II-48
II-51
II-21



QII.1-1305
I-1
II-48
II-51
II-22



QII.1-1306
I-1
II-48
II-51
II-47



QII.1-1307
I-1
II-48
II-51
II-52



QII.1-1308
I-1
II-48
II-51
II-53



QII.1-1309
I-1
II-48
II-51
II-55



QII.1-1310
I-1
II-49
II-50
II-15



QII.1-1311
I-1
II-49
II-50
II-21



QII.1-1312
I-1
II-49
II-50
II-22



QII.1-1313
I-1
II-49
II-50
II-47



QII.1-1314
I-1
II-49
II-50
II-52



QII.1-1315
I-1
II-49
II-50
II-53



QII.1-1316
I-1
II-49
II-50
II-55



QII.1-1317
I-1
II-49
II-51
II-15



QII.1-1318
I-1
II-49
II-51
II-21



QII.1-1319
I-1
II-49
II-51
II-22



QII.1-1320
I-1
II-49
II-51
II-47



QII.1-1321
I-1
II-49
II-51
II-52



QII.1-1322
I-1
II-49
II-51
II-53



QII.1-1323
I-1
II-49
II-51
II-55



QII.1-1324
I-1
II-50
II-51
II-15



QII.1-1325
I-1
II-50
II-51
II-21



QII.1-1326
I-1
II-50
II-51
II-22



QII.1-1327
I-1
II-50
II-51
II-47



QII.1-1328
I-1
II-50
II-51
II-52



QII.1-1329
I-1
II-50
II-51
II-53



QII.1-1330
I-1
II-50
II-51
II-55










Table QII.2: Quaternary mixtures QII.2-1 to QII.2-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-2 and therefore have the term “QII.2-” instead of “QII.1-” in front of the number of the mixture.


Table QII.3: Quaternary mixtures QII.3-1 to QII.3-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of compound I-1 the compound I-3 and therefore have the term “QII.3-” instead of “QII.1-” in front of the number of the mixture.


Table QII.4: Quaternary mixtures QII.4-1 to QII.4-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-4 and therefore have the term “QII.4-” instead of “QII.1-” in front of the number of the mixture.


Table QII.5: Quaternary mixtures QII.5-1 to QII.5-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-5 and therefore have the term “QII.5-” instead of “QII.1-” in front of the number of the mixture.


Table QII.6: Quaternary mixtures QII.6-1 to QII.6-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-6 and therefore have the term “QII.6-” instead of “QII.1-” in front of the number of the mixture.


Table QII.7: Quaternary mixtures QII.7-1 to QII.7-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-7 and therefore have the term “QII.7-” instead of “QII.1-” in front of the number of the mixture.


Table QII.8: Quaternary mixtures QII.8-1 to QII.8-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-8 and therefore have the term “QII.8-” instead of “QII.1-” in front of the number of the mixture.


Table QII.9: Quaternary mixtures QII.9-1 to QII.9-1330 which correspond to the quaternary mixtures QII.1-1 to QII.1-1330 in each case having the same numeration but which comprise, as component 1, instead of the compound I-1 the compound I-9 and therefore have the term “QII.9-” instead of “QII.1-” in front of the number of the mixture.


According to a further embodiment of the invention, preference is given to mixtures comprising four components (1, 2, 3 and 4) in which component 2 is selected from the group of the following compounds:

    • II-8 kresoxim-methyl
    • II-9 pyraclostrobin
    • II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide
    • II-26 sedaxane
    • II-28 fluopyram
    • II-29 penflufen
    • II-49 azoxystrobin
    • II-50 trifloxystrobin
    • II-51 penthiopyrad
    • and in which component 3 is a compound II selected from the group of the following compounds:
    • II-32a clothianidin
    • II-34a imidacloprid
    • II-35a thiamethoxan
    • and in which component 4 is fipronil (II-30a).


Such mixtures are listed explicitly in Table QIII below:









TABLE QIII







Mixtures QIII-1 to QIII-243 comprising, as component 1, a preferred


compound I, a component 2 selected from the preferred active


compounds of groups A to F, a component 3 selected from the preferred


active compounds of group I) and fipronil as component 4. In the table


below, in each case one row corresponds to a mixture according to the


invention having the respective mixture components 1 to 4 listed in the


row in question.













M
C1
C2
C3
C4







QIII-1
I-1
II-8
II-32a
II-30a



QIII-2
I-1
II-8
II-34a
II-30a



QIII-3
I-1
II-8
II-35a
II-30a



QIII-4
I-1
II-9
II-32a
II-30a



QIII-5
I-1
II-9
II-34a
II-30a



QIII-6
I-1
II-9
II-35a
II-30a



QIII-7
I-1
II-25
II-32a
II-30a



QIII-8
I-1
II-25
II-34a
II-30a



QIII-9
I-1
II-25
II-35a
II-30a



QIII-10
I-1
II-26
II-32a
II-30a



QIII-11
I-1
II-26
II-34a
II-30a



QIII-12
I-1
II-26
II-35a
II-30a



QIII-13
I-1
II-28
II-32a
II-30a



QIII-14
I-1
II-28
II-34a
II-30a



QIII-15
I-1
II-28
II-35a
II-30a



QIII-16
I-1
II-29
II-32a
II-30a



QIII-17
I-1
II-29
II-34a
II-30a



QIII-18
I-1
II-29
II-35a
II-30a



QIII-19
I-1
II-49
II-32a
II-30a



QIII-20
I-1
II-49
II-34a
II-30a



QIII-21
I-1
II-49
II-35a
II-30a



QIII-22
I-1
II-50
II-32a
II-30a



QIII-23
I-1
II-50
II-34a
II-30a



QIII-24
I-1
II-50
II-35a
II-30a



QIII-25
I-1
II-51
II-32a
II-30a



QIII-26
I-1
II-51
II-34a
II-30a



QIII-27
I-1
II-51
II-35a
II-30a



QIII-28
I-2
II-8
II-32a
II-30a



QIII-29
I-2
II-8
II-34a
II-30a



QIII-30
I-2
II-8
II-35a
II-30a



QIII-31
I-2
II-9
II-32a
II-30a



QIII-32
I-2
II-9
II-34a
II-30a



QIII-33
I-2
II-9
II-35a
II-30a



QIII-34
I-2
II-25
II-32a
II-30a



QIII-35
I-2
II-25
II-34a
II-30a



QIII-36
I-2
II-25
II-35a
II-30a



QIII-37
I-2
II-26
II-32a
II-30a



QIII-38
I-2
II-26
II-34a
II-30a



QIII-39
I-2
II-26
II-35a
II-30a



QIII-40
I-2
II-28
II-32a
II-30a



QIII-41
I-2
II-28
II-34a
II-30a



QIII-42
I-2
II-28
II-35a
II-30a



QIII-43
I-2
II-29
II-32a
II-30a



QIII-44
I-2
II-29
II-34a
II-30a



QIII-45
I-2
II-29
II-35a
II-30a



QIII-46
I-2
II-49
II-32a
II-30a



QIII-47
I-2
II-49
II-34a
II-30a



QIII-48
I-2
II-49
II-35a
II-30a



QIII-49
I-2
II-50
II-32a
II-30a



QIII-50
I-2
II-50
II-34a
II-30a



QIII-51
I-2
II-50
II-35a
II-30a



QIII-52
I-2
II-51
II-32a
II-30a



QIII-53
I-2
II-51
II-34a
II-30a



QIII-54
I-2
II-51
II-35a
II-30a



QIII-55
I-3
II-8
II-32a
II-30a



QIII-56
I-3
II-8
II-34a
II-30a



QIII-57
I-3
II-8
II-35a
II-30a



QIII-58
I-3
II-9
II-32a
II-30a



QIII-59
I-3
II-9
II-34a
II-30a



QIII-60
I-3
II-9
II-35a
II-30a



QIII-61
I-3
II-25
II-32a
II-30a



QIII-62
I-3
II-25
II-34a
II-30a



QIII-63
I-3
II-25
II-35a
II-30a



QIII-64
I-3
II-26
II-32a
II-30a



QIII-65
I-3
II-26
II-34a
II-30a



QIII-66
I-3
II-26
II-35a
II-30a



QIII-67
I-3
II-28
II-32a
II-30a



QIII-68
I-3
II-28
II-34a
II-30a



QIII-69
I-3
II-28
II-35a
II-30a



QIII-70
I-3
II-29
II-32a
II-30a



QIII-71
I-3
II-29
II-34a
II-30a



QIII-72
I-3
II-29
II-35a
II-30a



QIII-73
I-3
II-49
II-32a
II-30a



QIII-74
I-3
II-49
II-34a
II-30a



QIII-75
I-3
II-49
II-35a
II-30a



QIII-76
I-3
II-50
II-32a
II-30a



QIII-77
I-3
II-50
II-34a
II-30a



QIII-78
I-3
II-50
II-35a
II-30a



QIII-79
I-3
II-51
II-32a
II-30a



QIII-80
I-3
II-51
II-34a
II-30a



QIII-81
I-3
II-51
II-35a
II-30a



QIII-82
I-4
II-8
II-32a
II-30a



QIII-83
I-4
II-8
II-34a
II-30a



QIII-84
I-4
II-8
II-35a
II-30a



QIII-85
I-4
II-9
II-32a
II-30a



QIII-86
I-4
II-9
II-34a
II-30a



QIII-87
I-4
II-9
II-35a
II-30a



QIII-88
I-4
II-25
II-32a
II-30a



QIII-89
I-4
II-25
II-34a
II-30a



QIII-90
I-4
II-25
II-35a
II-30a



QIII-91
I-4
II-26
II-32a
II-30a



QIII-92
I-4
II-26
II-34a
II-30a



QIII-93
I-4
II-26
II-35a
II-30a



QIII-94
I-4
II-28
II-32a
II-30a



QIII-95
I-4
II-28
II-34a
II-30a



QIII-96
I-4
II-28
II-35a
II-30a



QIII-97
I-4
II-29
II-32a
II-30a



QIII-98
I-4
II-29
II-34a
II-30a



QIII-99
I-4
II-29
II-35a
II-30a



QIII-100
I-4
II-49
II-32a
II-30a



QIII-101
I-4
II-49
II-34a
II-30a



QIII-102
I-4
II-49
II-35a
II-30a



QIII-103
I-4
II-50
II-32a
II-30a



QIII-104
I-4
II-50
II-34a
II-30a



QIII-105
I-4
II-50
II-35a
II-30a



QIII-106
I-4
II-51
II-32a
II-30a



QIII-107
I-4
II-51
II-34a
II-30a



QIII-108
I-4
II-51
II-35a
II-30a



QIII-109
I-5
II-8
II-32a
II-30a



QIII-110
I-5
II-8
II-34a
II-30a



QIII-111
I-5
II-8
II-35a
II-30a



QIII-112
I-5
II-9
II-32a
II-30a



QIII-113
I-5
II-9
II-34a
II-30a



QIII-114
I-5
II-9
II-35a
II-30a



QIII-115
I-5
II-25
II-32a
II-30a



QIII-116
I-5
II-25
II-34a
II-30a



QIII-117
I-5
II-25
II-35a
II-30a



QIII-118
I-5
II-26
II-32a
II-30a



QIII-119
I-5
II-26
II-34a
II-30a



QIII-120
I-5
II-26
II-35a
II-30a



QIII-121
I-5
II-28
II-32a
II-30a



QIII-122
I-5
II-28
II-34a
II-30a



QIII-123
I-5
II-28
II-35a
II-30a



QIII-124
I-5
II-29
II-32a
II-30a



QIII-125
I-5
II-29
II-34a
II-30a



QIII-126
I-5
II-29
II-35a
II-30a



QIII-127
I-5
II-49
II-32a
II-30a



QIII-128
I-5
II-49
II-34a
II-30a



QIII-129
I-5
II-49
II-35a
II-30a



QIII-130
I-5
II-50
II-32a
II-30a



QIII-131
I-5
II-50
II-34a
II-30a



QIII-132
I-5
II-50
II-35a
II-30a



QIII-133
I-5
II-51
II-32a
II-30a



QIII-134
I-5
II-51
II-34a
II-30a



QIII-135
I-5
II-51
II-35a
II-30a



QIII-136
I-6
II-8
II-32a
II-30a



QIII-137
I-6
II-8
II-34a
II-30a



QIII-138
I-6
II-8
II-35a
II-30a



QIII-139
I-6
II-9
II-32a
II-30a



QIII-140
I-6
II-9
II-34a
II-30a



QIII-141
I-6
II-9
II-35a
II-30a



QIII-142
I-6
II-25
II-32a
II-30a



QIII-143
I-6
II-25
II-34a
II-30a



QIII-144
I-6
II-25
II-35a
II-30a



QIII-145
I-6
II-26
II-32a
II-30a



QIII-146
I-6
II-26
II-34a
II-30a



QIII-147
I-6
II-26
II-35a
II-30a



QIII-148
I-6
II-28
II-32a
II-30a



QIII-149
I-6
II-28
II-34a
II-30a



QIII-150
I-6
II-28
II-35a
II-30a



QIII-151
I-6
II-29
II-32a
II-30a



QIII-152
I-6
II-29
II-34a
II-30a



QIII-153
I-6
II-29
II-35a
II-30a



QIII-154
I-6
II-49
II-32a
II-30a



QIII-155
I-6
II-49
II-34a
II-30a



QIII-156
I-6
II-49
II-35a
II-30a



QIII-157
I-6
II-50
II-32a
II-30a



QIII-158
I-6
II-50
II-34a
II-30a



QIII-159
I-6
II-50
II-35a
II-30a



QIII-160
I-6
II-51
II-32a
II-30a



QIII-161
I-6
II-51
II-34a
II-30a



QIII-162
I-6
II-51
II-35a
II-30a



QIII-163
I-7
II-8
II-32a
II-30a



QIII-164
I-7
II-8
II-34a
II-30a



QIII-165
I-7
II-8
II-35a
II-30a



QIII-166
I-7
II-9
II-32a
II-30a



QIII-167
I-7
II-9
II-34a
II-30a



QIII-168
I-7
II-9
II-35a
II-30a



QIII-169
I-7
II-25
II-32a
II-30a



QIII-170
I-7
II-25
II-34a
II-30a



QIII-171
I-7
II-25
II-35a
II-30a



QIII-172
I-7
II-26
II-32a
II-30a



QIII-173
I-7
II-26
II-34a
II-30a



QIII-174
I-7
II-26
II-35a
II-30a



QIII-175
I-7
II-28
II-32a
II-30a



QIII-176
I-7
II-28
II-34a
II-30a



QIII-177
I-7
II-28
II-35a
II-30a



QIII-178
I-7
II-29
II-32a
II-30a



QIII-179
I-7
II-29
II-34a
II-30a



QIII-180
I-7
II-29
II-35a
II-30a



QIII-181
I-7
II-49
II-32a
II-30a



QIII-182
I-7
II-49
II-34a
II-30a



QIII-183
I-7
II-49
II-35a
II-30a



QIII-184
I-7
II-50
II-32a
II-30a



QIII-185
I-7
II-50
II-34a
II-30a



QIII-186
I-7
II-50
II-35a
II-30a



QIII-187
I-7
II-51
II-32a
II-30a



QIII-188
I-7
II-51
II-34a
II-30a



QIII-189
I-7
II-51
II-35a
II-30a



QIII-190
I-8
II-8
II-32a
II-30a



QIII-191
I-8
II-8
II-34a
II-30a



QIII-192
I-8
II-8
II-35a
II-30a



QIII-193
I-8
II-9
II-32a
II-30a



QIII-194
I-8
II-9
II-34a
II-30a



QIII-195
I-8
II-9
II-35a
II-30a



QIII-196
I-8
II-25
II-32a
II-30a



QIII-197
I-8
II-25
II-34a
II-30a



QIII-198
I-8
II-25
II-35a
II-30a



QIII-199
I-8
II-26
II-32a
II-30a



QIII-200
I-8
II-26
II-34a
II-30a



QIII-201
I-8
II-26
II-35a
II-30a



QIII-202
I-8
II-28
II-32a
II-30a



QIII-203
I-8
II-28
II-34a
II-30a



QIII-204
I-8
II-28
II-35a
II-30a



QIII-205
I-8
II-29
II-32a
II-30a



QIII-206
I-8
II-29
II-34a
II-30a



QIII-207
I-8
II-29
II-35a
II-30a



QIII-208
I-8
II-49
II-32a
II-30a



QIII-209
I-8
II-49
II-34a
II-30a



QIII-210
I-8
II-49
II-35a
II-30a



QIII-211
I-8
II-50
II-32a
II-30a



QIII-212
I-8
II-50
II-34a
II-30a



QIII-213
I-8
II-50
II-35a
II-30a



QIII-214
I-8
II-51
II-32a
II-30a



QIII-215
I-8
II-51
II-34a
II-30a



QIII-216
I-8
II-51
II-35a
II-30a



QIII-217
I-9
II-8
II-32a
II-30a



QIII-218
I-9
II-8
II-34a
II-30a



QIII-219
I-9
II-8
II-35a
II-30a



QIII-220
I-9
II-9
II-32a
II-30a



QIII-221
I-9
II-9
II-34a
II-30a



QIII-222
I-9
II-9
II-35a
II-30a



QIII-223
I-9
II-25
II-32a
II-30a



QIII-224
I-9
II-25
II-34a
II-30a



QIII-225
I-9
II-25
II-35a
II-30a



QIII-226
I-9
II-26
II-32a
II-30a



QIII-227
I-9
II-26
II-34a
II-30a



QIII-228
I-9
II-26
II-35a
II-30a



QIII-229
I-9
II-28
II-32a
II-30a



QIII-230
I-9
II-28
II-34a
II-30a



QIII-231
I-9
II-28
II-35a
II-30a



QIII-232
I-9
II-29
II-32a
II-30a



QIII-233
I-9
II-29
II-34a
II-30a



QIII-234
I-9
II-29
II-35a
II-30a



QIII-235
I-9
II-49
II-32a
II-30a



QIII-236
I-9
II-49
II-34a
II-30a



QIII-237
I-9
II-49
II-35a
II-30a



QIII-238
I-9
II-50
II-32a
II-30a



QIII-239
I-9
II-50
II-34a
II-30a



QIII-240
I-9
II-50
II-35a
II-30a



QIII-241
I-9
II-51
II-32a
II-30a



QIII-242
I-9
II-51
II-34a
II-30a



QIII-243
I-9
II-51
II-35a
II-30a







“C” denotes “component”,



“M” denotes “mixture”.






The mixtures of the compounds I and II (=mixtures according to the invention) I and the compositions thereof (=compositions according to the invention) are suitable as fungicides for controlling harmful fungi. They are distinguished by excellent activity against a broad spectrum of phytopathogenic fungi including soilborne pathogens which originate in particular from the classes of the Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes (syn. Fungi imperfecti). Some of them are systemically active and can be used in crop protection as foliar fungicides, fungicides for seed dressing and soil fungicides. In addition, they are suitable for controlling fungi which, inter alia, attack the wood or the roots of plants.


The mixtures according to the invention and the compositions according to the invention are of particular importance for the control of a large number of pathogenic fungi on various crop plants such as cereals, for example wheat, rye, barley, triticale, oats or rice; beets, for example sugar beets or fodder beets; pomaceous fruits, stone fruits and soft fruits, for example apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, currants or gooseberries; leguminous plants, for example beans, lentils, peas, lucerne or soybeans; oil plants, for example oilseed rape, mustard, olives, sunflowers, coconut, cocoa, castor beans, oil palms, peanuts or soybeans; cucurbits, for example pumpkins, cucumbers or melons; fiber plants, for example cotton, flax, hemp or jute; citrus fruits, for example oranges, lemons, grapefruits or mandarins; vegetable plants, for example spinach, lettuce, asparagus, cabbage plants, carrots, onions, tomatoes, potatoes, pumpkins or bell peppers; laurel plants, for example avocados, cinnamon or camphor; energy and raw material plants, for example corn, soybeans, wheat, oilseed rape, sugar cane or oil palms; corn; tobacco; nuts; coffee; tea; bananas; grapevines (grapes for eating and grapes for wine making); hops; grass, for example lawns; sweet leaf (Stevia rebaudania); rubber plants; ornamental and forest plants, for example flowers, shrubs, deciduous trees and coniferous trees, and also on the propagation material, for example seeds, and on the harvested material of these plants.


Preferably, the mixtures and compositions according to the invention are used for controlling a large number of fungal pathogens in agricultural crops, for example potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, oilseed rape, leguminous plants, sunflowers, coffee or sugar cane; fruit plants, grapevines and ornamental plants and vegetables, for example cucumbers, tomatoes, beans and pumpkins and also on the propagation material, for example seeds, and the harvested products of these plants.


The term plant propagation materials comprises all generative parts of the plant, for example seeds, and vegetative plant parts, such as seedlings and tubers (for example potatoes) which can be utilized for propagating a plant. These include seeds, roots, fruits, tubers, bulbs, rhizomes, shoots and other plant parts including seedlings and young plants which are transplanted after germination or after emergence. The young plants can be protected by partial or complete treatment, for example by immersion or watering, against harmful fungi.


The treatment of plant propagation materials with mixtures or compositions according to the invention is used for controlling a large number of fungal pathogens in cereal crops, for example wheat, rye, barley or oats; rice, corn, cotton and soybeans.


The term crop plants also includes those plants which have been modified by breeding, mutagenesis or genetic engineering methods including the biotechnological agricultural products which are on the market or under development (see, for example, http://www.bio.org/speeches/pubs/er/agri_products.asp). Genetically modified plants are plants whose genetic material has been modified in a manner which does not occur under natural conditions by crossing, mutations or by natural recombination (that is to say, a recombination of the genetic information). In general, one or more genes are integrated into the genetic material of the plant in order to improve the properties of the plant. Such modifications by genetic engineering include post-translational modifications of proteins, oligopeptides or polypeptides, for example by glycosylation or attachment of polymers such as, for example, prenylated, acetylated or farnesylated radicals or PEG radicals.


By way of example, mention may be made of plants which, by breeding and genetic engineering, have acquired tolerance to certain classes of herbicides, such as auxin herbicides such as, for example, dicamba or 2,4-D, bleaching herbicides such as hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors or phtoendesaturase (PDS)-inhibitors, acetolactate synthase (ALS) inhibitors, such as, for example, sulfonylureas, enolpyruvylshikimate 3 phosphate synthase (EPSPS) inhibitors, such as, for example, glyphosate, glutamine synthetase (GS) inhibitors, such as, for example, glufosinate, lipid biosynthesis inhibitors such as, for example, acetyl-COA carboxylase (ACCase) inhibitors or oxynil herbicides (for example, bromoxynil or loxynil). Furthermore, crop plants were generated which, owing to a plurality of genetic manipulations, are resistant to a plurality of herbicide classes, for example resistant to glyphosate and glufosinate, or to glyphosate and a herbicide of a different class, such as, for example, an ALS inhibitor, an HPPD inhibitor, an auxine herbicide or an ACCase Inhibitor. These herbicide resistant technologies are described, for example, in Pest Managem. Sci. 61, 2005, 246; 61, 2005, 258; 61, 2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Austral. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1185; and the references cited therein. Clearfield® oilseed rape (BASF SE, Germany), for example, which is tolerant to imidazolinones, for example imazamox, or ExpressSun® sunflowers (DuPont USA), which have a tolerance to sulfonylurea herbicides such as, for example, tribenuron was generated by breeding and mutagenesis. With the aid of genetic engineering methods, crop plants such as soybeans, cotton, corn, beets and oilseed rape were generated which are resistant to glyphosate or glufosinate, and which are obtainable under the trade names RoundupReady® (glyphosate-resistant, Monsanto, U.S.A.), Cultivance® (imidazolinone-resistant, BASF SE, Germany) and Liberty Link® (glufosinate-resistant, Bayer CropScience, Germany).


Also included are plants which, owing to interventions by genetic engineering, produce one or more toxins, for example those of the bacterial strain Bacillus. Toxins which are produced by such genetically modified plants include, for example, insecticidal proteins of Bacillus spp., in particular B. thuringiensis, such as the endotoxins Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1, Cry9c, Cry34Ab1 or Cry35Ab1; or vegetative insecticidal proteins (VIPs), for example VIP1, VIP2, VIP3, or VIP3A; insecticidal proteins of nematode-colonizing bacteria, for example Photorhabdus spp. or Xenorhabdus spp.; toxins of animal organisms, for example wasp, spider or scorpion toxins; fungal toxins, for example from Streptomycetes; plant lectins, for example from peas or barley; agglutinins; proteinase inhibitors, for example trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; ribosome-inactivating proteins (RIPs), for example ricin, corn-RIP, abrin, luffin, saporin or bryodin; steroid-metabolizing enzymes, for example 3-hydroxysteroid oxidase, ecdysteroid-IDP glycosyl transferase, cholesterol oxidase, ecdyson inhibitors, or HMG-CoA reductase; ion channel blockers, for example inhibitors of sodium channels or calcium channels; juvenile hormone esterase; receptors of the diuretic hormone (helicokinin receptors); stilbene synthase, bibenzyl synthase, chitinases and glucanases. In the plants, these toxins may also be produced as pretoxins, hybrid proteins or truncated or otherwise modified proteins. Hybrid proteins are characterized by a novel combination of different protein domains (see, for example, WO 2002/015701). Further examples of such toxins or genetically modified plants which produce these toxins are disclosed in EP-A 374 753, WO 93/07278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 and WO 03/52073. The methods for producing these genetically modified plants are known to the person skilled in the art and disclosed, for example, in the publications mentioned above. Many of the toxins mentioned above bestow, upon the plants by which they are produced, tolerance to pests from all taxonomic classes of arthropods, in particular to beetles (Coeleropta), dipterans (Diptera) and butterflies (Lepidoptera) and to nematodes (Nematoda). Genetically modified plants which produce one or more genes coding for insecticidal toxins are described, for example, in the publications mentioned above, and some of them are commercially available, such as, for example, YieldGard® (corn varieties which produce the toxin Cry1Ab), YieldGard® Plus (corn varieties which produce the toxins Cry1Ab and Cry3Bb1), Starlink® (corn varieties which produce the toxin Cry9c), Herculex® RW (corn varieties which produce the toxins Cry34Ab1, Cry35Ab1 and the enzyme phosphinothricin-N-acetyltransferase [PAT]); NuCOTN® 33B (cotton varieties which produce the toxin Cry1Ac), Bollgard® I (cotton varieties which produce the toxin Cry1Ac), Bollgard® II (cotton varieties which produce the toxins Cry1Ac and Cry2Ab2); VIPCOT® (cotton varieties which produce a VIP toxin); NewLear® (potato varieties which produce the toxin Cry3A); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Bt11 (for example Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France (corn varieties which produce the toxin Cry1Ab and the PAT enzyme), MIR604 from Syngenta Seeds SAS, France (corn varieties which produce a modified version of the toxin Cry3A, see WO 03/018810), MON 863 from Monsanto Europe S.A., Belgium (corn varieties which produce the toxin Cry3Bb1), IPC 531 from Monsanto Europe S.A., Belgium (cotton varieties which produce a modified version of the toxin Cry1Ac) and 1507 from Pioneer Overseas Corporation, Belgium (corn varieties which produce the toxin Cry1F and the PAT enzyme).


Also included are plants which, with the aid of genetic engineering, produce one or more proteins which have increased resistance to bacterial, viral or fungal pathogens, such as, for example, pathogenesis-related proteins (PR proteins, see EP-A 0 392 225), resistance proteins (for example potato varieties producing two resistance genes against Phytophthora infestans from the wild Mexican potato Solanum bulbocastanum) or T4 lysozyme (for example potato varieties which, by producing this protein, are resistant to bacteria such as Erwinia amylvora).


Also included are plants whose productivity has been improved with the aid of genetic engineering methods, for example by enhancing the potential yield (for example biomass, grain yield, starch, oil or protein content), tolerance to drought, salt or other limiting environmental factors or resistance to pests and fungal, bacterial and viral pathogens.


Also included are plants whose ingredients have been modified with the aid of genetic engineering methods in particular for improving human or animal diet, for example by oil plants producing health-promoting long-chain omega 3 fatty acids or monounsaturated omega 9 fatty acids (for example Nexera® oilseed rape, DOW Agro Sciences, Canada).


Also included are plants which have been modified with the aid of genetic engineering methods for improving the production of raw materials, for example by increasing the amylopectin content of potatoes (Amflora® potato, BASF SE, Germany).


Specifically, the mixtures and compositions according to the invention are suitable for controlling the following plant diseases:



Albugo spp. (white rust) on ornamental plants, vegetable crops (for example A. candida) and sunflowers (for example A. tragopogonis); Alternaria spp. (black spot disease, black blotch) on vegetables, oilseed rape (for example A. brassicola or A. brassicae), sugar beet (for example A. tenuis), fruit, rice, soybeans and also on potatoes (for example A. solani or A. alternata) and tomatoes (for example A. solani or A. alternata) and Alternaria spp. (black head) on wheat; Aphanomyces spp. on sugar beet and vegetables; Ascochyta spp. on cereals and vegetables, for example A. tritici (Ascochyta leaf blight) on wheat and A. hordei on barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), for example leaf spot diseases (D. maydis and B. zeicola) on corn, for example glume blotch (B. sorokiniana) on cereals and for example B. oryzae on rice and on lawn; Blumeria (old name: Erysiphe) graminis (powdery mildew) on cereals (for example wheat or barley); Botryosphaeria spp. (Slack Dead Arm Disease') on grapevines (for example B. obtusa); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: gray mold, gray rot) on soft fruit and pomaceous fruit (inter alia strawberries), vegetables (inter alia lettuce, carrots, celeriac and cabbage), oilseed rape, flowers, grapevines, forest crops and wheat (ear mold); Bremia lactucae (downy mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (blue stain fungus) on deciduous trees and coniferous trees, for example C. ulmi (Dutch elm disease) on elms; Cercospora spp. (Cercospora leaf spot) on corn (for example C. zeae-maydis), rice, sugar beet (for example C. beticola), sugar cane, vegetables, coffee, soybeans (for example C. sofina or C. kikuchii) and rice; Cladosporium spp. on tomato (for example C. fulvum tomato leaf mold) and cereals, for example C. herbarum (ear rot) on wheat; Claviceps purpurea (ergot) on cereals; Cochliobolus (anamorph: Helminthosporium or Bipolaris) spp. (leaf spot) on corn (for example C. carbonum), cereals (for example C. sativus, anamorph: B. sorokiniana: glume blotch) and rice (for example C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorph: Glomerella) spp. (anthracnosis) on cotton (for example C. gossypii), corn (for example C. graminicola: stem rot and anthracnosis), soft fruit, potatoes (for example C. coccodes: wilt disease), beans (for example C. lindemuthianum) and soybeans (for example C. truncatum); Corticium spp., for example C. sasakii (sheath blight) on rice; Corynespora cassiicola (leaf spot) on soybeans and ornamental plants; Cycloconium spp., for example C. oleaginum on olives; Cylindrocarpon spp. (for example fruit tree cancer or black foot disease of grapevine, teleomorph: Nectria or Neonectria spp.) on fruit trees, grapevines (for example C. liriodendri, teleomorph: Neonectria liriodendri, black foot disease) and many ornamental trees; Dematophora (teleomorph: Rosellinia) necatrix (root/stem rot) on soybeans; Diaporthe spp. for example D. phaseolorum (stem disease) on soybeans; Drechslera (syn. Helminthosporium, teleomorph: Pyrenophora) spp. on corn, cereals, such as barley (for example D. teres, net blotch) and on wheat (for example D. tritici-repentis DTR leaf spot), rice and lawn; Esca disease (dieback of grapevine, apoplexia) on grapevines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (old name Phaeoacremonium chlamydosporum), Phaeoacremonium aleophilum and/or Botryosphaeria obtusa; Elsinoe spp. on pome fruit (E. pyri) and soft fruit (E. veneta: anthracnosis) and also grapevines (E. ampelina: anthracnosis); Entyloma oryzae (leaf smut) on rice; Epicoccum spp. (black head) on wheat; Erysiphe spp. (powdery mildew) on sugar beet (E. betae), vegetables (for example E. pisi), such as cucumber species (for example E. cichoracearum) and cabbage species, such as oilseed rape (for example E. cruciferarum); Eutypa lata (Eutypa cancer or dieback, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, grapevines and many ornamental trees; Exserohilum (syn. Helminthosporium) spp. on corn (for example E. turcicum); Fusarium (teleomorph: Gibberella) spp. (wilt disease, root and stem rot) on various plants, such as for example F. graminearum or F. culmorum (root rot and silver-top) on cereals (for example wheat or barley), F. oxysporum on tomatoes, F. solani on soybeans and F. verticillioides on corn; Gaeumannomyces graminis (take-all) on cereals (for example wheat or barley) and corn; Gibberella spp. on cereals (for example G. zeae) and rice (for example G. fujikuroi: bakanae disease); Glomerella cingulate on grapevines, pomaceous fruit and other plants and G. gossypii on cotton; grainstaining complex on rice; Guignardia bidwellii (black rot) on grapevines; Gymnosporangium spp. on Rosaceae and juniper, for example G. sabinae (pear rust) on pears; Helminthosporium spp. (syn. Drechslera, teleomorph: Cochliobolus) on corn, cereals and rice; Hemlleia spp., for example H. vastatrix (coffee leaf rust) on coffee; Isariopsis clavispora (syn. Cladosporium vitis) on grapevines; Macrophomina phaseolina (syn. phaseoli) (root/stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink snow mold) on cereals (for example wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monillnia spp., for example M. laxa, M. fructicola and M. fructigena (blossom and twig blight) on stone fruit and other Rosaceae; Mycosphaerella spp. on cereals, bananas, soft fruit and peanuts, such as for example M. graminicola (anamorph: Septoria tritici, Septoria leaf blotch) on wheat or M. fijiensis(sigatoka disease) on bananas; Peronospora spp. (downy mildew) on cabbage (for example P. brassicae), oilseed rape (for example P. parasitica), bulbous plants (for example P. destructor), tobacco (P. tabacina) and soybeans (for example P. manshurica); Phakopsora pachyrhizi and P. meibomiae (soybean rust) on soybeans; Phialophora spp. for example on grapevines (for example P. tracheiphila and P. tetraspora) and soybeans (for example P. gregata: stem disease); Phoma lingam (root and stem rot) on oilseed rape and cabbage and P. betae (leaf spot) on sugar beet; Phomopsis spp. on sunflowers, grapevines (for example P. viticola: dead-arm disease) and soybeans (for example stem canker/stem blight: P. phaseoli, teleomorph: Diaporthe phaseolorum); Physoderma maydis (brown spot) on corn; Phytophthora spp. (wilt disease, root, leaf, stem and fruit rot) on various plants, such as on bell peppers and cucumber species (for example P. capsici), soybeans (for example P. megasperma, syn. P. sojae), potatoes and tomatoes (for example P. infestans: late blight and brown rot) and deciduous trees (for example P. ramorum: sudden oak death); Plasmodiophora brassicae (club-root) on cabbage, oilseed rape, radish and other plants; Plasmopara spp., for example P. viticola (peronospora of grapevines, downy mildew) on grapevines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on Rosaceae, hops, pomaceaus fruit and soft fruit, for example P. leucotricha on apple; Polymyxa spp., for example on cereals, such as barley and wheat (P. graminis) and sugar beet (P. betae) and the viral diseases transmitted thereby; Pseudocercosporella herpotrichoides (eyespot/stem break, teleomorph: Tapesia yallundae) on cereals, for example wheat or barley; Pseudoperonospora (downy mildew) on various plants, for example P. cubensis on cucumber species or P. humili on hops; Pseudopezicula tracheiphila (angular leaf scorch, anamorph Phialophora) on grapevines; Puccinia spp. (rust disease) on various plants, for example P. triticina (brown rust of wheat), P. striiformis (yellow rust), P. hordei (dwarf leaf rust), P. graminis (black rust) or P. recondita (brown rust of rye) on cereals, such as for example wheat, barley or rye, P. kuehnii on sugar cane and, for example, on asparagus (for example P. asparagi); Pyrenophora (anamorph: Drechslera) tritici-repentis (speckled leaf blotch) on wheat or P. teres (net blotch) on barley; Pyricularia spp., for example P. oryzae (teleomorph: Magnaporthe grisea, rice blast) on rice and P. grisea on lawn and cereals; Pythium spp. (damping-off disease)on lawn, rice, corn, wheat, cotton, oilseed rape, sunflowers, sugar beet, vegetables and other plants (for example P. ultimum or P. aphanidermatum); Ramularia spp., for example R. collo-cygni (Ramularia leaf and lawn spot/physiological leaf spot) on barley and R. beticola on sugar beet; Rhizoctonia spp. on cotton, rice, potatoes, lawn, corn, oilseed rape, potatoes, sugar beet, vegetables and on various other plants, for example R. solani (root and stem rot) on soybeans, R. solani (sheath blight) on rice or R. cerealis (sharp eyespot) on wheat or barley; Rhizopus stolonifer (soft rot) on strawberries, carrots, cabbage, grapevines and tomato; Rhynchosporium secalis (leaf spot) on barley, rye and triticale; Sarocladium oryzae and S. attenuatum (sheath rot) on rice; Sclerotinia spp. (stem or white rot) on vegetable and field crops, such as oilseed rape, sunflowers (for example Sclerotinia sclerotiorum) and soybeans (for example S. rolfsii); Septoria spp. on various plants, for example S. glycines (leaf spot) on soybeans, S. tritici (Septoria leaf blotch) on wheat and S. (syn. Stagonospora) nodorum (leaf blotch and glume blotch) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on grapevines; Setospaeria spp. (leaf spot) on corn (for example S. turcicum, syn. Helminthosporium turcicum) and lawn; Sphacelotheca spp. (head smut) on corn, (for example S. reiliana: kernel smut), millet and sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucumber species; Spongospora subterranea (powdery scab) on potatoes and the viral diseases transmitted thereby; Stagonospora spp. on cereals, for example S. nodorum (leaf blotch and glume blotch, teleomorph: Leptosphaeria [syn. Phaeosphaeria] nodorum) on wheat; Synchytrium endobioticum on potatoes (potato wart disease); Taphrina spp., for example T. deformans (curly-leaf disease) on peach and T. pruni (plum-pocket disease) on plums; Thielaviopsis spp. (black root rot) on tobacco, pome fruit, vegetable crops, soybeans and cotton, for example T. basicola (syn. Chalara elegans); Tilletia spp. (bunt or stinking smut) on cereals, such as for example T. tritici (syn. T. caries, wheat bunt) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (gray snow mold) on barley or wheat; Urocystis spp., for example U. occulta (flag smut) on rye; Uromyces spp. (rust) on vegetable plants, such as beans (for example U. appendiculatus, syn. U. phaseoli) and sugar beet (for example U. betae); Ustilago spp. (loose smut) on cereals (for example U. nuda and U. avaenae), corn (for example U. maydis: corn smut) and sugar cane; Venturia spp. (scab) on apples (for example V. inaequalis) and pears and Verticillium spp. (leaf and shoot wilt) on various plants, such as fruit trees and ornamental trees, grapevines, soft fruit, vegetable and field crops, such as for example V. dahliae on strawberries, oilseed rape, potatoes and tomatoes.


Moreover, the mixtures and compositions according to the invention are suitable for controlling harmful fungi in the protection of stored products (and of harvested products) and in the protection of materials and buildings. The term “protection of materials and buildings” comprises the protection of industrial and non-living materials such as, for example, adhesives, glues, wood, paper and cardboard, textiles, leather, paint dispersions, plastic, cooling lubricants, fibers and tissues, against the attack and destruction by unwanted microorganisms such as fungi and bacteria. In the protection of wood and materials, particular attention is paid to the following harmful fungi: Ascomycetes, such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp., Trichurus spp.; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichoderma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes such as Mucor spp., and in addition in the protection of materials to the following yeast fungi: Candida spp. and Saccharomyces cerevisae.


The compounds of the formula I, and also those of the formula II, may be present in various crystal modifications which may differ in their biological activity. Their mixtures are included in the scope of the present invention.


The mixtures and compositions according to the invention are suitable for improving plant health. Moreover, the invention relates to a method for improving plant health by treating the plants, the plant propagation material and/or the site at which the plants grow or are intended to grow with an effective amount of the compounds I or the compositions according to the invention.


The term “plant health” comprises those states of a plant and/or its harvested material which are determined by various indicators individually or in combination, such as, for example, yield (for example increased biomass and/or increased content of utilizable ingredients), plant vitality (for example increased plant growth and/or greener leaves (“greening effect”)), quality (for example increased content or composition of certain ingredients) and tolerance to biotic and/or abiotic stress. The indicators mentioned here for a state of plant health may occur independently of one another or may influence each other.


The mixtures according to the invention are employed as such or in the form of a composition by treating the harmful fungi, their habitat or the plants or plant propagation materials, for example seed materials, to be protected from fungal attack, the soil, areas, materials or spaces with a fungicidally effective amount of the mixture according to the invention. The application can be carried out both before and after the infection of the plants, plant propagation materials, for example seed materials, the soil, the areas, materials or spaces by the fungi.


Plant propagation materials can be treated prophylactically during or even before sowing or during or even before transplanting with mixtures according to the invention or a composition thereof (a composition comprising at least one compound I and at least one compound II, preferably one or two compounds II).


The invention furthermore relates to agrochemical compositions comprising a solvent or solid carrier and the mixture according to the invention, and also to their use for controlling harmful fungi.


In this context, the term “preparation” often has the same meaning as “composition”, in particular “agrochemical composition”, and “formulation”.


An agrochemical composition comprises a fungicidally effective amount of the mixture according to the invention. The term “effective amount” refers to an amount of the agrochemical composition or of the mixture according to the invention which is sufficient for controlling harmful fungi on crop plants or in the protection of materials and buildings and does not cause any significant damage to the treated crop plants. Such an amount may vary within a wide range and is influenced by numerous factors, such as, for example, the harmful fungus to be controlled, the respective crop plant or materials treated, the climatic conditions and compounds.


The compounds I and the one or more compounds II can be applied simultaneously, that is jointly or separately, or in succession, the order, in the case of separate application, generally not having any effect on the control results. The method for controlling harmful fungi is carried out by separate or joint application of the compound I and the compound(s) II or of mixtures of the compound I and the compound(s) II by spraying or dusting the seed, the plants or the soil before or after sowing of the plants or before or after emergence of the plants.


The compounds I and II may be present in a joint composition or in separate compositions. Here, type and preparation of the composition in question corresponds to type and preparation as described here in a general manner for compositions.


The compounds I and the compounds II, and also their N-oxides and salts and their mixtures, can be converted into the types customary for agrochemical compositions, for example solutions, emulsions, suspensions, dusts, powders, pastes and granules. The type of composition depends on the respective intended purpose; in each case, it should ensure a fine and even distribution of the compounds of the mixtures according to the invention.


Here, examples of types of compositions are suspensions (SC, OD, FS), emulsifiable concentrates (EC), emulsions (EW, EO, ES), pastes, pastilles, wettable powders or dusts (WP, SP, SS, WS, DP, DS) or granules (GR, FG, GG, MG) which may either be water-soluble or dispersible (wettable), and also gels for treating plant propagation materials such as seed (GF).


In general, the composition types (for example EC, SC, OD, FS, WG, SG, WP, SP, SS, WS, GF) are used in diluted form. Composition types such as DP, DS, GR, FG, GG and MG are generally employed in undiluted form.


The agrochemical compositions are prepared in a known manner (see, for example, U.S. Pat. No. 3,060,084, EP-A 707 445 (for liquid concentrates), Browning, “Agglomeration”, Chemical Engineering, Dec. 4, 1967, 147-48, Perry's Chemical Engineer's Handbook, 4th edition, McGraw-Hill, New York, 1963, 8-57 and ff., WO 91/13546, U.S. Pat. No. 4,172,714, U.S. Pat. No. 4,144,050, U.S. Pat. No. 3,920,442, U.S. Pat. No. 5,180,587, U.S. Pat. No. 5,232,701, U.S. Pat. No. 5,208,030, GB 2,095,558, U.S. Pat. No. 3,299,566, Klingman: Weed Control as a Science (John Wiley & Sons, New York, 1961), Hance et al.: Weed Control Handbook (8th Ed., Blackwell Scientific Publications, Oxford, 1989) and Mollet, H. and Grubemann, A.: Formulation technology (Wiley VCH Verlag, Weinheim, 2001).


The agrochemical compositions may furthermore also comprise auxiliaries customary for crop protection compositions, the selection of the auxiliaries depending on the specific use form or the active compound.


Examples of suitable auxiliaries are solvents, solid carriers, surfactants (such as further solubilizers, protective colloids, wetting agents and tackifiers), organic and inorganic thickeners, bactericides, antifreeze agents, antifoams, if appropriate colorants and adhesives (for example for the treatment of seed).


Suitable solvents are water, organic solvents, such as mineral oil fractions having a medium to high boiling point, such as kerosene and diesel oil, furthermore coal tar oils, and also oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example paraffins, tetrahydronaphthalene, alkylated naphthalenes and derivatives thereof, alkylated benzenes and derivatives thereof, alcohols, such as methanol, ethanol, propanol, butanol and cyclohexanol, glycols, ketones, such as cyclohexanone, gamma-butyrolactone, dimethyl fatty amides, fatty acids and fatty acid esters and strongly polar solvents, for example amines, such as N-methylpyrrolidone. In principle, it is also possible to use solvent mixtures, and also mixtures of the solvents mentioned above and water.


Solid carriers are mineral earths such as silicas, silica gels, silicates, talc, kaolin, limestone, lime, chalk, bolus, loess, clay, dolomite, diatomaceous earth, calcium sulfate and magnesium sulfate, magnesium oxide, ground plastics, fertilizers, such as ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas and vegetable products such as cornmeal, bark dust, sawdust, nutshell meal, cellulose powder or other solid carriers.


Suitable surfactants (adjuvants, wetting agents, tackifiers, dispersants or emulsifiers) are the alkali metal, alkaline earth metal and ammonium salts of aromatic sulfonic acids, for example of lignosulfonic acid (Borresperse® types, Borregaard, Norway), phenolsulfonic acid, naphthalenesulfonic acid (Morwet® types, Akzo Nobel, USA) and dibutylnaphthalenesulfonic acid (Nekal® types, BASF, Germany), and also of fatty acids, alkyl- and alkylarylsulfonates, alkyl, lauryl ether and fatty alcohol sulfates, and also salts of sulfated hexa-, hepta- and octadecanols, and also of fatty alcohol glycol ethers, condensates of sulfonated naphthalene and its derivatives with formaldehyde, condensates of naphthalene or of the naphthalenesulfonic acids with phenol and formaldehyde, polyoxyethylene octyl phenol ether, ethoxylated isooctylphenol, octylphenol or nonylphenol, alkylphenyl polyglycol ether, tributylphenyl polyglycol ether, alkylaryl polyether alcohols, isotridecyl alcohol, fatty alcohol/ethylene oxide condensates, ethoxylated castor oil, polyoxyethylene alkyl ethers or polyoxypropylene alkyl ethers, lauryl alcohol polyglycol ether acetate, sorbitol esters, lignosulfite waste liquors, and also proteins, denatured proteins, polysaccharides (for example methylcellulose), hydrophobically modified starches, polyvinyl alcohol (Mowiol® types, Clariant, Switzerland), polycarboxylates (Sokalan® types, BASF, Germany), polyalkoxylates, polyvinylamine (Lupamin® types, BASF, Germany), polyethyleneimine (Lupasol® types, BASF, Germany), polyvinylpyrrolidone and copolymers thereof.


Examples of thickeners (i.e. compounds which impart modified flow properties to the composition, i.e. high viscosity in the state of rest and low viscosity in motion) are polysaccharides and also organic and inorganic sheet minerals, such as xanthan gum (Kelzan®, CP Kelco, USA), Rhodopol® 23 (Rhodia, France) or Veegum® (R.T. Vanderbilt, USA) or Attaclay® (Engelhard Corp., NJ, USA).


Bactericides can be added for stabilizing the composition. Examples of bactericides are bactericides based on dichlorophen and benzyl alcohol hemiformal (Proxel® from ICI or Acticide® RS from Thor Chemie and Kathon® MK from Rohm & Haas), and also isothiazolinone derivatives, such as alkylisothiazolinones and benzisothiazolinones (Acticide® MBS from Thor Chemie).


Examples of suitable antifreeze agents are ethylene glycol, propylene glycol, urea and glycerol.


Examples of antifoams are silicone emulsions (such as, for example, Silikon® SRE, Wacker, Germany or Rhodorsil®, Rhodia, France), long-chain alcohols, fatty acids, salts of fatty acids, organofluorine compounds and mixtures thereof.


Examples of colors are both pigments, which are sparingly soluble in water, and dyes, which are soluble in water. Examples which may be mentioned are the dyes and pigments known under the names Rhodamin B, C. I. Pigment Red 112 and C. I. Solvent Red 1, Pigment blue 15:4, Pigment blue 15:3, Pigment blue 15:2, Pigment blue 15:1, Pigment blue 80, Pigment yellow 1, Pigment yellow 13, Pigment red 48:2, Pigment red 48:1, Pigment red 57:1, Pigment red 53:1, Pigment orange 43, Pigment orange 34, Pigment orange 5, Pigment green 36, Pigment green 7, Pigment white 6, Pigment brown 25, Basic violet 10, Basic violet 49, Acid red 51, Acid red 52, Acid red 14, Acid blue 9, Acid yellow 23, Basic red 10, Basic red 108.


Examples of adhesives are polyvinylpyrrolidone, polyvinyl acetate, polyvinyl alcohol and cellulose ether (Tylose®, Shin-Etsu, Japan).


Suitable for the preparation of directly sprayable solutions, emulsions, pastes or oil dispersions are mineral oil fractions of medium to high boiling point, such as kerosene or diesel oil, furthermore coal tar oils and oils of vegetable or animal origin, aliphatic, cyclic and aromatic hydrocarbons, for example toluene, xylene, paraffin, tetrahydro-naphthalene, alkylated naphthalenes or their derivatives, methanol, ethanol, propanol, butanol, cyclohexanol, cyclohexanone, isophorone, strongly polar solvents, for example dimethyl sulfoxide, N-methylpyrrolidone and water.


Powders, materials for spreading and dustable products can be prepared by mixing or concomitantly grinding the compounds I and the further active compounds II with at least one solid carrier.


Granules, for example coated granules, impregnated granules and homogeneous granules, can be prepared by binding the active compounds to at least one solid carrier. Solid carriers are, for example, mineral earths, such as silica gels, silicates, talc, kaolin, attaclay, limestone, lime, chalk, bole, loess, clay, dolomite, diatomaceous earth, calcium sulfate and magnesium sulfate, magnesium oxide, ground synthetic substances, fertilizers, such as ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas and vegetable products, such as cereal meal, tree bark meal, sawdust and nutshell meal, cellulose powder or other solid carriers.


The following are examples of types of composition:


1. Types of Composition for Dilution with Water


i) Water-Soluble Concentrates (SL, LS)


10 parts by weight of the active compounds are dissolved with 90 parts by weight of water or with a water-soluble solvent. As an alternative, wetters or other auxiliaries are added. The active compound dissolves upon dilution with water. This gives a composition having an active compound content of 10% by weight.


ii) Dispersible Concentrates (DC)


20 parts by weight of the active compounds are dissolved in 70 parts by weight of cyclohexanone with addition of 10 parts by weight of a dispersant, for example polyvinylpyrrolidone. Dilution with water gives a dispersion. The active compound content is 20% by weight.


iii) Emulsifiable Concentrates (EC)


15 parts by weight of the active compounds are dissolved in 75 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). Dilution with water gives an emulsion. The composition has an active compound content of 15% by weight.


iv) Emulsions (EW, EO, ES)


25 parts by weight of the active compounds are dissolved in 35 parts by weight of xylene with addition of calcium dodecylbenzenesulfonate and castor oil ethoxylate (in each case 5 parts by weight). This mixture is added to 30 parts by weight of water by means of an emulsifying machine (e.g. Ultraturrax) and made into a homogeneous emulsion. Dilution with water gives an emulsion. The composition has an active compound content of 25% by weight.


v) Suspensions (SC, OD, FS)


In an agitated ball mill, 20 parts by weight of the active compounds are comminuted with addition of 10 parts by weight of dispersants and wetters and 70 parts by weight of water or an organic solvent to give a fine active compound suspension. Dilution with water gives a stable suspension of the active compound. The active compound content in the composition is 20% by weight.


vi) Water-Dispersible Granules and Water-Soluble Granules (WG, SG)


50 parts by weight of the active compounds are ground finely with addition of 50 parts by weight of dispersants and wetters and made into water-dispersible or water-soluble granules by means of technical appliances (for example extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active compound. The composition has an active compound content of 50% by weight.


vii) Water-Dispersible Powders and Water-Soluble Powders (WP, SP, SS, WS)


75 parts by weight of the active compounds are ground in a rotor-stator mill with addition of 25 parts by weight of dispersants, wetters and silica gel. Dilution with water gives a stable dispersion or solution of the active compound. The active compound content of the composition is 75% by weight.


viii) Gels (GF)


20 parts by weight of the active compounds, 10 parts by weight of dispersant, 1 part by weight of gelling agent and 70 parts by weight of water or an organic solvent are ground in a ball mill to give a fine suspension. Dilution with water gives a stable suspension with an active compound content of 20% by weight.


2. Types of Composition to be Applied Undiluted

ix) Dusts (DP, DS)


5 parts by weight of the active compounds are ground finely and mixed intimately with 95 parts by weight of finely divided kaolin. This gives a dustable product with an active compound content of 5% by weight.


x) Granules (GR, FG, GG, MG)


0.5 part by weight of the active compounds is ground finely and associated with 99.5 parts by weight of carriers. Current methods are extrusion, spray-drying or the fluidized bed. This gives granules with an active compound content of 0.5% by weight to be applied undiluted.


xi) ULV Solutions (UL)


10 parts by weight of the active compounds are dissolved in 90 parts by weight of an organic solvent, for example xylene. This gives a composition with an active compound content of 10% by weight to be applied undiluted.


In general, the compositions of the mixtures according to the invention comprise from 0.01 to 95% by weight, preferably from 0.1 to 90% by weight, of the compounds I and II or their mixtures. The compounds I and II are preferably employed in a purity of from 90% to 100%, preferably from 95% to 100% (NMR spectrum).


Water-soluble concentrates (LS), suspensions (FS), dusts (DS), water-dispersible and water-soluble powders (WS, SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are usually used for the treatment of plant propagation materials, in particular seed. These compositions can be applied to the propagation materials, in particular seed, in undiluted or, preferably, diluted form. In this case, the corresponding composition can be diluted 2 to 10 times so that in the compositions used for the seed dressing from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight of active compound are present. The application can be carried out before or during sowing. The treatment of plant propagation material, in particular the treatment of seed, is known to the person skilled in the art and is carried out by dusting, coating, pelleting, dipping or drenching the plant propagation material, the treatment preferably being carried out by pelleting, coating and dusting or by furrow treatment, such that, for example, premature germination of the seed is prevented.


For seed treatment, preference is given to using suspensions. Such compositions usually comprise from 1 to 800 g of active compound/I, from 1 to 200 g of surfactants/I, from 0 to 200 g of antifreeze agents/I, from 0 to 400 g of binders/I, from 0 to 200 g of colorants/I and solvents, preferably water.


The compounds I and II or their mixtures can be used as such or in the form of their compositions, for example in the form of directly sprayable solutions, powders, suspensions, dispersions, emulsions, oil dispersions, pastes, dustable products, materials for spreading or granules, by means of spraying, atomizing, dusting, spreading, raking in, immersing or pouring. The types of composition depend entirely on the intended purposes; the intention is to ensure in each case the finest possible distribution of the active compounds or active compound mixtures according to the invention.


Aqueous use forms can be prepared from emulsion concentrates, pastes or wettable powders (sprayable powders, oil dispersions) by adding water. To prepare emulsions, pastes or oil dispersions, the substances, as such or dissolved in an oil or solvent, can be homogenized in water by means of a wetter, tackifier, dispersant or emulsifier. Alternatively, it is also possible to prepare concentrates composed of active substance, wetter, tackifier, dispersant or emulsifier and, if appropriate, solvent or oil, and such concentrates are suitable for dilution with water.


The active compound concentrations in the ready-to-use preparations can be varied within relatively wide ranges. In general, they are from 0.0001 to 10%, preferably from 0.01 to 1%.


The active compounds may also be used successfully in the ultra-low-volume process (ULV), by which it is possible to apply compositions comprising over 95% by weight of active compound, or even to apply the active compound without additives.


When used in crop protection, the application rates are from 0.001 to 2.0 kg of active compound per ha, preferably from 0.005 to 2 kg per ha, particularly preferably from 0.05 to 0.9 kg per ha, especially from 0.1 to 0.75 kg per ha, depending on the nature of the desired effect.


In the treatment of plant propagation materials, for example seed, the amounts of active compound (or amounts of active compound mixtures) used are generally from 0.1 to 1000 g/100 kg of propagation material or seed, preferably from 1 to 1000 g/100 kg, particularly preferably from 1 to 100 g/100 kg, especially from 5 to 100 g/100 kg.


When used in the protection of materials or stored products, the active compound or active compound mixture application rate depends on the kind of application area and on the desired effect. Amounts typically applied in the protection of materials are, for example, from 0.001 g to 2 kg, preferably from 0.005 g to 1 kg, of active compound per cubic meter of treated material.


Various types of oils, wetters, adjuvants, herbicides, bactericides, other fungicides and/or pesticides may be added to the active compounds or active compound mixtures or the compositions comprising them, if appropriate not until immediately prior to use (tank mix). These compositions can be admixed with the compositions according to the invention in a weight ratio of from 1:100 to 100:1, preferably from 1:10 to 10:1.


The following are particularly suitable as adjuvants in this context: organically modified polysiloxanes, for example Break Thru S 240®; alcohol alkoxylates, for example Atplue® 245, Atplue® MBA 1303, Plurafac® LF 300 and Lutensol® ON 30; EO-PO block polymers, for example Pluronic® RPE 2035 and Genapol® B; alcohol ethoxylates, for example Lutensol® XP 80; and sodium dioctylsulfosuccinate, for example Leophen® RA.







SYNTHESIS EXAMPLES

The compounds of the formula I are synthesized as described below (and in PCT/EP2008/067394).


With appropriate modification of the starting materials, the procedures given in the synthesis examples below were used to obtain further compounds of the formula I or the precursors thereof.


Melting points were obtained on a MeI-Temp II instrument and are uncorrected. 1H-NMR spectra were recorded on a Bruker AC 300 spectrometer at 300 MHz and are referenced to tetramethylsilane as internal standard (from Aldrich or Cambridge Isotope Laboratories).


ESI mass spectra were recorded on a Shimadzu LCMS-2010 EV mass spectrometer. APCI mass spectra were recorded on a Shimadzu LCMS-2010 EV mass spectrometer. HPLC analyses were carried out using an Alltech Alltima C18 Rocket column with PDA detection at 254 nm on a Shimadzu Prominence HPLC system, unless indicated otherwise. At a flow rate of 2.5 ml per minute, the following time program was used:















Percent by volume of A




(H2O with
Percent by volume of B


Time
0.05% trifluoroacetic acid
(CH3CN with


[min]
TFA)
0.05% trifluoroacetic acid TFA)

















1.00
90
10


4.50
0
100


10.00
0
100


11.50
90
10









Example I-1
Synthesis of 1-[rel-(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-1H-[1,2,4]triazole-3-thiol (=1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-1H-[1,2,4]triazole-5(4H)-thione)

At −78° C., 60.6 ml of a 1.7M solution of n-butyllithium in hexane were added dropwise to a solution of 30 g of 1-[rel-(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-1H-[1,2,4]triazole in 800 ml of anhydrous THF. 5.5 g of sulfur were then added, and the mixture was stirred at −78° C. for 90 minutes. At −78° C., saturated ammonium chloride solution was added to the solution, and after thawing to room temperature, the mixture was extracted three times with ethyl acetate. The combined organic phases were washed with saturated sodium chloride solution, dried and concentrated. The residue was repeatedly taken up in a methyl tert-butyl ether/ethyl acetate mixture until the excess sulfur had been removed. The product was finally crystallized from ethyl acetate/diisopropyl ether/cyclohexane. This gave 25 g of 1-[rel-(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-1H-[1,2,4]triazole-3-thiole in the form of a white powder (melting point 159-160° C.).



1H-NMR (DMSO-d6): 13.3 (s, 1H), 8.2 (s, 1H), 7.6 (m, 2H), 7.5 (m, 2H), 7.4 (m, 1H), 7.3 (m, 1H), 7.0 (m, 1H), 4.5 (d, 1H), 4.4 (s, 1H), 4.1 (d, 1H).


Example I-2
Synthesis of 1-[(2S,3R)-2-(3,4-difluorophenyl)-3-o-tolyloxiran-2-ylmethyl]-1H-1,2,4-triazole-5(4H)-thione

At −78° C., lithium diisopropylamide (LDA, 11.8 ml, 23.9 mmol, 2.0 M in THF) was added dropwise to a solution of 1-[(2S,3R)-2-(3,4-difluorophenyl)-3-o-tolyloxiran-2-ylmethyl]-1H-1,2,4-triazole (6.0 g, 18.3 mmol) in dry tetrahydrofuran (THF, 80 ml). After 30 minutes, sulfur (1.2 g, 36.6 mmol) was added. The reaction mixture was stirred for 24 hours, during which time it was allowed to warm from −78° C. to 20° C. Saturated ammonium chloride solution (30 ml) was added, and the reaction mixture was then extracted with ethyl acetate (50 ml). The organic phase was washed with saturated sodium chloride solution (three times 40 ml each), dried with sodium sulfate and concentrated. The residue was purified by column chromatography (silica gel, 3:2 hexane/ethyl acetate) and recrystallized from hexane/methylene chloride. This gave the target compound (3.6 g, 55%) as a beige solid.


HPLC-MS: 3.481 min (360)


1H NMR (300 MHz, CDCl3) δ 7.93 (s, 1H), 7.48-7.17 (m, 7H), 4.88 (d, 1H), 4.08 (s, 1H), 3.81 (d, 1H), 2.41 (s, 3H).


Example I-3
Synthesis of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiran-2-ylmethyl]-1H-1,2,4-triazole-5(4H)-thione

At −78° C., lithium diisopropylamide (LDA, 10.5 ml, 21.0 mmol, 2.0 M in THF) was added dropwise to a solution of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiran-2-ylmethyl]-1H-1,2,4-triazole (6.0 g, 17.5 mmol) in dry tetrahydrofuran (THF, 60 ml). After 25 minutes, sulfur (1.2 g, 38.0 mmol) was added. The reaction mixture was stirred at −78° C. for 5 hours. Saturated ammonium chloride solution (30 ml) was added, and the reaction mixture was then extracted with ethyl acetate (50 ml). The organic phase was washed with saturated sodium chloride solution (three times 40 ml each), dried with sodium sulfate and concentrated. The residue was purified by recrystallization from hexane/methylene chloride. This gave the target compound (1.24 g, 19%) as a white solid (melting point 165° C.).


Example I-4
Synthesis of 1-[rel-(2S,3R)-2-(3,4-difluorophenyl)-3-(2-(trifluoromethyl)phenyl)oxirane-2-ylmethyl]-1H-1,2,4-triazole-5(4H)-thione

At −78° C., lithium diisopropylamide (5.5 ml, 10.9 mmol, 2.0 M in THF) was added dropwise to a solution of 1-[rel-(2S,3R)-2-(3,4-difluorophenyl)-3-(2-(trifluoromethyl)phenyl)oxiran-2-ylmethyl]-1H-1,2,4-triazole (3.5 g, 9.1 mmol) in dry tetrahydrofuran (THF, 100 ml). After 20 minutes, sulfur (582 mg, 18.2 mmol) was added. Beginning at −70° C., the reaction mixture was stirred for 4 hours and slowly brought to room temperature overnight. Saturated ammonium chloride solution (30 ml) was added, and the reaction mixture was then extracted with ethyl acetate (50 ml). The organic phase was washed with saturated sodium chloride solution (three times 40 ml each), dried with sodium sulfate and concentrated. The residue was purified by recrystallization from hexane/methylene chloride. This gave the target compound (1.7 g, 45%) as a beige solid (melting point 143-146° C.).


Example I-5
Synthesis of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiran-2-ylmethyl]-5-(methylthio)-1H-1,2,4-triazole

At −78° C., n-butyllithium (0.61 ml, 0.95 mmol, 1.6 M in hexane) was added dropwise to a solution of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiran-2-ylmethyl]-1H-1,2,4-triazole (300 mg, 0.86 mmol) in dry tetrahydrofuran (THF, 5 ml). After 15 minutes, dimethyl disulfide (79 μl, 0.87 mmol) was added, and the solution was stirred at −78° C. for 1.5 hours. Saturated ammonium chloride solution (15 ml) was added, and the reaction mixture was then extracted with ethyl acetate (20 ml). The organic phase was washed with saturated sodium chloride solution (three times 20 ml each), dried with sodium sulfate and freed from the solvent. The residue was purified by column chromatography (silica gel, 9:1 to 2:1 hexane/ethyl acetate). This gave the target compound (59 mg, 17%) as a white solid (melting point 79-81° C.).


Example I-6
Synthesis of 1-[rel-(2S,3R)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiran-2-ylmethyl]-5-(methylthio)-1H-1,2,4-triazole

At −78° C., n-butyllithium (0.67 ml, 1.09 mmol, 1.6 M in hexane) was added dropwise to a solution of 1-[rel-(2S,3R)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiran-2-ylmethyl]-1H-1,2,4-triazole (300 mg, 0.91 mmol) in dry tetrahydrofuran (THF, 10 ml). After 20 minutes, dimethyl disulfide (81 μl, 0.91 mmol) was added, and the solution was stirred at −78° C. for 30 minutes. Methanol (10 ml) and saturated ammonium chloride solution (15 ml) were added, and the reaction mixture was then extracted with ethyl acetate (20 ml). The organic phase was washed with saturated sodium chloride solution (three times 20 ml each), dried with sodium sulfate and freed from the solvent. The residue was purified by column chromatography (silica gel, 43:7 methylene chloride/ethyl acetate). This gave the target compound (135 mg, 40%) as a white solid (melting point 65-68° C.).


Example I-7
Synthesis of 1-[rel-(2S,3R)-3-(2-chlorophenyl) 2-(2,4-difluorophenyl)oxiran-2-ylmethyl]-5-(methylthio)-1H-1,2,4-triazole

300 mg of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-1H-[1,2,4]triazole-5(4H)-thione were dissolved in 6 ml of THF, and 21 mg of sodium hydride were added at room temperature. The mixture was stirred briefly, and 112 mg of methyl iodide were then added. The mixture was stirred at room temperature overnight, water was added and the mixture was repeatedly extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated. The crude product was purified by column chromatography using cyclohexane/ethyl acetate. This gave 270 mg of the desired product (87%, melting point 116-117° C.).


Example I-8
Synthesis of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiran-2-ylmethyl]-5-thiocyanato-1H-1,2,4-triazole

A mixture of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-1H-[1,2,4]triazole-5(4H)-thione (150 mg, 0.4 mmol), triethylamine (110 μl, 0.8 mmol) and cyanogen bromide BrCN (63 mg, 0.59 mmol) in dry tetrahydrofuran (THF, 5 ml) was stirred at room temperature for 3 hours. Ethyl acetate (20 ml) was added, and the mixture was washed with saturated sodium chloride solution (three times 20 ml each), dried with sodium sulfate and freed from the solvent. The residue was purified by column chromatography (silica gel, 10:1 methylene chloride/ethyl acetate). This gave the target compound (110 mg, 69%) as a white solid.


HPLC-MS: 3.756 min (405)


Example I-9
Synthesis of rel-(2S-3R)—S-{2-[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-(1,2,4]triazol-3-yl}methyl thiocarbonate

300 mg of 1-[rel-(2S,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol were dissolved in 5 ml of THF, and 21 mg of sodium hydride were added at room temperature. The mixture was stirred briefly, and 75 mg of methyl chloroformate were then added. The mixture was stirred at room temperature overnight, water was added and the mixture was repeatedly extracted with ethyl acetate. The organic phase was washed with water, dried and concentrated. The crude product was purified by column chromatography using cyclohexane/ethyl acetate. This gave 100 mg of the desired product (29%).


HPLC-MS: 3.974 min (438)


Use Examples

The fungicidal action of the mixtures according to the invention can be demonstrated by the following tests:


Microtest
Preparation of Active Compound

The active compounds were formulated separately or jointly as a stock solution having a concentration of 10 000 ppm in DMSO.


The active compound orysastrobin was used as a commercial formulation and, with respect to the active compound, diluted with water.


The determined values (measured parameters) for the percentage of infection on the leaves were compared to the growth of the active compound-free control variant and the fungus- and active compound-free blank value to determine the relative growth in % of the pathogens in the individual active compounds and were thus converted into efficacy % of the untreated control. An efficacy of 0 means the same degree of infection as in the untreated control; an efficacy of 100 means 0% infection. The expected efficacies for active compound combinations were determined using the Colby formula (Colby, S. R.


“Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds, 15, pp. 20-22, 1967) and compared to the observed efficacies.


The efficacy (E) is calculated as follows using Abbot's formula:






E=(1−α/β)·100


α corresponds to the fungicidal infection of the treated plants in % and


β corresponds to the fungicidal infection of the untreated (control) plants in %


At an efficacy of 0 the degree of infection of the treated plants corresponds to that of the untreated control plants; at an efficacy of 100 the treated plants are not infected.


The expected efficacies for active compound combinations were determined using the Colby formula (Colby, S. R. “Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds, 15, pp. 20-22, 1967) and compared to the observed efficacies.


Colby's formula:






E=x+y−x·y/100

  • E expected efficacy, expressed in % of the untreated control, when using the mixture of the active compounds A and B at the concentrations a and b
  • x efficacy, expressed in % of the untreated control, when using the active compound A at the concentration a
  • y efficacy, expressed in % of the untreated control, when using the active compound B at the concentration b


Use Example No. M1
Activity Against the Late Blight Pathogen Phytophthora infestans in the Microtiter Test (Phytin)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous pea juice-based zoospore suspension of Phytophthora infestans was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Binary Mixtures

















Active







compound/



Effect


active
Concen-


calculated


compound
tration

Observed
according to
Synergism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-3
63

31




I-8
4

7


boscalid
16

20


chlorothalonil
0.25

16


I-3
63
4:1
100
45
55


boscalid
16


I-8
4
16:1 
89
22
67


chlorothalonil
0.25









Ternary Mixtures





















Effect







calcu-






lated






accord-
Syn-


Active compound/
Concen-

Ob-
ing
er-


active compound
tration

served
to
gism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-3 + epoxiconazole
63 + 1
63:1
35




I-8 + pyraclostrobin
16 + 0.063
250:1 
12



4 + 0.016
250:1 
2


I-8 + epoxiconazole
63 + 1
63:1
24



4 + 0.063
63:1
15


I-8 + boscalid
4 + 1
 4:1
4


I-5 + pyraclostrobin
63 + 0.25
250:1 
67


orysastrobin
1

22


epoxiconazole
0.25

15


boscalid
16

20



4

11


chlorothalonil
0.25

16


I-3 + epoxiconazole
63 + 1
63:1:1
99
49
50


orysastrobin
1


I-8 + pyraclostrobin
16 + 0.063
250:1:4
49
26
23


epoxiconazole
0.25


I-8 + pyraclostrobin
16 + 0.063
250:1:63
56
22
34


boscalid
4


I-8 + pyraclostrobin
4 + 0.016
250:1:16
97
17
80


chlorothalonil
0.25


I-8 + epoxiconazole
63 + 1
63:1:16
70
39
31


boscalid
16


I-8 + epoxiconazole
4 + 0.063
63:1:4
97
29
68


chlorothalonil
0.25


I-8 + boscalid
4 + 1
16:4:1
95
20
75


chlorothalonil
0.25


I-5 + pyraclostrobin
63 + 0.25
250:1:63
97
74
23


boscalid
16









Phytin





















Effect







calcu-






lated






accord-






ing


Active
Concen-

Ob-
to
Syn-


compound/active
tration

served
Colby
er-


compound mixture
(ppm)
Mixture
effect
(%)
gism




















binary mixtures







I-1
63

53



16

14



1

3


I-4
63

31


fenpropimorph
1

26


flumorph
0.25

0


fluazinam
1

24


fenarimol
1

28


fludioxonil
1

27


dodine
0.25

34


tolylfluanid
0.25

16


boscalid
4

24


I-1
63
63:1
92
65
27


fenpropimorph
1


I-1
1
 4:1
31
3
28


flumorph
0.25


I-1
63
63:1
96
64
32


fluazinam
1


I-1
63
63:1
94
66
28


fenarimol
1


I-1
63
63:1
97
66
31


fludioxonil
1


I-1
63
250:1 
94
69
25


dodine
0.25


I-1
16
63:1
98
28
70


tolylfluanid
0.25


I-4
63
16:1
94
48
46


boscalid
4


ternary mixtures


I-1 + flumorph
1 + 0.25
 4:1
31


I-2 + epoxiconazole
16 + 0.063
250:1 
16


I-4 + epoxiconazole
63 + 0.25
250:1 
39


I-4 + kresoxim-
4 + 0.25
16:1
15


methyl


fenarimol
0.016

5


pyraclostrobin
0.016

13


boscalid
4

24


metconazole
0.25

21


orysastrobin
0.25

1


I-1 + flumorph
1 + 0.25
63:16:1
52
34
18


fenarimol
0.016


I-2 + epoxiconazole
16 + 0.063
1000:4:1
53
26
27


pyraclostrobin
0.016


I-4 + epoxiconazole
63 + 0.25
250:1:16
97
54
43


boscalid
4


I-4 + epoxiconazole
63 + 0.25
250:1:1
96
52
44


metconazole
0.25


I-4 + Kresoxim-
4 + 0.25
16:1:1
39
16
23


methyl


orysastrobin
0.25


quaternary


mixtures


I-1 + captan +
4 + 0.25 +
16:1:1
35


mancozeb
0.25


I-1 + dithianon +
16 + 0.25 +
63:1:1
34


fluazinam
0.25


I-1 + fludioxonil +
16 + 0.25 +
63:4:1
12


dodine
0.063


dithianon
0.063

4


fenarimol
0.25

12


tolylfluanid
0.25

16


I-1 + captan +
4 + 0.25 +
63:4:4:1
67
38
29


mancozeb
0.25


dithianon
0.063


I-1 + dithianon +
16 + 0.25 +
63:1:1:1
62
42
20


fluazinam
0.25


fenarimol
0.25


I-1 + fludioxonil +
16 + 0.25 +
63:4:1:4
97
26
71


dodine
0.063


tolylfluanid
0.25


5-component


mixture


I-1 +
16 + 0.25 +
63:1:1:1
62


dithianon +
0.25 + 0.25


fluazinam +


fenarimol


fludioxonil
0.25

20


I-1 +
16 + 0.25 +
63:1:1:1:1
98
70
28


dithianon +
0.25 + 0.25


fluazinam +


fenarimol


fludioxonil
0.25









Use Example No. M2
Activity Against the Gray Mold Pathogen Botrytis cinerea in the Microtiter Test (Botrci)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Botrytis cinerea was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Binary Mixtures

















Active







compound/



Effect


active
Concen-


calculated


compound
tration

Observed
according to
Synergism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-6
4

9




I-3
63

25



4

8


I-8
16

19


I-5
16

9


I-7
16

25


orysastrobin
1

13



0.063

4


pyraclostrobin
0.016

8


chlorothalonil
1

40


I-6
4
63:1
51
12
39


orysastrobin
0.063


I-3
4
250:1 
47
15
32


pyraclostrobin
0.016


I-3
63
63:1
56
35
21


orysastrobin
1


I-8
16
16:1
100
51
49


chlorothalonil
1


I-5
16
16:1
73
45
28


chlorothalonil
1


I-7
16
16:1
81
55
26


chlorothalonil
1









Ternary Mixtures





















Effect







calcu-






lated






accord-
Syn-


Active compound/
Concen-

Ob-
ing
er-


active compound
tration

served
to
gism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-6 + pyraclostrobin
16 + 0.063
250:1
18




I-3 + epoxiconazole
4 + 0.063
 63:1
13


I-8 + pyraclostrobin
16 + 0.063
250:1
8


I-5 + epoxiconazole
16 + 0.25
 63:1
55


chlorothalonil
1

40


orysastrobin
0.063

4


I-6 + pyraclostrobin
16 + 0.063
250:1:16
98
51
47


chlorothalonil
1


I-3 + epoxiconazole
4 + 0.063
63:1:1
79
16
63


orysastrobin
0.063


I-8 + pyraclostrobin
16 + 0.063
250:1:16
99
45
54


chlorothalonil
1


I-5 + epoxiconazole
16 + 0.25
63:1:4
92
73
19


chlorothalonil
1









Botrci





















Effect



Active



calculated


compound/active
Concentration

Observed
according to


compound mixture
(ppm)
Mixture
effect
Colby (%)
Synergism




















Binary mixtures







I-1
63

53


I-2
16

21


I-4
16

14


fenpropimorph
1

45


metconazol
0.063

41


boscalid
0.25

40


prochloraz
0.016

18


I-1
63
63:1
94
74
20


fenpropimorph
1


I-2
16
250:1 
89
54
35


metconazole
0.063


I-4
16
250:1 
86
49
37


metconazole
0.063


Ternary mixtures


I-1 + epoxiconazole
16 + 0.063
250:1 
37


I-1 + boscalid
4 + 0.25
16:1
49


I-1 + captan
4 + 0.25
16:1
60


I-2 + epoxiconazole
16 + 0.063
250:1 
38


I-2 + boscalid
4 + 0.25
16:1
44


I-4 + boscalid
1 + 0.063
16:1
14


pyraclostrobin
0.016

12


kresoxim-methyl
0.25

5



0.063

0


dithianon
0.063

1


metconazole
0.063

41



0.004

0


boscalid
0.25

40


prochloraz
0.016

18


I-1 + epoxiconazole
16 + 0.063
1000:4:1
66
44
22


pyraclostrobin
0.016


I-1 + boscalid
4 + 0.25
16:1:1
90
52
38


kresoxim-methyl
0.25


I-1 + captan
4 + 0.25
63:4:1
100
60
40


dithianon
0.063


I-2 + epoxiconazole
16 + 0.063
250:1:1
92
62
30


metconazole
0.063


I-2 + boscalid
4 + 0.25
16:1:1
93
47
46


kresoxim-methyl
0.25


I-4 + boscalid
1 + 0.063
250:16:1
34
14
20


metconazole
0.004


I-4 + boscalid
1 + 0.063
16:1:1
52
14
38


kresoxim-methyl
0.063


Quaternary mixture


I-1 +
4 + 0.25 +
250:16:1
39


boscalid +
0.016


metconazole


I-1 + orysastrobin +
16 + 1 + 0.016
1000:63:1
18


azoxystrobin


I-1 + flumorph +
4 + 1 + 0.063
63:16:1
18


fluazinam


I-4 + boscalid +
4 + 0.25 +
250:16:1
37


metconazole
0.016


I-4 +
4 + 0.25 +
250:16:1
20


kresoxim-methyl +
0.016


Prochloraz


I-2 +
4 + 0.25 +
250:16:1
47


boscalid +
0.016


metconazole


I-2 +
63 + 4 + 0.063
1000:63:1
32


orysastrobin +


azoxystrobin


kresoxim-methyl
0.25

5



0.063

0


chlorothalonil
0.25

18



0.063

5


fenarimol
0.063

10


orysastrobin
0.25

0


boscalid
0.25

40


prochloraz
0.016

18


I-1 + boscalid +
4 + 0.25 +
250:16:1:16
92
42
50


metconazole
0.016


kresoxim-methyl
0.25


I-1 + orysastrobin +
16 + 1 + 0.016
1000:63:1:4
52
23
29


azoxystrobin


chlorothalonil
0.063


I-1 + flumorph +
4 + 1 + 0.063
63:16:1:1
63
26
37


fluazinam


fenarimol
0.063


I-4 + boscalid +
4 + 0.25 +
250:16:1:16
91
40
51


metconazole
0.016


kresoxim-methyl
0.25


I-4 +
4 + 0.25 +
250:16:1:16
57
20
37


kresoxim-methyl +
0.016


prochloraz


orysastrobin
0.25


I-2 + boscalid +
4 + 0.25 +
250:16:1:16
92
50
42


metconazole
0.016


kresoxim-methyl
0.25


I-2 + orysastrobin +
63 + 4 + 0.063
1000:63:1:4
70
45
25


azoxystrobin


chlorothalonil
0.25


5-component


mixture


I-1 +
4 + 0.25 +
250:16:1:16
44


kresoxim-methyl +
0.016 + 0.25


prochloraz +


orysastrobin


I-1 +
16 + 1 + 1 +
1000:63:63:1
23


kresoxim-methyl +
0.016


orysastrobin +


azoxystrobin


I-1 +
4 + 0.063 +
63:1:16:1
26


dithianon +
 1 + 0.063


flumorph +


fluazinam


azoxystrobin
0.004

6


chlorothalonil
0.063

5


fenarimol
0.063

10


kresoxim-methyl
0.25

5


I-1 +
4 + 0.25 +
1000:63:4:63:1
76
48
28


kresoxim-methyl +
0.016 + 0.25


prochloraz +


orysastrobin


azoxystrobin
0.004


I-1 +
16 + 1 + 1 +
1000:63:63:1:4
52
27
25


kresoxim-methyl +
0.016


orysastrobin +


azoxystrobin


chlorothalonil
0.063


I-1 +
4 + 0.063 +
63:1:16:1:1
98
33
65


dithianon +
1 + 0.063


flumorph +


fluazinam


fenarimol
0.063









Use Example No. M3
Activity Against the Rice Blast Pathogen Pyricularia oryzae in the Microtiter Test (Pyrior)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Pyricularia oryzae was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Binary Mixtures

















Active



Effect



compound/



calculated



active



according
Syn-


compound
Concentration

Observed
to
ergism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-6
63

75




I-3
63

36


I-5
63

27


I-7
63

19


boscalid
16

19


I-6
63
4:1
100
80
20


boscalid
16


I-3
63
4:1
100
48
52


boscalid
16


I-5
63
4:1
81
41
40


boscalid
16


I-7
63
4:1
81
34
47


boscalid
16









Ternary Mixtures





















Effect



Active compound/



calculated


active compound
Concentration

Observed
according to
Synergism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-3 + epoxiconazole
4 + 0.063
 63:1
12




I-8 + pyraclostrobin
1 + 0.004
250:1
38


I-8 + epoxiconazole
16 + 0.25
 63:1
10


orysastrobin
0.063

25


chlorothalonil
0.063

16


boscalid
4

4


I-3 + epoxiconazole
4 + 0.063
 63:1:1
88
34
54


orysastrobin
0.063


I-8 + pyraclostrobin
1 + 0.004
250:1:16
69
48
21


chlorothalonil
0.063


I-8 + epoxiconazole
16 + 0.25
 63:1:16
72
14
58


boscalid
4









Pyrior





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Binary mixtures







I-1
63

63


fenpropimorph
1

12


flumorph
16

10


fluazinam
1

22


dodine
0.25

11


cymoxanil
16

14


I-1
63
63:1
100
68
32


fenpropimorph
1


I-1
63
 4:1
100
67
33


flumorph
16


I-1
63
63:1
100
71
29


fluazinam
1


I-1
63
250:1 
99
67
32


dodine
0.25


I-1
63
 4:1
98
68
30


cymoxanil
16


Ternary mixture


I-1 + fludioxonil
1 + 0.016
63:1
42


I-2 + epoxiconazole
16 + 0.063
250:1 
49


I-2 + boscalid
16 + 1
16:1
34


I-2 + orysastrobin
1 + 0.063
16:1
45


I-4 + epoxiconazole
16 + 0.063
250:1 
76


I-4 + kresoxim-methyl
1 + 0.063
16:1
34



0.25 + 0.016
16:1
16


dodine
0.004

2


metconazol
0.063

9


azoxystrobin
0.001

0


boscalid
1

3


orysastrobin
0.016

8


metalaxyl
4

11


chlorothalonil
0.004

1


I-1 + fludioxonil
1 + 0.016
250:4:1
75
43
32


dodine
0.004


I-2 + epoxiconazole
16 + 0.063
250:1:1
74
54
20


metconazole
0.063


I-2 + boscalid
16 + 1
250:16:1
65
40
25


metconazole
0.063


I-2 + orysastrobin
1 + 0.063
1000:63:1
70
45
25


azoxystrobin
0.001


I-4 + epoxiconazole
16 + 0.063
250:1:16
100
76
24


boscalid
1


I-4 + epoxiconazole
16 + 0.063
250:1:1
100
78
22


metconazole
0.063


I-4 + kresoxim-methyl
0.25 + 0.016
16:1:1
41
22
19


orysastrobin
0.016


I-4 + kresoxim-methyl
1 + 0.063
1000:63:1
73
47
26


azoxystrobin
0.001


Quaternary mixtures


I-1 + dithianon +
16 + 0.25 + 0.25
63:1:1
41


fenpropimorph


I-1 + flumorph +
16 + 4 + 0.25
63:16:1
22


fluazinam


I-1 + fludioxonil +
4 + 0.063 + 0.016
250:4:1
60


dodine


flumorph
4

2


fenarimol
0.25

10


tolylfluanid
0.063

9


I-1 + dithianon +
16 + 0.25 + 0.25
63:1:1:16
94
42
52


fenpropimorph


flumorph
4


I-1 + flumorph +
16 + 4 + 0.25
63:16:1:1
95
30
65


fluazinam


fenarimol
0.25


I-1 + fludioxonil +
4 + 0.063 + 0.016
250:4:1:4
83
64
19


dodine


tolylfluanid
0.063









Use Example No. M4
Activity Against the Septoria Leaf Spot Pathogen Septoria tritici in the Microtiter Test (Septtr)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Septoria tritici was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Binary Mixtures





















Effect



Active



calculated


compound/
Concen-


according


active compound
tration

Observed
to
Synergism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-6
16

25




I-7
4

18


orysastrobin
0.25

28


epoxiconazole
0.063

66


I-6
16
63:1
100
46
54


orysastrobin
0.25


I-7
4
63:1
97
72
25


epoxiconazole
0.063









Ternary Mixtures





















Effect







calcu-






lated






accord-
Syn-


Active compound/
Con-

Ob-
ing
er-


active compound
centration

served
to
gism


combination
(ppm)
Mixture
effect
Colby
(%)




















I-3 + epoxiconazole
1 + 0.016
63:1
44




I-8 + pyraclostrobin
1 + 0.004
250:1 
72


I-8 + boscalid
1 + 0.25
 4:1
63


I-1 + orysastrobin
0.25 + 0.004
63:1
12


I-5 + epoxiconazole
1 + 0.016
63:1
12


orysastrobin
0.016

8


chlorothalonil
0.063

13



0.016

3


I-3 + epoxiconazole
1 + 0.016
63:1:1
100
49
51


orysastrobin
0.016


I-8 + pyraclostrobin
1 + 0.004
250:1:16
96
76
20


chlorothalonil
0.063


I-8 + boscalid
1 + 0.25
16:4:1
 90
68
22


chlorothalonil
0.063


I-1 + orysastrobin
0.25 + 0.004
63:1:4
34
14
20


chlorothalonil
0.016


I-5 + epoxiconazole
1 + 0.016
63:1:4
44
24
20


chlorothalonil
0.063









Septtr





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Binary mixtures







I-1
63

73



0.25

29


I-4
63

55


fenpropimorph
1

16


flumorph
0.063

0


iprodion
1

15


azoxystrobin
0.016

30


I-1
63
63:1
98
77
21


fenpropimorph
1


I-1
0.25
 4:1
48
29
19


flumorph
0.063


I-4
63
63:1
89
62
27


iprodion
1


Ternary mixtures


I-1 + orysastrobin
4 + 0.25
16:1
54


I-1 + flumorph
4 + 1
 4:1
56


azoxystrobin
0.004

6


chlorothalonil
0.016

4


fludioxonil
0.063

6


metconazole
0.016

20


orysastrobin
0.004

0


I-1 + orysastrobin
4 + 0.25
1000:63:1
89
57
32


azoxystrobin
0.004


I-1 + orysastrobin
4 + 0.25
250:16:1
89
56
33


chlorothalonil
0.016


I-1 + flumorph
4 + 1
63:16:1
90
59
31


fludioxonil
0.063


Quaternary mixtures


I-1 +
0.063 + 0.004 +
16:1:1
17


kresoxim-methyl +
0.004


orysastrobin


I-1 + dithianon +
1 + 0.016 +
63:1:1
48


fluazinam
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
33


fluazinam


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
55


fenarimol


I-1 + fludioxonil +
1 + 0.016 +
63:1:1
38


tolylfluanid
0.016


azoxystrobin
0.000063

1


fenarimol
0.016

35


fludioxonil
0.016

0


cymoxanil
0.25

7


I-1 +
0.063 + 0.004 +
1000:63:63:1
44
18
26


kresoxim-methyl +
0.004


orysastrobin


azoxystrobin
0.000063


I-1 + dithianon +
1 + 0.016 +
63:1:1:1
88
66
22


fluazinam
0.016


fenarimol
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
77
57
20


fluazinam


fenarimol
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
75
55
20


fenarimol


fludioxonil
0.016


I-1 + fludioxonil +
1 + 0.016 +
63:1:1:16
65
42
23


tolylfluanid
0.016


cymoxanil
0.25


5 component


mixture


I-1 + dithianon +
0.25 + 0.004 +
63:1:16:1
28


flumorph +
0.063 +


fluazinam
0.004


fenarimol
0.004

6


I-1 + dithianon +
0.25 + 0.004 +
63:1:16:1:1
55
32
23


flumorph +
0.063 +


fluazinam
0.004


fenarimol
0.004









Use Example No. M5
Activity Against Alternaria solani in the Microtiter Test (Alteso)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water, An aqueous malt-based spore suspension of Alternaria solani was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Alteso





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Binary mixtures







I-1
4

16


epoxiconazole
0.016

7


I-1
4
250:1 
42
22
20


epoxiconazole
0.016


Ternary mixtures


I-1 + orysastrobin
4 + 0.25
16:1
31


I-1 + captan
16 + 1
16:1
75


I-1 + dithianon
1 + 0.016
63:1
10


I-1 + flumorph
4 + 1
 4:1
35



1 + 0.25
 4:1
13


I-1 + fludioxonil
1 + 0.016
63:1
24


azoxystrobin
0.004

29


chlorothalonil
0.016

6


dithianon
0.25

22


flumorph
0.25

0


fluazinam
0.063

3


fludioxonil
0.016

13


iprovalicarb
0.016

1


tolylfluanid
0.016

13


dodine
0.004

15


I-1 + orysastrobin
4 + 0.25
1000:63:1
77
51
26


azoxystrobin
0.004


I-1 + orysastrobin
4 + 0.25
63:16:1
55
34
21


chlorothalonil
0.016


I-1 + captan
16 + 1
63:4:1
100
81
19


dithianon
0.25


I-1 + dithianon
1 + 0.016
63:1:16
46
10
36


flumorph
0.25


I-1 + flumorph
4 + 1
63:16:1
68
37
31


fluazinam
0.063


I-1 + flumorph
1 + 0.25
63:16:1
45
25
20


fludioxonil
0.016


I-1 + fludioxonil
1 + 0.016
63:1:1
45
25
20


iprovalicarb
0.016


I-1 + fludioxonil
1 + 0.016
250:4:1
56
35
21


dodine
0.004


I-1 + fludioxonil
1 + 0.016
63:1:1
59
34
25


tolylfluanid
0.016


Quaternary mixtures


I-1 + captan +
4 + 0.25 + 0.25
16:1:1
34


mancozeb


I-1 + captan +
4 + 0.25 + 0.063
63:4:1
47


dithianon


I-1 + captan +
1 + 0.063 +
63:4:1
32


fenpropimorph
0.016


I-1 + dithianon +
1 + 0.016 +
63:1:1
30


fenpropimorph
0.016


I-1 + dithianon +
1 + 0.016 +
63:1:1
27


fluazinam
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
28


fluazinam


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
38


fenarimol


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
45


fludioxonil


I-1 + fludioxonil +
1 + 0.016 +
63:1:1
45


iprovalicarb
0.016


I-1 + fludioxonil +
0.25 + 0.004 +
63:1:1
40


tolylfluanid
0.004


dithianon
0.063

8


fenpropimorph
0.063

3


flumorph
0.25

0


fenarimol
0.016

14


fludioxonil
0.016

13


iprovalicarb
0.016

1


dodine
0.004

15


cymoxanil
0.063

4


I-1 + captan +
4 + 0.25 + 0.25
63:4:4:1
80
39
41


mancozeb


dithianon
0.063


I-1 + captan +
4 + 0.25 + 0.063
63:4:1:1
80
49
31


dithianon


fenpropimorph
0.063


I-1 + captan +
1 + 0.063 +
63:4:1:16
59
32
27


fenpropimorph
0.016


flumorph
0.25


I-1 + dithianon +
1 + 0.016 +
63:1:1:16
59
30
29


fenpropimorph
0.016


flumorph
0.25


I-1 + dithianon +
1 + 0.016 +
63:1:1:1
61
37
24


fluazinam
0.016


fenarimol
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
77
38
39


fluazinam


fenarimol
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
69
46
23


fenarimol


fludioxonil
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
72
45
27


fludioxonil


iprovalicarb
0.016


I-1 + fludioxonil +
1 + 0.016 +
250:4:4:1
73
53
20


iprovalicarb
0.016


dodine
0.004


I-1 + fludioxonil +
0.25 + 0.004 +
63:1:1:16
63
42
21


tolylfluanid
0.004


cymoxanil
0.063









Use Example No. M6
Activity Against Fusarium culmorum in the Microtiter Test (Fusacu)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Fusarium culmorum was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Fusacu





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Ternary mixtures







I-1 + captan
16 + 1
16:1
50


dithianon
0.25

4


I-1 + captan
16 + 1
63:4:1
100
52
48


dithianon
0.25


Quaternary mixture


I-1 + captan +
16 + 1 + 0.25
63:4:1
29


fenpropimorph


I-1 + flumorph +
4 + 1 + 0.063
63:16:1
39


fludioxonil


I-2 + boscalid +
63 + 4 + 0.25
250:16:1
29


metconazole


kresoxim-methyl
4

26



0.004

0


flumorph
4

3


iprovalicarb
0.063

1


I-1 + captan +
16 + 1 + 0.25
63:4:1:16
71
31
40


fenpropimorph


flumorph
4


I-1 + flumorph +
4 + 1 + 0.063
63:16:1:1
60
40
20


fludioxonil


Iprovalicarb
0.063


I-2 + boscalid +
63 + 4 + 0.25
250:16:1:16
47
29
18


metconazole


kresoxim-methyl
4









Use Example No. M7
Activity Against Letosphaeria Nodorum in the Microtiter Test (Leptno)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Letosphaeria nodorum was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Leptno





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Binary mixtures







I-1
1

63


I-2
4

26


I-4
4

26


dithianon
0.016

6


epoxiconazole
0.016

18


pyraclostrobin
0.016

62



0.004

16


azoxystrobin
0.001

3


prochloraz
0.004

4


I-1
1
63:1
98
65
33


dithianon
0.016


I-2
4
250:1 
66
39
27


epoxiconazole
0.016


I-4
4
250:1 
63
39
24


epoxiconazole
0.016


I-4
4
1000:1 
65
38
27


pyraclostrobin
0.004


I-4
1
1000:1 
37
12
25


azoxystrobin
0.001


Ternary mixtures


I-1 + orysastrobin
4 + 0.25
16:1
32


I-1 + captan
1 + 0.063
16:1
64


azoxystrobin
0.004

12


chlorothalonil
0.016

10


dithianon
0.016

6


pyraclostrobin
0.004

16


I-1 + orysastrobin
4 + 0.25
1000:63:1
58
40
18


azoxystrobin
0.004


I-1 + orysastrobin
4 + 0.25
250:16:1
70
39
31


chlorothalonil
0.016


I-1 + captan
1 + 0.063
63:4:1
84
66
18


dithianon
0.016


Quaternary mixtures


I-1 + captan +
1 + 0.063 +
16:1:1
71


mancozeb
0.063


I-1 + captan +
1 + 0.063 +
63:4:1
48


fenpropimorph
0.016


I-1 + dithianon +
1 + 0.016 +
63:1:1
48


fluazinam
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1
37


fluazinam


I-1 + flumorph +
0.25 + 0.063 +
63:16:1
24


fludioxonil
0.004


I-1 + fludioxonil +
1 + 0.016 +
63:1:1
34


iprovalicarb
0.016


I-1 + fludioxonil +
1 + 0.016 +
63:1:1
34


tolylfluanid
0.016


I-4 + boscalid +
4 + 0.25 + 0.25
16:1:1
57


kresoxim-methyl


I-4 +
1 + 0.063 +
16:1:1
8


kresoxim-methyl +
0.063


orysastrobin


dithianon
0.016

6


flumorph
0.25

0


fenarimol
0.016

9


iprovalicarb
0.004

0


dodine
0.004

0


cymoxanil
0.25

0


metalaxyl
0.25

9


azoxystrobin
0.001

3


kresoxim-methyl
0.063

39


prochloraz
0.004

4


I-1 + captan +
1 + 0.063 +
63:4:4:1
97
73
24


mancozeb
0.063


dithianon
0.016


I-1 + captan +
1 + 0.063 +
63:4:1:16
67
48
19


fenpropimorph
0.016


flumorph
0.25


I-1 + dithianon +
1 + 0.016 +
63:1:1
81
52
29


fluazinam
0.016


fenarimol
0.016


I-1 + flumorph +
1 + 0.25 + 0.016
63:16:1:1
66
42
24


fluazinam


fenarimol
0.016


I-1 + flumorph +
0.25 + 0.063 +
63:16:1:1
55
24
31


fludioxonil
0.004


iprovalicarb
0.004


I-1 + fludioxonil +
1 + 0.016 +
250:4:4:1
67
34
33


iprovalicarb
0.016


dodine
0.004


I-1 + fludioxonil +
1 + 0.016 +
63:1:1:16
52
34
18


tolylfluanid
0.016


cymoxanil
0.25


I-4 + boscalid +
4 + 0.25 + 0.25
16:1:1
82
61
21


kresoxim-methyl


metalaxyl
0.25


I-4 +
1 + 0.063 +
1000:63:63:1
53
28
25


kresoxim-methyl +
0.063


orysastrobin


azoxystrobin
0.001


5-component


mixture


I-1 + captan +
0.25 + 0.016 +
63:4:1:1
29


dithianon +
0.004 +


fenpropimorph
0.004


I-1 + dithianon +
1 + 0.016 +
63:1:1:16
55


fenpropimorph +
0.016 + 0.25


flumorph


I-1 + dithianon +
0.25 + 0.004 +
63:1:16:1
32


flumorph +
0.063 +


fluazinam
0.004


flumorph
0.063

0


fluazinam
0.016

0


fenarimol
0.004

6


I-1 + captan +
0.25 + 0.016 +
63:4:1:1:16
47
29
18


dithianon +
0.004 +


fenpropimorph
0.004


flumorph
0.063


I-1 + dithianon +
1 + 0.016 +
63:1:1:16:1
76
55
21


fenpropimorph +
0.016 + 0.25


flumorph


fluazinam
0.016


I-1 + dithianon +
0.25 + 0.004 +
63:1:16:1:1
56
36
20


flumorph +
0.063 +


fluazinam
0.004


fenarimol
0.004









Use Example No. M8
Activity Against Septoria glycines in the Microtiter Test (Septgl)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Septoria glycines was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Septgl





















Effect







calculated


Active



according


compound/active
Concentration

Observed
to Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Binary mixtures







I-1
63

61



16

30



0.25

9



0.063

16


I-4
63

23



16

5


I-2
63

40


boscalid
0.04

9


prochloraz
0.00025

8


dithianon
0.004

3


fenpropimorph
0.25

71


flumorph
16

21


fluazinam
1

24


fenarimol
1

39


iprovalicarb
1

3


cymoxanil
16

27


epoxiconazole
0.063

2


pyraclostrobin
0.016

69


metconazole
0.25

19


metalaxyl
4

18


azoxystrobin
0.016

20


iprodione
1

0


I-1
0.063
16:1
59
24
35


boscalid
0.004


I-1
0.063
250:1 
42
22
20


prochloraz
0.00025


I-1
0.25
63:1
63
12
51


dithianon
0.004


I-1
16
63:1
99
79
20


fenpropimorph
0.25


I-1
63
 4:1
88
69
19


flumorph
16


I-1
63
63:1
96
70
26


fluazinam
1


I-1
63
63:1
97
76
21


fenarimol
1


I-1
63
63:1
88
62
26


iprovalicarb
1


I-1
63
 4:1
97
71
26


cymoxanil
16


I-4
16
250:1 
84
7
77


epoxiconazole
0.063


I-4
16
1000:1 
90
70
20


pyraclostrobin
0.016


I-4
63
250:1 
83
38
45


metconazole
0.25


I-4
63
16:1
95
37
58


metalaxyl
4


I-4
16
1000:1 
51
24
27


azoxystrobin
0.016


I-4
63
63:1
52
23
29


iprodione
1


I-2
63
250:1 
90
51
39


metconazole
0.25


I-2
63
16:1
97
50
47


metalaxyl
4


Ternary mixture


I-1 + epoxiconazole
0.25 + 0.001
250:1 
38


I-1 + kresoxim-methyl
0.063 + 0.004
16:1
55


I-1 + orysastrobin
0.063 + 0.004
16:1
11


I-1 + captan
1 + 0.063
16:1
39


boscalid
0.016

10


prochloraz
0.00025

8


azoxystrobin
0.000063

0


dithianon
0.016

37


chlorothalonil
0.063

6


I-1 + epoxiconazole
0.25 + 0.001
250:1:16
64
45
19


boscalid
0.016


I-1 + kresoxim-methyl
0.063 + 0.004
250:16:1
78
58
20


prochloraz
0.00025


I-1 + orysastrobin
0.063 + 0.004
1000:63:1
38
11
27


azoxystrobin
0.000063


I-1 + captan
1 + 0.063
63:4:1
98
61
37


dithianon
0.016


Quaternary mixture


I-1 + epoxiconazole +
0.25 + 0.001 +
1000:4:1
32


pyraclostrobin
0.00025


I-1 + boscalid +
0.25 + 0.016 +
16:1:1
52


metalaxyl
0.016


I-1 + captan +
1 + 0.063 +
16:1:1
34


mancozeb
0.063


I-1 + captan +
0.25 + 0.016 +
63:4:1
39


dithianon
0.004


I-1 + dithianon +
1 + 0.016 +
63:1:16
72


flumorph
0.25


I-1 + dithianon +
1 + 0.016 +
63:1:1
69


fluazinam
0.016


boscalid
0.016

10


prochloraz
0.001

11


dithianon
0.016

37


fenpropimorph
0.004

1


fluazinam
0.016

7


fenarimol
0.016

11


I-1 + epoxiconazole +
0.25 + 0.001 +
1000:4:1:63
77
40
37


pyraclostrobin
0.00025


boscalid
0.016


I-1 + boscalid +
0.25 + 0.016 +
250:16:16:1
79
58
21


metalaxyl
0.016


prochloraz
0.001


I-1 + captan +
1 + 0.063 +
63:4:4:1
100
58
42


mancozeb
0.063


dithianon
0.016


I-1 + captan +
0.25 + 0.016 +
63:4:1:1
76
40
36


dithianon
0.004


fenpropimorph
0.004


I-1 + dithianon +
1 + 0.016 +
63:1:16:1
92
74
18


flumorph
0.25


fluazinam
0.016


I-1 + dithianon +
1 + 0.016 +
63:1:1:1
90
72
18


fluazinam
0.016


fenarimol
0.016


5 component


mixture


I-1 + captan +
0.25 + 0.016 +
63:4:4:1
39


mancozeb +
0.016 +


dithianon
0.004


I-1 + dithianon +
1 + 0.016 +
63:1:1:16
25


fenpropimorph +
0.016 + 0.25


flumorph


fenpropimorph
0.004

1


fluazinam
0.016

7


I-1 + captan +
0.25 + 0.016 +
63:4:4:1:1
67
40
27


mancozeb +
0.016 +


dithianon
0.004


fenpropimorph
0.004


I-1 + dithianon +
1 + 0.016 +
63:1:1:16:1
58
30
28


fenpropimorph +
0.016 + 0.25


flumorph


fluazinam
0.016









Use Example No. M9
Activity Against Colleotrichum Truncatum in the Microtiter Test (Colltr)

The stock solution was pipetted into a microtiter plate (MTP) and diluted to the stated active compound concentration with water. An aqueous malt-based spore suspension of Colleotrichum truncatum was then added. The plates were placed in a water vapor-saturated chamber at temperatures of 18° C. Using an absorption photometer, the MTPs were measured at 405 nm on day 7 after the inoculation.


Colltr





















Effect



Active



calculated


compound/active
Concentration

Observed
according to


compound mixture
(ppm)
Mixture
effect
Colby (%)
Synergism




















Binary mixtures







I-1
63

30



16

6



1

5


I-2
63

38


I-4
63

26


kresoxim-methyl
4

37



1

27


azoxystrobin
0.063

46


dithianon
0.016

3


epoxiconazole
0.25

7


orysastrobin
4

29


chlorothalonil
0.25

23


iprodion
1

9


pyraclostrobin
0.016

7


I-1
16
16:1
53
32
21


kresoxim-methyl
1


I-1
63
1000:1 
99
62
37


azoxystrobin
0.063


I-1
1
63:1
52
7
45


dithianon
0.016


I-2
63
16:1
100
61
39


kresoxim-methyl
4


I-4
63
250:1 
95
31
64


epoxiconazole
0.25


I-4
63
16:1
98
53
45


kresoxim-methyl
4


I-4
63
16:1
100
47
53


orysastrobin
4


I-4
63
250:1 
98
43
55


chlorothalonil
0.25


I-4
63
63:1
75
33
42


iprodione
1


Ternary mixtures


I-2 + boscalid
63 + 4

27


I-4 + boscalid
63 + 4

52


kresoxim-methyl
4

37


pyraclostrobin
0.016

7


I-2 + boscalid
63 + 4
16:1:1
100
54
46


kresoxim-methyl
4


I-4 + boscalid
63 + 4
16:1:1
100
70
30


kresoxim-methyl
4


Quaternary mixtures


I-4 + epoxiconazole +
63 + 0.25 + 4
250:1:16
57


boscalid


I-4 + epoxiconazole +
63 + 0.25 +
250:1:1
35


metconazole
0.25


I-4 + boscalid +
63 + 4 + 0.25
250:16:1
67


metconazole


kresoxim-methyl
4

37


metconazole
0.25

5


I-4 + epoxiconazole +
63 + 0.25 + 4
250:1:16:1
97
59
38


boscalid


metconazole
0.25


I-4 + epoxiconazole +
63 + 0.25 +
250:1:1:16
100
59
41


metconazole
0.25


kresoxim-methyl
4


I-4 + boscalid +
63 + 4 + 0.25
250:16:1:16
100
79
21


metconazole


kresoxim-methyl
4


5-component


mixture


I-1 + captan +
4 + 0.25 + 0.25 +
63:4:4:1
25


mancozeb +
0.063


dithianon


fenpropimorph
0.063

5


I-1 + captan +
4 + 0.25 + 0.25 +
63:4:4:1:1
86
29
57


mancozeb +
0.063


dithianon


fenpropimorph
0.063









The measured parameters were in each case compared to the growth of the active compound-free control variant and the fungus- and active compound-free blank value to determine the relative growth in % of the pathogens in the individual active compounds. The determined values for the % of relative growth were initially converted into a mean value and then converted into efficacies in % of the active compound-free control variant. An efficacy of 0 is the same growth as in the active compound-free control variant, an efficacy of 100 is 0% growth. The expected efficacies for active compound combinations were determined using Colby's formula (Colby, S. R. “Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds, 15, pp. 20-22, 1967) and compared to the observed efficacies.


The test results show that, by virtue of the synergism, the mixtures according to the invention were considerably more effective than had been calculated beforehand using Colby's formula.


Greenhouse
Active Compound Preparation

The active compounds were prepared separately or jointly as a stock solution with 25 mg of active compound which was made up to 10 ml using a mixture of acetone and/or DMSO and the emulsifier Wettol EM 31 (wetting agent having emulsifying and dispersing action based on ethoxylated alkylphenols) in a volume ratio of solvent:emulsifier of 99:1. The mixture was then made up with water to 100 ml. This stock solution was diluted with the solvents/emulsifier/water mixture described to give the active compound concentrations stated below. Alternatively, the active compounds were used as commercial finished formulation and diluted with water to the stated active compound concentration. The active compound orysastrobin was used as a commercially available formulation, and diluted with water with reference to the active compound.


The visually determined values for the percentage of infected leaf area were initially converted into a mean value and then converted into efficacies in % of the untreated control. An efficacy of 0 means the same degree of infection as in the untreated control, an efficacy of 100 means 0% infection. The expected efficacies for the active compound combinations were determined using Colby's formula (Colby, S. R. “Calculating synergistic and antagonistic responses of herbicide combinations”, Weeds, 15, pp. 20-22, 1967) and compared to the observed efficacies.


Use Example No. G1
Activity Against Late Blight of Tomato Caused by Alternaria solani (Alteso P1)

Leaves of potted tomato plants were sprayed to run off point with an aqueous suspension having the active compound concentration stated below. The next day, the leaves were inoculated with an aqueous spore suspension of Alternaria solani in a 2% biomalt solution. The plants were then placed in a water vapor-saturated chamber at temperatures between 18 and 20° C. After 5 days, the disease on the untreated but infected control plants had developed to such an extent that the infection could be determined visually in %.


Alteso P1





















Effect



Active



calculated



compound/active
Concentration

Observed
according to



compound mixture
(ppm)
Mixture
effect
Colby (%)
Synergism







Untreated control


80%







infection


Ternary mixtures


I-1 + boscalid
0.25 + 1
1:4
44


I-1 + pyraclostrobin
0.25 + 0.25
1:1
14


I-1 + kresoxim-methyl
0.25 + 16
 1:64
15


mancozeb
16

0


benalaxyl
16

2


I-1 + boscalid
0.25 + 1
63:16:1
80
44
36


mancozeb
16


I-1 + pyraclostrobin
0.25 + 0.25
1:1:63
44
14
30


mancozeb
16


I-1 + kresoxim-methyl
0.25 + 16
1:63:63
57
17
40


benalaxyl
16


Quaternary mixtures


I-2 +
0.25 + 0.25 +
1:1:1
20


kresoxim-methyl +
0.25


pyraclostrobin


I-2 +
0.25 + 0.25 + 1
1:1:4
68


kresoxim-methyl +


boscalid


mancozeb
16

0


I-2 +
0.25 + 0.25 +
1:1:1:63
51
20
31


kresoxim-methyl +
0.25


pyraclostrobin


mancozeb
16


I-2 +
0.25 + 0.25 + 1
1:1:4:63
91
68
23


kresoxim-methyl +


boscalid


mancozeb
16









Use Example No. G2
Activity Against Grey Mold on Bell Pepper Leaves Caused by Botrytis cinerea, 1 Days Protective Application (Botrci P1)

Bell pepper seedlings were, after 2-3 leaves were well developed, sprayed to run off point with an aqueous suspension having the active compound concentrations stated below. The next day, the treated plants were inoculated with a spore suspension of Botrytis cinerea in a 2% biomalt solution. The test plants were then placed in a dark climatized chamber at 22 to 24° C. and high atmospheric humidity. After 5 days, the extent of the fungal infection on the leaves could be determined visually in %.


Botrci P1

















Active



Effect



compound/



calculated


active



according


compound
Concentration

Observed
to Colby
Syner-


mixture
(ppm)
Mixture
effect
(%)
gism




















Untreated


80%




control


infection


Binary


mixture


I-1
4

2


mancozeb
250

15


tebuconazole
1

0


I-1
4
1:63
51
17
34


mancozeb
250


I-1
4
4:1 
44
2
42


tebuconazole
1









Use Example No. G3
Protective Activity Against Puccinia Recondite on Wheat (Brown Rust of Wheat) (Puccrt P1)

Leaves of potted wheat seedlings were sprayed to run off point with an aqueous suspension having the active compound concentration stated below. The next day, the treated plants were inoculated with a spore suspension of brown rust of wheat (Puccinia recondita). The plants were then placed in a chamber of high atmospheric humidity (90 to 95%) at 20 to 24° C. for 24 hours. During this time, the spores germinated and the germ tubes penetrated into the leaf tissue. The next day, the test plants were returned to the greenhouse and cultivated at temperatures between 20 and 24° C. and 65 to 70% relative atmospheric humidity for a further 7 days. The extent of rust fungus development on the leaves was then determined visually.


Puccrt P1





















Effect







calculated


Active



according to


compound/active
Concentration

Observed
Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Untreated control


90%







infection


Binary mixtures


I-1
0.25

13


pyraclostrobin
0.25

29


boscalid
1

13


I-1
0.25
1:1
62
39
23


pyraclostrobin
0.25


I-1
0.25
1:4
62
25
37


boscalid
1


Quaternary mixtures


I-1 +
0.063 + 0.016 +
4:1:4
18


tebuconazole +
0.063


prochloraz


I-8 +
0.063 + 0.063 +
1:1:4
18


kresoxim-methyl +
0.25


boscalid


captan
0.25

6


mancozeb
4

5


I-1 +
0.063 + 0.016 +
4:1:4:16
41
22
19


tebuconazole +
0.063


prochloraz


captan
0.25


I-8 +
0.063 + 0.063 +
1:1:4:63
62
22
40


kresoxim-methyl +
0.25


boscalid


mancozeb
4









Use Example No. G4
Curative Activity Against Soybean Rust Caused by Phakopsora Pachyrhizi (Phakpa K4)

Leaves of potted soybean seedlings were inoculated with a spore suspension of soybean rust (Phakpsora pachyrhizi). The pots were then placed in a chamber of high atmospheric humidity (90 to 95%) and 20 to 24° C. for 24 hours. During this time, the spores germinated and the germ tubes penetrated into the leaf tissue. The infected plants were then cultivated further in a greenhouse at temperatures between 23 and 27° C. and 60 to 80% relative atmospheric humidity. After three days, the plants were sprayed to run off point with the active compound solution described above at the active compound concentration stated below. After the spray coating had dried on, the test plants were cultivated in a greenhouse at temperatures between 23 and 27° C. and 60 to 80% relative atmospheric humidity for a further 10 days. The extent of the rust fungus development on the leaves was then determined visually in %.


Phakpa K4





















Effect







calculated


Active



according to


compound/active
Concentration

Observed
Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Untreated control


90%







infection


Binary mixtures


I-1
0.25

24



0.063

6


boscalid
0.25

2


captan
1

0


I-1
0.063
1:4
49
8
41


boscalid
0.25


I-1
0.25
1:4
47
24
23


captan
1


Ternary mixtures


I-1 + prochloraz
1 + 1
1:1
47


I-1 + fluoxastrobin
1 + 1
1:1
49


I-1 + tebuconazole
0.25 + 0.063
4:1
49


captan
4

0



1

0


prochloraz
1

7


I-1 + prochloraz
1 + 1
1:1:4
71
47
24


captan
4


I-1 + fluoxastrobin
1 + 1
1:1:1
87
52
35


prochloraz
1


I-1 + tebuconazole
0.25 + .0063
4:1:16
76
49
27


captan
1


Quaternary mixtures


I-4 +
1 + 1 + 1
1:1:1
60


kresoxim-methyl +


pyraclostrobin


I-4 +
1 + 1 + 4
1:1:4
53


kresoxim-methyl +


boscalid


I-4 + pyraclostrobin +
1 + 1 + 4
1:1:4
62


boscalid


I-8 +
0.25 + 0.25 + 1
1:4:4
26


kresoxim-methyl +


boscalid


I-8 + pyraclostrobin +
1 + 1 + 4
1:1:4
53


boscalid


mancozeb
63

0



16

7


fluoxastrobin
1

15


I-4 +
1 + 1 + 1
1:1:1:63
84
60
24


kresoxim-methyl +


pyraclostrobin


mancozeb
63


I-4 +
1 + 1 + 4
1:1:4:63
83
53
30


kresoxim-methyl +


boscalid


mancozeb
63


I-4 + pyraclostrobin +
1 + 1 + 4
1:1:4:63
88
62
26


boscalid


mancozeb
63


I-4 +
1 + 1 + 1
1:1:1:1
90
66
24


kresoxim-methyl +


pyraclostrobin


fluoxastrobin
1


I-4 +
1 + 1 + 4
1:1:4:1
89
60
29


kresoxim-methyl +


boscalid


fluoxastrobin
1


I-8 +
0.25 + 0.25 + 1
1:1:4:63
53
32
21


kresoxim-methyl +


boscalid


mancozeb
16


I-8 + pyraclostrobin +
1 + 1 + 4
1:1:4:63
84
53
31


boscalid


mancozeb
63









Use Example No. G5
Protective Activity Against Septoria Leaf Blotch of Wheat Caused by Septoria tritici (Septtr P1)

Leaves of potted wheat seedlings were sprayed to run off point with an aqueous suspension having the active compound concentration stated below. 24 hours after the spray coating had dried on, they were inoculated with an aqueous spore suspension of Septoria tritici. The test plants were then placed in a greenhouse at temperatures between 18 and 22° C. and a relative atmospheric humidity close to 100% for four days and then at temperatures between 18 and 22° C. and an atmospheric humidity of about 70%. After 21 days, the extent of the development of the disease was determined visually in % infection of the total leaf area.


Septtr P1





















Effect







calculated


Active



according to


compound/active
Concentration

Observed
Colby


compound mixture
(ppm)
Mixture
effect
(%)
Synergism




















Untreated control


80%







infection


Binary mixtures


I-1
4

41


benalaxyl
250

0


I-1
4
 1:63
63
41
22


benalaxyl
250


Ternary mixtures


I-1 + epoxiconazole
0.25 + 0.25
1:1
19


I-1 + fluoxastrobin
1 + 1
1:1
14


I-1 + prochloraz
4 + 4
1:1
10


pyraclostrobin
0.25

57


tebuconazol
0.25

0


captan
16

0


prochloraz
1

0


I-1 + epoxiconazole
0.25 + 0.25
1:1:1
91
65
26


pyraclostrobin
0.25


I-1 + fluoxastrobin
1 + 1
4:4:1
61
14
47


Tebuconazol
0.25


I-1 + prochloraz
4 + 4
1:1:4
53
10
43


captan
16


I-1 + fluoxastrobin
1 + 1
1:1:1
66
14
52


prochloraz
1


Quaternary mixtures


I-1 +
0.063 + 4 + 4
1:63:63
45


kresoxim-methyl +


benalaxyl


I-1 +
0.063 + 4 + 4
1:63:63
9


kresoxim-methyl +


chlorothalonil


I-4 +
1 + 1 + 4
1:1:4
57


kresoxim-methyl +


boscalid


I-8 +
0.25 + 0.25 + 1
1:1:4
16


kresoxim-methyl +


boscalid


chlorothalonil
4

0


cyprodinil
4

0


mancozeb
63

18



16

3


I-1 +
0.063 + 4 + 4
1:63:63:63
77
45
32


kresoxim-methyl +


benalaxyl


chlorothalonil
4


I-1 +
0.063 + 4 + 4
1:63:63:63
50
9
41


kresoxim-methyl +


chlorothalonil


cyprodinil
4


I-4 +
1 + 1 + 4
1:1:4:63
85
64
21


kresoxim-methyl +


boscalid


mancozeb
63


I-8 +
0.25 + 0.25 + 1
1:1:4:63
44
18
26


kresoxim-methyl +


boscalid


mancozeb
16









The test results show that, by virtue of the synergism, the mixtures according to the invention are considerably more effective than had been calculated using Colby's formula.

Claims
  • 1-14. (canceled)
  • 15. A fungicidal mixture comprising 1) a compound of the general formula I
  • 16. The mixture of claim 15, further comprising a second compound II selected from the group consisting of compounds of groups A to I, with the proviso that the two compounds II are not identical.
  • 17. The fungicidal mixture of claim 15, wherein the compound of formula I is selected from the group consisting of wherein I-1 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is SH;I-2 A is 3,4-difluorophenyl, B is 2-methylphenyl, and D is SH;I-3 A is 3,4-difluorophenyl, B is 2-chlorophenyl, and D is SH;I-4 A is 3,4-difluorophenyl, B is 2-trifluoromethylphenyl, and D is SH;I-5 A is 3,4-difluorophenyl, B is 2-chlorophenyl, and D is SMe;I-6 A is 2,4-difluorophenyl, B is 2-fluorophenyl, and D is SMe;I-7 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is SMe;I-8 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is S—CN; andI-9 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is S—CO—OCH3.
  • 18. The fungicidal mixture of claim 15 wherein the compound of formula I is selected from the group consisting of: I-1 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-2 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-o-tolyloxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol;I-4 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-(2-trifluoromethylphenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-8 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole; andI-9 S-{2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazol-3-yl}methyl thiocarbonate.
  • 19. The fungicidal mixture of claim 15 wherein the compound II is selected from the group consisting of: II-1 epoxiconazole,II-2 metconazole,II-3 tebuconazole,II-4 fluquinconazole,II-5 flutriafol,II-6 triticonazole,II-7 prothioconazole,II-8 kresoxim-methyl,II-9 pyraclostrobin,II-10 orysastrobin,II-11 dimethomorph,II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine,II-13 pyrimethanil,II-14 metalaxyl,II-15 fenpropimorph,II-16 dodemorph,II-17 iprodione,II-18 mancozeb,II-19 metiram,II-20 thiophanate methyl,II-21 chlorothalonil,II-22 metrafenone,II-23 bixafen,II-24 boscalid,II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,II-26 sedaxane,II-27 isopyrazam,II-28 fluopyram, andII-29 penflufen.
  • 20. The fungicidal mixture of claim 15 where the mixture is selected from the group consisting of the following binary mixtures: I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and boscalid II-24;I-8 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole and chlorothalonil II-21;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and orysastrobin II-10;I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and pyraclostrobin II-9;I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and orysastrobin II-10;I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and chlorothalonil II-21;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and chlorothalonil II-21;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24;I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24; andI-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and epoxiconazole II-1.
  • 21. The fungicidal mixture of claim 16 wherein the second compound II is selected from the group consisting of: II-1 epoxiconazole,II-2 metconazole,II-3 tebuconazole,II-6 triticonazole,II-7 prothioconazole,II-8 kresoxim-methyl,II-9 pyraclostrobin,II-11 dimethomorph,II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine,II-13 pyrimethanil,II-14 metalaxyl,II-15 fenpropimorph,II-18 mancozeb,II-19 metiram,II-20 thiophanate methyl,II-21 chlorothalonil,II-22 metrafenone,II-23 bixafen,II-24 boscalid,II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,II-26 sedaxane,II-27 isopyrazam,II-28 fluopyram, andII-29 penflufen.
  • 22. The fungicidal mixture of claim 15 wherein the two compounds are present in a weight ratio of from 100:1 to 1:100.
  • 23. The fungicidal mixture of claim 16 wherein the two compounds II are present in a weight ratio of from 100:1 to 1:100.
  • 24. An agrochemical composition comprising a solvent or a solid carrier and a fungicidal mixture of claim 15.
  • 25. A seed treated with a fungicidal mixture of claim 15.
  • 26. A method for controlling phytopathogenic fungi comprising treating fungi or the materials, plants, the soil or seed to be protected from fungal attack with an effective amount of a fungicidal mixture of claim 15.
  • 27. The method of claim 26, wherein the mixture further comprises a second compound II selected from the group consisting of compounds of groups A to I, with the proviso that the two compounds II are not identical.
  • 28. The method of claim 26, wherein the compound of formula I is selected from the group consisting of I-1 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is SH;I-2 A is 3,4-difluorophenyl, B is 2-methylphenyl, and D is SH;I-3 A is 3,4-difluorophenyl, B is 2-chlorophenyl, and D is SH;I-4 A is 3,4-difluorophenyl, B is 2-trifluoromethylphenyl, and D is SH;I-5 A is 3,4-difluorophenyl, B is 2-chlorophenyl, and D is SMe;I-6 A is 2,4-difluorophenyl, B is 2-fluorophenyl, and D is SMe;I-7 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is SMe;I-8 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is S—CN; andI-9 A is 2,4-difluorophenyl, B is 2-chlorophenyl, and D is S—CO—OCH3.
  • 29. The method of claim 26, wherein the compound of formula I is selected from the group consisting of: I-1 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-2 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-o-tolyloxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol;I-4 2-[rel (2R,3S)-2-(3,4-difluorophenyl)-3-(2-trifluoromethylphenyl)oxiranylmethyl]-2,4-dihydro-[1,2,4]triazole-3-thione;I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole;I-8 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole; andI-9 S-{2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazol-3-yl} methyl thiocarbonate.
  • 30. The method of claim 26, wherein the compound II is selected from the group consisting of: II-1 epoxiconazole,II-2 metconazole,II-3 tebuconazole,II-4 fluquinconazole,II-5 flutriafol,II-6 triticonazole,II-7 prothioconazole,II-8 kresoxim-methyl,II-9 pyraclostrobin,II-10 orysastrobin,II-11 dimethomorph,II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine,II-13 pyrimethanil,II-14 metalaxyl,II-15 fenpropimorph,II-16 dodemorph, II-17 iprodione,II-18 mancozeb,II-19 metiram,II-20 thiophanate methyl,II-21 chlorothalonil,II-22 metrafenone,II-23 bixafen,II-24 boscalid,II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,II-26 sedaxane,II-27 isopyrazam,II-28 fluopyram, andII-29 penflufen.
  • 31. The method of claim 26 where the mixture is selected from the group consisting of the following binary mixtures: I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and boscalid II-24;I-8 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-thiocyanato-1H-[1,2,4]triazole and chlorothalonil II-21;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and orysastrobin II-10;I-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and pyraclostrobin II-9;II-3 2-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-2H-[1,2,4]triazole-3-thiol and orysastrobin II-10;I-5 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and chlorothalonil II-21;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and chlorothalonil II-21;I-6 1-[rel (2R,3S)-2-(2,4-difluorophenyl)-3-(2-fluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(3,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24;I-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and boscalid II-24; andI-7 1-[rel (2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxiranylmethyl]-5-methylsulfanyl-1H-[1,2,4]triazole and epoxiconazole II-1.
  • 32. The method of claim 27, wherein the second compound II is selected from the group consisting of: II-1 epoxiconazole,II-2 metconazole, 11-3 tebuconazole,II-6 triticonazole,II-7 prothioconazole,II-8 kresoxim-methyl,II-9 pyraclostrobin,II-11 dimethomorph,II-12 5-ethyl-6-octyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ylamine,II-13 pyrimethanil,II-14 metalaxyl,II-15 fenpropimorph,II-18 mancozeb,II-19 metiram,II-20 thiophanate methyl,II-21 chlorothalonil,II-22 metrafenone,II-23 bixafen,II-24 boscalid,II-25 N-(3′,4′,5′-trifluorobiphenyl-2-yl)-3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxamide,II-26 sedaxane,II-27 isopyrazam,II-28 fluopyram, andII-29 penflufen.
  • 33. The method of claim 26 wherein the two compounds are present in a weight ratio of from 100:1 to 1:100.
  • 34. The method of claim 27 wherein the two compounds II are present in a weight ratio of from 100:1 to 1:100.
Priority Claims (2)
Number Date Country Kind
09162818.0 Jun 2009 EP regional
09175202.2 Nov 2009 EP regional
PCT Information
Filing Document Filing Date Country Kind 371c Date
PCT/EP2010/058341 6/15/2010 WO 00 12/13/2011